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Abstract
In the year 2000, the United Kingdom government produced a report called 
“Organisation With a Memory” in response to the problem of safety in the 
healthcare sector and committed to reduce the number of serious medication 
errors. Whilst patient safety research in other healthcare settings such as the 
primary and secondary care has been under way for the past two decades, 
patient safety research in care homes has largely been neglected. The 
increasing age of the general population in the UK also motivates the need to 
understand the problem of patient safety, particularly medication safety in the 
care home. The review of the care home medication safety literature found that it 
was difficult to construct a view of the care home medication system and the 
extent of the problem of medication errors in care homes in England.
This thesis presents the findings of the first large-scale epidemiological study of 
the prevalence and types of medication errors in England that was conducted as 
part of a wider study. A total of 31 residents in seven care homes were studied 
for prescribing, monitoring, dispensing and medication administration errors. 
Each type of error was detected using different methods. The study found six in 
ten care home residents experienced at least one medication error. Dispensing 
and medication administration errors were the most common medication errors 
identified in the study. To understand the causes of errors and derive 
recommendations for system improvements, an established systems analytical 
framework. The London Protocol, was used. However, the limitations of the 
analytical framework particularly the lack of context and relationships between 
the error contributory factors in the framework led to the exploration of other 
methods for analysing work systems.
The feasibility of a commonly used task analysis method, hierarchical task 
analysis (HTA) to analyse complex healthcare systems was explored. An HTA of 
medication provision in a hospital was performed. However, it was difficult to
represent the complexities and variability of medication provision in the hospital 
using the HTA. A formative approach to analysing complex systems was 
advocated and the potential of cognitive work analysis (CWA) was explored. 
Work domain analysis is the first of five analysis phases in CWA and was used to 
analyse the care home medication system for the first time. The resultant model 
of the care home medication system, the abstraction hierarchy (AH), provided a 
systems view of the whole care home medication system. It was the first time 
that the care home medication system was represented this way. The AH 
provided a knowledge base of the care home medication system and was also 
used as an error analytical framework. A novel method for analysing the errors 
was developed. The same medication errors identified in the epidemiological 
study was analysed using the AH.
It was the first time that two different methods, namely The London Protocol and 
the AH were used to analyse the same care home medication errors. A 
comparison of their advantages and disadvantages was made and the AH was 
found to be a more suitable method for analysing errors than The London 
Protocol because the means-ends links in the AH guided the analyst to identify 
different work categories that contributed to the medication errors. The AH also 
provided information about the work system that was important for analysis and 
the generation and evaluation of recommendations for system improvement. 
Finally, the thesis discussed future research and developments relating to error 
identification and analysis, methods for understanding complex healthcare 
systems and the use of CWA in healthcare.
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Chapter 1 : Medication safety in care homes
1.1 Introduction
This first chapter of the thesis describes and brings together the ideas that 
form the basis of this research: those of medication safety and care 
homes. First, the initial motivations for this research are presented. Then, 
care homes in England are introduced. From a human factors 
perspective, the characteristics of care homes helped inform the design of 
a research study investigating the problem of medication safety. A review 
of the current care home literature was undertaken to understand what 
has been studied. Gaps in the current literature were identified and these 
informed the research goals of the thesis.
1.2 Motivations for research
In the year 2000, the United Kingdom (UK) government produced a report 
called “Organisation With a Memory” in response to the problem of safety 
in the healthcare sector (Department of Health 2000a). The report, 
produced by an expert group, highlighted that 10% of admissions to 
National Health Service (NHS) hospitals were a result of adverse events 
and half of these events that had resulted in patient harm could have been 
prevented (DH 2000a). The cost was an estimated £2 billion a year in 
additional hospital stays alone, without taking into account any human or 
wider economic costs (DH 2000a). The government committed to reduce 
the number of serious medication errors and this commitment was 
highlighted in one of the core principles of the NHS, to work continuously 
to improve service quality and to minimise errors (DH 2000b). More 
recently in 2004, the government published a report called “Building A 
Safer NHS for Patients -  Improving Medication Safety” that highlighted the
need to explore the causes and frequency of medication errors (DH & 
Smith 2004). The report identified different types of medication errors that 
were relevant to the care homes setting.
Accompanying these reports, the National Service Framework for Older 
People highlighted the specific needs of the elderly (DH 2001a). The 
older population generally has multiple healthcare problems requiring 
services from different healthcare professionals. As the life expectancy of 
the population increases, the older population will also increase in size. 
Hence, the need to meet the increasing demand for healthcare services is 
evident.
Care homes in England are inspected by an independent body called the 
Commission for Social Care Inspection (CSCI) against national minimum 
standards (NMS) that are determined by the government. “Handled with 
care?” published by the CSCI in 2006 reported that despite slight 
improvements in the overall performance in care homes, nearly half of all 
nursing and care homes still failed to meet the NMS on managing 
medicines. This report was produced two years after the first report in 
2004 that highlighted poor performance regarding the giving, handling, 
storage and recording of medication (CSCI 2006a).
The motivations and drivers for research into medication safety in care 
homes are as follows: the current problem of safety in the healthcare 
sector, the government's commitment to reduce medication errors in 
healthcare, the increasing older population and the ongoing difficulties that 
care homes face to meet the NMS for managing medicines.
1.3 Overview of care homes
As at 31 March 2007, there were around 442,000 care home adult places 
available in registered care homes in England (CSCI 2008). In this 
section, an overview of care homes is provided. First, the definition of a 
care home is presented. Care home residents have different needs 
depending on their medical conditions, physical and cognitive abilities. 
Hence, different types of care homes have been set up to meet the 
different needs of care home residents. The profiles of care home 
residents are then described, together with the reasons and sources of 
admissions. One of the primary tasks in the care home medication 
system is the administration of medication to care home residents. This is 
described in brief. Care home residents with different needs require the 
services of different healthcare providers. These healthcare providers are 
described. Finally, the laws and regulations surrounding the running of 
care homes are discussed.
1.3.1 Definition of a care home
According to the Care Standards Act 2000 Part 1 of Section 3 (DH 2000c), 
a care home is an establishment that provides accommodation, together 
with nursing or personal care, for any of the following persons: 
persons who are or have been ill 
persons who have or have had a mental disorder 
III persons who are disabled or infirm
iv persons who are or have been dependent on alcohol or
drugs
Care homes do not include hospitals, independent clinics or children's 
homes.
Before the Care Standards Act 2000 was implemented in April 2002, there 
was a defined difference between the two main types of care homes:
residential and nursing homes. Now, all homes are termed ‘care’ homes, 
with the distinction that nursing care homes are registered to provide 
nursing care on a 24-hour basis. The terms ‘residential’ and ‘nursing’ 
home have also ceased to apply following the implementation of the Care 
Standards Act. If a care home has different wings for nursing and 
personal care that together form one registered premise, the entire site is 
regarded as a care home with nursing (CPPE 2004).
Care homes vary in size from small informal units consisting of a few 
residents to large purpose-built establishments with hundreds of residents. 
Care homes are owned by various organisations such as small private 
companies, business consortia, housing associations, local authorities, 
charitable trusts and voluntary organisations. Care homes can generally 
be categorised into the following (CPPE 2004):
i Care homes for younger adults (18-65 years) providing personal 
care.
ii Care homes for older people (over 65 years) providing personal care.
iii Care homes for younger adults (18-65 years) providing personal and 
nursing care. These homes offer 24-hour nursing care.
iv Care homes for older people (over 65 years) providing personal and 
nursing care. These care homes provide 24-hour nursing care.
Most care homes for older people will have a number of residents who 
have mental health problems such as dementia, depression and anxiety. 
There are also care homes that provide specialist care services for 
residents such as care homes for people with dementia.
The majority of care settings are care homes providing personal care only. 
They provide accommodation, meals and personal care like assistance 
with eating and washing. Care homes with nursing provide the same 
services as care homes providing personal care only, but in addition, they
provide 24-hour nursing care where at least one registered nurse is on 
duty in the care home. For both types of care homes, there is a 
requirement for 50% of all care home and agency staff to have National 
Vocational Qualifications (NVQ) in care at level 2 or equivalent (DH 2002).
The focus of this research was care homes providing nursing and/or 
personal care to older people.
1.3.2 Care home residents
People who live in care homes are commonly described as service users, 
residents or clients. In this thesis, “care home residents” or “residents” is 
preferred and used.
The definition of care homes suggests that care home residents vary in 
their healthcare problems and needs. Although residents’ healthcare 
needs may differ depending on the reason(s) for admission, they are 
usually vulnerable and in need of extra care, be it personal and/or nursing 
care. Most care home residents are older people who are frail (aged over 
65 years). A smaller proportion are younger residents aged 18 to 65 
years. Care home residents often present with physical and/or mental 
health problems, learning disabilities and/or physical disabilities (CPPE 
2004). They are also likely to suffer from specific types of problems. For 
example, older frail residents are generally likely to suffer falls and 
accidents (often due to medication), osteoporosis, incontinence and 
pressure sores, while older residents with mental health conditions may 
suffer from anxiety, depression and dementia (CPPE 2004).
For the majority of care home residents, the care home may be the final 
place of residence in their life. However, with the current government 
health plan to move patients closer to their homes, the types of services
provided in care homes have changed to cater to the different needs of 
care home residents. As part of the Department of Health's programme to 
promote independence and improve the quality of life of older people, 
intermediate care has been introduced as a core element. Intermediate 
care can be provided in different forms. In care homes, this is called 
‘residential rehabilitation’ which is a short-term programme of therapy and 
enablement for patients who are not ill enough to be in hospital but still 
cannot manage on their own at home (DM 2001b). Care homes, usually 
those providing nursing care, provide a few beds for these patients who 
are typically NHS-funded (OPPE 2007). Some care homes have residents 
requiring palliative care. Care home residents, particularly the elderly may 
require the services of community mental health teams and these teams 
may be based in care homes (CPPE 2007).
1.3.3 Reasons for admission
There is no one typical condition that triggers admission to a care home. 
Generally, residents have difficulty performing particular activities of daily 
living. Table 1.1 presents the reasons older people are admitted to a care 
home, taken from a longitudinal survey published by The Office of Fair 
Trading (OFT 2005). More than one reason for admission may be given in 
the survey and the OFT found that the most common reason for 
admission was a problem with physical health. Although reasons such as 
fear of being the victim of crime, abuse, loneliness and isolation and 
homelessness are less common, these show, in addition to the complex 
physical and mental health problems, the social and emotional aspects of 
providing care to care home residents. Their complex needs require 
specialist skills by different healthcare practitioners. The research was 
conducted more than a decade ago in 1995-96 and there have been no 
more recent findings.
Table 1.1 Reasons for admission to care homes (OFT 2005)
Reasons for admission Percentage (%)
Physical health problems 69
Mental health problems 43
Physical disablement 42
Stress on carers 38
Lack of motivation 22
Present home physically unsuitable 15
Family breakdown (including loss of carer) 8
Need for rehabilitation 6
Fear of being the victim of crime 4
Abuse 2
Loneliness and isolation 2
Homelessness 1
Since the survey was conducted, the English healthcare system has been 
moving towards providing healthcare in the community and a certain 
number of beds in care homes have been allocated as intermediate care 
beds (briefly explained in section 1.3.2). The CSCI reported temporary 
admissions to care homes with nursing have increased year on year from 
2003-04 to 2005-06 but there has been a yearly decline in the permanent 
admission (nursing and personal care) and temporary admission (personal 
care) (CSCI 2006b). This suggests that the reasons for admission are 
changing with increased need for respite and intermediate care.
The reported reasons for care home admission reflect the complex health 
and social care needs of care home residents. It is not unusual for 
residents with a wide range of healthcare needs to be placed in the same 
care home. This highlights the need for wide ranging staff skill sets and 
expertise for the provision of healthcare to residents. It also suggests that 
effective co-ordination between different healthcare professionals is 
required to ensure optimal provision of care to care home residents.
1.3.4 Sources of admission
In the report produced by the OFT (2005), more than half (52%) of care 
home admissions were found to be from hospitals. This is not surprising 
since the most common reasons for admission into care homes were 
found to be physical and mental health problems (as discussed in section 
1.3.3). Another 29% of residents were admitted from their own homes 
(OFT 2005). Care home residents may also be transferred from another 
care home (13%) for various reasons (OFT 2005).
The large proportion of residents admitted from the hospital coupled with 
physical and mental health problems as the most common reasons for 
care home admissions clearly indicate that care homes deal with 
vulnerable groups of people. Individually and collectively, care home 
residents have specific healthcare needs that require a range of skill sets 
and expertise that can rarely be met solely by care home staff. Expertise 
and skills from other healthcare settings are essential to meet the complex 
demands and needs of vulnerable care home residents.
1.3.5 Medication administration in care homes
In care homes providing personal care, staff members who administer 
medications must be suitably trained and competent. The NMS (DH 
2002) published by the Department of Health requires them to have:
■ a basic knowledge of how medicines are used and how to 
recognise and deal with problems in use
■ the principles behind all aspects of the care home's policy on 
medication handling and record-keeping
There are some medications that need to be administered by specialised 
techniques such as through percutaneous endoscopic gastrostomy (PEG) 
tubes, recta I ly such as rectal diazepam for epileptic fits, injections such as 
insulin for diabetic residents and oxygen. These are usually administered
by the community or district nurse but can be delegated to care home staff 
members provided the community or district nurse trains the relevant care 
staff and is satisfied that they are competent to carry out the task. This 
training needs to be documented and regular refresher courses should 
also be in place. The community or district nurse however remains 
responsible for the delegated duty (NMC 2006).
In care homes providing nursing care, the registered person (usually the 
care home manager) is required to ensure that the nurses they employ 
can provide evidence that they have the competencies to meet the nursing 
care needs of residents (CPPE 2007). The Nursing and Midwifery Council 
Code of Professional Conduct requires each nurse to be individually 
accountable for making sure all medicines are administered correctly 
(NMC 2006). The NMS 9.6 states that “medicines, including Controlled 
Drugs, for service users receiving nursing care, are administered by a 
medical practitioner or registered nurse” (DH 2002). This means that in 
care homes providing both personal and nursing care, staff members who 
are not nurses cannot administer medication to patients who are 
registered to receive nursing care. However, whether care homes provide 
nursing care or not (personal care only); they are subject to the same 
regulations and inspections (CPPE 2007). Hence, care homes need to 
demonstrate that they can meet the need for each resident. Care home 
residents’ needs may change over time and if the care home cannot meet 
their needs, an alternative must be found such as to provide specialist 
nurse services or in extreme circumstances, to move residents to another 
care home that can meet their needs (CPPE 2007).
1.3.6 Care home service providers
The types of care homes, and reasons and sources of care home 
admissions suggest that care home residents have complex healthcare
needs. Typically, individual healthcare practitioners with different 
expertise working in different geographical locations are involved in 
providing services to care home residents. In the care home, nurses and 
care assistants care for residents. Community pharmacies dispense 
medication and General Practitioners (GPs) provide medical services such 
as diagnosing, prescribing and monitoring the effects of medication and 
medical conditions. Some GPs located in rural areas also provide 
dispensing services to residents. In the community setting, community 
nurses, district nurses, specialist nurses, physiotherapists, occupational 
therapists, dieticians, dentists, speech and language therapists could also 
be involved in the resident’s care. As most care home admissions are 
from the hospital, hospital doctors, nurses and pharmacists also play a 
role. The list here is not exhaustive but it highlights the range of 
healthcare professionals that can potentially be involved in caring for care 
home residents. The wide range of skills, knowledge, expertise and 
professional standards of various healthcare professionals make effective 
communication within and among healthcare professionals a challenge.
1.3.7 Regulation in care homes
Before the Care Standards Act was passed in 2000, the range of care 
services was regulated under the Registered Homes Act 1984. The 
Registered Homes Act 1984 was passed to protect the welfare of 
vulnerable adults in residential care in the private sector. The major 
issues that were encountered with the 1984 Act were the inconsistent 
application of regulations and the exemption of some forms of supported 
housing from regulation. The Care Standards Act 2000 was passed to 
ensure that the care of vulnerable people, in different types of supported 
housing including care homes owned by the Local Authority is properly 
regulated.
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At the same time of the passing of the Care Standards Act in 2000, an 
independent regulatory body for social care known as the National Care 
Standards Commission (NCSC) was introduced to monitor care homes on 
a national basis. The NMS of care were also introduced by the 
government. In 2004, the NCSC was replaced by two new inspectorates, 
the Healthcare Commission and the CSCI. The Healthcare Commission 
is the regulatory body for healthcare in England and regulates both the 
NHS and all independent (private and voluntary) healthcare organisations 
in England ensuring that they provide a high standard of care (Healthcare 
Commission 2005). CSCI carry out local inspections of all social care 
organisations (public, private, and voluntary) against national standards 
and publish reports, and register services that meet NMS, among other 
functions (CSCI 2005). By law, care homes are required to register with 
CSCI and are legally required to conduct business in accordance with the 
Care Standards Act 2000 and the Care Homes Regulation 2001 (CSCI 
2007). CSCI appoints pharmacist inspectors, who have statutory right of 
access to registered care homes at any time. These inspectors can insist 
on seeing every place where medicines are stored and all relevant 
records. They focus on achievable outcomes for individuals and measure 
the care home’s performance against the national minimum standards 
(CSCI 2005).
Future organisational changes will take place in 2008/9 when CSCI’s 
regulatory and inspecting social care services functions for adults will be 
merged with the Healthcare Commission and Mental Health Commission 
to become a new Social Care and Health Inspectorate.
The legal basis for regulation of care homes is the Care Standards Act 
2000 and The Care Home Regulations 2001. There is other legislation 
relevant to medicines and care homes. These include:
■ The Medicines Act 1968
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The Misuse of Drug Act 1971 
The Misuse of Drug Regulations 2001 
The Misuse of Drugs (Safe Custody) Regulations 1973 
The Hazardous Waste (England and Wales) Regulations 2005 
Data Protection Act 1998 
Access to Health Records Act 1990 
Disability Discrimination Act 1995 and 
Mental Capacity Act 2005 (CPPE 2007).
Besides legislation, there are also regulations relating to medicines 
covering care homes for adults in England in The Care Homes 
Regulations 2001. The Department of Health has also produced NMS for 
care homes and these are published by the Secretary of State and 
included in the Care Standards Act 2000, which underpins the standards 
(DH 2002). These standards are in place to protect care home residents 
and safeguard and promote their health, welfare and quality of life (DH
2002). Although compliance with the NMS is not in itself enforceable, 
compliance with regulations is subject to the national standards being 
taken into account.
1.3.8 Summary
Care home residents have complex health and social care needs. Within 
a care home, residents with different types of needs may reside. Different 
healthcare professionals with a range of skills and expertise are required 
to meet the needs of care home residents. They are usually placed in 
different geographical locations. The provision of healthcare involves 
different types of tasks such as prescribing, dispensing, monitoring and 
administering medication. Hence, co-ordination among healthcare 
professionals in different healthcare settings is important to ensure a 
seamless and safe service. To facilitate this, it is important for care home
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service providers to understand how the wider care home system 
functions and their role within the system.
1.4 Medication safety in care homes
From a human factors perspective, several important issues were 
identified from the current understanding of the care home system. These 
are presented below and help inform the design of studies investigating 
medication safety in care homes.
■ There is a need for a systems approach to examine medication safety 
in care homes because care home residents are treated by 
practitioners from different parts of the healthcare system.
■ Different healthcare practitioners perform a variety of functions and 
care home studies focusing on the use of medication need to examine 
all types of errors related to those functions such as prescribing, 
monitoring of the effects of medication, dispensing and administering 
medication.
■ The different healthcare settings involved in providing healthcare to 
care home residents highlight the need for effective co-ordination 
across individual system boundaries such as the care home and GP 
surgery.
■ The skills and expertise of different healthcare professional groups are 
needed to provide healthcare to residents. This shows the need for 
effective co-ordination across healthcare professional groups such as 
between the care home nurse and the GP. Communication, whether 
verbal or written is an important aspect.
The next section reviews the current care home literature relating to the 
four points listed above. Before this, the problem of the variability of terms 
and definitions describing medication safety is highlighted. Then, the
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literature is reviewed under the following headings: the design of care 
home medication safety studies, methods for detecting and measuring 
medication errors and communication problems across different 
healthcare settings and healthcare practitioners.
1.4.1 Terms describing the problem of medication safety
Different terms have been used in care home medication safety studies to 
describe the problem of medication safety. There are inconsistencies in 
the terms and definitions used. This can lead to confusion when 
interpreting the results of studies. One review found 25 terms related to 
medication safety and 119 definitions from searching the websites of 33 
organisations involved in medication safety (Yu et al. 2005). These 
included ‘adverse drug events', ‘medication errors’ and ‘medication 
incident’ (Yu et al. 2005). Other studies have used terms such as 
‘inappropriate medication use’ (Mamun et al. 2004), ‘inappropriate 
prescribing’ (Gallagher et al. 2007) and ‘medication-related adverse 
events’ (Handler et al. 2006). Yu et al. (2005) also found that the same 
terms used in different studies have been defined differently.
Morimoto et al. (2004) systematically mapped how terms used in 
medication safety studies relate to each other. They observed that some 
of the terms can and do often overlap. Figure 1.1, taken from Morimoto et 
a/.’s (2004) paper shows the relationship between the commonly used 
terms: adverse drug events (ADEs), potential AD Es and medication 
errors. Potential ADE is a medication error ‘with the potential to cause an 
injury but which does not actually cause any injury’ (Morimoto et al. 
2004;306-307). They defined ADE as an injury due to medication such as 
a cough due to taking a type of medication called angiotensin converting 
enzyme (ACE) inhibitors. Morimoto et al. (2004) continued to explain that 
some ADEs and all potential ADEs are medication errors. ADEs that 
result from medication errors are considered to be errors (Morimoto et al.
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2004). Following on from the example of the ACE inhibitor, if a patient 
with a previous history of ACE inhibitor induced cough was given the 
medication, the ADE was a result of a medication error. If the patient did 
not have a previous history, it was not a medication error and the ADE 
was not the result of a medication error. ADEs can be further categorised 
as preventable and non-preventable. An injury that is the result of an error 
at any stage in the use of medication is preventable but if there was no 
error in the medication process such as an allergy that was not previously 
known, the ADE was non-preventable (Morimoto et al. 2004). They 
considered non-preventable ADEs to be adverse drug reactions. 
Morimoto et al. (2004) further categorised ADEs as ameliorable and non- 
ameliorable. Ameliorable ADEs are injuries where the severity of duration 
could have been substantially reduced if actions had been taken whilst for 
non-ameliorable ADEs, no reasonable actions could have been taken 
(Morimoto et al. 2004).
Preventable
Medication
Errors
ADEs
Adverse drug 
reactionsPotential
ADEs
Ameliorable
Figure 1.1 Relationship between the commonly used terms when 
discussing medication safety (Morimoto et al. 2004)
Morimoto et al. (2004) however did not clearly define ‘medication errors'. 
Their work showed the difficulty of understanding the terms used in 
medication safety studies especially in studies where the definitions of the
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terms used had not been clearly described. For example, general terms 
such as ‘adverse event’ may or may not describe ‘medication errors’. This 
makes comparison and interpretation of results difficult. Without using 
universally agreed terms and definitions that are understood by 
researchers and practitioners, the collection, analysis and comparison of 
results for medication safety studies is difficult.
1.4.2 Research study design
Current care home literature reporting medication safety studies showed a 
fragmented approach to studying medication errors. Some studies 
investigated medication errors according to the different stages of 
medication provision whilst others focused on one type of medication 
error.
The largest care homes studies were conducted in the United States by 
Gurwitz et al. (2000; 2005). They investigated the incidence and 
preventability of adverse drug events (ADEs) and potential adverse drug 
events or near misses at different stages of care such as ordering or 
prescribing, transcription, dispensing, medication administration and 
monitoring. In contrast, Lunn et al. (1997) in one of the few medication 
safety studies of English care homes investigated only the 
appropriateness of prescribing in nursing homes. They did not study 
medication errors at other stages of healthcare provision so it was difficult 
to gain an overview of the problems related to the use of medication.
In the earlier reviews of care home literature, Monette et al. (1995) 
identified specific medication issues relating to the inappropriate use of 
medication such as antipsychotic medications. To date, the majority of 
care home medication safety studies have focused on identifying 
inappropriate medication use according to the type or class of medication 
such as antipsychotic, cardiovascular or gastrointestinal medications
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(Avorn & Gurwitz 1995; Cooper 1999; Field et al. 2001; Furniss et a/. 1998; 
Gurwitz et al. 2007; Hansen et al. 2006; Lau et al. 2004; Mamun et al. 
2004; Roberts et al. 1998; Ruths et al. 2003). Focusing on types of 
medication provides a limited view of the care home medication system. 
Medication error reduction strategies that focus on particular types of 
medication are likely to result in little improvement on the overall level of 
medication safety because errors are often a result of multiple factors.
The majority of care home medication studies have taken an isolated view 
of the care home medication system. The few studies such as Gurwitz et 
a/.’s (2000; 2005) investigated medication safety according to different 
stages of care such as prescribing, dispensing, medication administration 
and monitoring provided an overview of the problem. However, the 
methods and data sources used to identify adverse drug events (ADEs) in 
Gurwitz et a/.’s (2000; 2005) studies lacked a comprehensive systems 
approach that considered a range of factors across different healthcare 
settings that may have led to ADEs. It was difficult to identify possible 
contributors to ADEs such as work organisation and environment that 
could originate either within the care home or other healthcare settings 
that provide care to residents. A comprehensive systems approach that 
considers the wider care home medication system across different 
healthcare settings and healthcare practitioners should be used when 
studying medication safety in care homes.
1.4.3 Detecting and measuring errors
In the wider healthcare literature, different methods have been used to 
detect or measure medication errors or adverse events. Thomas & 
Petersen (2003) reviewed the strengths and weaknesses of eight error 
and adverse event measurement methods that have been used in 
healthcare and these are presented in Table 1.2. Depending on the
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approach and aim of the study, different methods have their relative 
advantages and disadvantages.
In the context of the care home, several issues need to be considered. To 
study medication safety in care homes using a systems approach, the 
error detection and measurement methods should identify latent errors 
(conditions embedded within the system that may lead to active errors; 
those normally identified as ‘errors’). Different types of medication errors 
can occur at different stages of care such as prescribing, dispensing, 
medication administration and monitoring. Each stage of care involves 
different processes so different detection and measurement methods may 
be needed.
Some of the methods presented in Table 1.2 may not be suitable or the 
data sources not readily available to researchers studying English care 
homes, such as morbidity and mortality conferences and autopsy (where 
typically surgeons attend), malpractice claims analysis and administrative 
data analysis. Thomas & Peterson (2003) discussed the strength of 
malpractice claims analysis as its ability to identify latent errors but these 
are highly selected cases and difficult to generalise. In the UK, clinical 
negligence data are available but they are difficult or impossible to access 
and ‘held in unstructured paper records, distributed across a number of 
organisations, fragmented across multiple sets of records for the same 
cases, and not collected consistently using common data definitions and 
standards’ (Vincent et al. 2006:144). Hence, studying medication safety 
using malpractice claims analysis can be difficult. Administrative or billing 
data are used to reimburse healthcare settings for their services, usually 
by insurance companies. In the UK, where the majority of healthcare is 
paid for by the government, this type of data may be lacking or difficult to 
obtain for research purposes.
18
c>
0)
12
>
T3
(Q
• u
C
(Ü
cn
(D
2
3
(0
(0
Q)
E
T3
Q)
(0
3
0)
T3
OJZ
o
£
s
O )
Bc
>
■D
(0 
(/)
■D 
C  
(Ü
0) 0ÔÎS
s
o >
iSc
g
"U
(0
(0
COoo
CM
c
CD
2
0)
Q .
E o
x :
t  
2  
8 
Q) £
JD m 
CD 0)
J -  . c
c
>
<
CM
(/)
0)
jSc
>
<
T3
O
.C
0
E
4-1c
0
E
2
3U)
8
E
UJ
■§
CO
oi
■O
c
05
CO
c  
o  
c
1q c ^
II
I
•o
§
■S
IIIîîlT D: z
T3
C
CD
(2
CD
T 3
I
Q.
2 2o TOg ü
0 £
CDc 0B sz
TO
0 20
05
05
3 TO
0
C 1,CD CD
O LL
0
0
o
c
2
1
co
ü
"CD■e
G
E
■o
c
CD > .0
a r
ca.
o
3
L5 CD
O
2
T3
C
05
CO
2
D)
8
CD
3
CT
CD
CD
C
CD
CO
E
JD
Ü
8
■■8
2
a .
CD
18.2 
S  -Q
O)
I I
I
I  01
I I
1.8
e Ira c
î ê
II
c  ■o
O CD
CD 05 
«- "O
^  i=
2
c
.2
"to
ca.
'
0
0
o
0
ca.
2
2 2
ca. o o
t t
0 0
g . 0  c "c
0 0
3
£E CD —
- "ü "ü
2 . 2 20 0  0 0"O 3  -o "O
1 1 8 cCD
û . Œ ü O
CO
c
0
1
CD
8  o '
2 2  
CD ■-*=
o  qI o
I
T3
0)
JO
_CD
1
tlII
.;= CD
= ) S
CO
I
0 5
C
■■e
R
(D
g
LU
I
CD
C
05
"O
I
.1
Ç
E
<
0)
.Q
.2
2
"o
c
Ig
g
3
O
05
I
1a.
E
8
_c
2 
CD 
CO
"2  CO
i f
If
II
I
■D
_aj
roL 
L
II
5  Ü
3
>»
§
1
■c
CDsz
Ü
c
CDI
"O
T3
C
CD
05
C
E
E
2
8^
05
xa
■■S.
8 2 
3  ê
œ  CD
2
g
0)
"c
4-» CD 
C  —  
05 05II
.1 1
It
2
a
05
CO
.Q
O
05
za
.2
2
Ç
CD
g ,
.c  p
ll
05 05 
C
CE ^  
■o
05
E
CD 05
. 1 ^
C  3
05 U
05 CO
ill
o •=  .o
;% I :  TO CD o  TO o
IIILU O IILL LL
2?
D
05 =II
ca. 3
CD
=  05 "O 
-  E  05lit
—  CO
s  
2
g
>
CO
I . - 2
0  o
"O 0
II
IÎ1II
0f
§
£
2
i
1TO
2 
o
If
Q  E
2
§
I
05
I
I
II
0  05 §1
I
g
■S
0
■n
2
Q.
"O
CTO
I
iTO
ll
8
2
8
%
E
Ü
1
LU
0
&
c
0
1
0
O Ü
o\
0
"to
0
1
II
E  o  
8  g
.5  ô0 .o
IIil
1  §
05 05
O X5H
"O CD 
C
CD 0  
La
| iCD c
I I
i l0 "O1■s; — CD o
li
!l
II
W 03 
2 1  
0
h h4. %
From the eight methods discussed by Thomas & Peterson (2003), chart 
reviews have been the most common method used to measure 
medication errors or ADEs, notably Gurwitz et a/.’s (2000;2005) large- 
scale studies. It is clear that there is no one method that is capable of 
capturing a wide range of information relating to medication errors or 
ADEs. There is a need for greater use of other methods that can capture 
latent errors and provide information about the environment of the work 
setting within which the errors occurred. Interviews can be used to identify 
and clarify information relating to medication errors or ADEs. The 
integrated results gained from different error measurement methods can 
provide a clearer view of the care home medication system.
Prescribing errors
Prescribing treatment is a complex decision and involves knowledge about 
the patient’s condition, medication, the patient’s wishes and the good of 
the population (Cribb & Barber 1997). Spinewine et al. (2007), describing 
Brook’s (1977) work suggests that the appropriateness of prescribing can 
be assessed by process or outcome measures that are explicit (criterion- 
based) or implicit (judgement-based). Explicit indicators are usually drug- 
oriented or disease-oriented and may not take into account all factors that 
define a high quality of care, whilst implicit approaches focus on the 
patient and are potentially more sensitive (Spinewine et al. 2007). 
However, implicit approaches can be time-consuming and can have low 
reliability (Spinewine et al. 2007). There is no ideal measure according to 
Spinewine et al. (2007) but the advantages and disadvantages of explicit 
and implicit approaches should be considered.
In the care home setting, it would be appropriate to adopt implicit 
approaches to detect prescribing errors because explicit criteria may not 
detect and capture the complexity of prescribing. For example, the Beers
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scale that is widely used in medication safety studies identified 3 types of 
potentially inappropriate medication (Beers eta l. 1991; Beers 1997);
1. Inappropriate drug choice: medications that generally should be 
avoided among any elderly patients
2. Excess dosage: medications at a dose or duration that should not be 
exceeded for any elderly patient
3. Drug-disease interactions: medication that should be avoided among 
certain elderly patients with specific co-morbid conditions
These criteria do not capture the complexities of prescribing such as the 
variability and uncertainty of the patients, and the environment of the care 
home. Spinewine et al. (2007) also discuss three disadvantages with 
using lists of inappropriate medication.
1. No general consensus on the contents of medication lists.
2. Inappropriate prescribing of particular types of medication is less 
important than other prescribing issues. For example, they considered 
the underuse of medication, medication monitoring and drug disease 
interaction to be of more importance than the prescribing of particular 
types of medication.
3. Reliability of the process to generate these lists not established.
A common problem with using classes of medication to determine adverse 
events or inappropriate prescribing, such as Beers' criteria (Dhalla et al. 
2002; Lane et al. 2004) or consensus derived criteria (Lunn et al. 1997) is 
that it is difficult to derive and implement strategies that can lead to 
systemic and sustainable change to improve medication safety.
Clinical judgement such as clinical medication reviews is an example of an 
implicit approach. Several studies have been conducted in care homes 
involving medication reviews by pharmacists and general practitioners 
(GPs) and have been found to reduce inappropriate prescribing of
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medications. Furniss et al. (2000) conducted a randomised controlled trial 
(RCT) investigating the effect of a medication review by a pharmacist in 14 
homes in Manchester, UK over eight months. The trial showed that the 
number of inappropriate medicines prescribed to elderly people in nursing 
and residential homes can be reduced with minimal impact on the 
residents' physical and mental health. In a more recent study, Zermansky 
et al. (2006) conducted an RCT comparing a clinical medication review by 
a pharmacist with usual care in care homes in Leeds, UK and this led to a 
substantial change in patients' medication regimes without change in drug 
costs, and a reduction in the number of falls.
The results of the two UK RCTs (Furniss et al. 2000 and Zermansky et al. 
2006) were similar to the results of a RCT conducted by Roberts et al.
(2001) in Australian care homes. They evaluated the effects of a clinical 
pharmacy program that involved the development of professional 
relationships amongst healthcare professionals, nurse education on 
medication and a medication review conducted by pharmacists over a 12 
month period. They found a reduction in medication use without adversely 
affecting survival and morbidity rates. Khunti & Kinsella (2000) conducted 
a study to evaluate whether a comprehensive review of repeat prescribing 
by two GPs could reduce the consumption of inappropriate drugs in 
nursing homes. The systematic medication reviews were conducted by 
the two GPs (together) in 4 randomly selected nursing homes and 
prescriptions were altered in 65% of patients: a prescription item was 
stopped in 51% of patients and cheaper alternatives of drugs or a 
reduction in drug dose was implemented in 26% of patients (Khunti & 
Kinsella 2000).
The studies described above showed the value of medication reviews as 
an implicit approach that resulted in a reduction in inappropriate 
medication being prescribed to care home residents. A clinical medication
22
review considers every medication that is prescribed to residents, not just 
a list of medication. It also takes a complete and holistic view of the 
resident’s medical condition and their wishes. This suggests that the 
environment within which the care home resident resides would be 
considered when conducting medication reviews.
Although medication reviews were found to have influenced the safe use 
of medication, these studies did not aim to identify medication errors. 
There is a need for clearer guidance when using medication reviews to 
identify medication errors.
Dispensing errors
Medication dispensing is usually performed by the community pharmacy 
or dispensing GP surgeries. Dispensing is largely process-driven with an 
element of clinical judgement by pharmacists where pharmacists assess 
the clinical appropriateness of prescribed medications. There has been 
no published study investigating dispensing errors experienced by care 
homes residents in England. However, several studies have investigated 
dispensing errors in community pharmacies. Ashcroft et al. (2005), Chua 
et al. (2003) and Warner & Gerrett (2005) investigated dispensing errors in 
community pharmacies using self-reporting methods by pharmacy staff. 
The ratio of near misses to dispensing errors in Ashcroft et a/.’s (2005) 
study was found to be similar to Chua et a/.’s (2003) study; near misses 
occurred around six times more than dispensing errors. However, the 
rates of near misses and dispensing errors identified in Chua et a/.’s 
(2005) study was double the rates found in Ashcroft et a/.’s (2005) study:
0.48% vs. 0.22% for near misses and 0.08% vs. 0.04% for dispensing 
errors. In contrast to Ashcroft et al. (2005) and Chua et a/.’s (2003) 
studies, Warner & Gerrett (2005) reported a much higher dispensing error 
rate of 16%.
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Differences in the way pharmacy staff were trained to self-report, whether 
definitions of dispensing errors were specified and used, and the length of 
time the studies were conducted make it difficult to compare the results of 
the three studies. Self-reporting by pharmacy staff of dispensing errors 
may be an underestimation of the prevalence of errors because individual 
self-reporters may have missed reporting errors and there may be a lack 
of consistency across different pharmacies participating in the study. 
However, the duration of the study could potentially be longer without 
incurring large expenses, producing larger data sets.
In a more recent study, Franklin & O'Grady (2007) identified dispensing 
errors in community pharmacies by checking dispensed items awaiting 
collection by patients and compared them against the original prescription. 
Checking dispensed medication can detect dispensing errors but does not 
provide any information about the system within which the dispensing 
process took place. Observing the dispensing process and the 
environment where dispensing takes place using the observation method 
mentioned in Table 1.2, in addition to checking could potentially suggest 
latent errors and identify dispensing errors.
Medication administration errors
There has been no published study reporting medication administration 
errors in UK care homes. In two large-scale US care home studies, 
Gurwitz et al. (2000; 2005) reported medication administration errors but 
the methods used to identify medication administration errors were not 
clearly stated in their paper nor the classification form provided by the lead 
author (Jerry Gurwitz 2008, personal communication). Their studies 
identified the incidences of adverse drug events and preventable drug 
events. Preventable drug events represented medication errors (refer to 
discussion in section 1.4.1 for clarification of different types of terms used 
in medication safety studies).
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Observation is widely acknowledged as the best technique for the 
estimation of medication administration error rates in hospital and the 
Hawthorne effect (explained in the footnote in Table 1.2) that is of concern 
has not been shown to markedly affect the error rates (Dean & Barber 
2001). The process of medication administration in the care home is 
similar to that in the hospital. Care home documents and medication 
administration charts do not indicate whether an error had occurred. 
There are also difficulties obtaining information and evidence surrounding 
the actual administration of medication. These reasons suggest that the 
method of observation is more suitable for identifying medication 
administration errors in care homes.
Monitoring errors
Monitoring errors have not been studied extensively. Disease states may 
change and patients should be monitored to detect any changes. 
Particular types of medication may also require biochemical monitoring 
such as blood tests. The acceptable range of monitoring results can be 
subjective; hence identifying monitoring errors is difficult. More research 
is needed to explore methods of identifying monitoring errors.
1.4.4 Care home co-ordination across different healthcare 
settings
Few studies have explored the problem of co-ordination across healthcare 
settings in relation to care homes. Midlov et al. (2005) investigated the 
frequency and nature of medication errors during patient transfer between 
the care home and hospital. Sixty nine patient transfers were 
investigated; 34 were admitted to hospital and 35 were discharged from 
hospital. Midlov et al. (2005) defined a medication error as “any error in 
the process of prescribing, dispensing or administering a drug, whether
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there are adverse consequences or not” and found at least one 
medication error in 85% of patients admitted to hospital and 54% of 
patients discharged from hospital. The most common error on hospital 
admission was the withdrawal of a drug whilst the addition of a drug was 
the most common error at discharge. The study also found an increased 
risk in medication errors at discharge with the use of a specific medication 
dispensing system (they did not describe the system) intended to reduce 
the risk of errors (Midlov et al. 2005).
One of the core elements of effective co-ordination is communication. The 
review of care home literature identified a problem with communication; 
the absence of, insufficient and poor quality information. Sackley & Pound
(2002) examined the content of discharge letters of stroke patients 
entering nursing homes from hospitals in Nottingham (UK) and found 
hospital discharge letters were often incomplete and inaccurate. There 
have also been anecdotal reports of poor information on hospitai 
discharge letters but these have not been reported widely.
Reed & Morgan (1999) investigated the experiences of older people 
discharged from hospital to a care home and identified possible forms of 
support that older people might need during this move. They interviewed 
older people and family members and conducted focus groups with staff. 
Although the study's focus was not on medication use, their findings 
showed that there was a lack of co-ordination across healthcare settings 
in providing support for older people in the moving process. Older people 
did not have sufficient information about the moving process, their choices 
and what life in a care home would be like. Older people's family 
members found the process of finding a care home rushed and they felt a 
huge sense of responsibility in choosing the right home. Hospital nurses 
indicated that there was no standardised approach to dealing with 
discharge to a care home and nursing staff knew little about care homes
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and could not offer more support. Social workers felt that they were under 
pressure from medical staff to organise discharges and did not have time 
to spend with patients discussing their choices and preferences. Medical 
staff felt that their role was mainly in making discharge decisions and 
deciding the level of care required from a medical point of view (Reed & 
Morgan 1999).
The need for effective co-ordination across healthcare settings is clear but 
there is currently a lack of understanding of the relationships between and 
across different healthcare settings within the context of the wider care 
home system particularly regarding medication safety. Hence, the 
information requirements to enable effective co-ordination across 
healthcare settings are not clear.
1.4.5 Roles and expectations of healthcare practitioners
Co-ordination across healthcare practitioners providing care to residents is 
another important issue in the care home medications system. Perry et al.
(2003) explored the understanding of registered general nurses (RGNs) 
and care assistants (CA) about their roles in UK nursing homes. They 
interviewed 9 RGNs and 12 CAs and found that RGNs had difficulty 
defining and limiting their roles because they have “all-embracing roles, 
doing everything and anything within the home" whilst CAs limit their roles 
to what they are not allowed to do within the nursing home (Perry et al.
2003).
Workload demands and expectations of healthcare practitioners that 
provide services to care home residents were explored by Crosby et al. 
(2000), Donald et al. (2002) and Goodman et al. (2005). Donald et al.
(2002) reported that the demand for district nursing services was about 
one visit per month per resident in long term care and there was no
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difference in the types of care homes the residents were living in. In an 
earlier study, Crosby et al. (2000) included GPs in their data set and they 
identified a greater demand for GP services compared to nurses in care 
homes.
Goodman et al. (2005) reported their findings of two consecutive studies 
that involved focus groups with district nurses, community staff nurses, 
care home managers. Care Standards commissioners and care home 
staff. The care home managers and nurses that they interviewed believed 
that they had good working relationships but their expectations of each 
other’s roles differed (Goodman et al. 2005). Differing role expectations 
were also found in Crosby et a/.’s (2000) study. They examined the views 
of nursing and residential homes, GPs, district nurses and other primary 
health care team members on service provision to residents. They found 
disagreement between the nursing and residential homes and GPs on the 
urgency of GP cases and whether there was sufficient information to judge 
the urgency of cases. The disagreement calls for a clearer understanding 
of “urgent cases” so that GPs are not overwhelmed with increasing 
workload. The increase in GP workload echoes the result of another 
study assessing the utilisation of GPs by elderly residents in nursing 
homes where nursing home residents were found to use GP services 
more than those in residential care homes (Kavanagh & Knapp 1998).
These studies suggest that there is no structured co-ordination of roles 
within the care home setting. Expectations of different healthcare 
practitioners were not met because these were not made known. The 
expertise and potential contributions of healthcare practitioners should be 
further explored.
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1.4.6 Summary and implications
Although numerous medication safety studies have been conducted 
across different healthcare settings and in care homes, there is no 
standardisation of terms and definitions used to describe medication 
errors or adverse events. Almost two decades ago, Gurwitz et al. (1990) 
recognised and highlighted the difficulty of defining “inappropriate 
medication” and the inherent difficulties with deciding what ideal or 
acceptable treatment goals are. This problem has not yet been resolved.
The majority of care homes studies have focused on identifying 
medication errors or adverse events that occurred in types or classes of 
medication. This approach presents an isolated view of the problems of 
medication safety. The care home is a complex system and the provision 
of healthcare occurs across different care stages. A systems approach 
investigating medication errors that occur across different care stages is 
needed because it presents a wider view of the care home medication 
system.
The provision of healthcare and medication in the care home medication 
system also involves a variety of healthcare settings and healthcare 
practitioners. This shows the importance of a co-ordinated approach to 
healthcare service provision across healthcare settings and healthcare 
practitioners. However, current studies have not investigated this aspect 
extensively. A study identified medication errors at the hospital and care 
home interface whilst another studied the content of discharge letters from 
hospital to care homes. Other studies investigated the social component 
of the care home medication system and highlighted poor communication 
and a lack of understanding of the roles of different healthcare 
practitioners. These issues compromise safety because important 
information about the patient is not communicated effectively and by the 
appropriate healthcare practitioners. Healthcare practitioners often have
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to cope with information gaps. Cook et al. (2000) described gaps as 
losses of information or momentum or interruptions in the delivery of care 
and “ .... are most readily seen when they are aligned with organisational 
and institutional boundaries that mark changes in responsibility or 
authority, different roles of professionals, or formal divisions of labour” 
(Cook et al. 2000:792).
There is currently a lack of knowledge base of the English care home 
system and the current approaches to understanding medication safety in 
care homes have been fragmented. There is a need to study the complex 
care home medication system using a systems approach. Validated or 
widely accepted modelling techniques are needed to document and 
describe the system. The description of the system can help to 
understand where and how errors occur. Based on a comprehensive 
system analysis, solutions to improve medication safety can be 
developed.
1.5 Research goals
From the review of the care home medication safety literature, it was 
difficult to construct a view of the care home medication system and the 
extent of the problem of medication errors in care homes in England. The 
lack of understanding of the care home medication system hinders the 
identification of the requirements for a safe system. In such a complex 
system where multiple healthcare practitioners have to work together to 
provide healthcare to care home residents, a systems-based approach to 
understanding, analysing and designing systems is vital. Figure 1.2 
presents a systems-based approach to healthcare design centred on the 
user (Buckle et al. 2003). This model can be used to characterise the 
research goals.
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Figure 1.2 A systems-based user-centred approach to healthcare design 
(Buckle et al. 2003)
Research goal 1
The first research goal was to provide a knowledge base of the care home 
medication system. Referring to Figure 1.2, building a knowledge base 
serves as a cornerstone to understanding and defining the requirements 
of a system. This is crucial in the design of a system and for managing 
risks. To study a complex system such as the care home system, a 
systems approach is vital so that all parts of the system are studied and 
analysed collectively. This provides a powerful resource for further work 
into finding solutions to improve the existing system.
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A knowledge base can be built from an understanding of the care home 
system and the current medication problems. Hence, the first research 
goal was to identify the prevalence and types of medication errors in care 
homes.
Research goal 2
Understanding the extent of the problem of medication errors alone in 
terms of the prevalence and types of medication errors is unlikely to 
provide enough information to generate solutions to reduce the rates of 
medication errors. It is vital to understand why these errors occur. The 
second research goal was to understand the causes of medication errors 
using an appropriate systems analytical framework.
Research goal 3
After identifying the causes of medication errors, informed 
recommendations can then be made to reduce the rates of medication 
errors in care homes. System design requirements can then be
implemented and evaluated. The final research goal is to identify the 
information requirements for a safe care home medication system and 
generate recommendations for system improvements.
1.6 Structure of the thesis
This chapter provided an overview of medication safety in English care 
homes. The rest of the thesis discusses how the research goals are met. 
A summary of the structure of the thesis is presented in Figure 1.3. The 
first research goal was to understand the care home medication system by 
identifying the prevalence and types of medication errors.
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Chapter 1 ; 
Overview of the care home
Chapter 9: 
Conclusion
Chapter 7:
Revisiting error analysis using 
work domain analysis
Chapter 8: 
Discussion
Chapter 6:
Work domain analysis of the 
care home medication system
Chapter 4: 
Analysing medication errors 
using The London Protocol
Chapter 3:
An empirical study of the prevalence 
and types of medication errors
Chapter 5:
Modelling the care home medication system. 
An HTA of part of a medication system was 
constructed. Cognitive work analysis and work 
domain analysis were introduced.
Chapter 2;
Care home familiarisation studies.
Two studies were conducted to explore the 
interactions among healthcare practitioners and 
communication between healthcare practitioners.
Figure 1.3 Structure of the thesis
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Before this, it was important to gain familiarisation with the care home 
system. Chapter 2 presents two exploratory studies that investigated the 
interactions and communication among healthcare practitioners involved 
in providing care to care home residents. The findings of these studies 
helped inform the research design of the research study investigating the 
prevalence and types of medication errors in care homes. This study is 
presented in Chapter 3. The epidemiological data from Chapter 3 
provided an overview of the problem of medication safety in care homes. 
However, to improve the safety of the system, there is a need to 
understand why errors occur. An understanding of the factors that 
contribute to errors can help inform the generation of recommendations for 
system improvement. The London Protocol (Taylor-Adams & Vincent
2004) was used to analyse medication errors identified in Chapter 3. 
Chapter 4 presents the analysis of medication errors and the generation of 
recommendations for system improvements.
Several problems were identified in the analysis of medication errors using 
The London Protocol and this led to the identification of a need to model 
the whole care home medication system. Chapter 5 reports a study using 
hierarchical task analysis (HTA) to represent a part of a medication 
system. However, there were several problems using HTA and this led to 
the exploration of cognitive work analysis (CWA). CWA was found to be a 
potentially useful method for analysing complex systems and work domain 
analysis (WDA), the first of five analysis phases in CWA (Rasmussen et 
al. 1994; Vicente 1999) was conducted. This is reported in Chapter 6. 
Chapter 7 explores whether the systems model developed in Chapter 6 
was useful for understanding medication errors and whether it provided 
more robust information for developing system recommendations 
compared to The London Protocol. Finally, chapter 8 brings together the 
research findings and discusses the limitations of the research and future 
research and developments.
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Chapter 2: Care home familiarisation studies
2.1 Introduction
Chapter 1 presented an overview of medication safety in care homes. 
Current care home literature presented a fragmented view of the care 
home system. It was therefore important to gain familiarisation and 
preliminary information about the care home domain to inform the design 
of the research studies. To do this, two exploratory studies were 
conducted in chronological order. The first study focussed on exploring 
the complex interactions among healthcare practitioners involved in caring 
for care home residents. Coupled with the complexity of interactions 
among healthcare practitioners is the problem of communication, 
discussed in the previous chapter. The second study investigated the 
issue of communication and explored how medication information is 
communicated between healthcare practitioners. Together, these two 
studies provided preliminary information about the research domain, 
helped refine the research goals and explored possible research methods.
2.2 Healthcare providers and communication in the 
care home system
2.2.1 introduction
Care homes provide services to a vulnerable group of people who often 
have multiple health and social problems. Their complex needs require 
general and specialist skills across different healthcare settings. Hence, 
the provision of healthcare to residents in care homes relies on the skills 
of a variety of healthcare practitioners who are usually located in different 
geographical areas. For example, GPs, community pharmacists, hospital
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pharmacists and care home nurses routinely provide care to care home 
residents and they are usually placed in different healthcare settings. 
Each one has different roles and performs different tasks that may all take 
place at any one time. To build a knowledge base of the care home 
system, it is important to identify the key stakeholders or healthcare 
practitioners in the system and understand their respective work systems. 
Communication in the care home system is important because the care 
home system requires accurate, relevant, reliable and timely information 
for the safe delivery of healthcare. Medication forms a large part of the 
provision of healthcare to care home residents. Hence, understanding 
how medications are physically transferred in the care home system is 
important.
2.2.2 Aim and objectives
The aims of this exploratory study were to identify the range of healthcare 
practitioners that provided healthcare to care home residents and explore 
the communication pathways in the care home domain.
Three objectives were identified. The first was to identify healthcare 
practitioners that provide care to care home residents. The second 
objective was to explore the information flow within the care home domain. 
Finally, the flow or transfer of medication in the system was explored.
This study was conducted in two consecutive phases. The first involved 
data collection and the second phase involved validation of the data.
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2.2.3 Phase 1: Data collection 
Participants
The first phase involved identifying the range of healthcare practitioners 
who provide care in care homes and describing the information and 
medication flow across healthcare settings. Section 1.4.4 discussed a 
study conducted by Midlov et al. (2005) who reported a high rate of 
medication errors at the care home and hospital interface particularly 
when patients were admitted to hospital. This suggests a safety problem 
at the care home and hospital interface. The researcher was an honorary 
research pharmacist at the pharmacy department in a district hospital and 
access to hospital pharmacists was gained. Hence, hospital pharmacists 
were recruited to participate in this exploratory study.
Care home residents who were admitted to the hospital often arrived at 
the Medicine Admissions Unit (MAU), care for the elderly ward or the 
surgical ward. Hence, pharmacists who worked in these three wards were 
approached to participate in the first stage of this exploratory study. Four 
pharmacists were recruited; one who worked in the MAU, two in the care 
for the elderly wards and another one in the surgical ward. These 
pharmacists had varying levels of experience in hospital pharmacy 
practice depending on the length of time they had been a pharmacist.
Method
The work organisational routines of hospital pharmacy meant that 
pharmacists often had little time to spare during work hours. Informal 
semi-structured one-to-one interviews were conducted with each of the 
four pharmacists at a time that was convenient to them.
Pharmacists were asked to identify from their experience, the healthcare 
practitioners that routinely provided care for care home residents even if
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pharmacists themselves had not witnessed healthcare practitioners doing 
so. Then, they were asked to explain how information was relayed in the 
care home system. Finally, they were asked to describe how medication 
is transferred in the care home system. The interview questions and 
prompts were;
1. Can you identify the healthcare practitioners that you think are involved 
in providing care to care home residents?
2. Can you describe their (healthcare practitioners) relationship with the 
care home resident?
3. Is there a working relationship among the healthcare practitioners you 
identified?
4. Is information about the care home resident communicated between 
and among the healthcare practitioners you identified?
5. Can you describe how medicines are provided in the care home 
system?
Handwritten notes were taken during the interviews. These were 
organised according to the research aims independently by the 
researcher. The findings of the study were also informed directly by the 
researcher because of her background as a community pharmacist with 
experience providing pharmaceutical services to care homes. This could 
introduce bias because additional information that was not identified from 
the interviews was introduced in to the research findings. However, this 
was an exploratory study to familiarise the researcher with the care home 
system.
Analysis and findings 
Care home service providers
A map of the identified healthcare practitioners linked to the care home 
resident was developed, informed by Clarkson et a/.’s (2004) study. 
These findings, also informed by the researcher's experience are
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presented in Figure 2.1. The links shown in the map indicate likely 
interactions (thin lines) and routine interactions (thick lines) between the 
care home resident and healthcare practitioners. Lines with one arrow 
indicate the direction of interaction whilst lines with arrows at both ends 
indicate the possibility of both the care home resident and healthcare 
practitioners initiating interactions.
Key:
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^  Routine interactions and 
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Community 
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care home
PCI pharmacists
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pharmacists
Non-dispensing
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District/practice
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resident
Care home nurses
MCT, Social services Other healthcare 
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Figure 2.1 Care home healthcare providers
Eleven healthcare practitioners who provide services to care home 
residents were identified by the pharmacist participants. From these, five 
were considered to have routine interactions with care home residents and 
the interaction could be initiated either by the resident or healthcare 
practitioners. They included dispensing GPs (GPs who also provide 
dispensing services in addition to medical services), non-dispensing GPs, 
community pharmacies that provide pharmaceutical services to care 
homes, care home nurses and district or practice nurses. Each healthcare
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practitioner is usually located in a distinct geographical area and performs 
a variety of roles.
Pharmacist participants also mentioned the intermediate care team (ICT). 
The concept of the ICT was previously explained section 1.3.2. Social 
services and CSCI inspectors were also mentioned by pharmacists. This 
group of practitioners does not directly provide healthcare to care home 
residents but they influence the type and level of healthcare provided to 
residents. For example, 0801 inspectors inspect the way that medications 
are managed in the care home. They make recommendations to improve 
the management of medications in the care home. This has a direct 
impact on the way the care home medication system functions thereby 
influencing the way that nurses provide healthcare. Social services may 
identify certain healthcare needs and these may influence the healthcare 
received by residents. This showed that the provision of healthcare can 
be affected by different groups of practitioners that may not directly 
provide healthcare to care home residents. The category “other 
healthcare professionals” shown in Figure 2.1, includes dentists, 
podiatrists, dieticians, nutritionists, occupational therapists, speech and 
language therapists and physiotherapists.
Information and medication flow in the care home system
Figure 2.1 was used as the basis for the development of an interaction 
map that showed the flow of information and medication between the care 
home resident and healthcare practitioners. The information and 
medication flow map is presented in Figure 2.2. Based on the 
researcher's experience and knowledge of the healthcare system, 
additional items were added onto the map. Physical spaces such as 
hospital pharmacy and physical objects such as ward stock medication 
and care home stock medication were identified and described as part of 
the provision of medication. Connections or lines were then drawn
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between healthcare practitioners and the care home resident to indicate 
the likely flow of information and the transfer of medication.
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Figure 2.2 Information and medication transfer in the care home system
From the figure, it can be seen that information and medication can be 
transferred via many routes in the care home system and across different 
healthcare settings. This suggests that a wide range of healthcare 
practitioners possess and require relevant information so that they can 
provide care to care home residents. Medication can also be obtained 
from different sources including the non-dispensing GP surgery. 
Documenting the provision of healthcare to care home residents is difficult 
because of the complexity involved.
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2.2.4 Phase 2: Validation of the findings 
Participants
The second phase involved validating the findings of phase 1. A separate 
group of pharmacists was recruited. Six pharmacists from different 
backgrounds such as primary care, academic, hospital and community 
pharmacy were recruited to validate the results found in phase 1.
A chief pharmacist of a district hospital, two academic pharmacists, two 
primary care pharmacists and a research pharmacist were recruited. The 
chief pharmacist was concerned with the large number of care home 
residents admitted to the hospital and had a good knowledge of hospital 
pharmacy services. Patient safety was an area of interest for the two 
academic pharmacists. They also had previous hospital pharmacy 
experience. Primary care pharmacists recruited were involved in 
identifying the service needs of care homes. Hence, they had a good 
overview of the healthcare providers that were involved in providing care 
to care home residents. Finally, the research pharmacist was also 
researching a particular area in care homes and she had previously 
worked as a hospital and community pharmacist.
Method
The results of the findings from phase 1 were presented to the six 
pharmacists recruited. The researcher met with them on three separate 
sessions. The first session involved the chief pharmacist of a district 
hospital; the second, two primary care pharmacists and the last session 
consisted of two academic pharmacists and a research pharmacist. In 
each session, the researcher explained the findings of phase 1 of the 
study and presented the results as two interaction maps. Figures 2.1 and 
2.2. Figure 2.1 showed the range of healthcare practitioners who were 
involved in providing healthcare to care home residents. Pharmacists
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were asked to examine the map and comment on the accuracy and 
completeness of the map and add to it as necessary. The second map, 
Figure 2.2 showed information and medication flow in the care home 
system and pharmacists were asked to examine the individual items in the 
map and the links that connected them. Like the first map, pharmacists 
were asked to comment on the accuracy and completeness of the map 
and add to the map as necessary.
Analysis and findings
Additional healthcare practitioners were identified by pharmacist 
participants and these were handwritten directly onto the map during the 
validation process. Figures 2.3 and 2.4 show the validated maps.
Care home service providers
Whilst Figure 2.1 differentiated the likelihood of interactions between the 
care home resident and healthcare practitioners and the direction of 
information flow, the lines connecting healthcare practitioners to the care 
home resident in Figure 2.3 did not bear such implications. In addition to 
the increased number of healthcare practitioners identified in the validation 
stage, pharmacists identified numerous possibilities of information being 
transferred between healthcare practitioners and the care home resident. 
It was difficult to represent the flow of information so Figure 2.3 did not 
distinguish between likely and routine interactions.
A wide range of healthcare practitioners from different parts of the health 
system is presented in Figure 2.3. For example, hospital doctors and 
hospital pharmacists are part of secondary care; community pharmacists, 
PCT pharmacists and GPs are part of primary care; and CSCI inspectors, 
drug representatives via nurses and social services do not directly provide 
healthcare services but they can influence the way that healthcare is 
provided. Most of these healthcare practitioners are also located in
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different geographical areas and have specific skill sets and expertise. 
This suggests and reinforces previous conclusions about the complexity 
and diversity of healthcare provision in the care home system.
Out of hours 
GP
Community
pharmacistLocum GP
GP
Community 
pharmacy staffGP practice staff
PCT pharmacistDispensers in 
dispensing GP
Hospital doctor
Care home 
residentCSCI inspectors
Hospital pharmacistDrug reps via 
nurses
Care home staff
Community psychiatric 
nurse
Counsellor
Specialist doctors/ 
consultatns District nurses
Physiotherapist Specialist nurses
Social services- 
different tiers DieticiansOccupational
therapist
Figure 2.3 Validated map linking the resident and healthcare providers
Information and medication flow in the care home system
Figure 2.4 shows the validated map showing information flow and 
medication transfer in the care home system. Pharmacist participants 
identified additional information and medication links between and among 
the healthcare practitioners and care home residents. It was difficult to 
map the complexity of the information and medication flow in the care 
home system. Nevertheless, from this map, four main healthcare settings
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can be identified. These are the hospital, GP surgery, community 
pharmacy and the care home and are circled in Figure 2.4.
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Figure 2.4 Validated map showing information flow and medication transfer 
in the care home system
2.2.5 Discussion
Many healthcare practitioners were identified by pharmacist participants to 
provide healthcare to care home residents. These healthcare practitioners 
were located at different geographical areas and have different set of skills 
or expertise. Each had relevant information about the care home resident 
depending on their professional roles. Hence, it would not be unusual for 
a care home resident with multiple health problems to be cared for by 
different healthcare practitioners at any one time.
The information and medication flow map showed the complexity of 
interactions between the care home resident and healthcare practitioners.
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and among healthcare practitioners. The map did not portray all possible 
interactions but clearly showed that information and medication frequently 
crossed healthcare boundaries. For example, a resident's medication 
would normally be prescribed by the GP. The GP would write a 
prescription and a care home staff member would bring the prescription to 
the community pharmacy for the medication to be dispensed. The 
dispensed medication would then be collected or transported to the care 
home. Only then can medications be administered to care home 
residents. In this example, three healthcare settings were involved in the 
provision of medication without which the task of medication 
administration could not have been possible. These were the GP surgery, 
community pharmacy and the care home. A good and robust 
communication system needs to be in place to ensure healthcare 
practitioners from different healthcare settings have relevant, accurate, 
reliable and timely information. This also facilitates the safe and timely 
transfer of medication to the care home resident.
The complexity shown in the information and medication flow map 
highlighted problems associated with mapping interactions. It is difficult to 
map every interaction that exists, not only within the care home but also 
across different care settings. The workers in the care home medication 
system, the locations that they work in, the tasks processes and work 
organisation were difficult to capture using this mapping technique. 
Complex mapping of interactions may not provide relevant information to 
answer the research questions. Despite that, a high level map is useful 
for highlighting system components, representing and simplifying some of 
the interactions within the system. The analysis identified four main 
healthcare settings namely the hospital, GP surgery, community pharmacy 
and the care home. Each of these healthcare settings functions 
differently. Considering these factors collectively, the complexity of the 
care home system greatly increases. More information is needed on how
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each healthcare setting functions and how healthcare practitioners and 
healthcare settings interact and co-ordinate activities. This presents a 
challenge to identify an appropriate method to study the care home 
medication system.
2.2.6 Conclusions
The care home is a complex system consisting of a range of healthcare 
practitioners. Care home residents are usually cared for by multiple 
healthcare practitioners who work across different healthcare settings at 
any one time. A good communication system is paramount for the safe 
delivery of healthcare to care home residents. The care home medication 
system needs to be resilient to cope with the complexity and variability of 
healthcare provision. Difficulty mapping the interactions in the care home 
system suggests the need for methods that are capable of capturing the 
complexity and the variability in information and medication transfer in the 
care home system.
2.3 Exploring variations in medication information 
transfer in the care home system
2.3.1 Introduction
The previous study provided an initial high-level view of the complexities 
of the care home system. In this study, the focus is on exploring the 
variations in the transfer of information, particularly information related to 
medication across the four main healthcare settings in the care home 
identified in the previous study. These were the care home, GP surgery, 
community pharmacy and hospital. Within each of these healthcare 
settings, many healthcare practitioners work together to achieve their
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individual and system goals. Doctors or GPs, community pharmacists, 
care home nurses and hospital pharmacists are the key healthcare 
practitioners who prescribe, dispense, administer and monitor the effects 
of medicines. To explore the transfer of medication information in the care 
home system in more depth, the experiences of these healthcare 
practitioners can provide invaluable information and they were recruited 
for this study.
2.3.2 Aim and objectives
The aim of the study was to understand the variations in medication 
information transfer in the care home system.
There were two objectives to the study. First, it is important to understand 
the roles of the healthcare practitioners who use information in the care 
home system before understanding how information is used in the care 
home system. The previous study showed a range of healthcare 
practitioners in the care home system but in this study, the objective was 
to understand the roles of the main healthcare practitioners in the four 
main healthcare settings identified. The first objective was to understand 
the roles of GPs, care home nurses, hospital pharmacists and community 
pharmacists in the provision of healthcare to care home residents. The 
information provides a background to understand the transfer of 
medication information. The second objective was to understand the 
medication information pathways in more detail in the four main healthcare 
settings identified in the first study: care homes, GP surgeries, community 
pharmacies and hospital.
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2.3.3 Participants
GPs, care home nurses, community pharmacists and hospital pharmacists 
were approached to participate in this study. Individual healthcare 
practitioners were identified through a contact from a primary care trust 
(PCT) and another research project: Care Home Use of Medicines Study 
(CHUMS) (AI Id red et al. 2008), which is explained in more detail in 
Chapter 3. Sampling participants from personal contacts could introduce 
bias. Healthcare practitioners in the CHUMS research team were involved 
in a research study investigating medication errors in care homes and 
although they may be more familiar with the care home system, they may 
be more critical of the system or present an idealistic view of the system. 
The sample of participants recruited for this study was not a
representative sample of the four types of healthcare practitioners.
However, the aim was to gain a comprehensive view of the care home 
system from healthcare practitioners who work within it.
Participants were recruited in two ways. First, individual healthcare 
practitioners were identified by a contact in the PCT who wrote letters 
introducing the study. Potential participants were then contacted by the 
researcher via the telephone. Five GPs and a care home manager 
agreed to participate.
Second, participants were identified from the CHUMS research team that 
consisted of a range of healthcare professionals (Alldred et al. 2008). A 
GP, a care home nurse and three pharmacists were recruited for the 
study. They were initially contacted via email and were given an 
explanation of the aim and objectives of the study. The researcher 
followed up via telephone to assess their interest in the study.
In total, 6 GPs, 1 care home manager, 1 care home nurse and 3
pharmacists were recruited for the study.
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2.3.4 Method
Semi-structured interviews were used in this study so that individual 
healthcare practitioners had the opportunity to talk about their individual 
experiences. It would be difficult for healthcare practitioners to talk about 
their experiences in a focus group consisting of a mixed group of 
healthcare practitioners. Some may find it difficult to speak openly and 
freely in the group or may be influenced by others in the group. On a 
practical level, it was difficult to gather healthcare practitioners who were 
located in different parts of the country.
Separate interview schedules were prepared for each type of healthcare 
practitioners; care home nurses, GPs, community pharmacists and 
hospital pharmacists and are presented in full in Appendices 1 to 4. At the 
start of the interviews, participants were asked to briefly describe their 
roles providing care to care home residents. Subsequent interview 
questions were based around events or situations that had implications for 
information transfer. These were specific to each group of healthcare 
practitioners. The interview questions were designed to find out what 
information was transferred to healthcare practitioners in the particular 
situation presented. The following situations were presented to healthcare 
practitioners.
Care home nurse
Situation 1 : A resident is admitted to and discharged from hospital 
Situation 2: A resident has an urgent admission to the hospital 
Situation 3: A resident receives a routine visit by the GP 
Situation 4: A resident needs urgent medical attention from the GP
GP
Situation 1 ; The GP makes a routine visit to the care home 
Situation 2: The GP is called to make an urgent visit to the care home.
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Situation 3: The GP decides that the resident needs to be admitted to the 
hospital (not in an emergency).
Situation 4: The GP decides that the resident needs to be admitted to the 
hospital urgently.
Community pharmacist
Situation 1: Community pharmacy supplies care home residents with 
regular repeat medication
Situation 2; Community pharmacy receives an acute prescription for a 
resident
Situation 3: The resident requires an emergency supply of a medicine
Situation 4: The resident's repeat medicine is changed
Situation 5: The resident is discharged from hospital
Situation 6: An acute Rx is brought to another pharmacy to be dispensed.
Hospital pharmacist
Situation 1 : A patient has a planned admission to the elderly ward in the 
hospital.
Situation 2: A patient is discharged to a care home 
Situation 3: Patient's medication changed during hospital stay 
Situation 4: A patient changes ward within the same hospital 
Situation 5: Pharmacy services for patients during the weekend 
Situation 6: A patient is transferred to a different hospital
Probes were used to elicit additional information from the participants. 
Participants were also asked to list the types of healthcare practitioners 
whom they knew were involved in providing healthcare to care home 
residents. Finally, the participants were asked to briefly describe their 
working relationship with each of the healthcare practitioners they 
identified.
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Interviews were either conducted face-to-face or via the telephone for the 
convenience of participants. Telephone interviews were conducted with 
one GP, one care home nurse and three pharmacists. A face-to-face 
group interview was conducted with four partners of a GP surgery. A GP 
from a dispensing GP surgery and a care home manager were also 
interviewed face-to-face. Dispensing GPs are GPs who also dispense 
medication to patients who live in rural areas because of the lack of 
community pharmacies. Handwritten notes were taken at each interview 
and these were analysed for common themes.
2.3.5 Analysis and findings
Care home nurse interviews
A care home nurse and a care home manager who is also a nurse were 
interviewed. Their roles involved providing personal and healthcare to care 
home residents including assessing and planning of resident’s daily 
activities and ensuring standards of care are met. The nurses described 
providing care from a holistic approach and facilitating residents towards a 
good quality of life.
A full description of the findings of the care home nurse interviews 
surrounding the four events or situations that have implications for 
information transfer are presented in Appendix 5. A summary of the 
findings is presented in Table 2.1. From the table, it can be seen that the 
transfer of information about medication and the resident is variable. Care 
homes usually initiate the monitoring of resident's health and have to 
request information. Hospital discharge information may or may not be 
received by the care home from the hospital. Discharge medication may 
or may not be transported with residents when they are discharged to the 
care home.
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Table 2.1 Summary findings of interviews with care home nurses
Event/situation Information Medication Monitoring of 
progress
Hospital admission 
and discharge
Information transfer 
between care home and 
hospital poor. MAR charts 
may or may not be 
transported with the 
resident. Hospital may or 
may not have history of 
resident.
May or may not 
be transported 
with the resident.
Initiated by care 
home. Not unusual to 
rely on relatives for 
information.
Urgent admission to 
the hospitai
Information transfer 
between care home and 
hospital poor. MAR charts 
may or may not be 
transported with the 
resident. Hospitai may or 
may not have history of 
resident.
Unlikely to be 
transported with 
the resident.
Initiated by care 
home. Not unusual to 
rely on relatives for 
information.
Routine visit by the 
GP
Information transfer 
between care home and 
GP variable.
GP do not usually
supply
medication.
initiated by care 
home.
Urgent medical 
attention from the 
GP
Information transfer 
between care home and 
GP variable.
GP may or may 
not supply 
medication.
Initiated by care 
home.
Care home nurses described a range of healthcare practitioners involved 
in providing care to residents. These included GPs, social workers, 
community psychiatric nurses, physiotherapists, occupational therapists, 
chiropodists, district nurses, palliative care team members, pharmacists 
and dispensers. The nurse who worked in the care home serviced by 
dispensing GPs had little contact with community pharmacies but had 
regular contact with the dispenser in the dispensing GP surgery. The 
other care home nurse described varying levels of communication with 
community pharmacists. Some care homes developed good working 
relationships with their community pharmacy(ies) having regular contact 
either through the telephone or face-to-face while others did not. 
Occupational therapists and physiotherapists were two healthcare 
practitioners identified by one nurse that may need information about 
residents’ medication.
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A theme from the interviews with care home nurses was the variability in 
communication pathways; which healthcare practitioners provided and 
required information, how it was provided and the level of information 
provided across the wider care home system.
GP interviews
Three separate interviews were conducted involving one dispensing GP, 
one non-dispensing GP and a group interview with four partners of a GP 
practice surgery. GPs held different responsibilities towards care home 
residents and had different perceptions of their roles. One GP saw his 
role as providing services to enhance care in care homes. Another GP 
was a designated care home GP and was responsible for all care home 
residents registered with the surgery. Routine fortnightly home visits were 
made to care homes in addition to requests for home visits by care home 
staff. The designated care home GP welcomed input from care home 
staff about any problems that care home residents may have had. She 
found that the routine fortnightly home visits reduced the frequency of 
requested visits.
The four GPs interviewed as a group viewed their roles as any other GP 
who treated patients when requested. A GP in the group of four GPs 
expressed reluctance to make home visits because care home staff 
sometimes made inappropriate requests. Some examples included care 
home staff wanting the GP to discuss care home residents’ health with 
relatives and care home staff requesting home visits for minor problems. 
Time constraint was an issue because some care homes are located far 
away and GPs were concerned about travelling time. GPs were often 
requested to do other tasks by care home staff when they were in the care 
home, adding to their time pressure. It would not be unusual to get called 
to three or four homes in any day for visits. Although they only visit care 
homes when called, the frequency of them being called meant that they
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would usually visit the care home at least once a week. Some GPs 
suggested that care home residents should come to the surgery for 
consultations if they are able to, just like most patients. But there are 
other practical considerations in the care home such as sending a 
member of staff to accompany the care home resident when the care 
home is already short-staffed.
A full description of the findings of the GP interviews surrounding the four 
events or situations that have implications for information transfer are 
presented in Appendix 6. A summary of the findings are presented in 
Table 2.2.
Table 2.2 Summary findings of interviews with GPs
Event/situation Information
Routine visit to care home Information transfer between GP and care home 
variable
Urgent visit to care home Information transfer between GP and care home
variable
Planned admission to hospital Information transfer between GP and hospital, GP and 
care home variable. Lack of information on hospital 
discharge letters.
Urgent admission to hospital Information transfer between GP and hospital, GP and 
care home variable. Lack of information on hospital 
discharge letters.
It can be seen from Table 2.2 that information was variable in all four 
situations presented to GPs. Very rarely would the GP be informed about 
residents’ hospital discharge. They were usually only made aware when 
they received hospital discharge letters or were informed by care home 
staff. GPs complained about the lack of information on hospital discharge 
letters. Discharge letters detail the diagnosis but do not always indicate 
which medications had been initiated or stopped in the hospital, and the 
reasons for the change.
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GPs described a range of healthcare practitioners who are involved in 
providing care to care home residents. Besides GPs themselves, these 
included other GPs in the same practice, GP registrars, nurse 
practitioners, out-of-hours service, care home nurses, carers, community 
pharmacists, dentists, podiatrists, district nurses (for residential homes), 
community physiotherapists, hospital specialists, psychiatrists, psychiatric 
nurses, physicians specialising in elderly care, community matrons and 
phlebotomists.
All GPs interviewed did not have direct contact with the community 
pharmacy but described good relationships with them, although they had 
not defined how the relationship was ‘good’. One GP reported having a 
good relationship with a psychiatrist and district nurse. Psychiatrists will 
inform GPs of their treatment plan in the form of a letter. They seldom 
write prescriptions and usually leave this to the GP. The same GP 
described difficulties communicating with psychiatric nurses.
Community pharmacist interviews
Two pharmacists with previous experience in community pharmacy were 
interviewed. One pharmacist provided a weekly multi-dose monitored 
dosage system (MDS) for a few care homes that provided personal care. 
She visited the care home every half a year to look at medication storage, 
adherence to medication policies, medical fridge temperature records and 
ensure that the care home followed basic ‘rules’ regarding medication. 
Her role did not involve reviewing residents’ medication charts. The 
second pharmacist was a pharmacist in charge of care home MDS 
dispensing. Her pharmacy provided services to 42 care homes. She 
provided advice to care homes and also visited care homes every 6 
months to check the storage of medication in the care home, the use of 
the medication administration record (MAR) for record-keeping, the actual 
medications that residents were prescribed and how it was administered
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to residents. In both pharmacies, a dispenser dispensed medications and 
pharmacists checked the medicines dispensed.
According to the two pharmacists, no two care homes function the same 
way. Some care home residents have more complex needs than others. 
The pharmacists who worked in the community pharmacy that provided 
services to a large number of care homes found it difficult to communicate 
effectively with each care home. It was difficult to meet the needs of 
individual care homes. The community pharmacy that took on fewer care 
homes was able to provide personalised service. There was regular 
contact between the pharmacy and care homes. Whereas the pharmacist 
who serviced fewer care homes was able to develop a relationship with 
each care home, the other pharmacist had never been to some of the care 
homes that her pharmacy provided services to. This was largely due to 
the time and financial constraints imposed by the company.
A full description of the community pharmacist interviews surrounding the 
six situations that have implications for information transfer are presented 
in Appendix 7. A summary of the findings is presented in Table 2.3.
In the first situation, if residents’ prescriptions are not received by the 
pharmacists in time for dispensing, different information sources may be 
used to identify which medications to dispense such as the previous 
month’s MAR or the patient medication record (PMR) on the pharmacy 
computer system. Emergency supplies of medication are not usually 
requested by the care home. However, if emergency requests were made 
by the care home, pharmacists were generally reluctant to provide the 
service.
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Table 2.3 Summary findings of interviews with community pharmacists
Event/situation information Medication
Supply regular repeat 
medication
Prescriptions may or may not be 
received in time for dispensing
Medication may be dispensed 
referring to information 
sources other than the 
prescription
Supply acute 
medication
Prescription may be received via 
fax, telephone or care home brings 
to the pharmacy. MAR chart may 
or may not be provided
May be delivered by the 
pharmacy or collected by the 
care home. May or may not 
be dispensed in an MDS
Emergency supply of 
medication
Not a common situation Not a common situation
Repeat medication is 
changed
May or may not know of medication 
change. Information gained by 
default. Lack of communication 
between care home and GP 
surgery
Medication dispensed like 
other patients
Hospital discharge May or may not know that patient 
was admitted or discharged. There 
was no contact with the hospital 
and a lack of information about 
resident’s medication. Information 
usually obtained via a third party
May or may not be dispensed 
in an MDS
Acute prescription 
dispensed by another 
pharmacy
May or may not know that 
medication had been dispensed by 
another pharmacy
Not relevant
From Table 2.3, it can be seen that community pharmacists may or may 
not have information about a change in the resident’s medication therapy. 
They may receive information if the care home brings a prescription to the 
pharmacy. Changes to repeat medications were often unclear and could 
pose a risk to residents because residents could potentially receive a 
wrong dose of medication. Residents discharged from hospital may be 
supplied with medication dispensed in original packs or a different MDS 
system. Care homes may not use these supplies because they were not 
dispensed in their usual MDS. This is a potential safety issue because 
residents may have two sets of medication increasing the risk of them 
being given the same medication twice. Community pharmacists would 
not normally know that the resident’s medication had been dispensed by 
another pharmacy unless informed by the care home. They may know
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about the change from the old MAR chart where information about the 
new drug had been recorded or when the pharmacy receives a new 
prescription for the new medication in the next month. This suggests that 
the PMR on the community pharmacy’s computer may not be a complete 
and accurate medication history. The lack of information may result in the 
care home using two types of dispensing system and this may lead to 
confusion.
Community pharmacists listed healthcare practitioners that provided care 
to care home residents and these included the GPs, care home nurses, 
CSCI inspectors, care assistants, care home managers who are usually 
nurses, dentists, community psychiatric nurses and psychiatrists. 
Participants reported that there was minimal communication between 
themselves and GPs and little contact with other healthcare providers 
outside the care home.
Hospital pharmacist interviews
Two pharmacists with experience in hospital pharmacy were interviewed. 
One of the pharmacists interviewed was the same pharmacist who was 
interviewed as a community pharmacist because she had experience 
working in both sectors of pharmacy. They were clinical ward pharmacists 
and their roles involved checking hospital patients’ medication to ensure 
that medications are safe, appropriate and available in the hospital. They 
also counselled patients about their prescribed medication.
Hospital pharmacist participants were presented with six situations. A full 
description of the findings of the interviews is provided in Appendix 8. A 
summary of the results are presented in Table 2.4.
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Table 2.4 Summary findings of interviews with hospital pharmacists
Event/situation Medication Information
Hospital admission May or may not be brought to 
hospital. Do not usually use 
medication dispensed in MDS
Usually informed about patient 
admission by chance
Hospital discharge May or may not be dispensed in a 
MDS
Usually informed about patient 
discharge when medication is 
required
Medication change in 
hospital ward
Medication dispensed like other 
hospital patients
Information transfer variable
Patient changes 
wards
May or may not be transferred to 
new ward
May or may not be informed that 
patient was changing wards
Weekend pharmacy 
services
Skeleton services May or may not know about 
patient discharges
Transfer to another 
hospital
May or may not be brought to 
new hospital
May or may not know that patient 
was to be transferred
In each situation, hospital pharmacists may or may not have information 
regarding patient’s medication. Hospital pharmacists may receive 
information when nurses request them to dispense discharge medication 
or when they realise that the patient is not physically in the hospital ward. 
The timing and level of information received by pharmacists were 
dependent on their level of involvement in the ward. Hospital pharmacies 
provided skeleton services during the weekend and pharmacists would not 
know about any discharges until after the weekend. However, patients 
were very rarely discharged on weekends. Hospital pharmacists 
commented that it was difficult to keep different healthcare practitioners 
involved in the transfer of patients to another hospital and the process 
could sometimes be very disjointed.
Hospital pharmacists named healthcare practitioners involved in caring for 
care home residents including discharge nurses, occupational therapists, 
geriatric team consisting of mainly doctors, community liaison nurses, 
diabetic nurses, palliative care nurses, generic nursing staff, GPs and
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physiotherapists. Hospital pharmacists found some GPs helpful and 
maintained contact with the ward nurse.
Summary
In different healthcare settings, professional roles were defined differently 
resulting in different work practices and interactions with care homes. 
There were variable levels of communication between healthcare 
practitioners and healthcare practitioners did not have a complete view of 
the care home medication system. For example, the hospital did not have 
an understanding of the links between the hospital and community 
pharmacists (refer to the green dashed line linking ‘hospital 
doctor/specialist nurse/nurse’ and ‘community pharmacy servicing care 
home’ in Figure 2.5, which is an annotated copy of Figure 2.4). Not 
providing information about medication changes initiated in the hospital 
increases the risk of residents receiving the wrong medication.
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Figure 2.5 Annotated map showing information flow and medication 
transfer in the care home system
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2.3.6 Discussion
Roles of healthcare providers
The same healthcare practitioners had different responsibilities and 
perceptions of their roles. The variation in GP roles in different GP 
practices was greatest. Practical issues about time constraints and the 
types of services provided by GPs were raised. A care home GP had the 
opinion that her designated role as a care home GP and regular fortnightly 
visits to the care home helped reduce the amount of request visits by the 
care home. Care home nurses had multiple roles in the care home 
depending on their skill set and expertise. Community pharmacists’ roles 
differed depending on their workload and funding from the employer. 
Hospital pharmacists’ roles seemed to be influenced by the amount of 
information that they received. The variability in healthcare roles suggests 
that some care homes may have to take on extra tasks to ensure that 
residents receive adequate, appropriate and safe care. In these care 
homes, care home staff members need to be equipped with the relevant 
skills and information to provide the level of healthcare that residents 
need.
Communication in the care home system
Each healthcare setting had their system of communication and 
documentation. Communication among healthcare settings differed 
greatly depending on their roles. For example, the designated care home 
GP developed good communication with care home staff because they 
had negotiated an agreed understanding of healthcare provision to care 
home residents.
Healthcare practitioners were not always aware of the importance of 
relevant, accurate and timely information to other healthcare practitioners. 
Community pharmacists and hospital pharmacists had little access to
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information and their knowledge about the care home resident was often 
gained in chance situations such as when a new prescription is presented 
to the community pharmacy or when the hospital pharmacy receives a 
discharge prescription. It is a safety concern that community pharmacists 
were usually unaware of changes to care home residents' medicines 
because they have the important role of supplying residents’ monthly 
medicines. The risk of supplying medicines that have been stopped by 
the GP is great if they are ‘left out’ of the communication loop. In addition, 
care homes may continue to administer discontinued medicines to 
residents. Hospital pharmacists may also not be aware about changes to 
patients’ care in the hospital.
Every type of healthcare practitioner interviewed discussed the lack of 
information surrounding residents’ hospital discharge. Care home nurses 
and hospital pharmacists may be informed about the discharge prior to 
residents being discharged. The arrival of discharge letters to the GP is 
usually the point when GPs know about a resident’s admission and/or 
discharge from hospital. Community pharmacists may never know that 
the resident has been admitted or discharged from the hospital unless 
informed by the care home or when they received a prescription for 
medication.
When asked to name healthcare practitioners that provided care to care 
home residents, participants were able to identify a range of healthcare 
practitioners. This suggests that they were aware of the wider system 
within which they function and the possible complexities of care. 
However, they did not have a complete understanding of how the system 
functioned as reflected by the level of information that was communicated 
among them.
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There needs to be a co-ordinated approach to improve communication 
involving key healthcare practitioners. A greater understanding among 
healthcare practitioners about each others’ roles and skill set could also 
help facilitate better use of time and skill resources. The study identified a 
need to understand the information needs for each healthcare practitioner 
in order to provide safe and effective services to care home residents.
2.4 Conclusions
There were variations in responsibilities and perceptions of roles within 
each type of healthcare practitioners interviewed. This highlights the need 
for effective communication. Communication is not formalised and 
appeared to be largely determined by individual priorities and practices. It 
was evident that healthcare practitioners develop their own strategies for 
overcoming the communication problems. The success of such strategies 
is likely to depend on the motivation and knowledge of the individuals 
involved and this is risky. A particular problem involved the availability of 
information for community and hospital pharmacists. Healthcare 
practitioners did not have a complete view of the system and focussed on 
their own work setting. There is a need for a co-ordinated communication 
strategy among key healthcare practitioners and a systems view of the 
care home medication system.
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Chapter 3: Prevalence and types of medication 
errors in care homes
3.1 Introduction
This chapter presents the findings of a major epidemiological study that 
investigated the prevalence and types of medication errors in care homes. 
This study formed part of a larger project called the Care Home Use of 
Medication Study (referred to hereafter as ‘the CHUMS study’) (AI Id red et 
al. 2008). The CHUMS study was a 3-year long study commissioned by 
the UK Department of Health and was conducted between the years 2005 
and 2008. The research foundations of the CHUMS study were based on 
a systems approach to investigating medication use in UK care homes. 
The study was conducted in three geographical areas in England, namely 
Bradford, London and Cambridgeshire, This chapter reports one part of 
the research study conducted by the author, in the Cambridgeshire area.
The review of care home literature in Chapter 1 revealed inconsistencies 
in the definitions and methods used to investigate medication safety 
problems. Inappropriate prescribing and adverse drug events were 
primary outcome measures for care home studies conducted across 
different countries (Dhalla at ai. 2002; Gurwitz et al. 2000; Gurwitz et al. 
2005; Lane et al. 2004; Lunn et al. 1997). Measuring safety using these 
outcomes provides only a narrow view of the system and it will be difficult 
to derive and implement strategies that can lead to systemic and 
sustainable change to improve medication safety. To provide a wider view 
of the care home medication system, a systems analysis of the processes 
involved in healthcare provision is needed. Although Gurwitz et a/.’s 
(2000; 2005) studies identified adverse drug events, they also categorised 
events into types of medication errors according to the stages of the care
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process such as prescribing, monitoring, dispensing and administration. 
Their studies provided a clearer view of the weak areas of the care home 
system.
In this study, a systems approach to understanding the care home 
medication system in the UK is adopted. Medication errors at four 
healthcare stages namely, prescribing, dispensing, medication 
administration and monitoring were investigated. A unique feature of 
healthcare provision in Cambridgeshire is the existence of a group of GPs 
who also dispense medication called dispensing GPs (DGPs). DGPs exist 
only in rural areas where the nearest pharmacy is more than one mile 
away. The GP’s primary roles are to diagnose and treat medical 
conditions. Dispensing GPs perform an additional role of dispensing 
medication; a role normally performed by community pharmacies.
3.2 Aim and Objectives
The aim of this study was to establish the prevalence and typology of 
medication errors in care homes. The objectives of the study were to 
identify the prevalence of medication errors at different care stages 
namely, prescribing, monitoring, dispensing and medication 
administration, and to provide a typology of errors. The final study 
objective investigated possible relationships between dispensing services 
provided by dispensing GPs and community pharmacies and dispensing 
error rates.
The level of harm caused by identified errors was an outcome of the 
CHUMS study but was not within the scope of the Cambridgeshire study. 
Nevertheless, the results of the harm assessment study conducted in the 
CHUMS study for the Cambridgeshire area are discussed in parallel with 
the results of this present study.
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3.3 Ethical Approval
Ethical approval was required from several ethics committees. Several 
participants were identified for this study. First, care homes had to 
consent to the study before care home residents were approached. 
Several healthcare practitioners were involved in providing medication to 
residents. These included care home nurses, carers, GPs and community 
pharmacists and participation from them was also crucial for the study. 
Ethical approval was gained from the following research ethics 
committees:
■ NHS Research Ethics Committee, and Huntingdonshire PCT, East 
Cambridgeshire and Fenland PCT, Greater Peterborough Primary 
Care Partnership (PCP) Ethics Committees (Appendix 9)
■ University of Surrey (UniS) Ethics Committee (Appendix 10)
The UniS Ethics committee required additional information to be added to 
the study’s information leaflet. These included a contact number for 
possible complaints and to include a witness signature on the consent 
forms. A letter (see Appendix 11) stating acceptance of these two 
conditions was provided to the ethics committee.
Because elderly residents in care homes are a vulnerable group of people 
in society, the government requires a Criminal Record Bureau (CRB) 
check for those working closely with them. Clearance was granted to the 
researcher.
3.4 Study sample
The sample of resident participants for this present study was dictated by 
the CHUMS study. In the CHUMS study, the target number of residents 
was 300, including 30 from Cambridgeshire. A total of 31 were studied in
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Cambridgeshire from a total of 256 residents studied in the CHUMS study. 
It is recognised that the results from this part of the study, when presented 
independently of the wider CHUMS study could be underpowered.
Care Home
Care homes were sampled from the three PCTs where ethical approvals 
were given. Two types of care homes were sampled: care homes 
providing personal care only and care homes providing personal and 
nursing care. Care homes within these categories that received services 
from dispensing GPs and/or non-dispensing GPs were sampled.
Care home resident
Care home residents who received one or more repeat medications were 
eligible to enter the study. They were excluded if their GP had not 
consented to the study, if they had a prognosis of less than three months 
to live or if they were already part of another study.
GP surgery
Care home residents in care homes that consented to the study are 
registered with GPs. Every GP surgery that provided services to 
consented care homes was approached to participate in the study.
3.5 Participants
3.5.1 Recruitment process
Recruitment was a demanding and lengthy process. Several healthcare 
settings were identified to study four types of medication errors: 
prescribing, monitoring, dispensing and medication administration errors. 
The following healthcare settings were identified:
6 8
■ Care homes
■ GP surgeries
■ Community pharmacies
Healthcare practitioners working within these settings and care home 
residents or their next-of-kin (if residents were not able to consent to the 
study due to cognitive impairments) were the participants of this study.
Figure 3.1 shows the recruitment process. There were twelve steps in the 
recruitment process. These were conducted in order for every care home 
except one where the particular GP surgery was identified and 
approached prior to the recruitment of the care home. The PCT contact 
had established initial contact with the GP surgery instead of the care 
home due to previous working relationships.
Steps 1 to 10 had to be fulfilled before data collection commenced. 
Consent was first gained from care homes, followed by GP surgeries and 
care home residents. It was important to obtain consent in this order to 
avoid care home residents losing confidence in the care home or their 
GPs if either the care home or GPs did not want to participate in the study. 
Pharmacists were initially approached to gain ‘consent to contact' (Step 11 
in Figure 3.1) because they were only contacted if dispensing errors were 
found. During recruitment, the researcher emphasised the adoption of the 
systems approach in the study that avoided targeting specific individuals 
who seemed to have made errors. Confidentiality of every participant was 
also assured.
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Consent
Assent DeclineConsent Decline
Consent
Consent
Able to consent Unable to consent
Decline participation
Decline participation
Decline participation
Step 7: Obtain consent
Step 5; Identify GP surgeries
Step 1: Identify care homes
Step 4: Obtain consent
Step 2: Contact care homes
Step 9: Approach resident and 
provide written information
Step 6: Contact GP surgeries and 
provide written information
Step 3; Provide written information 
to care homes
Step 8: Identify care home residents 
and ability to consent
Step 10: Identify and approach next- 
of-kin, provide written information
Step 12: Provide written information, 
obtain consent
Step 11: Identify and approach 
community pharmacies
Figure 3.1 Participant recruitment process
70
step 1 : Identify care homes
The primary contact point was PCTs. Contact with care homes was 
gained via contacts from each of the three PCTs where ethical approvals 
were gained. The aims, objectives and research approach of the study 
were explained to PCT contacts. They identified potential care homes and 
made initial contact to assess their initial interest in the study.
Step 2: Make initial contact with care homes
From the list of care homes provided by the PCT contacts, the researcher 
made initial contacts with care home managers. For three care homes, 
the researcher physically visited the care homes accompanied by a PCT 
contact. The PCT contact made initial introductions between the 
researcher and care home managers. Other care homes were contacted 
directly by the researcher via telephone. In both methods of making initial 
contact, an introduction to the study was given and an informal response 
gained, usually at the end of the meeting, from care home managers 
about their interest or not in the study.
Step 3: Provide written information to care homes
The third step involved providing written information about the study to 
care home managers. An initial letter introducing the study (Appendix 12) 
and information leaflets (Appendix 13) detailing the study were provided. 
These were provided during initial visits to the care homes or posted in 
cases where contact was initially made via telephone.
Step 4: Obtain written informed consent from the care home
Care home managers were given at least one week to consider their 
participation. Then, they were contacted by telephone first to gain an 
initial response on their interest in the study. If verbal consent was given, 
arrangements were made to visit the care home to explain the study
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again, to provide opportunities for questions and to gain written consent. 
A sample consent form is presented in Appendix 14.
Step 5: Identify GP surgeries and GPs
GP surgeries were identified from care homes that had given consent to 
participate in the study. Collectively, care home residents were typically 
registered with more than one GP surgery. Information about GPs and 
GP surgeries were obtained from care home managers or senior care 
home staff members.
Step 6: Approach GP surgeries and provide written information 
to GPs
Access to GPs was via the GP practice managers. Telephone contact 
was made with practice managers and a brief introduction to the study 
was provided. If their initial interest in the study was either neutral or 
positive, an information pack was posted. The information pack contained 
several documents namely, an introduction letter to the study for practice 
managers (Appendix 15), personalised introduction letter to individual GPs 
(Appendix 16), information leaflet about the study for GPs (Appendix 17) 
and consent forms (Appendix 18). Help was requested from practice 
managers to collate the consent forms from GPs and return them to the 
researcher.
Step 7: Obtain informed consent from GP surgeries
GPs were given approximately two weeks to return the consent forms by 
post via the practice manager. If there was no response by this time, 
practice managers were contacted by telephone to enquire about GPs’ 
interest in the study. Multiple attempts to contact the practice managers 
were usually made. If GPs did not consent, the recruitment process would 
start all over from step 1.
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step 8: Identify care home residents/relatives/carers
Ten residents were initially randomly selected from each care home that 
had consented to the study using a random sampling list (Appendix 19). 
The criteria for recruitment were provided previously in section 3.4 and 
listed again here:
■ Prescribed one or more repeat medications
■ Not already in another study
■ Have a life expectancy of more than 3 months
■ Registered GP gave consent to the study
From the ten randomly selected care home residents, care home 
managers or senior care staff members gave their opinion as to whether 
these residents were able to give consent to the study. If residents were 
considered to be unable to give informed consent, their nearest relative 
was identified. For residents who did not have a nearest relative, the 
resident’s primary carer in the care home was identified. It was important 
not to exclude residents who were unable to give informed consent 
because doing so would seriously undermine the validity of the study due 
to the increased risk of medication errors in residents who are unable to 
understand and engage in their treatment (Alldred et al. 2008).
Step 9: Approach care home residents, provide written 
information and obtain informed consent
All eligible care home residents who were able to give informed consent 
were visited in their care homes. Care home residents were provided with 
an information pack containing an introduction letter (Appendix 20), 
information leaflet (Appendix 21) and consent forms (Appendix 22). The 
researcher explained the study to care home residents in the presence of 
a care home staff member. The contents of the information leaflet were 
explained and residents were provided with the opportunity to ask 
questions during the researcher’s visit. Care home managers were helpful
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in agreeing to answer further questions that residents may have had after 
the researcher had left the care home. They also helped to collate and 
return consent forms to the researcher.
Step 10: Identify and approach relatives/carers, provide written 
information and obtain assent
Care home residents’ next-of-kin were identified if they were unable to 
give informed consent. Care home managers were helpful in either 
providing contact details of relatives or passing information packs on to 
them. Relative information packs consisted of an introduction letter 
(Appendix 23), information leaflet (Appendix 24), assent forms (Appendix 
25) and a stamped self-addressed envelope.
For residents who did not have relatives, the procedure was to approach 
their appointed carer in the care home but none of the randomly selected 
residents fell into this category. However, if there was such a case, the 
carer information pack would include an introduction letter (Appendix 26), 
information leaflet (Appendix 27) and assent forms (Appendix 28).
Step 11: Identify and approach community pharmacies
Community pharmacies providing dispensing services to care homes that 
consented to the study were identified. They were initially contacted via 
telephone and an introduction to the study was provided. Several types of 
responses were obtained at this stage.
■ Pharmacies owned by large pharmacy companies directed the 
researcher to approach personnel at their ‘head office’. Telephone 
contact was made and written information about the study was 
provided if they agreed to receive it.
■ Individual pharmacies agreed to receive written information about the 
study.
■ Pharmacies declined participation.
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step 12: Provide written information and obtain consent to 
contact from community pharmacies
Information packs containing an introduction letter to the study (Appendix 
29), information leaflets (Appendix 30) and consent to contact forms 
(Appendix 31) were posted to community pharmacies that agreed to 
receive information. Consent to contact the pharmacist was obtained at 
this stage because the pharmacist would only be contacted further if 
dispensing errors were identified in the study.
3.5.2 Participant demographics 
Care homes
A total of seven care homes consented to the study.
Nine care homes were approached. From the seven homes that 
consented to the study, three provided personal care only whilst the rest 
provided personal and nursing care. Personal care services include daily 
care such as washing, dressing and feeding. The type of ownerships of 
care homes was well represented. The majority of the care homes 
recruited (n=3, 43%) were part of a large organisation (organisation owns 
more than five care homes). This is followed by private single homes 
(n=2, 29%), private organisations owning between two to five homes (n=1, 
14%) and care homes owned by the local authority which is part of the 
government (n=1, 14%).
GP surgeries
A total of 19 GP surgeries consented to the study: seven DGPs and 12 
non-DGPs.
A total of 25 GPs provided services to the seven care homes recruited for 
the study. Figure 3.2 shows the types of GP surgeries; ten were DGPs
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and 15 were non-DGPs. Between two and nine GP surgeries provided 
care to care homes. Six of the seven recruited care homes received 
services from at least one DGP.
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Figure 3.2 Types of GP surgeries servicing care homes
A total of 23 of the 25 GP surgeries were approached for this study. The 
other two GP surgeries were not approached because they each had only 
one resident registered with them and it was not time efficient to recruit 
every GP surgery. GPs took from one week to two months to respond. 
Table 3.1 shows consent rates from GPs. High consent rates from both 
DGPs and non-DGPs were found. There was however a lot of difficulty in 
recruiting GP surgeries, primarily due to the lack of initial response from 
GP practice managers and GPs. The delay in gaining response delayed 
the study.
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Table 3.1 GP surgery recruitment
Type of GP surgery No. approached No. consented
Dispensing GP surgery 9 7
Non-dispensing GP surgery 14 12
Residents
A total of 34 residents were recruited for the study but only 31 residents 
were studied because a resident was hospitalised during data collection, a 
resident died before data collection and an assent form arrived after data 
collection had commenced.
Table 3.2 shows a summary of resident recruitment. A total of 52 care 
home residents were approached to enter the study ranging from three to 
eight residents per care home. A high recruitment rate of 65% (34/52) 
was found. Most of the residents were unable to give consent to 
participate in the study (n=40) and assent was obtained from their nearest 
relative. A higher assent rate from relatives at 68% (27/40) was found 
compared to consent from residents at 58% (7/12).
Table 3.2 Resident recruitment
Resident recruitment No. approached No. consented/assented
Resident 12 7
Relative 40 27
From the 31 residents studied, 81% were female and they were generally 
slightly older than the men: 85.8 compared to 83 years old. The average 
age of residents was 85.3 years and the range was between 68 to 101 
years old. Care homes from which residents were recruited provided 
personal care only or personal and nursing care. In care homes that 
provide both personal and nursing care, residents can either be registered
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as a residential or nursing resident. There were slightly more residential 
residents (n=17) studied compared to nursing residents (n=14).
Dispensing service providers
The sample of care homes recruited for the study received dispensing 
services from community pharmacies and DGP surgeries. A total of 11 
community pharmacies and three DGP surgeries provided dispensing 
services to the seven care homes recruited for the study.
It was the assumption at the start of the study that DGP surgeries would 
provide dispensing services to care home residents that registered with 
them. However, this was not the case. Only three of the seven DGP 
surgeries recruited dispensed to care home residents. More interestingly, 
only two of the three DGP surgeries provided full dispensing services. 
The third part-dispenses, meaning that only particular medications are 
dispensed such as medication that cannot be packaged into an MDS. 
MDS is described in more detail in section 3.9.1. From the six care homes 
that received medical services from DGP surgeries, only two received 
dispensing services. Despite that, every care home used dispensing 
services from at least a community pharmacy.
Community pharmacies were approached to gain ‘consent to contact’ 
because the procedure for identifying dispensing errors determined by the 
CHUMS methodology did not involve observing dispensing practices in 
community pharmacies or dispensing GP surgeries. Pharmacies were 
only contacted if dispensing errors were identified during the study. There 
were difficulties approaching some of the community pharmacies either 
because there were no permanent pharmacists who dealt with care 
homes or the requirement to contact the head office of the larger multiple 
community pharmacy companies. Nevertheless, information about the
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study was posted to eight community pharmacies. Only one community 
pharmacy returned a ‘consent to contact’ form at this stage of the study.
3.6 Data collection tools
Investigating the use of medication in care homes was complex. The 
systems approach advocated for this study required an understanding of 
the context in which medication was prescribed to care home residents. 
Therefore, this study also investigated the care home and its environment. 
The complexity of the study led to the development of several tools and a 
data collection guide. The “Dimmies Guide to CHUMS data collection” 
(referred to hereafter as “the CHUMS data collection guide”) was 
developed by the CHUMS team (Alldred et al. 2008). The CHUMS data 
collection guide introduced and explained the use of the data collection 
tools that were adopted in this current study. The next two sub-sections 
discuss these tools.
3.6.1 The care home and its environment
Background information about the care home was collected using a 
template called the care home familiarisation profile (Appendix 32). 
Information collected in this profile included the type of care provided, the 
size of the care home, staffing levels, staff credentials and relevant 
training received, healthcare practitioners involved in residents’ care, 
processes relating to medication provision and descriptive information 
about the care home’s relationships with relevant healthcare practitioners.
The care home familiarisation profile provided background information 
about the structure and processes in the care home. However, the 
environment of the care home was not easily captured by the profile. 
Therefore, general observations of the care home were conducted to
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provide a better understanding of the care home environment. These 
observations were recorded using a field notes template (Appendix 33). 
Aspects of the care home environment observed included the care home 
building, residents, staff, general documents, MAR charts, observations of 
drug rounds, communication with additional prescribers, availability of 
computer software or hardware and any additional comments including 
the general atmosphere in the care home.
3.6.2 Care home residents and provision of healthcare
A database was developed by the CHUMS team to collect information 
about care home residents. The database provided the background 
information for the identification of medication errors. Information 
recorded in the database included patient information such as age, 
gender, reason for care home admission, renal and liver function tests, 
height and weight. Residents’ medical history, current medication 
prescribed, allergies, other types of medication administered or taken by 
the resident, health monitoring results, the data sources used to collect 
resident information and details of any errors identified were also recorded 
in the database. The CHUMS data collection guide provided a detailed 
account of the use of the database. Figure 3.3 shows a snapshot of the 
database.
Additional data collection tools were developed by the CHUMS team to 
collect data related to different stages of care. At the prescribing stage of 
care, a medication review form (Appendix 34) was developed as a tool for 
identifying prescribing errors. A data collection form for dispensed items 
(Appendix 35) and a medication administration data collection form 
(Appendix 36) were used to collect information about dispensed items and 
medication administration. These aided the identification of dispensing 
and medication administration errors respectively.
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Figure 3.3 Database for resident data collection
A notebook was also kept during data collection and used to record any 
information about the care home or the care home residents’ care that 
was not already recorded elsewhere. The notebook also served as a 
reminder to the researcher to investigate specific issues that may be 
relevant to the healthcare of care home residents.
3.7 Method familiarisation and standardisation
This study was conducted as part of the CHUMS study that also studied 
care homes in the Bradford and London areas in England. To become 
familiar with the methods used to collect data and to ensure consistency 
across the three research areas, pharmacist researchers attended a two- 
day training course conducted by the CHUMS team. The content of the 
two-day training included:
■ Aims and objectives of the CHUMS study.
■ The role of pharmacist researchers.
■ General introductions to care homes including the context of care 
homes such as the types of care homes, the running of a typical care 
home, types of documentations used in the care home, the laws and 
regulations governing the running of care homes, introduction to key 
stakeholders and establishing relationships with them.
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■ Ethical and research governance issues including recruitment of 
participants and gaining informed consent.
■ Introduction to the qualitative and quantitative methods used in the 
research study and guidance on
o recording information about the care home and its environment 
o observing medication administration rounds 
o action on discovery of an error 
o interviewing healthcare staff (including role-play) and 
o medication reviews.
Definitions of errors and differentiating between errors and optimum 
practice were introduced. Data collection forms, the CHUMS database 
and data management issues were discussed.
■ Nature of the research in terms of separating research and practice.
■ Introduction to error theories and ways of studying the causes of 
errors.
■ Health and safety issues relating to performing research in the care 
home.
Because the other two research pharmacists had begun collecting 
research data and it was important to ensure consistency in the methods 
used for data collection, the researcher shadowed each of the 
pharmacists in Bradford and London. Although the data collection method 
was largely similar, both pharmacists had different experiences because 
they had varying years of practice as pharmacists. Hence there were 
slight differences in their approach to the research study. Table 3.3 
summarises the research activities observed in a total of four visits; one in 
Bradford and three in London. These research activities ranged from 
approaching care homes for recruitment, data collection in care homes 
and a GP surgery, and conducting medication reviews. However, not 
every activity was observed in both Bradford and London. Hence, the
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researcher may not know how the other pharmacist collected some types 
of data.
Table 3.3 Method familiarisation process: research activities observed in 
Bradford and London
Research Activity Bradford London
1. Care home introductory visit N Y
2. Care home profiiing N Y
3. Use of database V Y
4. Writing field notes Y Y
5. Dispensing check Y N
6. Medication administration rounds Y Y
7. GP surgery visit: accessing resident information Y N
8. Medication reviews Y Y
9. Care home staff interview Y Y
Key: Y = observed, N = not observed
A discussion about interviewing GPs was conducted separately with the 
principal investigator of the London research area. The first four 
medication reviews of care home residents conducted by the researcher in 
the Cambridgeshire area were reviewed by the CHUMS project manager 
(who is a clinical pharmacist experienced in conducting medication 
reviews) and the research pharmacist from the Bradford research area to 
ensure consistency. This method familiarisation and standardisation 
process was necessary to deal with issues of rigour such as the validity 
and reliability of the research findings.
3.8 Procedure
3.8.1 Care home information
A profile of the care home was first developed using the care home 
familiarisation profile (Appendix 32). Care home managers and/or senior
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care home staff members were involved in this data collection process. 
Observations of the care home environment were recorded using the field 
notes template (Appendix 33). Observations were recorded throughout 
the data collection period that typically lasted around two full working 
days.
3.8.2 Resident data
Care home resident data were primarily collected using the CHUMS study 
database introduced in section 3.6.2. Data sources from the care home 
and the GP surgery were used. In the care home, data sources used 
included:
■ current MAR charts
■ previous MAR charts (at least one month)
■ resident’s repeat medication lists
■ GP communication book
■ care records/nursing notes/client profile
■ hospital discharge information
■ other healthcare professionals’ communications (if available)
■ laboratory reports/investigations (if available)
■ anticoagulant clinic book (if relevant)
■ other shared care books (if available)
■ accident book
■ any other documents relating to medication
Most GP surgeries have computerised patient records and these were 
accessed to obtain information about resident’s medical history, including 
current and past prescribed medication, GP consultation notes, 
investigations and laboratory results. In GP surgeries that did not use 
computerised records, paper records were accessed.
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3.8.3 Prescribing errors
Prescribing errors were identified using definitions, clinical judgement and 
medication reviews.
Definition
The definition of a prescribing error used in this study was adopted from 
the CHUMS study and is as follows:
“A prescribing error occurs when as a result of a prescribing 
decision or prescription writing process there is an unintentional, 
significant reduction in the probability of treatment being timely and 
effective or an increase in the risk of harm when compared to 
generally accepted practice” (Alldred et al. 2008:28).
The study reviewed medications that were prescribed by the GP and 
generally included tablets, capsules, creams, ointments, gels, inhalers, 
sprays, liquids, patches, enemas, suppositories and injections. Some 
exceptions included dressings, catheters, nutrition drinks and vitamins 
whether prescribed by the GP or not.
Identifying errors
Identifying prescribing errors depended on clinical judgment and the use 
of data sources such as the CHUMS database, medical and 
pharmaceutical references such as the British National Formulary (BNP) 
and medical textbooks, and clinical medication reviews. A clinical 
medication review was conducted for each participating care home 
resident. Detailed preparation was made before each medication review. 
This included gathering all information about each resident’s medical 
problems and medication prescribed, noting any previously documented 
issues with medication, identifying possible problems and preparing
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questions to clarify any ambiguous issues with residents or healthcare 
practitioners. These were recorded on a standard form as shown in 
Appendix 34.
Medication reviews were then conducted with resident participants, senior 
care home staff members or the care home manager. Reviews with 
residents were conducted face-to-face whilst reviews with care home staff 
members were either conducted face-to-face or via the telephone. 
Problems and questions relating to resident’s medication that were 
prepared earlier were discussed. During the medication review, additional 
prescribing issues may be identified. These were further analysed by 
referring back to the information sources. The researcher produced a 
report of the review using a standard template (Appendix 37) and these 
were sent to care home residents’ GPs.
Prescribing issues identified in the medication reviews were not 
necessarily errors. They were classified using a list of definitions of the 
types of prescribing errors presented in Table 3.4, used and developed by 
the CHUMS team (Alldred et al. 2008:31). The CHUMS data collection 
guide also provided examples of prescribing errors. However, if the 
researcher thought that the prescribing issue could be an error despite it 
not matching the list in Table 3.4, the prescribing issue was discussed with 
the other two CHUMS research pharmacists that collected data in the 
Bradford and London areas. If an agreement was not reached, the issue 
was discussed with the CHUMS team that consisted of a range of 
healthcare professionals including GPs and clinical and academic 
pharmacists.
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Table 3.4 Types of prescribing errors (Alldred et al. 2008:31)
Type of error Description
Omission Failure to prescribe a drug that has been previously prescribed or had 
been initiated by another HOP and which was not intentionally stopped 
by prescriber, or failure to prescribe a drug that was clinically 
Indicated.
Patient incorrect Prescribing for the wrong patient.
Unnecessary drug Prescribing a drug for which there is no indication. Note that not all 
diagnoses are always written in the notes. Excludes when residents 
and/or relatives put pressure on the GP to prescribe an unnecessary 
drug.
Duplication Two drugs which have the same action are prescribed together in 
error e.g. generic and branded, two different statins, two different 
forms of the same drug. Excludes intentional prescribing e.g. anti- 
Parkinsonism drugs.
Drug incorrect Choosing the wrong drug e.g. when two drugs have similar names.
Allergy error Prescribing a drug for which the patient has a known drug allergy.
Contraindication Prescribing a drug which is contraindicated because of a co-existing 
clinical condition.
Interaction Prescribing a drug which may cause a serious drug interaction, unless 
this was a recognised risk and appropriate action taken to reduce risk 
e.g. if two interacting drugs were both considered essential for patient 
and dose adjustments had been made or a further drug added to 
address this.
Dose/strength error Prescribing a drug in a dose above or below that appropriate for that 
patient and/or for their clinical condition.
Formulation error Prescribing a drug in a formulation that is unsuitable for the route of 
administration including modified release preparations for 
administration via a PEG.
Frequency error Prescribing a drug for which the frequency is inappropriate and would 
result in a sub-therapeutic effect or risk of toxicity.
Timing error Prescribing a drug for a time which is unsuitable for that preparation 
e.g. prescribing simvastatin in the morning.
Information Omission of strength for drugs available in more than one strength.
incomplete Omission of route for drugs that can be given by more than one route 
e.g. eye, ear and nose drops. Patient name omitted. Omission of 
maximum daily dosing frequency for an “as required” medicine when 
overdose could result in harm. Omission of directions for correct 
administration (eg prescribing GTN tablets “as directed”.
MAR transcription Poor transcription on to the MAR by the prescriber which results in an
error error e.g. use of Latin abbreviations on MAR in a residential home.
Other Record anything else that is not covered in the above.
Linked error To be used if a prescribing error is linked to another error e.g. 
prescription and dispensing of penicillin to a penicillin allergic patient.
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Classified prescribing errors were subsequently entered into the CHUMS 
study database. Prescribing errors could be linked to other types of 
medication errors such as if a dispensing or medication error was a direct 
result of a prescribing error. For example, a resident with a penicillin 
allergy was prescribed penicillin. This medication was dispensed and/or 
administered to the care home resident. These errors are recorded as 
‘linked errors’.
Denominator
The determination of denominators or opportunities for prescribing errors 
followed the CHUMS study and is as follows:
“The number of opportunities for error was the number of 
prescription items written, plus any omissions” (Alldred et al. 
2008:30).
3.8.4 Monitoring errors
Monitoring errors were identified using definitions and information from 
care home and GP records.
Definition
There had been no agreed definitions to date for monitoring resident’s 
drug levels and clinical conditions. Hence, a concurrent study by the 
CHUMS team was conducted to develop a definition of a monitoring error. 
The Delphi technique was used and the study participants included 
general practitioners and clinical pharmacists. The resultant definition was 
used in this study and is as follows:
“A monitoring error occurs when a prescribed drug or disease is not 
monitored in the way which would be considered acceptable in
routine general practice. It will include the absence of tests being 
carried out at the frequency listed in the tables below with tolerance 
of +50%. This means that if a drug requires liver function tests 
(LFTs) at 3 monthly intervals, we would class as an error if a test 
has not been conducted within 18 weeks. If a patient refused to 
give consent for a test, then this would not constitute an error.” 
(Alldred et al. 2008: 33).
Tables 3.5 and 3.6 show the required type(s) of monitoring on 
maintenance and initiation of specific medication prescribed by the GP.
Table 3.5 Medication monitoring for maintenance therapy (Alldred e ta l.
2008: 34)
Drug/drug group Maintenance monitoring
ACE inhibitor 12 monthly U&E
Amiodarone 6 monthly TFT 
6 monthly LFT
Azathioprine 3 monthly FBC
Carbimazole 3 monthly TFT (6 monthly if patient been stabilised for over 1 year)
Digoxin Digoxin level if toxicity or lack of efficacy suspected
Diuretics 12 monthly U&E
Glitazones 12 monthly LFT
Levothyroxine 12 monthly TFT
Lithium 3 monthly lithium levels 
12 monthly TFT
Methotrexate 3 monthly FBC 
3 monthly LFT 
6 monthly U&E
Sulfasalazine FBC 3 monthly in f  year 
LFT 3 monthly in 1®* year 
FBC 6 monthly in 2" year 
LFT 6 monthly in 2"  ^year 
No further monitoring if stable
Theophylline Theophylline level if toxicity suspected
Valproate 3 monthly LFT for first 6 months
Warfarin 12 weekly INR
Key:
ACE inhibitors = angiotensin converting enzyme inhibitors
U&E = urea and electrolytes
LFT = liver function test
TFT = thyroid function test
FBC = full blood count
INR = international normalised ratio
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Table 3.6 Medication monitoring for initiation of therapy (Alldred etal. 
2008:35)
Drug/drug group Monitoring on initiation
ACE inhibitors On initiation: Pre U&E and 2 weeks after
Digoxin Pre U&E
Diuretics Pre U&E and 1 month after starting
Glitazones Pre LFT
Key:
ACE inhibitors = angiotensin converting enzyme inhibitors 
U&E = urea and electrolytes 
LFT = liver function tests
Identifying errors
Monitoring errors were identified using the list of criteria listed in Tables 
3.5 and 3.6 and information recorded in the database. Each prescribed 
medication is matched to the list of specific drugs that need monitoring 
presented in Table 3.5 and 3.6. If the prescribed medication requires 
monitoring, the information recorded in the CHUMS database showed 
whether the relevant test(s) had been performed and whether it was within 
the required frequency of tests stated in the criteria. The CHUMS study 
identified and described four types of monitoring errors. These were used 
in this study and presented in Table 3.7. Classified monitoring errors were 
then entered into the CHUMS study database.
Denominator
Prescribed medication for each resident, that required monitoring 
according to the validated criteria presented in Tables 3.5 and 3.6 were 
the denominators for monitoring errors.
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Table 3.7 Types of monitoring errors (Alldred et al. 2008:35) 
Type of error Description
Monitoring not 
requested
Requested but not 
done
Results not available
Results not acted 
upon
The prescriber has not requested monitoring, which would normally be 
considered necessary -see Tables 3.5 and 3.6. Note that if the patient 
has refused to be monitored this should be recorded as this is unlikely 
to be considered an error.
For example, blood pressure, blood sample, urine sample etc have not 
been taken although it has been requested by the prescriber. Note as 
much detail as possible in the comments box. The cut-off point will be 
the requested time + 50%. For example: GP requests thyroid function 
tests in 6 weeks time. Not done more than 9 weeks later. Cut off 
point= Sweeks + 3 weeks = 9weeks, therefore considered to be an 
error.
The tests have been done but the results either have not been sent or 
have been lost.
The results have been received and clinically significant results 
recorded but these have not been acted upon.
3.8.5 Dispensing errors
Dispensing errors were identified using definitions and a visual check of 
dispensing accuracy.
Definition
The definition of dispensing errors adopted from the CHUMS study was as 
follows:
“One or more deviations from an interpretable written prescription 
or medication order, including any written modifications to the 
prescription made by a pharmacist following contact with the 
prescriber. In contrast to many studies of dispensing errors, 
‘clinical’ screening errors, such as dispensing a drug to which the 
patient has a documented allergy, will be included” (Alldred et al. 
2008:36).
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Identifying errors
A visual check of dispensed medication was conducted to identify 
dispensing errors. Firstly, the CHUMS database was used to make a list 
of all the medication prescribed for the resident. Then, information printed 
on the dispensing labels of every medication for the particular resident 
found in the drug trolley and in separate cupboards was recorded onto a 
data collection form (Appendix 35). This information was checked against 
the list of medication prescribed to the resident that was previously 
extracted from the CHUMS database. Any discrepancies were matched 
against the list of types of dispensing errors presented in Table 3.8 that 
was developed and used in the CHUMS study.
Classified dispensing errors were subsequently entered into the CHUMS 
study database. Errors could be linked to other types of medication errors 
such as prescribing and medication administration errors and these were 
recorded as ‘linked errors'.
Denominator
The number of prescription items dispensed or omitted constituted the 
number of opportunities for dispensing errors, as determined by the 
CHUMS study.
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Table 3.8 Types of dispensing errors (Alldred et al. 2008:36-38)
Type of error Description
Content errors
Omission Failure to dispense a prescribed item.
Un prescribed drug Dispensing a medication that was not prescribed e.g. supplying a drug 
that had been discontinued.
Drug incorrect Dispensing a drug that is different to that prescribed. Excludes changes 
made following the pharmacist contacting the prescriber to correct an 
error.
Dose/strength error Dispensing a dose unit containing the wrong amount of the correct drug, 
without an appropriate adjustment to the dosing instructions.
Formulation Dispensing the correct drug in a dosage form different to that prescribed.
error Includes supplying a modified release formulation when a standard 
formulation was prescribed.
Extra dose(s) Dispensing a larger quantity of medication to that prescribed. If a MDS is 
used it will include where an extra tablet has been put in a compartment 
by mistake.
Missing dose(s) Dispensing a smaller quantity of medication to that prescribed. If a MDS 
is used it will include where a tablet has been left out of a compartment. 
N.B: if a tablet has “slipped” so one compartment has none and another 
has extra this will be two separate dispensing errors.
Timing error Dispensing a medication into a monitored dosage system (MDS) at a 
different time of day to that prescribed or usually recommended for that 
drug. Dispensing medicine in the wrong colour tray or sheet eg 
donepezil prescribed at night but dispensed in pink “morning” tray; 
warfarin dispensed in white “short course “ or “as required” tray.
Frequency error Dispensing a medication into a MDS at a different frequency to that 
prescribed. This includes dispensing a drug prescribed to be taken 
“when required” into the regular dosing sections of the MDS.
Patient incorrect Dispensing the correct medications but for the wrong patient e.g. if two 
patients had similar names.
Deteriorated drug Dispensing a medication that has exceeded its expiry date or has been 
stored at a temperature different to that required, or for which the 
primary packaging is damaged.
N.B: Drugs in a heat sealed MDS system have a shelf life of 8 weeks.
Labelling errors
Patient name Omission of the patient’s name or use of a different name to that on the
incorrect prescription.
Drug name The drug name on the label deviated from that specified by the
incorrect prescriber, except where amendments are necessary to conform to good 
pharmaceutical practice. An example would include a modified release 
product which was not labelled as such.
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Drug strength Where more than one strength available, the strength on the label is
incorrect different to the strength of the drug supplied.
Quantity incorrect The drug quantity on the label deviated from that specified by the
prescriber, except where amendments are necessary to conform to good 
pharmaceutical practice, or where there is a record of medication owing.
The dosage on the label deviated from that specified by the prescriber 
except where amendments are necessary to conform to good 
pharmaceutical practice, (eg: substituting a specific dose or maximum 
daily dose when prescriber has indicated “as directed”).
Omission of the date of dispensing or use of a date different to that on 
which the product was dispensed. Note that MDS are sometimes pre­
packed and if so should have an additional label (probably out of sight) 
which has batch number, original expiry date and date of dispensing.
Route The route has not been stated for medicines which can be administered
error/omission via more than one route e.g. eye, ear and nose drops.
Dosage incorrect
Date incorrect
Instructions
incorrect
The instructions deviated from those prescribed, except where 
amendments are necessary to conform to written local policy or good 
pharmaceutical practice.
Additional
warning(s)
Omission or use of incorrect additional warnings, according to 
professional references (for example the BNF in the UK). E.g. omitting 
BNF label 25 for modified release preparations.
Pharmacy address
Other labeling 
errors
Failure to include the correct name and address of the supplying 
pharmacy on the label. This is down as “additional information” error in 
database.
No label Failure to add a dispensing label (eg tube of cream or inhaler; multiple
packs dispensed with only one label on transparent outer wrap.
Any other labelling error not included in the above categories.
Clinical errors
Allergy error
Contraindication
Interaction
Dispensing a drug for which the patient has an allergy and the pharmacy 
is aware of the allergy.
Dispensing a drug which is contraindicated in that patient and where the 
pharmacy could be reasonably expected to have had knowledge of this 
e.g. from the other drugs that the patient is taking.
Dispensing a drug which could result in a serious drug interaction.
Other Any other error not included in the above categories.
Linked error Use to record that the dispensing error is linked to another error e.g. 
administration error.
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3.8.6 Medication administration errors
Medication administration errors were identified using definitions and the 
observation of two medication administration rounds.
Definition
The definition of medication administration errors used in the CHUMS 
study was defined as:
“Any deviation between the medication prescribed and that 
administered" (Alldred et al. 2008:39).
The CHUMS study considered the timing of particular types of medication 
to be important (see Table 3.9) and deviation from the correct 
administration time was considered to be an error.
Identifying errors
Two medication administration rounds were observed for each care home: 
one evening and one morning following informed written consent from 
care home staff. An information leaflet (Appendix 13) was provided and 
the study was explained to care home staff. They were given time to 
consider their participation and a consent from (Appendix 38) was signed 
if they agreed to be observed during the medication administration rounds.
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Table 3.9 Medications for which timing is considered clinically significant 
(Alldred etal. 2008: Appendix F)
Medications Description
Blsphosphonates If given less than 30 minutes before breakfast or other medications, or 
after food or other medications.
Nitrates If timing is such that there is no nitrate free period.
Antibacterials Only note these if you consider the timing is such so that it is possible 
that the drug would not be clinically effective e.g. those antibiotics which 
should be taken on an empty stomach but have been given at mealtimes, 
or there is a significant gap between doses which has not been due to the 
resident refusing a dose.
NSAIDs Given on an empty stomach.
Antidiabetic E.g. sulphonylureas or short acting insulin given late at night when no
medication food will be consumed until breakfast thus increasing the risk of 
hypogiycaemia.
Nateglinide/ Have short duration of action and should therefore be given shortly
repaglinide before each main meal. Timing error should be considered if either drug 
is given more than one hour before food.
Anti-Parkinsonism Where medication has been prescribed to be given at specified times in
drugs order to control symptoms adequately, but is being given more than 1 
hour before or after.
Opioids If given in such a way that there is a risk of overdose or clinicai 
ineffectiveness, e.g. MST Continus given 8 hours instead of 12 hours 
apart can potentially result in breakthrough pain.
Paracetamol Doses of Igm given less than 4 hours apart.
Statins Except atorvastatin, which are given in the morning rather than in the 
evening.
Warfarin If not given at the regular time for that resident, usually 5 or 6pm.
Antacids If given at a time so that the absorption of other drugs is adversely 
affected e.g. lansoprazole, tetracyclines, bisphosphonates, ciprofloxacin.
Prior to observation of a medication administration round, a list of all the 
medication that should be administered to each resident during the 
particular medication administration round was made by referring to the 
CHUMS database. These were recorded onto a data collection form 
presented in Appendix 36. Just before the medication administration 
round, the researcher re-iterated the purpose of the observation to the 
care home staff and stressed that the care home staff member should try 
to conduct the medication administration round as he/she normally does.
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The researcher positioned herself near to the drug trolley that contained 
residents’ medication during observation (an example of a typical drug 
trolley is presented in Figure 4.2 in Chapter 4). This was important so that 
the researcher gained a clear view of the care home staff preparing 
medication from the drug trolley and to ensure that the information on the 
MARs could be easily read. The MARs were usually placed near or on 
top of the drug trolley (an example of a MAR chart is presented in Figure 
4.3 in Chapter 4).
During the medication administration round, the researcher would note 
whether each resident’s medication was administered and whether the 
correct technique was used. These were recorded onto the same data 
collection form in Appendix 36. Any discrepancies were matched with the 
types of errors described in Table 3.10.
Classified medication administration errors were then entered into the 
CHUMS study database. Errors could be linked to other types of 
medication errors such as dispensing and prescribing and these were 
recorded as ‘linked errors’.
Denominator
The denominator for medication administration errors was determined by 
adding the number of doses of medication given to residents and any 
doses that had been omitted.
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Table 3.10 Types of medication administration errors (Alldred etal. 
2008:40)
Type of error Description
Omission A dose of medication that has not been administered by the time of the 
next scheduled dose. Does not include doses omitted according to doctor’s 
instructions, nurse’s clinical judgement (N.B. only be relevant in care 
homes with nursing), if resident refuses or if resident not at the home).
Allergy error Administration of a drug for which the patient has a known drug allergy
Extra dose(s) The administration of an additional dose of a prescribed medication. 
Includes administration of a drug more times in the day than prescribed 
and administration of a dose of drug after it has been crossed off the MAR.
Wrong dose The administration of the correct drug by the correct route but in a quantity 
that was not that prescribed. Includes administering inhaled steroid without 
spacer when one is available; administration of incorrect number of dose 
units; failure to shake a bottle of suspension prior to admission; 
measurement of an incorrect volume of an oral liquid. Where liquid 
preparations are not measured correctly or poured into non-graduated 
medicines cups, a wrong dose error has occurred only when the observer 
is certain that the wrong volume has been administered. If wrong strength 
is given because of a dispensing error this is still an MAE, but it will be 
linked to the dispensing error.
Unprescribed The administration of a drug that was not prescribed for the patient
drug concerned (classified as a “drug incorrect” error if drug X prescribed but 
drug Y given instead). This may occur if medication had been stopped by 
the prescriber but was not removed from drug trolley.
Drug A dose of a drug administered that is not the drug prescribed. This could
incorrect occur if administration followed an undetected dispensing error and would 
be a linked error.
Formulation The administration of the correct dose of the drug by the correct route but
error in a formulation that was not prescribed. Includes administration of a 
modified release when non-modified prescribed, and vice versa. This may 
be linked to a dispensing error if the wrong form was dispensed.
Route error The administration of the correct drug by a route or site which was not that 
prescribed.
Deteriorated Administration of a drug that has exceeded its expiry date or a drug with its
drug physical or chemical integrity compromised, where none of above error 
types occurred. N.B. Note that MDS have a shelf life of 8 weeks from date 
of dispensing and are sometimes prepacked and if so should have an 
additional label (probably out of sight) which has batch number, original 
expiry date and date of dispensing.
Timing error Timing errors will only be recorded if the timing of the administration could 
have clinical significance -see Table 3.9.
Other Use to record anything that is not covered above.
Linked error Use to record that the MAE is linked to another error e.g. dispensing error.
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3.8.7 Review data and validate database
Three meetings were held with the research pharmacists in the Bradford 
and London areas and the CHUMS research steering group during the 
data collection period to resolve any ambiguities regarding the 
identification of medication errors. On completion of data collection and 
identification or errors, the research pharmacist in the Bradford area 
reviewed all the identified medication errors in this study. Any 
disagreements were discussed and resolved. Independent reviews of 
resident care records were however not performed due to time 
constraints.
After collating, analysing and identifying different medication errors, 
information collected for each resident participant was reviewed. The 
information on the database, data collection forms and relevant notes 
recorded on the notebook were revisited to check the accuracy of the 
information used to identify medication errors and whether any errors had 
been missed. The information in the database was checked using a 
standardised method (see Appendix 39) developed by the CHUMS team.
3.9 Findings
3.9.1 Medication and dispensing systems 
Medication
A total of 213 prescription medications were prescribed to 31 residents 
(based on the denominator for prescribing error) and these were 
examined. Of these, 77% were repeat medication. There was a lack of 
information to indicate whether medications were repeat or acute in 12% 
of the medication examined. The mean number of medications prescribed 
to residents was 7.5 and ranged from 1 to 15.
99
Medication dispensing
Two types of dispensing systems were used in care homes. Medications 
were either dispensed in their original containers or in an MDS. MDS can 
supply a calendar month, 28 or 7 days’ worth of medication. Single tablets 
or capsules are removed from their original packaging and re-packed into 
single dose or multi-dose MDS systems. In single dose MDS, only one 
capsule or tablet is placed in the compartment. Figure 3.4 shows an 
example of a single-dose MDS (Manrex Ltd. 2008).
Figure 3.4 Single-dose MDS
Multi-dose MDS can contain more than one medication prescribed to 
residents at that particular time of day in the compartment. See Figure 3.5 
for an example of a multi-dose MDS (Surgichem Ltd. 2008).
Figure 3.5 Multi-dose MDS
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The study found the majority of care homes (n=5) used a type of 
monitored dosage system (MDS). A total of 74% of residents used either 
a multi-dose or a single dose MDS system. The multi-dose MDS (61%) 
was more popular than the single-dose (39%).
3.9.2 Prevalence and typology of medication errors
Because of the small study sample size and the fact that the population 
standard deviation is unknown, confidence intervals were calculated using 
the t distribution rather than the normal distribution (Dawson & Trapp 
2001). In this calculation the standard error is used as an estimate of the 
population standard deviation. This results in wider confidence intervals 
than would be the case if the normal distribution was used.
Overall findings
Table 3.11 presents the overall findings of the study. Overall, over half of 
the residents studied (58.1%) experienced at least one medication error. 
The overall number of errors per opportunities of error (prescribing, 
monitoring, dispensing and medication administration) was 7.2% (95%CI 
5.1-9.2). The range of errors was 1 to 10 errors per resident.
The most common type of medication error per opportunities of error was 
dispensing (8.5%) and medication administration (7.3%) errors.
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Table 3.11 Summary of the prevalence of medication errors
Prescribing Monitoring Dispensing Medication
administration
Overall
No. residents 
with an error 
[n=31] 
(%;95%CI)
10
(32.3%;
14.8-49.7)
1
(3.2%;
0.0-9.8)
9
(29%;
12.1-46.0)
7
(22.6%;
7.0-38.2)
18
(58.1%;
39.7-76.5)
Mean no. of
errors/
resident
[n=31]
(95%CI)
0.42
(0.16-0.68)
0.03
(0.00-0.10)
0.68
(0.08-1.27)
0.29
(0.08-0.51)
1.42
(0.68-2.16)
No. of errors/ 
opportunities 
of error 
% (95%CI)
13/213 
6.1 (2.9-9.3)
1/29 
3.5 (0.0-10.5)
21/246 
8.5 (5.0-12.0)
9/124 
7.3 (2.7-11.9)
44/612 
7.2 (5.1-9.2)
Prescribing Errors
The prevalence of prescribing error was 6.1% (95%CI 2.9-9.3). Thirteen 
errors were identified from the total number of opportunities for error. Ten 
residents had at least one prescribing error representing 32% of the 
residents studied. The mean number of prescribing errors per resident 
was 0.42 (95%CI 0.16-0.68).
Table 3.12 shows the nature or typology of prescribing errors. The most 
common type of prescribing error was incomplete information being 
provided when prescribing (53.8%). An example of a prescribing error 
classified under ‘information incomplete' included the direction ‘as 
directed’ for administering inhalers and glyceryl trinitrate spray. Specific 
instructions need to be provided to avoid under-dosing or over-dosing the 
resident. The second most common type of prescribing error was ‘other 
prescribing error’ (23.1%) and examples included continuous prescribing 
of a particular medication without review, prescribing the old dose of a 
medication and ambiguous prescribing instructions.
1 0 2
Table 3.12 Nature or typology of prescribing errors
Type Number %
Unnecessary drug: no Indication 1 7.7
Contraindication 1 7.7
Dose/strength error 1 7.7
Information Incomplete 7 53.8
Other prescribing error 3 23.1
Total 13 100
Monitoring Errors
The prevalence of monitoring error was 3.5% (95%CI 0-10.5). One error 
was identified from the 29 opportunities for error. Medications prescribed 
to residents that were listed in Tables 3.5 and 3.6 were examined for 
monitoring errors. One resident experienced a monitoring error. The 
mean number of monitoring errors per resident was 0.03 (95%CI 0-0.10).
The one monitoring error found was classified as ‘results not acted upon’. 
The care home resident was prescribed Levothyroxine tablets 50 
micrograms “One daily” for hypothyroidism. These tablets were crushed 
and administered via a percutaneous endoscopic gastrostomy (PEG) 
tube, a type of feeding tube for people who have difficulties swallowing. 
Residents taking Levothyroxine tablets should have a yearly TSH level 
test. This test was performed more than a year ago and recorded a high 
level of 7mlU/L. There was no recorded action taken to correct the 
abnormal level.
Dispensing errors
The prevalence of dispensing errors was 8.5% (95%CI 5-12) where 21 
errors were identified from 246 opportunities for error. The majority of 
errors identified (17/21) involved the use of an MDS with 13/17 found in 
medications dispensed in a multi-dose MDS. A total of 29% of residents 
had at least one dispensing error (9/31) with 4 of the 21 errors found in
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nursing residents. The mean number of dispensing errors per resident 
was 0.68 (95%CI 0.08-1.27).
The most frequent types of dispensing error were labelling errors followed 
by content errors. ‘Other labelling errors' (48%) was the most frequent 
type of labelling error (refer to Table 3.13). Examples included no 
description or wrong description of tablets or capsules in the MDS. The 
most frequent type of content error was ‘deteriorated drug’ (14%) where 
dispersible tablets were dispensed into the MDS. Dispersible medication 
should not be dispensed into MDS because they are hygroscopic (absorb 
moisture) and unstable in a MDS.
Table 3.13 Nature or typology of dispensing errors
Type Number %
Content error
Missing dose 1 4.8
Timing error 1 4.9
Deteriorated drug 3 14.3
Labelling error
Instruction incorrect 6 28.6
Other labelling error 10 47.6
Total 21 100
Medication administration errors
The prevalence of medication administration errors was 7.3% (95%CI 2.7- 
11.9). Nine errors were identified from 124 opportunities for error. A total 
of 14 medication administration rounds were observed in seven care 
homes involving 31 residents. From the nine errors identified, three were 
identified in nursing residents (33.3%). A total of 22.6% of residents had 
at least one medication administration error (7/31). Three of the seven
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residents who experienced an error were nursing residents. The mean 
number of medication administration errors per resident was 0.29 (95%CI
0.08-0.51).
Table 3.14 shows the typology of medication administration errors. The 
most common type of medication administration error was ‘other 
administration error’ (44%) and examples of this type of error included not 
following specific instructions for administering medication. The second 
most common type of medication administration error was omission or not 
administering prescribed medication (33%).
Table 3.14 Nature or typology of medication administration errors
Type Number %
Omission 3 33.3
Extra dose 1 11.1
Wrong dose 1 11.1
Other administration errors 4 44.1
Total 9 100
One of the nine errors (11.1%) identified involved the use of an MDS. 
Other errors involved the use of an inhaler (n=1 ), medications not suitable 
for dispensing in MDS (n=3), acute medications such as antibiotics (n=2) 
and medications that were previously prescribed to be given when 
required (n=2).
3.10 Discussion
To date, few studies have been conducted in English care homes focusing 
on medication safety. Care homes where most care home studies have 
been conducted, particularly the US, vary in terms of work organisation, 
how medicines are prescribed, supplied and financed, and the laws and 
regulations that surround the provision of healthcare. Hence, this
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discussion focuses on care home studies conducted in England. This 
study was part of the wider CHUMS study, the first large-scale care home 
research study in the UK. Because of the lack of care home studies in 
England, references were made to the overall CHUMS study results in this 
discussion. The CHUMS study was conducted in three geographical 
areas in England namely, Bradford, London and Cambridgeshire (this 
study).
3.10.1 Demographics and medication dispensing systems
According to a market study conducted by the Office of Fair Trading in the 
year 2000 that looked at care homes across the UK, 75% of residents 
were female (OFT 2005). In this study, 80.5% of the residents studied 
were female. The overall CHUMS study studied 69.1% female residents 
(Alldred et al. 2008). The proportion of females studied in this study was 
largely representative of the gender proportion in care homes.
The average age of care home residents was 84 years old, according to 
the OFT study (OFT 2005). The average age of residents both in this 
study and the overall results of the CHUMS study was 85 years old, 
similar to the findings of the OFT.
The mean number of medications prescribed per resident in this study 
was 7.5, with a range of 1-15 medications. A similar mean was found in 
the Bradford area, 7.7 (range 1-19) and London, 8.4 (range 1-25) (Alldred 
at ai. 2008). Overall, the mean number of medication prescribed was 
similar to the figure identified in Lunn et a/.’s (1997) study that investigated 
inappropriate prescribing in English care homes where the mean was 7.1 
(range 0-15).
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There were slightly more residential residents (54.8%) recruited for this 
study compared to nursing residents (45.2%) and this was similar to the 
wider CHUMS study where 54.3% of residents studied were residential 
residents.
The use of MDS in this study and the London area was similar at 74% and 
76.9% respectively (Alldred et al. 2008). Bradford found a very high 
usage of MDS at 96% (Alldred et al. 2008). Overall, the CHUMS study 
found single-dose blister systems (70.4%) more widely used than multi­
dose cassette systems (18.5%). However, this was contrary to this study 
where multi-dose cassette systems (61%) were more popular than the 
single-dose blister systems (39%). To date there have been no published 
studies investigating the use of MDS in care homes so it is difficult to know 
whether the results were representative of the types of dispensing 
systems used in care homes.
The average number of GP surgeries per care home was 2.7, ranging 
from 2-9. The CHUMS study found variation in the London and Bradford 
areas where the average number was 1.35 (range 1-3) and 5.3 (range 1- 
14) respectively (Alldred et al. 2008). Although the majority of care homes 
recruited in this study received services from DGPs, not every DGP 
provided dispensing services to care home residents. Every care home 
used at least one community pharmacy. The provision of care in care 
homes in Bradford and London did not involve DGPs. Variation in the 
organisation of healthcare in different parts of England showed the 
complexity and suggests the potential for variation in the provision of 
healthcare.
The assumption at the start of the study was that DGPs dispensed 
medication to care home residents. However, the results of this study 
showed otherwise. There was insufficient number of DGPs recruited for
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this study that dispensed to care homes to investigate whether the rates of 
dispensing error were affected by the dispensing service provider.
3.10.2 Prevalence and typology of medication errors
The same methods and definitions were used across the three 
geographical areas in the CHUMS study. However, the sample size of 
this study was small compared to Bradford and London. Where data for 
the CHUMS study conducted in the Bradford and London areas are cited, 
usually referred to in the discussion as the Bradford and London areas, 
these were taken from the CHUMS report (Alldred et al. 2008).
Prescribing errors
The prevalence of prescribing errors in this study was slightly lower than 
the Bradford and London areas; 32% vs. 41% and 40% in the Bradford 
and London areas, respectively. Prescribing errors were identified in 6.1% 
of all prescription medications examined. This was slightly lower than the 
results in Bradford and London where they found the prevalence of errors 
to be 9.8% and 7.5% respectively. The mean number of errors per 
resident was 0.42 and was also slightly lower than Bradford and London 
where the means were 0.67 and 0.57 respectively.
Although the prescribing error results were lower in this study compared to 
Bradford and London, there was no statistically significant difference in the 
prevalence of prescribing errors per resident, per medication examined 
and the mean number of errors per resident (Alldred et al. 2008).
Literature reporting prescribing error rates in UK care homes was limited 
at the time of this study. Besides the results reported by CHUMS, Lunn et 
al. (1997) was one of the very few studies reporting prescribing issues in 
UK care homes. They assessed the extent of inappropriate prescribing in
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five nursing home involving 101 residents using consensus derived criteria 
by an expert panel. Lunn et al. (1997) found a higher percentage (53%) of 
residents experiencing one or more inappropriate prescriptions. Several 
methodological differences made it difficult to interpret the results of this 
study in light of Lunn et a/.’s (1997) study. Lunn et al. (1997) studied only 
commonly used medication, not every medication that was prescribed to 
residents and also included dressings. They also included monitoring 
issues in their assessment of inappropriate prescribing. Consensus 
derived criteria were used to assess inappropriate prescribing whilst this 
study used clinical judgement and clinical medication reviews to identify 
prescribing errors. Lunn et al. (1997) commented that the true number of 
inappropriately prescribed medication was likely to be greater than what 
they found because their study only examined a limited number of more 
commonly used medication.
The most common type of prescribing error was incomplete information 
being provided when prescribing (53.8%). The overall CHUMS study also 
found “incomplete information” to be the most common type of prescribing 
error at 37.9%. There were no other studies that provided information 
about the types of prescribing errors for comparison.
There are inherent difficulties defining “inappropriate medication” and 
deciding what ideal or acceptable treatment goals are (Gurwitz et al. 
1990). The task of determining the prevalence of prescribing errors is 
therefore a very challenging one. The reliability of the results could be 
increased by using a second independent researcher to review the data 
sources. Time and financial constraints however did not allow this to 
happen in this study. Hence the results may be an underestimation of 
prescribing errors because a second reviewer may identify prescribing 
errors that may have been missed in the first review. A second researcher 
did however reviewed prescribing errors that were identified in this study
109
and any disagreements with classification were resolved, improving the 
reliability of identified prescribing errors. The second review did not 
uncover additional prescribing errors that may have been missed out in 
the initial analysis.
Monitoring errors
The prevalence of monitoring errors was lower than the Bradford and 
London areas. The number of residents with at least one monitoring error 
was 3.2% compared to 5.8% in Bradford and 18.3% in London. The 
prevalence of monitoring errors was 3.5% per medication, much lower 
than the findings of the other two CHUMS research areas with 6.3% in 
Bradford and 30.8% in London. There was a statistically significant 
difference between the results in this study and the Bradford area, with the 
London results (Alldred et al. 2008). The mean number of errors per 
resident was 0.03 for this study, lower than 0.06 for Bradford and 0.23 for 
London.
Only one monitoring error was identified in this study and the type of error 
was “results not acted upon", contrary to Bradford and London where the 
most common type of monitoring error was “not requested” representing 
100% and 91.7% respectively.
There have not been other studies that investigated monitoring errors in 
English care homes. Although the three research areas in the CHUMS 
study used the same definitions and methods to identify errors, other 
factors such as work organisation may have influenced the prevalence of 
monitoring errors. Differences in work organisation in GP practices in the 
London research area could have contributed to the high monitoring error 
rate (Alldred et al. 2008). This shows the complexities of monitoring the 
effects of medication that extend beyond the process of testing and 
interpreting biochemical results.
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Dispensing errors
Twenty nine per cent of residents examined in this study had at least one 
dispensing error, lower than that identified in the Bradford and London 
areas. There was a statistically significant difference between the 
CHUMS study areas with Bradford having the highest prevalence of 
dispensing error at 47.1% (Alldred of al. 2008). A rate of 8.5% of the 
medications examined had at least one error. This was a lower rate 
compared to Bradford and London. There was a statistically significant 
difference between the CHUMS study areas, with Bradford having the 
highest rate at 13.2% (Alldred at al. 2008). The mean number of 
dispensing errors per resident was 0.68 compared to 0.85 for Bradford 
and 0.63 for London with no statistically significant differences between 
areas (Alldred et al. 2008).
Most of the dispensing errors identified in this study involved the use of an 
MDS and the majority of these were found in medications dispensed in 
multi-dose MDS systems. The wider CHUMS study found that residents 
who had experienced a dispensing error were statistically more likely to 
have their medications dispensed in a multi-dose MDS rather than a 
single-dose MDS but there was no difference between single-dose MDS 
and non-MDS (Alldred et al. 2008). Looking at individual dispensing 
errors rather than residents, medications dispensed in multi-dose MDS 
were statistically more likely to have an error compared to single-dose 
MDS and non-MDS (Alldred et al. 2008).
The most common type of dispensing error was “other labelling errors” 
(n=10, 48%). The London area also reported “other labelling error” to be 
the most common type of dispensing error at 42.4%. However, the 
Bradford area reported “no label” to be the most common type of 
dispensing error at 27.3%.
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There have been no reported studies investigating dispensing errors in 
English care homes. The methods used in the CHUMS study involved 
visually checking dispensed medication by a single researcher at a 
specified point in time. An inherent problem when checking dispensing 
systems visually is the reliability of the results. There had not been a 
second visual check by the same researcher or by another researcher. 
This may have resulted in over or under-estimation of dispensing errors.
Medication administration errors
There were no other UK care home studies that reported medication 
administration error rates. In this study, 22.6% of residents had at least 
one medication administration error and this figure was similar to Bradford 
and London with 21.5% and 25% respectively, with no statistically 
significant difference between the three study areas (Alldred et a/.2008).
The prevalence of medication administration error was 7.3%, lower than 
Bradford and London with 8.1% and 9.2% respectively (Alldred et al. 
2008). The mean number of medication administration errors per resident 
in this study was 0.29. The Bradford and London areas found a higher 
mean at 0.40 and 0.58 respectively (Alldred et al. 2008). Although the 
Bradford and London research areas found higher prevalence and higher 
mean number of medication administration errors per resident, there were 
no statistically significant difference to the results found in this study 
(Alldred et al. 2008).
The most common type of medication administration error was “other 
administration error” (n=4, 44.4%) followed by “omission” (n=3, 33.3%). 
However, the Bradford and London areas identified “omission” and “wrong 
dose” to be the most frequent type of medication administration error.
1 1 2
This study found the majority of medication administration errors in 
residential residents, consistent with the overall CHUMS study. There 
was increased odds of a medication administration error with the use of 
non-MDS medication delivery system versus an MDS system in the 
overall CHUMS results, whether it was a multi-dose cassette or single­
dose blister system (Alldred et al. 2008). The most common type of errors 
related to the use of inhalers and liquid medication in the wider CHUMS 
study (Alldred et al. 2008). The results of this study were consistent with 
the wider CHUMS findings, with only one of the nine errors involving the 
use of an MDS. There is a need for further research to assess the impact 
of the use of MDS on medication administration error rates.
Overall findings
The results of the study showed a high prevalence of medication errors. 
Six in ten residents experienced at least one medication error (prescribing, 
monitoring, dispensing and medication administration). This figure was 
comparable to the overall CHUMS results where seven in ten residents 
experienced at least one medication error.
A total of 7.2% of medications examined (per opportunities for error) had 
at least one medication error, lower than the overall CHUMS results at 
9.1%. The mean number of errors per resident found in this study was 
also lower than the overall CHUMS results, 1.42 versus 1.91.
The most common type of medication error per opportunities of error was 
dispensing (8.5%) and medication administration (7.3%); contrary to the 
overall CHUMS study where monitoring (14.7%) and dispensing (9.8%) 
errors were the most common.
There have been many studies that investigated medication errors in other 
healthcare settings besides the care home in the UK. The prevalence of
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prescribing errors identified in this study was 6.1%, similar to Shah et a/.’s 
(2001) study involving GPs in primary care where 7.5% of prescribed 
items examined had an error. They also identified the most common error 
related to directions, similar to this study (Shah et al. 2001). Dean et al. 
(2002a) examined prescribing errors in hospitals by reviewing medicines 
charts and they found a lower rate of prescribing errors at 1.5%. No 
studies that examined monitoring errors were found in the current 
literature.
Dispensing errors identified in this study were higher at 8.5% compared to 
rates identified by Dean Franklin & O’Grady (2007) in community 
pharmacy (3.3%) and Beso et al. (2005) in hospital (less than 1%). 
Alldred et al. (2008) reviewed 10 comparable medication administration 
studies conducted in UK hospitals and found an average error rate of 5% 
(range 3% to 8%). The result of this study at 7.3% showed slightly higher 
rate of medication administration error than the average error rate in 
hospitals. There was no comparable study of medication administration 
errors in the primary care setting. Overall, the prevalence of medication 
errors in care homes was higher than that found in primary and secondary 
care when comparing available studies. However, the differences in the 
study methods made it difficult to compare the results of different studies.
Despite the high prevalence of medication errors, most of these errors 
were not considered to have caused serious harm to residents. This study 
did not assess the level of harm of medication errors but the wider 
CHUMS study conducted a harm assessment. They used an expert panel 
to assess the potential of harm for each error using a 0-10 scale (0=no 
effect, 10=death) (Alldred et al. 2008). The following results were taken 
from the CHUMS report. The largest mean harm score was for monitoring 
errors at 3.7 (range 2.8-5.2), followed by prescribing errors at 2.6 (range
0.2-5.8), dispensing errors at 2.0 (range 0.2-6.6) and medication 
administration errors at 2.1 (range 0.1-5.8). However, only identified
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errors were assessed for their potential harm. Because this study was not 
designed to assess harm, errors that may have the potential to cause 
serious harm may not have been captured. Residents may be in hospital 
because of their need for medical treatment that cannot be provided within 
the care home. These residents were excluded from the study. The 
prevalence of medication errors and the possible harm caused to 
residents could be underestimated in this study.
This current study suffered from the problem of a small sample size and 
large confidence intervals, thereby affecting the reliability of the findings. 
Further studies are needed, with a larger representative sample of 
different types of care homes to confirm the findings of this study, as 
conducted in the CHUMS study.
3.10.3Study challenges and limitations
There were several challenges conducting this complex study. 
Recruitment of participants was challenging especially the GP surgeries 
because of difficulty contacting the surgery and delays in obtaining written 
consent. As residents were only recruited after obtaining GP's consent, 
the recruitment process and data collection were delayed considerably. 
Access to residents' medication was restricted in some care homes and 
led to difficulties collecting information about medication.
Identifying medication errors was a complex and difficult process. 
Although the study identified errors based on definitions, there was still an 
element of subjectivity in identifying and classifying errors. In cases where 
there was ambiguity in deciding whether an error had occurred, 
discussions with the CHUMS research team, including the two research 
pharmacists from the Bradford and London areas, were held and a 
decision made.
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There were several limitations to the study. The sample of care home 
residents and care homes studied was small totalling 31 residents and 7 
care homes. Sampling of care homes was largely opportunistic. 
Participating GP surgeries were those that provided services to care 
homes which consented to the study. The estimation of medication errors 
may be an underestimation because those who had concerns about their 
practice may have been less willing to participate in the study than those 
who agreed to participate.
The investigation was performed by one pharmacist researcher. Due to 
time and financial constraints, primary data sources were not reviewed by 
a second researcher and this may have some implications for the validity 
and reliability of the medication error results. However, a second reviewer 
did review identified errors independently and any disagreements between 
pharmacist researchers were resolved. A continuous observation period 
may have revealed more accurate dispensing and medication 
administration error rates. However, continuous observations require 
considerable resources that may not be practical in many studies.
3.11 Conclusion
The primary outcome for this current study was to establish the 
prevalence and a typology of medication errors. Six in ten residents 
studied experienced at least one medication error. These results were 
comparable to the results of the overall CHUMS study, the first large scale 
study in England that investigated the prevalence and typology of 
medication errors in care homes according to care stages where they 
found seven in ten residents had at least one medication error (Alldred et 
al. 2008). A typology of medication errors was also provided in this study.
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This type of data is important and useful for understanding the problem of 
medication errors in care homes. However, it would be difficult to identify 
strategies to reduce medication errors based solely on the data obtained 
in this study. By identifying the causes of medication errors, more 
informed strategies could be derived to improve the safety of the care 
home medication system. It is clear from this study that the care home 
medication system involves various healthcare settings such as the GP 
and community pharmacy. When investigating the causes of medication 
errors, a whole systems view of the care home system that considers the 
wider context of where and why medication errors happen should be used. 
The next chapter analyses the causes of medication errors identified in 
this study.
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Chapter 4: System analysis of medication errors
4.1 Introduction
The previous chapter discussed the potential shortcomings of only 
exploring the prevalence and types of medication errors and advocated a 
need to understand the causes of these errors so that strategies for 
system improvements can be developed. Several studies have used a 
systems approach to analyse the causes of adverse events or medication 
errors (see among others, Dean et al. 2002b; Garnerin et al. 2006; 
Gawande et al. 2003; Knudsen et al. 2007; Neale et al. 2001; Rex et al. 
2000; Rogers 2002; Taylor-Adams et al. 1999). The systems approach 
acknowledges that incidents or errors occur as a result of several factors, 
largely because of decisions made at higher levels of the organisation and 
these decisions filtering through different layers of the system before 
resulting in errors (Reason 1990). Hence, focusing on individuals at the 
sharp end of the error seldom leads to sustainable change in the system 
or reduces incident or error rates (Reason 1990).
In this chapter, a systems approach is used to understand the causes of 
medication errors using ‘Systems Analysis of Clinical Incidents: The 
London Protocol’ (Taylor-Adams & Vincent 2004). This is the updated 
version of a method developed following the first large scale UK study 
investigating adverse events in hospitals. This established systems 
analysis method uses a standardised analytical framework to analyse 
errors and was pilot tested in primary care, secondary care and mental 
health settings (Taylor-Adams & Vincent 2004).
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4.2 Aim and objectives
The aim of the study was to identify factors contributing to medication 
errors and develop strategies for reducing medication errors in care 
homes.
The objectives of the study were to use a systems incident analysis 
method called the ‘Systems Analysis of Clinical Incidents; The London 
Protocol’ (referred to hereafter as The London Protocol) (Taylor-Adams & 
Vincent 2004) to analyse the factors contributing to the medication errors 
identified in the previous study and develop strategies to reduce 
medication errors.
4.3 Sample
Medication errors, identified in Chapter 3, for which there was contextual 
information were analysed. The following sections describe the data 
sources used to gather information about medication errors.
Resident and care home data
Data collected about residents and care homes for the study described in 
Chapter 3 were used. These included:
1. Care home profile of care homes where errors occurred,
2. CHUMS database of information about residents who experienced 
a medication error,
3. Observation notes of the care home environment and medication 
administration rounds and,
4. Medication reviews of residents who experienced errors.
These data sources provided background information about residents, the 
care provided to residents, medication errors and the environment of the 
care home where errors occurred.
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Interviews
Although resident and care home data provided useful information about 
the medication errors, information about the context in which these errors 
occurred could not be derived. Each medication error was explored 
further by interviewing relevant healthcare practitioners about factors that 
may have contributed to medication errors. These were semi-structured 
interviews.
GPs were approached if prescribing or monitoring errors were identified. 
For dispensing errors, community pharmacists were interviewed. The 
care home staff members who conducted the relevant medication 
administration rounds were approached if medication administration 
error(s) was identified. The intention was to interview relevant healthcare 
practitioners as soon as errors were identified. However, this was not 
always possible for prescribing and monitoring errors. The following 
sections explain why.
Prescribing and monitoring errors
Determining which GP was directly involved in the identified prescribing or 
monitoring error was not always possible. In some cases, it was difficult to 
identify when a prescribing error was first introduced or when monitoring 
tasks were not performed by GPs. Hence, determining which GP to 
interview was not straightforward. Care home residents were normally 
registered with one GP but in some GP surgeries, appointed GPs take 
charge of the care of all care home residents. Hence, care home 
residents may be registered with a GP but treated by another GP. It was 
also the norm for care home residents to be routinely treated by more than 
one GP. Sometimes, it was possible to identify which GP had initiated 
changes in medication therapy from the consultation notes on the GP's 
computer. In other cases, it was ambiguous. As a result, care home
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residents’ registered GP or the appointed GP were approached to be 
interviewed.
Semi-structured interviews were conducted and guided by a GP interview 
schedule (see Appendix 40). All interviews were audio-taped with the 
permission of the GP. Interviews were transcribed by the researcher (also 
the interviewer) on the same day or the next day following the interview.
Dispensing errors
For dispensing errors, community pharmacists who provided dispensing 
services to care homes were approached for interviews. Section 3.5.2 
discussed the difficulty obtaining responses from community pharmacists 
to participate in the study. Community pharmacists were contacted by 
telephone again at this stage and the purpose of the interview was 
explained. Most pharmacists were either busy, claimed not to supply 
medication to care home residents or were not contactable. Only one 
pharmacist consented to be interviewed. Appendix 41 shows the 
interview schedule used to interview community pharmacists.
Medication administration errors
Care home staff members who conducted the relevant medication 
administration round where errors were identified were approached for 
interview as soon as the observed medication administration round was 
completed. The interview schedule used to interview care home staff is 
presented in Appendix 42.
Outcomes
A total of 11 interviews were conducted with different healthcare 
practitioners. Three GPs were interviewed and these explored eight of the 
13 prescribing errors identified in the previous study. One interview was 
conducted face-to-face, one via email contact and one via telephone. The
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only monitoring error identified in Chapter 3 was not explored further by 
interviewing the GP because the error was identified late in the study and 
the same GP had previously been interviewed about other prescribing 
errors. For dispensing errors, only one community pharmacist agreed to 
be interviewed and the interview explored one dispensing error. The 
interview was conducted via the telephone because the pharmacist was 
constrained by time. Finally, four carers and three nurses were 
interviewed face-to-face about six and three medication administration 
errors respectively, exploring all nine medication administration errors 
identified in Chapter 3.
However, only medication administration errors were analysed in this 
study because although GPs and pharmacists were interviewed about 
prescribing and dispensing errors, there were problems using the data to 
analyse the errors. It was difficult to explore the causes of specific 
prescribing and dispensing errors with GPs and pharmacists in the 
interviews because it was difficult for them to recall the particular incident. 
There was also a lack of background information about the GP and 
pharmacists' work environment.
4.4 Analysis of medication errors
Medication administration errors were analysed using The London 
Protocol (Taylor-Adams & Vincent 2004). The analysis involved five 
stages and is described in detail in the next sections.
4.4.1 Stages of analysis
Stage 1 ; Develop case summaries
The first stage of the analysis involved producing case summaries for 
each medication administration error. Data sources used to produce the
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nine case summaries included profiles of care homes, the CHUMS 
database with individual resident data, field notes about the care home 
environment and medication administration rounds, medication reviews for 
residents who had experienced a medication error and transcripts of 
interviews conducted with carers and nurses. Case summaries were 
presented using four general headings:
1. Resident information
2. Medication administration and supply in the care home
3. The care home environment
4. Other relevant information.
Stage 2: Determine chronology of events
Next, a chronology of events was determined for each error and presented 
as a timeline. The chronology of events was determined by reviewing the 
respective case summaries. In some cases, data sources described and 
used in stage 1 were revisited.
Stage 3: Identify care delivery problems (CDPs)
The third stage involved identifying CDPs. Two features of CDPs were 
described by Taylor-Adams & Vincent (2004:7):
■ Care deviated beyond safe limits of practice
■ The deviation had at least a potential direct or indirect effect on the 
eventual adverse outcome for the patient, member of staff or general 
public.
For each error, the chronology of events and error case summary were 
used to determine CDPs. The CDPs corresponded to the chronology of 
events.
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stage 4: Identify contributory factors
The ‘Framework of Contributory Factors influencing Clinical Practice’ 
(shown in Table 4.1) from The London Protocol was used to identify 
possible factors leading to each CDP.
Table 4.1 Framework of contributory factors influencing clinical practice 
(Taylor-Adams & Vincent 2004)
Factor Type Contributing influencing factor
Organisational & management factors Financial resources & constraints 
Organisational structure 
Policy, standards and goals 
Safety culture and priorities
Work environmental factors Administration 
Building and design 
Environment 
Equipment/supplies 
Staffing
Education and training 
Workload/hours of work 
Time factors
Team factors Verbal communication
Written communication
Supervision, seeking help and teamwork
Congruence/consistency
Leadership and responsibility
Staff colleagues response to incidents
Individual (staff) factors Competence
Skills and knowledge
Physical and mental stressors
Task components factors Availability and use of protocols 
Availability and accuracy of test results 
Decision-making aids 
Task design
Patient factors Condition
Personal
Treatment
History
Staff-patient relationship
This framework covered six categories of contributory factors: 
organisational and management, work environment, team, individual 
(staff), task and patient. Within each category, several contributory factors
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were listed. For example, verbal communication and written 
communication were factors within the team category. The relevance of 
each contributory factor was assessed for each CDP. Case summaries 
and data sources described in stage 1 were frequently referred to confirm 
or disconfirm the contributory factors that led to medication errors.
Stage 5: Develop recommendations
The final step was to make recommendations for system improvement 
using a systematic method. For every identified error contributory factor, a 
corresponding recommendation was derived. All the recommendations 
derived were abstracted to produce high-level system recommendations. 
To illustrate, recommendations derived from two separate error analyses 
could be to train staff to use inhalers and train staff to administer 
antibiotics. The corresponding high-level system recommendation would 
be to train staff on medication administration.
4.4.2 Example of an analysis
To provide a clearer description of the method used to analyse medication 
errors, an example of an analysis is presented here. The example used is 
the omission of a medication and is identified by code 02-01-02-CC-ZC1. 
The summary of the error is presented here and it is useful to read the 
case summary first to follow the subsequent stages of the analysis. The 
data sources are included in parentheses throughout the summary.
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Case Summary of error 02-01-02-CC-ZC1
Classification; Administration - Omission 
Home: 02-01-02 
Patient: GC-ZC
Date error identified: 25 ’^’ October 06.
Description o f Error: Care home resident not given paracetamol tablets in the 
m orning drug round by senior supervisor due to a lack of medication supply.
Inform ation about resident
Current medical condition: ZC has arthritis (pain) in her hands and takes 
paracetamol to help with this condition. Her GP increased the dose of 
paracetamol from ‘2 tablets four times a day when required’ to ‘1 to 2 tablets four 
times a day’ on 6^  ^October 06 (database: patient review).
History with paracetamol: Her lunchtime dose of paracetamol was omitted the 
whole of the previous month. It was 3 weeks into this month’s medication cycle 
and she had also not been taking her lunchtime dose of paracetamol. The 
evidence was seen by the unsigned MAR charts for the previous and current 
medication cycle (database: patient review). This may be due to ZC refusing 
paracetamol, her not been given paracetamol or that she had taken her 
medication but there had not been records to indicate the action. Whatever the 
reason, there had been no records to indicate any reasons for non-administration 
of the lunchtime doses of paracetamol. The senior supervisor who was 
interviewed reported that the GP had, in previous occasions, ordered to stop 
paracetamol but would re-start ZC on paracetamol within 2-3 weeks because of 
the recurring pain and swelling in her hands. The restarting dose was usually 
‘four times daily’. This was gradually reduced to ‘twice a day’. ZC would 
sometimes require the maximum 8 paracetamol tablets a day whilst on other 
days only 2 paracetamol tablets (interview).
Medication adm inistration and supply
Medication administration and training: Performed by senior supervisors or senior 
carers in this care home providing personal care only. Staff administering 
medication were trained to at least level 2 of the National Vocational Qualification 
(NVQ), and had undertaken a distance learning course on medication 
administration and the care home’s in-house training program before being able 
to administer medication (field notes, care home profile). The distance learning 
course ran in 5 parts over 3 months and included an assessment in the care 
home by an assessor from the college running the course. The in-house training 
program consisted of drug round observations and question and answer 
sessions and the trainee shadowed competent staff during training (care home 
profile).
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The senior supervisor being observed during the morning medication 
administration round had undertaken the distance learning course 18 months ago 
and was due to have a refresher course (interview).
Medication ordering: Performed by senior supervisors or the care home 
manager. The repeat medication list for each resident is normally used to order 
monthly repeat medications (care home profile). Medications collected from the 
community pharmacy were checked by the care home manager or senior 
supervisors (care home profile).
In this case, the senior supervisor who conducted the observed morning 
medication administration round had requested a new prescription for 
paracetamol from the GP surgery (interview). The repeat medication list showed 
the last request for paracetamol was on the 9^  ^ October 06. 224 tablets were 
issued and the dosage instructions was '2 tablets four times a day when 
required'. Other medications on the repeat medication list were last issued on 
the 17^  ^ October 06. The senior supervisor reported that ZG’s dose had been 
increased from twice a day to four times a day, and that the prescription had only 
supplied 100 tablets and that it was not sufficient for a month (interview). The 
GP had actually changed the dosage of paracetamol from ‘2 tablets four times a 
day when required’ to ‘1 to 2 tablets four times a day’ and the last prescription 
issued 224 tablets. On receipt of the new prescription for paracetamol, the 
prescription was brought to the pharmacy (care home profile) to be dispensed 
(care home profile, interview).
The process from requesting a new prescription for a medication to the 
medication being dispensed in the pharmacy normally takes a couple of days 
(interview). The care home profile recorded that this process takes 1 day or 
immediately. It was usual for the care home to collect dispensed medication 
from the pharmacy (care home profile, interview) and the observed senior 
supervisor said that she was going to collect the paracetamol from the pharmacy 
(interview). The supply of paracetamol had been ready in the pharmacy for at 
least 1 day (database; patient review) but had still not been collected. The 
pharmacy is located about 1/3 mile away (care home profile). Note: the 
researcher had asked the senior supervisor for directions to the GP surgery and 
the senior supervisor directed the researcher by driving her car to the surgery 
and asking the researcher to follow behind. The surgery was about 2 minutes 
drive from the care home.
As a result of non-availability of paracetamol, ZG had not been given 
paracetamol tablets the previous 2 days (data collection form for dispensed 
items). The senior supervisor said that stock supply of drugs e.g. paracetamol or 
co-codamol will be used if the resident’s own supply had run out because of a 
change in medication therapy (interview). The researcher observed that the 
senior supervisor had not checked the drug trolley or drug cupboard for stock 
supplies of paracetamol. The senior supervisor had not communicated with ZG
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to inform her that there were no paracetamol tablets. ZC had also not requested 
for any paracetamol tablets (observer recall). The care home encountered the 
same problem of a lack of paracetamol tablets supply the previous month, 
indicated by code ‘N' (no drug) on the MAR (medication administration record) 
(database).
Care home
The manager and two senior supervisors were on duty the day and the previous 
day (observer recall). On the day that the medication error was identified, a few 
care home staff members had called in sick and the care home manager had to 
cover their duties. The care home manager and senior supervisor worked a long 
shift that particular day from around 8am to around 7 to 8pm (field notes).
The care home was calm during the observed medication administration round 
(interview). It would usually be busy with the doorbell ringing, nurses arriving at 
the home, telephones ringing, worsened by the office staff being absent 
(interview). The medication administration round would last longer if there was a 
shortage of staff (interview). The senior supervisor commented that no two days 
were the same in the care home (interview). Despite the senior supervisor 
commenting on the calmness of the medication administration round, the 
researcher observed interruptions -  the senior supervisor was asked to perform 
different tasks during the medication administration round (field notes).
Care home staff members approached each other for help reflecting good 
teamwork. An example was a senior carer who approached senior staff 
members for advice when administering medication (field notes).
Other relevant information
Paracetamol is a very common ‘homely remedy'. Homely remedies are 
medications that can be bought in pharmacies without a prescription.
In the interview, the senior supervisor said that she knew that aspirin dispersible 
tablets should be dispersed before administration but she did not do it because 
the majority of residents had expressed their wish to swallow the tablet whole.
“I know that’s not how it’s supposed to do it but that’s how they want, so that’s 
what we go for.” (Excerpt from interview with senior supervisor)
Information conversations with the care home manager and senior supervisors 
revealed that they were very proud of their efforts with regards to medication 
administration. The care home had previously encountered problems and a 
primary care trust (POT) technician had helped them organise their medication 
system, advising them on medication ordering, storage and the use of medication 
administration records (MAR) (field notes). They had ‘come a long way’ and said 
that the current medication system worked very well (field notes).
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A chronology of events was developed from the case summary of the 
error. This was presented in a timeline and can be seen in the top row of 
Figure 4.1. The timeline showed events starting from the resident (ZC) 
being seen by the GP to her experiencing the medication administration 
error during the morning medication administration round. The events in 
this error happened within days but other errors could happen within hours 
or across a longer time period.
From the chronology of events, care delivery problems (CDP) were 
identified (see second row of Figure 4.1). Two CDPs were identified in 
this error. The arrowed lines between the first and second row of Figure
4.1 shows when the CDP occurred in the chronology of events. The first 
CDP was the care home not collecting dispensed medication 
(paracetamol) from the community pharmacy. ZC not receiving her 
morning dose of paracetamol was the second CDP identified.
The next stage involved identifying error contributory factors. This was 
performed using the ‘Framework of Contributory Factors Influencing 
Clinical Practice’ presented in Table 4.1 and the case summary of the 
error. The third row in Figure 4.1 presents a short description of factors 
that contributed to each CDP, taken from a more detailed analysis. Table
4.2 shows an excerpt of a detailed analysis of the first CDP identified in 
this error. A variety of error contributory factors were identified for each of 
the two CDPs identified. Examples included lack of verbal communication 
within the team category and problems with task design within the task 
category for the first CDP, and problems with equipment/supplies within 
the work environment category for the second CDP.
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Table 4.2 An excerpt of factors contributing to the first CDP in the example 
of error
CDP 1: Paracetamol supply uncollected from the community pharmacy
Organisational and management factors: Policy, standards and goals 
Quality Improvement; how long can the patient be without their regular prescribed medication? 
ZC had not been having her paracetamol for the past 2 days and most of the lunchtime doses 
were not signed, implying that she had not been taking the lunchtime doses. It was unclear why 
these administration boxes on the MAR chart were left empty -  did ZC refuse or was her 
paracetamol forgotten most lunchtime. There was no policy for a short-term review of whether 
residents had been given or taken their prescribed medication appropriately (paracetamol tablets 
were out of stock for a few days last month as well).
Work environment factors: Workload
Care home staff had called in sick. Senior supervisor had to cover their jobs.
Team factors: Verbal communication
Senior carer/trained staff administering medication had not reminded senior supervisor that the 
supply of paracetamol had run out.
Individual (staff) factors: Skiils and knowiedge
Senior supervisor may have thought that ZC did not desperately need her paracetamol, 
disregarding the new paracetamol dosage stating a regular four daily doses of paracetamol. (Any 
changes in medicine dosages should be discussed with the GP first.) This may have influenced 
the senior supervisor’s non-action to collect the paracetamol supply from the pharmacy.
Task factors: Decision-making aids
Senior supervisor had not been provided with decision-making aids which highlighted the 
importance of her daily tasks including collecting the paracetamol supply from the community 
pharmacy. This was seen from the example of the senior supervisor showing the researcher 
directions to the GP surgery that was 2 minutes drive from the care home instead of collecting 
medication from the community pharmacy located 1/3 mile away.
Patient factors: Staff-patient relationship
Senior supervisor had not communicated with ZC about non-availability of paracetamol for her 
pain. ZC had not requested for paracetamol.
Other comments
The same problem occurred the previous month.
The final stage of the analysis involved making recommendations for 
system improvement. A recommendation was made for each identified 
error contributory factor (see Table 4.3). For example, an error 
contributory factor was a lack of skills and knowledge within the individual 
(staff) category. The recommendation made was to train staff on 
medication related tasks such as record-keeping, the use of MAR charts 
and following GPs’ prescribing instructions.
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The method of analysing medication errors illustrated in the example was 
repeated for the rest of the eight identified medication administration 
errors.
4.5 Findings of the anaiysis
This section provides a summary of the findings from the analysis of all 
nine medication administration errors. Table 4.4 lists all nine medication 
administration errors analysed. It can be seen that the most frequent 
types of error were nurses or carers not following specific instructions to 
administer medication (n=5) and omission of medication (n=3). Each error 
is identified by a code and the classification and a short description of the 
error is presented. Errors 02-01-02-CC-ZC1 and 02-01-02-CC-ZC2 
represented identical errors committed by different care home staff 
members (bolded in the table) during different medication administration 
rounds (bolded in the table). Although errors 02-01-03-JJ-BG and 02-01- 
03-KK-AG were identified in two separate residents (bolded in the table), 
they involved the same medication administration round, the same care 
home staff member administering medication and the same medication. 
For errors 02-02-04-YY-MR1 and 02-02-04-YY-MR2, a different 
medication (bolded in the table) was administered in error by the same 
care home staff member in the same medication administration round 
involving the same resident. In the three pairs of errors described, the 
error analysis found similarities in their descriptions, care delivery 
problems (GDPs) and error contributory factors.
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Table 4.4 Classification and description of medication administration errors
Error Code Classification and description of error
02-01-02-CC-ZC1 Classification: Omission
Description: Medication unavailable and not administered by senior 
supervisor in the morning drug round.
02-01-02-CC-ZC2 Ciassification: Omission
Description: Medication unavailable and not administered by senior 
carer in the evening drug round.
02-01-03-JJ-BG Ciassification: Other -  administration instructions not followed 
Description: Dispersible tablets not dispersed in water before being 
administered.
02-01-03-KK-AG Ciassification: Other -  administration instructions not followed 
Description: Dispersible tablets not dispersed in water before being 
administered,
02-02-04-AAA-MC Ciassification: Extra dose, Other -  administration instructions not 
followed (wrong inhaler technique)
Description: Extra dose of inhaler administered. Wrong inhaler 
technique.
02-02-04-XX-DP Ciassification: Wrong dose
Description: Wrong dose of medication administered.
02-02-04-YY-MR1 Classification: Other-administration instructions not followed 
Description: Instructions to give penicillin (medication) before food not 
followed.
02-02-04-YY-MR2 Ciassification: Other -  administration instructions not followed 
Description: Instructions to give fiucloxaciilin (medication) before food 
not followed.
02-02-05-RR-DC Ciassification: Omission 
Description: Medication not given.
4.5.1 Care delivery problems (GDPs)
The analysis of the nine errors identified a total of 17 GDPs averaging two 
GDPs per error analysed. A range of problems was identified in the 
analysis involving tasks within and outside the care home. Since all the 
errors analysed were medication administration errors, GDPs identified 
related to the supply and administration of medication such as medication 
not given according to specified instructions and the omission of
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medication. Table 4.5 lists all the CDPs identified for all nine errors 
analysed.
Table 4.5 CDPs identified in each medication administration error
Error Code Care Delivery Problem (CDP)
02-01-02-CC-ZC1 1. Medication not collected from the community pharmacy.
2. Resident not given a prescribed morning medication.
02-01-02-CC-ZC2 1. Medication not collected from the community pharmacy.
2. Resident not given a prescribed evening medication.
02-01-03-JJ-BG 1. Dispersible medication dispensed into the same medicine container 
as other medication.
2. Resident received dispersed medication whole.
02-01-03-KK-AG 1. Dispersible medication dispensed into the same medicine container 
as other medication.
2. Resident received dispersed medication whole.
02-02-04-AAA-MC 1. Extra dose of medication administered.
2. Wrong inhaier technique.
02-02-04-XX-DP 1. Medication dispensing system and MAR charts not updated.
2. Wrong dose of medication administered.
02-02-04-YY-MR1 1. Medication should be administered before food, but administered 
with food.
02-02-04-YY-MR2 1. Medication should be administered before food, but administered 
with food.
02-02-05-RR-DC 1. Medication was omitted during medication preparation prior to 
administration.
2. Medication not administered.
3. MAR signed to indicate medication was administered.
4.5.2 Factors contributing to medication administration errors
Table 4.6 shows the factors contributing to errors from the analysis of the 
CDPs. The second column of the table shows the number of times factors 
were considered to have contributed to all nine medication errors. This 
frequency is also expressed in percentage in the same column.
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Table 4.6 Factors contributing to CDPs
Contributory Factors Number of times factors contributed to errors (%)
Organisational and management
Policy, standards and goals 9 (8.8)
Work environment
Education and training 10(9.8)
Workload 3 (2.9)
Equipment/supplies 6 (5.9)
Team
Supervision, seeking help and teamwork 6 (5.9)
Verbal communication 3 (2.9)
Written communication 1 (1.0)
Individual (Staff)
Skills and knowledge 13(12.7)
Physical and mental stressors 4 (3.9)
Task
Availability and use of protocols 13(12.7)
Decision-making aids 14(13.7)
Task design 3 (2.9)
Patient
History -  medically 3 (2.9)
History -  other 2 (2.0)
Staff-patient relationship 6 (5.9)
Treatment 1 (1.0)
Condition 5 (4.9)
Total 102 (100)
The results of Table 4.6 are discussed in the order of the most frequently 
identified error contributory factors. Factors within the task and individual 
categories were the most frequent error contributory factors. Within the 
task category, inadequate decision-making aids (13.7%) and non­
availability and use of protocols (12.7%) were most common. Within the 
individual category, lack of skills and knowledge (12.7%) was the most 
frequent contributor to medication administration errors.
Examples of inadequate decision-making aids within the task category 
included incomplete or inaccurate information on the MARs and the lack of 
a system to identify whether medication had been given to residents. The
136
other common factor within the task category was the non-availability and 
use of protocols. Examples of this included the lack of protocols detailing 
the administration of medication that require specific instructions such as 
to take medication before food, ensuring newly prescribed medication are 
administered accurately and detailing the process of changing MDS and 
MARs when a medication therapy is altered.
Problems with the lack of skills and knowledge related to staff not knowing 
how to administer particular types of medication such as inhalers and 
antibiotics. Incorrect understanding about the physical properties of 
medication was an issue identified. For example, a nurse reported that 
she thought the active ingredient of a dispersible tablet would be ‘lost’ if it 
was dispersed in water. Other issues identified under skills and 
knowledge included the manager and duty managers not being aware of 
the need to send all MDS back to the community pharmacy to be re­
packaged and to alter every MAR when a GP makes changes to a 
resident’s medication therapy. Not altering the MDS and MAR resulted in 
the resident being given the wrong dose of medication.
Another contributory factor to note is the inadequate policy, standards and 
goals (8.8%) in the organisational and management factors category. A 
large proportion of medication administration errors (4/9) were identified in 
one care home where the management (who rarely conducted medication 
administration rounds) communicated all changes to medication therapy to 
care home staff members who routinely administered medication. In this 
care home, between four and five medication administration rounds were 
conducted concurrently by different care home staff members. The 
analysis of errors identified that care home staff members had not 
received sufficient information about changes to medication from the care 
home management. There was also a lack of follow-up or monitoring from 
the care home management to ensure that changes to medication were
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implemented. Several task design issues were also identified within 
problems with ‘inadequate policy, standards and goals'. These included 
assigning only senior care home staff members to collect medication from 
the community pharmacy and inadequate instructions for determining how 
long medication can be uncollected from the community pharmacy. These 
problems resulted in care home residents being given the wrong dose of 
medication and not being given their prescribed medication.
Factors contributing to errors within the work environment category 
included problems with education and training, equipment or supplies and 
workload. There was a lack of education and training in areas of 
medication administration and the use of MARs. The monitored dosage 
system (MDS) is a system used to package and store individual doses of 
prescribed medication. The use of MDS contributed to medication 
administration errors. A wrong dose of medication was packaged into the 
MDS and this resulted in the resident receiving the wrong dose of 
medication. Another medication cannot be packed into the MDS because 
it would be chemically unstable when removed from its original packaging 
so residents had their medications dispensed in different dispensing 
systems. This contributed to a carer forgetting to administer a medication 
that cannot be packaged in the MDS.
Other error contributory factors were identified within the team and patient 
categories. Within the team category, there was a lack of supervision and 
teamwork in some care homes. Changes in medication were not 
monitored by the care home management who dealt with all medication 
changes. There were also examples of carers not asking how to 
administer particular types of medication such as inhalers and antibiotics 
when they were unsure. A senior supervisor had also not asked for help 
to collect medication from the community pharmacy when the medication 
had been left uncollected. Within the patient category, there was a lack of
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communication between staff and residents. Care home staff members 
had not communicated information such as the non-availability of 
medication to residents. Some residents were not able to communicate 
verbally and administering medication was challenging.
4.5.3 Recommendations for system improvement
This section presents the recommendations made by the researcher 
based on all the error contributory factors identified in the analysis of the 
nine medication administration errors. Table 4.7 details the 
recommendations made for system improvement. The first column in the 
table summarises the error contributory factors identified in the analysis. 
Recommendations were then made based on these factors, as shown in 
the second column of the table. These recommendations were then 
abstracted to derive three high-level system recommendations denoted by 
phrases such as training staff or review medication-related tasks in the 
third column of the table. The three high-level system recommendations 
are discussed.
1. Train care home staff
The analysis identified a lack of skills and knowledge across care home 
staff and management. Several areas were identified to be problematic. 
These include medication administration techniques, record keeping 
(including the use of MARs), basic knowledge of the physical properties 
and pharmacology of medication, the importance of adhering to 
prescribing instructions unless there has been prior consultation with the 
prescriber, the implications of non-adherence, and relevant changes that 
need to be made to the MDS and MAR when there is a change in 
medication therapy. Training care home staff and management in these 
areas may sharpen their skills and knowledge so that they are better able 
to cope with situations that may compromise medication safety.
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2. Review current medication-related tasks and policies
Medication-related tasks implicated in the errors analysed were 
medication administration, ordering, supply and storage, record­
keeping and the workload of care home staff members responsible for 
administering medication. Reviewing these tasks and the
corresponding policies can help identify areas that may be more 
susceptible to errors. Contingency planning could be incorporated in 
these reviews to include clinical issues such as the length of time 
residents can be without their long-term medication and medication 
supply and administration issues.
A system of checking the accuracy of the medication administered to 
residents should be in place. Double-checking is one method but there 
is currently no consensus on the effectiveness of double-checking 
medicines. A recent study by Armitage (2007) suggested that double­
checking medications for accuracy may contribute rather than deter 
errors. Further studies are needed to investigate the effectiveness of 
double-checking. Care home staff members were observed to be 
performing multiple tasks that were not related to the administration of 
medication. A review of the work organisation in the care home is 
recommended and appropriate tools provided to care staff to help them 
prioritise work. For example, collecting dispensed medication from the 
community pharmacy does not need to be the responsibility of senior 
care home staff members. Other trained staff could also perform this 
task. Regular systematic checking of the supply of medication can 
help ensure that the care home has an adequate supply of medication 
for residents. Current drug trolleys do not seem to accommodate the 
range of medications prescribed to care home residents. Refer to 
Figure 4.2 for an example of a typical drug trolley (Medisave UK Ltd. 
2008). A re-design of the drug trolley may allow adequate and 
appropriate storage of prescribed medications so that medications are 
not easily missed during medication administration rounds.
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Figure 4.2 A typical drug trolley
Accurate, timely and clear record-keeping is important in the care 
home medication system especially when changes are made to 
residents’ medication therapy. When the resident’s MDS is sent back 
to the community pharmacy for re-packaging, the entire supply of 
medication and the information on the MARs should be changed to 
reflect the new prescription. The task of updating records could be 
delegated to trained care home staff members who routinely administer 
medication and information should be recorded clearly, promptly and 
with sufficient detail in every document that contains information about 
medication. A second verification of the changes could help ensure 
that accurate information is recorded. Accessing relevant information 
during a medication administration round is important; so providing 
access to care home staff members who administer medication can be 
helpful. The MAR is a useful physical tool in the care home medication 
system. Its current function is mainly as a record of medication 
administration with some care homes utilising it to record the stock 
balance of medication. Figure 4.3 shows an example of a used MAR.
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Additional information such as specific instructions for medication 
administration like ‘with or after food' may help. The MAR does not 
usually contain a complete list of the medications that residents are 
prescribed despite it being the main document that care home staff 
members refer to when administering medication. A complete list of 
resident’s medication recorded in the MAR could help provide the 
information required when administering medication.
R E S i D E r r r - s  m a m e
WEEK 1
XP C C  iSooCt.
WEEK 2
PnESCRIPTIOWa «heqular medicines
a/
fig) ^
Figure 4.3 An example of a MAR 
3. Improve communication
Improved communication among care home staff and across the care 
home boundary to other parts of the system such as the community 
pharmacy is recommended. The two common forms of communication 
are written and verbal. Readily available written information such as
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patient information leaflets (PILs) in medication boxes provides very 
useful information about the medication including administration 
instructions. PILs are especially important when care home staff 
members do not have other sources of information. The use of PILs is 
encouraged. Relevant written information about residents' medication, 
in addition to verbal passing of information may be helpful to care 
home staff members who routinely administer medication. Verbal 
communication may be improved by creating a safe culture within the 
care home where care home staff members do not feel afraid or 
embarrassed to seek help. Both senior and junior care home staff 
members should feel able to seek help and guidance from staff at 
different levels. It would be important to establish this in further 
studies.
4.5.4 Summary
A total of nine medication administration errors were analysed and 17 
CDPs were identified. Closer analysis of CDPs revealed factors that 
were considered to have contributed to the errors. Task and individual 
factors were considered to be the most frequent contributors to 
medication errors. Inadequate decision-making aids, non-availability 
and use of protocols and the lack of skills and knowledge were the 
most frequent contributors to errors. Based on the contributory factors 
identified in the analysis, recommendations for system improvement 
were made. These were synthesised to produce three 
recommendations, namely, 1. Train care home staff, 2. Review 
medication-related tasks and policies and 3. Improve communication.
4.6 Discussion
This analysis represented one of the few studies that used The London 
Protocol (Taylor-Adams & Vincent 2004) to analyse factors that 
contributed to care home medication administration errors. Pepper & 
Towsley (2007) who recently conducted a review of the available care
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home literature reported a paucity of studies investigating factors that 
may increase medication administration errors. There were a limited 
number of care home studies and from their review, inadequate 
communication relating to the ambiguity of prescribing instructions, 
problems with staffing and problems with crushing medication were 
identified to be factors associated with medication administration errors 
(Pepper & Towsley 2007). However, the studies reviewed differed 
from the present study in their analytical paradigms and methods used, 
the study settings, types of errors, and outcome measures.
Hence, the discussion here focuses on the analytical framework rather
than the outcomes of the analysis in terms of the error contributory
factors and recommendations. The first part of the discussion reflects*
on the use of a predefined systems analysis framework to analyse 
medication errors. Then, the discussion considers the importance of 
providing the context of error cases when analysing errors, and the 
value of understanding the relationship among different system factors. 
This line of argument continues with a discussion about the need to 
have relevant information in order to make and prioritise 
recommendations for sustained system changes. Finally, the 
implications of using The London Protocol to analyse errors and a 
proposed analytical framework are discussed.
4.6.1 Predefined systems analysis framework
The London Protocol (Taylor-Adams & Vincent 2004), based on 
Reason's organisational accident model (1990) identified system and 
individual factors that can contribute to errors. These factors are 
organised into a ‘Framework of Contributory Factors Influencing 
Clinical Incidents' that was suitable for analysing incidents in any 
healthcare setting (Taylor-Adams & Vincent 2004). Using a framework 
that lists common error contributory factors helps the analyst define 
more clearly and fully the problem being analysed. This framework has 
a number of strengths. A systems framework guides the analyst to
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investigate areas in the system that may have otherwise been 
overlooked. Standardised frameworks provide standardised methods 
of analysis that can be potentially useful for comparative studies. 
Provided there is sufficient information for error analysis, a 
comprehensive analysis of the error is possible using the framework in 
The London Protocol. The same framework can also be especially 
useful if a quick analysis is required because analysts can quickly 
identify problems from the list of factors provided. Thus, there is 
flexibility in the depth of analysis depending on available resources. 
However, as with most analysis methods, the experience of the analyst 
using the analytical method is important and training to use the method 
is vital.
Although a predefined list of contributory factors is provided in The 
London Protocol, determining which of these contributed to errors can 
be difficult unless the analyst is familiar with the event or the context in 
which the error occurred. This is where the scope and level of detail 
contained in the error cases is crucial. The analytical framework can 
be used to guide the collection of relevant data relating to the error but 
if the relevant contributory factors were not listed within the analytical 
framework, such factors could easily be missed out. For example, 
Harrington et al. (2000) found care home facility and location to be 
strong predictors of care deficiencies in care homes. However, The 
London Protocol framework did not include the location of the 
healthcare facility as a contributory factor. In the example of an 
analysis of a medication error (see section 4.5.2), the resident had not 
received her prescribed medication because it was not collected from 
the community pharmacy which was located about 1/3 mile away from 
the care home. There was not a contributory factor related to location 
or distance in the systems analysis framework. Here, a significant 
limitation of predefined frameworks is demonstrated. It is difficult to list 
every factor that may contribute to errors. The implication is that the 
completeness of the analysis cannot be assured. A group of analysts 
with different expertise analysing these errors might provide different
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perspectives to the errors and reduce the possibilities of missed 
information. Involving interviewees in some parts of the analysis 
process such as identifying care delivery problems and contributory 
factors may also provide useful insights, as illustrated by Taylor-Adams 
& Vincent (2004).
Since it is difficult to list every possible factor that may contribute to 
errors, resulting in possibly incomplete analysis of errors, an analytical 
framework should ideally be able to present an overview of the system 
being studied and prospectively identify areas in a system that could go 
wrong. The framework should also provide the type of information and 
support that workers need so that they are better able to deal with 
unanticipated events. These characteristics in a framework are 
especially crucial when analysing complex socio-technical systems like 
the care home. Cognitive work analysis (GWA) (Rasmussen et al. 
1994; Vicente 1999) is a technique that proposes to provide a systems 
view of the work system and the information requirements to support 
workers to do their work. The use of this technique Is further explored 
in Chapters 6 and 7.
A characteristic of a complex socio-technical system, of which the care 
home is one, is tight-coupling with other systems. For care homes, 
these include different healthcare settings such as the GP surgery, 
hospital and community pharmacy that interact directly or indirectly with 
each other. Performing medication-related tasks often requires 
crossing the boundaries of different healthcare settings such as 
relaying information across the interface of healthcare settings. For a 
care home resident to receive a treatment involving prescription 
medication, several healthcare settings would be involved such as the 
GP surgery (prescribe), community pharmacy (dispense) and the care 
home (store and administer). The action performed in one healthcare 
setting can have a direct or indirect effect on another healthcare 
setting. The London Protocol framework had not highlighted factors at 
the Interface of healthcare settings, although it could possibly be
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implicitly drawn from categories such as team components and work 
environment. The analysis of medication administration errors in this 
study identified problems at the care home and pharmacy interface. 
The three high-level recommendations made for system improvement: 
improve communication, train care home staff and review medication 
policies and tasks can only succeed if there is cooperation amongst 
different healthcare settings. Therefore, it is important to represent 
factors at healthcare interfaces in an error analytical framework.
4.6.2 Context and relationship
The London Protocol provided a context-free predefined list of 
contributory factors within a general framework. The method of 
analysis required the analyst to understand the error by gathering 
relevant information about the actual medication error and the context 
within which it occurred. Then, information about the error was 
transposed onto the context-free framework. Implicit in the analysis 
process was a need to either ‘contextualise’ the framework or 
‘decontextualise’ the error case in the initial analysis stage, in order to 
identify the relevance of factors listed in the analytical framework. In 
this study, task and individual factors were identified as the most 
frequent contributors to medication administration errors. Inadequate 
decision-making aids and non-availability and use of protocols were the 
most frequent task factors whilst the lack of skills and knowledge of 
staff were the most common individual factor. An immediate 
impression gleaned from the results reported is the generality of 
contributory factors identified and the lack of information explaining 
how these factors contributed to errors. Hence, brief explanations of 
the rationale of the analysis were needed to provide meaning and 
context to the analysis and for making meaningful recommendations 
for system improvement.
Illustrating the analysis of medication errors with brief explanations is 
useful for the purposes of making systematic system improvement
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recommendations. However, the fundamental problem seems to lie 
with the completeness and relevance of the framework used to analyse 
errors. The previous section discussed the issue of potential omissions 
of relevant error contributory factors within a predefined framework. 
The wide variation in the way care homes function, as illustrated in 
Chapters 1 and 2, showed the complexity of the care home system. 
So, generalising a system analysis framework like The London 
Protocol to analyse errors in care homes may result in knowledge gaps 
about the vulnerable areas of the system despite The London Protocol 
being previously pilot tested in various healthcare settings.
Although the analytical framework provided a general system structure, 
the framework did not provide the analyst with a contextual view of the 
care home system being analysed. As the framework was based on 
Reason’s organisational accident model (1990) that described 
accidents as a result of a series of events or factors including latent 
conditions, the identified error contributory factors should be 
represented in context of other factors in the analytical framework. But, 
the factors incorporated within the framework in The London Protocol 
were independent of each other and there was no relationship between 
the factors. For example, the relationship between a lack of skills and 
knowledge and verbal communication as error contributory factors to a 
particular medication error is unclear when referring to the analytical 
framework. It is important to understand how different factors relate to 
each other within a system because a deficiency or an intervention 
introduced in one part of the system will invariably affect other related 
parts of the same complex system.
4.6.3 Information requirements for system changes
As the error contributory factors were identified using a context-free 
predefined systems analysis framework, the tendency when making 
recommendations was to focus on solving problems directly associated 
with the contributory factors without necessarily considering their
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implications on the wider system. This was largely because the 
analytical framework used to analyse errors was not designed to 
provide context to the system being analysed and prospectively 
analyse and identify the potential implications of recommendations. 
The problem encountered here will continue through to the 
implementation stages because the potential of particular 
recommendations to create new problems cannot be assessed easily. 
The actual impact of the solution and potential problems associated 
with the change on the wider system will also be difficult to monitor. 
Thus, making and prioritising recommendations for sustained system 
changes using The London Protocol is difficult.
Pepper & Towsley (2007) in their review of care home literature found 
five common strategies that have been implemented to reduce 
medication errors. These were:
1. Impose regulation such as that in the US where the use of 
psychotropic drugs is now regulated under the Nursing Home 
Reform Amendments of the Omnibus Budget Reconciliation Act in 
1987 (OBRA-87) because of problems with inappropriate use.
2. Educational interventions such as educating nurses and physicians, 
and academic detailing of physicians (educating physicians on 
specific areas).
3. Profile prescribing patterns and providing feedback.
4. Involve other healthcare professionals and communication within a 
multi-disciplinary team.
5. Use of technology.
However, there was a lack of a comprehensive approach to assess the 
impact of these strategies on system safety. A pertinent question when 
implementing error reduction strategies is how to assess the 
effectiveness of interventions.
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4.6.4 Implications for future study
The London Protocol provided a useful systems analysis framework to 
analyse medication administration errors. The framework was useful in 
so much as it guided the analyst to consider a wide range of system 
and individual factors that may have contributed to errors and provided 
a systematic method to analyse errors. However, several limitations 
were identified. There were problems with the completeness of the 
general framework used to analyse errors. The absence of 
relationships among the system factors posed further questions about 
the potential of generated recommendations to improve safety, the 
actual impact of the solutions and potential problems associated with 
the change on the wider system. Thus, making and prioritising 
recommendations for sustained system changes is difficult.
Taking the issues considered in this discussion, a systems analysis 
framework would ideally possess the following four features:
" Robust and contextual framework of the system being studied 
providing a knowledge base of the whole system being analysed
■ Reveal relationships between different error contributory factors
■ Systematic approach to error analysis
■ Same framework for use throughout the system's life-cycle from 
analysis, to the design of solutions for system improvement, to 
evaluation of improvements for their effect on safety
4.7 Conclusion
The aim of this analysis was to identify the causes of medication errors 
and derive recommendations for system improvement. The London 
Protocol (Taylor-Adams & Vincent 2004) was used to analyse the nine 
medication administration errors identified in Chapter 3. The lack of 
decision-making aids and non-availability and use of protocols within 
the task factor category, and the lack of skills and knowledge of
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individual or staff were the most frequent contributors to errors. Three 
recommendations for system improvement were made based on 
identified contributory factors. These were, 1. Train care home staff,
2. Review medication-reiated tasks and policies, and 3. Improve 
communication within and outside the care home. It was difficult to 
discuss the findings of these results in relation to current published 
heaithcare error analysis literature and the discussion critiqued the 
usefulness of using the predefined and context-free system analysis 
framework in The London Protocol.
Several fundamental questions about the usefulness and robustness of 
the framework beyond the analysis of errors were discussed and four 
important features of a systems anaiysis framework were suggested. 
The proposed systems analysis framework should be based on the 
work system being analysed, providing context to the analysis of 
errors. In the next chapter, methods to represent the complex care 
home medication system are explored.
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Chapter 5: Modelling the Care Home Medication 
System
5.1 Introduction
This chapter explores possible methods to represent the care home 
medication system. The exploratory studies in Chapter 2 identified the 
complexity and variability of the care home work domain suggesting 
that the method used to represent the care home medication system 
should also be able to capture the complexity and variability of the 
system. A common method used to analyse tasks and processes in a 
system is task analysis and may represent a suitable method for 
representing complex systems. One of the most commonly used task 
analysis methods is hierarchical task analysis (HTA). In this chapter, 
the feasibility of HTA to represent the complexity and variability of a 
medication system was explored in a study of the provision of 
medication in the hospital. However, it was difficult to capture the 
complexity and variability of the provision of medication in the hospital. 
This led to the exploration of other methods for system analysis and 
cognitive work analysis (GWA) was a potentially useful method. The 
rationale for using GWA and work domain analysis (WDA), the first 
phase of GWA is described in the rest of this chapter.
5.2 Hierarchical task anaiysis (HTA)
5.2.1 Introduction
Stanton (2006) reviewed HTA and described that its flexibility as an 
approach to analyse any system and its wide application to be reasons 
for it being a core method in ergonomics. The support for HTA was 
also reflected in an earlier piece of work by Ainsworth & Marshall 
(1998) where they analysed reports of task analysis methods
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conducted in the armed services and nuclear industries. They 
concluded that “HTA is perhaps the nearest thing to a universal task 
analysis technique” (Ainsworth & Marshall 1998; 83).
HTA was originally developed to understand training requirements but 
its use has extended to include error prediction, assessment of team 
performance, identification of person specification and workload 
assessment (Stanton 2006). Stanton (2006) described three main 
principles of HTA:
1. Goal-oriented analysis of a system
2. Sub-goals broken down from goals
3. Hierarchical relationship between goals and sub-goals that are 
guided by rules
In HTA, a system is described in terms of its goals and these goals can 
describe both human and non-human related tasks in the system. HTA 
describes goals for task and each task is described in terms of its 
goals. Each task is broken down to sub-tasks and each of these is 
described in terms of sub-goals. Finally, the HTA is represented as a 
hierarchical structure with goals and sub-goals and this relationship is 
guided by rules determining how the sub-goals are attained. To meet 
the goal of the task, the immediate sub-goals have to be fulfilled, and in 
a particular sequence unless specified that the order is not important.
5.2.2 Applications of HTA
HTA has been widely applied in different areas and these are 
represented in Table 5.1, taken from Stanton (2006). The table shows 
that in addition to training, allocation of function, job description and 
work organisation, HTA has also been used for error analysis, error 
prediction and procedure design. These previous applications suggest 
that HTA may provide a way to represent the care home medication 
system.
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Stanton (2006) also discussed extensions of the HTA method in 
determining the information requirements for an interface design. This 
suggests the potential of HTA as a method to identify the information 
requirements of a safe care home medication system. The HTA could 
provide the context of the system that can help inform 
recommendations for system change. Hence, it might be useful to test 
the feasibility of HTA as a suitable method to understand the care 
home medication system. The next section describes a study 
conducted to test the feasibility of using HTA to represent a medication 
system in the hospital.
Table 5.1 Application of HTA from ergonomics texts (Stanton 2006)
Application
Kirwan & 
Ainsworth 
(1992)*
Wilson & 
Corlett 
(1995)*
Stanton
(1996)*
An nett & 
Stanton 
(2000)*
Shepherd
(2001)*
Interface evaluation V V V V
Training V V V V V
Allocation of function V V V
Job description V V V V
Interface design V V V V V
Work organisation V V V V
Manuals design V V V V
Job aid design V V V V
Error analysis V V V V
Error prediction V V V V
Team task analysis V
Workload assessment V V V
Procedure design V V
* References as cited in Stanton (2006).
5.3 Method feasibility study: An HTA of medication 
provision in the hospital
5.3.1 Introduction
HTA was identified as a potentially suitable method for analysing tasks, 
identifying and predicting errors. This study examines the feasibility of 
HTA for analysing tasks in a healthcare setting, focusing on its ability to
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capture the complexity and variability of the system. It also reflects on 
the potential use of HTA to analyse medication errors and generate 
and evaluate safety improvement strategies. The provision of 
medication to patients in the hospital was chosen as the task to be 
analysed because it represented a similar task that is performed in the 
care home. Ease of access to the study participants in the hospital 
also led to the choice of this task.
5.3.2 Aim and objectives
The main aim of this study was to test the feasibility of HTA as a 
method for analysing and representing the provision of medication to 
patients in a hospital. A secondary aim was to reflect on the potential 
use of the HTA to analyse medication errors and generate and 
evaluate recommendations for system improvement. Before 
constructing a HTA of the provision of medication, it was important to 
first understand the patients' journey through the hospital to indicate 
the likely stages where medications were required. The first objective 
was to develop a map showing the patient journey through the hospital. 
The second objective was to construct a HTA of medication provision 
in the hospital.
5.3.3 Participants
Hospital pharmacists play an important role in the provision of 
medication in the hospital. Hence, they would have a good 
understanding of the medication provision system. A convenience 
sample of hospital pharmacists working in different types of wards in 
one district hospital were approached to participate in the study. 
Pharmacists with different levels of experience were approached.
A total of nine hospital pharmacists were recruited. These included two 
pre-registration pharmacists and seven registered pharmacists. Of the 
seven pharmacists, three were senior pharmacists holding directorate
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positions in the department and one was the deputy chief pharmacist. 
The nine pharmacists worked in eight different hospital wards including 
medical admission unit (MALI) (n=1), elderly care ward (n=4) and 
surgical ward (n=4).
5.3.4 Method
Different methods have been used to conduct an HTA. Stanton (2006) 
mentioned several including observations, interviews, walkthroughs, 
simulations and document analysis. There is no one recommended 
method but the use of multiple sources of information is encouraged to 
check the reliability and validity of the analysis (Stanton 2006).
In this study, semi-structured one-to-one interviews were conducted 
with the pharmacist participants because it allowed each pharmacist, 
with different levels of experience in hospital pharmacy to share their 
experiences providing medication to patients in the hospital. Focus 
groups could also help elicit information about the medication provision 
process in the hospital. However, organising ali nine pharmacists for a 
focus group would be difficult unless it was held outside their normal 
working hours. This was likely to have discouraged participation. As 
the aim of the study was to test the feasibility of HTA as a tool for 
representing a complex medication system, interviews as a source of 
information was considered to be adequate. No other data sources 
were used in the HTA. Hence, it is acknowledged that the HTA may 
not be valid and reliable or easily generalisable to other hospital 
medication provision systems.
An interview schedule was developed for this study. This was based 
on the findings from eariier studies reported in Chapter 2 indicating the 
variability and complexity in the transfer of medication information. The 
questions surrounded the provision of medication to hospital patients at 
four major points in the patients' journey through the hospital: 
admission, stay, discharge and post discharge. Probes were used to
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elicit more information from the pharmacists. Appendix 43 shows the 
interview schedule used in this study.
Interviews were conducted in a private area and lasted between 35 and 
85 minutes. These interviews were conducted across four days. Table 
5.2 shows the details of the interviews that were conducted in order. 
There was no relationship between the duration of interviews and the 
position held by pharmacist participants in the hospital or the order in 
which the interviews were conducted. The interviewer was aware of 
the potential bias of making assumptions about the information already 
obtained from preceding interviews.
Table 5.2 Position of pharmacist participants in the pharmacy 
department and the duration of interviews
Participant Position Duration o f interview 
(min)
1 Deputy chief pharmacist 75
2 Pre-registration pharmacist 60
3 Pre-registration pharmacist 35
4 Directorate pharmacist 50
5 Directorate pharmacist 75
6 Surgical ward pharmacist 45
7 Elderly ward pharmacist 85
8 Elderly ward pharmacist 55
9 Directorate pharmacist 60
A patient journey map to and from the hospital was developed with 
each pharmacist during the interviews. These were subsequently 
combined by the researcher, fulfilling the first objective of the study to 
develop a patient journey map.
Handwritten notes were taken during each interview. For each set of 
interview notes, the analyst searched for information that related to the
162
provision of medication in the hospital. These were grouped by 
processes or tasks. This information informed the HTA of the supply of 
medication to patients in the hospital.
5.3.5 Findings
Patient journey map
The patient journey map represented in Figure 5.1 is a compilation of 
maps developed with each pharmacist participants. The figure 
illustrates the complexity of the patient pathway to and from the 
hospital. There are multiple routes of entry and exit from a hospital. A 
patient could be admitted to the hospital via various routes such as 
patient’s own home, care homes, out-patient clinics, GP referral or out- 
of-hours doctors. Patients arriving at the hospital could either be 
directed to accident and emergency (A&E) for initial assessment, the 
medical admissions unit (MALI) or directly to a ward if it was a planned 
admission. There are multiple routes for a patient to be admitted to a 
suitable ward where they are treated. A patient leaves the hospital if 
they are deemed suitable for discharge to their own home or care 
home. At other times, they may be transferred to another hospital for 
further treatment or they may be deceased.
The figure shows multiple systems such as the GP, care homes, out­
patient clinics and other hospitals with which the hospital may interact. 
The system boundaries that a hospital system has to cope with were 
also represented suggesting the increased challenge of co-ordinating 
medication provision within the hospital.
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Figure 5.1 Patient journey through the hospitai
Hierarchical Task Analysis (HTA)
An HTA was constructed showing the tasks and processes required to 
supply medications to patients in the hospital (see Figure 5.2). This 
HTA lists tasks that are undertaken by anyone who contributes to this 
process. The words in italics indicate tasks that are not routinely 
performed by pharmacists. As described in section 5.2.1, tasks are 
represented as goals in the HTA.
To supply a medication to a patient in the hospital, an accurate 
medication history is first obtained (goal 1). This is then followed by the 
prescribing of a medication (goal 2). The suitability of the medication is 
then assessed (goal 3) before placing medication orders (goal 4). The 
medication is then supplied (goal 5) and administered (goal 6) to the 
patient. Finally, the effects of the medications are monitored (goal 7). 
To achieve goal 1, sub-goal 1.1 or sub-goals 1.1 and 1.2 need to be 
fulfilled. Referring to the HTA, to obtain an accurate medication history
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(goal 1), a medication history is obtained (sub-goal 1.1). The 
medication history is sometimes checked by a second person. Multiple 
information sources (see sub-goals 1.1.1 to 1.1.11) such as patient’s 
medications that were brought into the hospital, the patient themselves, 
family, carers, GP referral letter, repeat medication slips, medication 
administration record (MAR) provide information to fulfil sub-goals 1.1 
and 1.2. To fulfil goals 2 to 7, the relevant sub-goals need to be 
fulfilled.
Key: Not 
pharmacists'role
0. Supply medications to patient in hospital
Plan 0: do 1, 2, 3, 4, 5, 6, 7 in order
r Plan 1: Do 1.1 Or 1.1 and 1.2 Plan 2: Do 2.1, 2.2, 2.3 In order  ^j  Plan 3: Do 3.1, 3.2, 3.3, 3.4 In order
1. Obtain 
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history (DHx)
2. Prescribe 
med.
3. Assess 
med. suitability
1.2
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DHx
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Patient s
4. Order 
med. supply
5.
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2.1
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2.2
Decide
treatment
Plan 1.1: do any of 1.1.1 to 1.1.11 or any combination
3.1
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route on in-patient 
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Figure 5.2 HTA of medication supply to patients in the hospital
The HTA only showed the first few levels of tasks involved in the 
supply of medication. The description of sub-goals can continue to 
varying levels and the level of detail in the HTA will depend on the 
purpose of the HTA. In this study, the description of the sub-goals 
stopped at the second and third levels because there was insufficient 
information from the interviews to develop subsequent sub-goals. The 
wide variation found in task processes at the lower levels such as for
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goal 1 of the HTA poses questions about whether it is useful to have 
detailed descriptions at subsequent levels.
5.3.6 Discussion
Representing complexity and variability
There were various entry and exit routes to and from the hospital 
contributing to the complexity of the provision of medication in the 
hospital. HTA was successfully applied in the first few levels of the 
process model. Conducting the HTA could possibly help the analyst 
become more familiar with the processes and procedures so that they 
can critically assess the crucial aspects of the work. The HTA can also 
provide the framework to identify the inconsistencies between the 
current work practice and how the system is designed.
The usefulness of the method was however limited because it was 
difficult to capture the wide variation in task processes as hospital 
wards do not function in the same way and tasks are situation- 
dependent, reflecting the dynamic and complex hospital system. The 
HTA developed in this study represented both the ideal and current 
process stages involved in the provision of medication in the hospital. 
Vicente (1999) describes these as the normative (the ideal) and 
descriptive (current practices) approaches to work analysis. However, 
work in healthcare is complex and can be unanticipated or novel. 
Normative and descriptive approaches to analysing work do not take 
into account the unanticipated and novel events that workers might 
have to deal with. Any dormant problems within the system may not be 
identified. Dormant problems have the potential to surface and cause 
harm when the system’s defences fail.
Vicente (1999) further introduces another approach to analysing 
complex systems: a formative approach. This approach analyses what 
could happen in the system suggesting the potential to capture the 
variability and complexity of task processes. Methods that adopt a
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formative approach to analysis may be more suited to the analysis of 
complex healthcare systems. Although the HTA literature describes a 
largely descriptive and normative approach to performing a HTA 
(Stanton 2006), the HTA could potentially be constructed using a 
formative approach. To illustrate, the analyst could analyse what sub­
goals could be needed to meet the primary goal of the HTA or what the 
plan for fulfilling a particular goal might be. However, the HTA was 
constructed in this study was largely descriptive and normative. It may 
be useful to investigate methods that adopt a formative approach that 
can represent the whole system and provide the information needs for 
identifying current and potential problems in the system.
Although the plans for fulfilling individual goals in the HTA are cleariy 
specified, the HTA did not provide information about the potential 
consequences of choosing one plan over another on the wider system. 
It was also difficult to ascertain the potential effect on other goals of the 
system if a particular sub-goal cannot be achieved. Hence, it may be 
difficult to assess the recommendations for system improvement on 
particular areas in the system and evaluate their effects.
Limitations of the study
The aim of the study was not to construct an accurate HTA of the 
medication provision process in the hospital. However, the validity and 
reliability of the HTA need to be considered. The study used one data 
source to perform the HTA. There is potential to miss information that 
may have been relevant to the HTA. Using multiple data sources may 
provide additional information or check the accuracy of the information 
in the HTA. The HTA was performed by a single analyst. Multiple 
analysts or another independent analyst may confirm or disconfirm the 
accuracy of the HTA. Although multiple data sources were not used to 
develop the HTA, it is likely that the first level (goals 1 to 7) could be 
generalisable to other hospital medication provision systems. 
However, subsequent levels in the HTA may not be generalisabie and 
further validation of the HTA is required.
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5.3.7 Conclusion
The HTA of medication provision to patients in a hospital provided 
useful information but it was difficult to represent the complexities and 
variability of medication provision in the hospital. Although HTA has 
been purported to be able to perform many different types of analysis, 
it seemed that HTA in itself may not be a suitable method to answer 
the research questions in this thesis. There is a need for methods that 
can represent complex and dynamic socio-technical systems like 
healthcare and identify the information requirements for safe 
medication practices.
5.4 Analysing care homes
Section 5.3.6 alluded to an approach to work analysis suggested by 
Vicente (1999): a formative approach. In the following section, the 
formative approach is discussed in more detail and particular reference 
is made to its potential use as an alternative approach to analyse the 
care home medication system. Then, a technique that uses a 
formative approach, CWA, is introduced and a case is made as to why 
it is a potentially useful method to analyse the care home medication 
system. The rationale to conduct the first analysis phase of CWA, work 
domain analysis (WDA) is discussed. Finally, a brief overview of WDA 
is provided to familiarise the reader with this method that has not been 
widely used in healthcare research.
5.4.1 Formative approach
A formative approach supports the flexibility of work and how workers 
adapt to the complexity and variation in the system (Vicente 1999). 
This approach recognises that in a complex socio-technical system 
such as the care home medication system, there may be many tasks 
that are discretionary. Healthcare practitioners often have flexibility of
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what to do, when and how. The healthcare system entrust workers 
with cognitive tasks that may require workers to make judgements 
when performing their work. The formative approach recognises that 
humans are placed in systems to deal with unanticipated events which 
pose the greatest threat to system safety. Workers continually adapt 
the system to local contingencies and adapt to disturbances that have 
not been foreseen by designers (Vicente 1999). The complexities and 
variability of the provision of healthcare in the care home medication 
system suggests that healthcare practitioners have to continually deal 
with novel and unanticipated events. In order for workers to deal 
effectively with these events, they need information support that allows 
them to meet the goals of the work system. These are crucial 
elements to ensure system safety.
This is in contrast with the normative and descriptive approaches 
where the inherited deficiencies in the current system and unexpected 
and novel possibilities of work practices are not represented in the 
analysis. The normative approach allows little flexibility for workers 
because in this approach, work is represented as how it should be 
performed. Because of the variability in human performance and the 
nature of work in healthcare, it is difficult to prescribe how work should 
be performed. The normative approach is also limited by its ability to 
imagine situations and problems that may arise when workers interact 
with the work environment. A descriptive approach is also limited by a 
description of how work is actually done in practice and does not 
consider unexplored possibilities of how work is done especially in 
unusual or unanticipated situations that occur frequently in healthcare 
settings. Hence, the normative and descriptive approaches are 
unlikely to represent the complex and variable nature of work in the 
care home medication system. This suggests that a formative 
approach may be more suited to analyse the care home medication 
system.
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5.4.2 Cognitive Work Anaiysis
A technique that adopts a formative approach is cognitive work 
analysis (CWA). In addition to the formative approach, there are 
several characteristics of GWA that suggests its potential use to 
analyse the care home medication system. CWA analyses different 
types of constraints of the work system in five stages of anaiysis. It 
has also been used previously in different work domains including 
healthcare. The next section discusses these briefly in turn. The 
reader is directed to key references of CWA in Rasmussen et al. 
(1994) and Vicente (1999) for more detailed discussions of CWA.
CWA adopts a broad systems approach to work analysis by 
considering both the environment of the work system and the cognitive 
demands on the workers (Vicente 1999). The systems approach in 
CWA is consistent with Ramo’s (1973) definition
“...a technique for the application of a scientific approach to complex 
problems. It concentrates on the analysis and design of the whole, as 
distinct from the components or the parts. It insists upon looking at a 
problem in its entirety, taking into account all the facets and all the 
variables, and relating the social to the technological aspects.” (Ramo 
1973:15)
A systems approach is important to ensure that different aspects of the 
work system are anaiysed and the information requirements for 
ensuring a safe system can be identified.
Constraints
Although the formative approach recognises that workers have 
flexibility to perform work, it does not mean that workers have the 
liberty to do whatever they wish. This flexibility is set within the 
constraints afforded by the work system and CWA aims to identify the 
constraints and show the boundaries of acceptable system
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performance. Within these constraints, workers can form or generate a 
large variety of work patterns including novel behaviour to deal with 
unanticipated events (Vicente 1999). Understanding these constraints 
and work system boundaries could lead to better decision making by 
workers.
A useful description of the concept of constraints is given by Vicente 
(1999). He used the example of directions and maps. Directions 
provide a series of instructions, informing what to do, when and 
possibly how long each step should or would take. Hence, directions 
can be inflexible. There could be contingency plans in the event of 
unexpected incidence, but the set of directions are still instructional and 
cannot anticipate all eventualities. A map on the other hand provides 
the landscape or the information required to derive different routes 
allowing flexible adaptation in the event of unforeseen circumstances. 
Consequently, CWA can be used to provide workers with information in 
the form of a ‘map’ rather than ‘directions’ so that they can better deal 
with unanticipated events (Vicente 1999). Vicente (1999) describes 
several advantages to this approach:
■ Develop worker skill because they are provided with the information 
requirements to derive different work patterns, make decisions and 
the autonomy to do so
■ Improve worker control over how they work, improving worker 
health
The analysis of constraints not only concerns the workers in the system 
but also the technological and organisational requirements that need to 
be satisfied to support work (Vicente 1999). Thus, the analysis of 
constraints provides relevant information to workers about how work 
can be performed. The information includes the limitations of the work 
system.
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Analysis phases
A work system is governed by different levels of constraints. CWA 
considers five different aspects of work that need to be represented for 
complex socio-technical systems (Vicente 1999). These system 
behaviour-shaping constraints contribute to the suite of analyses in 
CWA. Each level of analysis is conceptualiy distinct. The first level of 
analysis is work domain analysis (WDA). A work domain represents 
the system that is being controlled or acted on independently of any 
particular worker, automation, event, task, goal or interface (Vicente 
1999). The ‘where’ of the system is analysed in WDA. The second 
level of analysis is control task analysis (ConTA). In this analysis, the 
goals that need to be achieved in the system, independent of how (the 
strategy) or who (actor) achieves it is identified (Vicente 1999). It is the 
‘what’ of the system, showing the boundaries that govern the activities 
performed on the work domain. ‘How’ these activities are performed 
on the work domain are analysed in the third analysis called strategies 
analysis (SA). SA analyses the strategies to accomplish the control 
tasks independent of who executes them (Vicente 1999). Social 
organisation and cooperation analysis (SOCA) is the fourth analysis 
and describes the relationship among actors, both workers and 
automation (Vicente 1999). The allocation of responsibilities, control 
tasks and distribution of strategies among actors are analysed (Vicente 
1999). The fifth level is worker competencies analysis (WCA) and 
describes the competencies of workers which represent the set of 
constraints associated with the workers themselves (Vicente 1999). 
The analysis not only considers the generic human capabilities and 
limitations but also identifies the competency requirements for example 
the knowledge, rules and skills that workers should have in order to 
function effectively (Vicente 1999).
The first three levels of CWA namely WDA, ConTA and SA describe 
the characteristics of the problem demands of the system being 
analysed. The last two levels of analysis, SOCA and WCA describe
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the characteristics of the organisation and actors who will be 
responsible for meeting the problem demands. An ideal socio- 
technical system is one that provides a seamless fit between these two 
groups of analyses (Vicente 1999).
Applications of CWA
Many researchers have explored the use of CWA for the analysis, 
design and evaluation of complex socio-technical systems. Table 5.3 
presents a summary of some of these studies. This list is not meant to 
be exhaustive rather represents a range of applications of CWA. CWA 
has been used widely to design interfaces but its use has extended to 
identifying strategies to detect and recover from human error. Although 
CWA was first developed in the nuclear industry, it has been applied 
across other work domains such as healthcare (e.g. Effken et al. 2001, 
Hajdukiewicz et al. 2001, Miller 2004), defence (e.g. Jenkins et al. 
2008; Naikar & Sanderson 1999; Naikar et al. 2003), naval command 
and control (Burns et al. 2005), manufacturing (Higgins 1998) and 
hydropower system (Memisevic et al. 2005).
The wide application of CWA in different work domains including 
healthcare suggests its potential to analyse the care home medication 
system. Healthcare systems are increasingly complex reflecting the 
characteristics of complex socio-technical systems, systems that CWA 
was initially developed to analyse. Healthcare systems have evolved 
with time unlike engineered systems in the nuclear, petrochemical and 
aviation domains where CWA has traditionally been applied. It is 
difficult to predict how the healthcare system will develop and change 
with time. CWA also has potential for analysing errors, as confirmed 
by Naikar & Saunders (2003) and Xu (2007).
173
Table 5.3 Applications of CWA (adapted from Naikar et al. 2005)
Application References
Designing interfaces Burns et al. 2000*; Dinadis & Vicente 1999*; Effken et al. 
(2001); Jenkins et al. (2008); Linegang & Lintern 2003*; 
Rasmussen 1998*; Reising & Sanderson 1998*; Vicente et 
al. 1995*; Watson & Sanderson 2007
Designing teams Gualtieri et al. 2000*; Naikar et al. 2003
Evaluating design proposals Naikar & Sanderson 2001
Developing strategies to 
detect and recover from 
human error
Naikar & Saunders 2003
Developing specifications Leveson 2000
Problem-solving Hajdukiewicz et al. 2001
Analyse problems and 
develop strategies based on 
error data
Xu 2007
Analysing training needs and 
training-system requirements
Naikar & Sanderson 1999
References cited in Naikar et al. (2005).
Summary
The care home medication system is complex and variable. A 
formative approach that focuses on how work could be done provides a 
useful alternative to analyse complex work systems. The CWA adopts 
a formative approach and focuses on helping workers adapt and deal 
with unfamiliar and unpredictable situations. CWA does this by 
providing the information requirements about the work system. The 
information is set within the constraints of the work system thereby 
both limiting and allowing workers to devise a range of solutions to deal 
with problems. CWA has previously been applied in the healthcare 
domain (Effken et al. 2001, Hajdukiewicz et al. 2001, Miiler 2004) and 
used to analyse errors (Naikar & Saunders 2003; Xu 2007) suggesting 
its possible use to analyse the care home medication system. Finally, 
the five phases of analysis in CWA focus on analysing different aspects 
of a complex system thereby providing an understanding of the whole
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work system. These key characteristics of CWA suggest its potential 
as a method to analyse the care home medication system.
CWA normally starts from the WDA, the first analysis stage in CWA 
because it provides the fundamental framework and set of constraints 
on which subsequent levels of analysis are based on. Hence, this 
research focuses on the WDA. In the next section, the WDA and its 
modelling tool are described in more detail. The intent is to familiarise 
the reader with this relatively new method in healthcare research 
before describing the application of WDA to model the care home 
medication system in Chapter 6.
5.4.3 Work Domain Analysis
The WDA represents a systems model of the work domain. The work 
domain is the setting where activities of a system take place. 
Modelling the work domain requires the representation of the entire 
network of means-ends relations relevant to the system being studied 
(Vicente 1999) (A detailed discussion of the concept of means-ends 
relations follows in the next section). Thus, the WDA is able to 
accommodate the requirements for all situations that the system might 
face, providing the fundamental problem space of workers.
The WDA is like a map that provides structure and helps define the 
work system being studied; identifying the functions of work, the 
relevant background information, even the physical objects available, 
thus it serves as a knowledge base to the system (Vicente 1999). An 
illustration used by Rasmussen et al. (1994) and Vicente (1999) when 
arguing the need for a representation of a work domain analysis is 
Simon's fable about the ant manoeuvring along a sandy beach. The 
ant follows a path along the sandy beach and the complexity of the 
path is determined by the complexity of the beach and not solely the 
ant itself. Accordingly, the complexity of the work performed by a 
worker in the work space can be explained by the complexity of the
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work domain together with the goals and resources of the worker. 
Workers in the system can navigate their way through the map, 
zooming in or out of the map and utilizing the information afforded by 
the WDA depending on their task requirements.
The purpose of the WDA is to model the constraints of a work domain 
(Vicente 1999). The constraints modelled relate to the purposive and 
physical context in which workers operate. The purposive context of a 
WDA specifies the purposes that the work system must fulfil, the 
values and priorities that the work system must satisfy and the 
functions that the work system must perform (Vicente 1999). The 
physical context describes the constraints placed on workers by 
specifying the physical objects that are available in the work system 
and the functional capabilities and limitations afforded by the physical 
objects (Vicente 1999). Constraints in the WDA are represented as 
categories instead of instances or examples (Vicente 1999). To 
illustrate, medication administration is used in a WDA instead of 
administering tablets, giving injections. This is an important
characteristic of the WDA because it would very difficult, if not 
impossible to capture every possible instance of work in complex 
systems because of the variability in work (Naikar et al. 2005).
Rasmussen et al. (1994) discussed the predictability or regularity of 
work system behaviour or in other words, the internal constraints, 
which shape the systems behaviour. They described two sources of 
regularity in work systems namely the causal and intentional. The 
causal source of regularity depends on the laws of nature (Rasmussen 
et al. 1994). Examples include work environments that are highly 
structured such as nuclear power plants and chemical production 
plants. The intentional category of work system “depends on human 
intentions to follow a socially accepted pattern of behaviour” 
(Rasmussen et al. 1994). Examples include public libraries and 
research institutions. The regularity of a work system is characterised 
by the weight or balance of each source of regularity described. Thus,
176
the properties of different work systems represent a continuum. An 
understanding of the regularity of the healthcare system can help 
analysts understand how the work system could function and can 
thereby inform system design and generate recommendations for 
system improvements.
There are distinct differences between WDA and task analysis. WDA 
analyses the work system independently of any particular worker, 
automation, event, task, goal or interface (Vicente 1999). This 
suggests that the WDA model is event and time-independent. In 
contrast, task analysis is the analysis of particular tasks or goals and 
the information requirements to fulfil tasks or goals are event and time- 
dependent making it suitable to support workers deal with anticipated 
situations (Hajdukiewicz & Vicente 2004). WDA being event and time- 
independent is suited for helping workers adapt to unanticipated and 
novel situations.
Abstraction-décomposition space (ADS)
The main modelling tool in WDA is the abstraction-décomposition 
space (ADS). The ADS is a two-dimensional modelling tool with the 
vertical axis typically representing the abstraction dimension and the 
horizontal axis typically representing the decomposition dimension 
(Naikar et al. 2005). Other labels for the abstraction dimension are 
abstraction hierarchy (AH) or means-ends dimensions. The 
decomposition dimension is also referred to as the decomposition 
hierarchy or part-whole dimension. An example of a generic ADS is 
presented in Figure 5.3.
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Whole System Subsystems Components
Functional
Purposes
Values and 
Priority Measures
Purpose-related
Functions
Object-related
Processes
Physical
Objects
Figure 5.3 A generic ADS with five levels of abstraction and three levels 
of decomposition
Levels of abstraction
There are typically five levels of abstraction;
1. Functional purposes
“Functional purposes” represents the first level of abstraction of an 
ADS. It describes the purposes served by the work system and the 
external constraints imposed by the environment on the work system 
(Naikar et al. 2005). It explains why a work domain exists or the 
reasons for its design (Sanderson 2003). Complex systems may have 
primary and secondary objectives. The primary objectives of the work 
system are the reasons that a work system exists whilst the secondary 
objectives refer to the values of the people within the work system 
(Naikar et al. 2005). The external constraints imposed by the 
environment on the work system refer to the values of the environment 
or society. Thus the functional purposes of the work system represent 
the relationship between the work system and its environment 
(Rasmussen etal. 1994).
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2. Values and priority measures
The second level of abstraction represents the criteria for measuring 
how well the system is moving towards its functional purposes, and 
ensures that the functional purposes of the work system are fulfilled by 
comparing, prioritising and directing resources to the various purpose- 
related functions (Naikar et al. 2005). In this level, the categories used 
are “in abstract terms referring neither to the work system nor the 
environment” (Rasmussen et al. 1994) so that the terms are 
independent of a particular work system. The criteria are derived from 
fundamental properties such as the laws of nature (in causal systems) 
and social laws, conventions, and human values (in intentional 
systems) and are considered to be “relatively stable properties that are 
not expected to disappear from the system in an uncontrolled fashion” 
(Naikar et al. 2005). The criteria can also be described as qualitative 
or quantitative. Social laws, conventions and human values cannot be 
easily quantified and these are described as properties to maximise or 
minimise. Criteria such as efficiency, reliability on the other hand can 
be more easily quantified.
3. Purpose-related functions
This level of abstraction relates to the functions that must be executed 
and co-ordinated to fulfil the functional purposes of the work system 
(Sanderson 2003). There are generally a variety of functions in a work 
system and they need to be co-ordinated to meet the criteria for 
assessing how well the work system is progressing towards fulfilling its 
functional purposes. This level also describes the uses of the object- 
related processes and physical objects (physical constraints) in a work 
domain (Naikar et al. 2005). Like the first two levels of abstraction, the 
terms represented at this level should be of structural categories 
independent of a particular work domain (Naikar et al. 2005).
4. Object-reiated processes
“Object-related processes” represents the functionality afforded by 
physical objects in the work domain and significant environmental
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conditions (Sanderson 2003). This level not only describes the 
capabilities but also the limitations of physical objects. It is important to 
note that natural objects or significant environmental conditions are 
also described here (Naikar et al. 2005). These may include 
professional abilities or categories of personnel. The representation at 
this level helps fulfil the purpose-related functions of the work system. 
An important distinction between object-related processes and 
purpose-related functions is that in the former, the functions are stable 
and related to the functionality or limitations of physical objects. 
“Purpose-related functions” on the other hand describes the uses that 
the object-related processes are commonly put to in a work system.
5. Physical objects
The final level of abstraction is “physical objects”. It describes the 
physical objects that are available in the work system to fulfil the 
requirements at the higher levels of abstraction (Naikar et al. 2005). 
This level not only represents the physical objects for example tools or 
equipment, but can also include personnel categories, geography work 
premises or infrastructure (Naikar et al. 2005). The description at this 
level can take many forms for example an inventory of the physical 
objects, material characteristics of the physical objects or even the 
topography or organisation of the physical objects (Naikar et al. 2005). 
These can be presented textually, as drawings, maps and may be used 
in combination. This level of abstraction represents the physical world 
of the work domain that is available to see.
The first three levels of the ADS represent the purposive properties of 
the work space; the reasons for the work system's behaviour. The last 
two levels of the ADS represent the physical properties of the work 
space. Each of the five levels represents the same work system but 
uses a different language or set of concepts. It is like viewing the work 
domain with different conceptual lenses at each of the five levels. To 
illustrate, a view of the work domain at the functional purposes level 
provides the view of the purposes of the work system. A view at the
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purpose-related functions level provides a view of the functions that are 
required to be performed in the work system. These views do not 
change or alter the properties of the work domain rather it provides a 
different view of the work system at that level.
Means-ends links
The five levels of the abstraction dimension are means-ends related. 
This means that the representation of the work domain at one level 
provides the means for achieving the immediate ends of another levei. 
Rasmussen et al. (1994) and Vicente (1999) explain means-end 
relations using the how-what-why triad (see Figure 5.4).
Means-Ends
Functional purposes WH^:
Values and priority 
measures
Purpose-related functions WHY WHAT HOW 
\  \
Object-related processes WHAT HOW 
\
Physical objects HOW
Figure 5.4 How-what-why triad
Taking the third level purpose-related functions (refer to Figure 5.4) as 
the object of attention ('what'), the questions why and how can be 
asked in the analysis of the work domain. Moving one level below 
which is object-related processes, the question ‘how’ can be answered. 
The functions required to be performed in a work system can be 
afforded by the functional capabilities and limitations of the physical 
objects found in the work system, thus the ‘how’. Moving one level up 
to values and priority measures, the reasons ‘why’ these functions are
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required are answered. This triad can be applied starting from any 
level of the abstraction dimension. Vicente (1999) stressed that the 
means-ends relations described here should be structural means-ends 
rather than action means-ends relations. This means that these 
relations are not based on actions to fulfil goals rather the structural 
work domain constraints in order to achieve the goals. Vicente (1999) 
identifies this as an important feature of the abstraction dimension 
because from a psychological perspective, workers can focus their 
attention on the aspects of the work domain that are relevant following 
the linkages or means-ends relations identified by the analysis of the 
work domain. There could also be many-to-many mappings between 
nodes at various levels of abstraction, especially in complex socio- 
technical systems (Vicente 1999). Clearly identifying the means-ends 
relations helps provide the information requirements for workers to deal 
with the complexity of the work system.
Levels of decomposition
The levels of decomposition represented in an ADS usually depend on 
the level of detail required in the work analysis. Figure 5.3 showed 
three levels of decomposition in an ADS: whole system, subsystem 
and components. The first level of decomposition describes the work 
system as a single whole. The second level describes each of the 
subsystems in the work system and the third level describes the 
components that characterise the work system. Moving along the 
levels of decomposition from left to right, the levels of granularity or 
detail characterising the work system increases. The relationships 
between the levels of decomposition are part-whole relations meaning 
that the lower levels of decompositions are parts of the higher levels of 
decomposition. Components are part of the subsystems and 
subsystems are part of the whole system. As with the abstraction 
dimension, each level of decomposition represents the same work 
system but differing from the abstraction dimension, the view of the 
system moving from left to right increases the resolution of the system 
providing a more detailed view of the work system.
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Summary
This section discussed the key characteristics of WDA and provided an 
overview of the modelling tool, ADS. The next chapter explores the 
use of WDA to analyse the care home medication system.
5.5 Conclusion
This chapter explored the use of a common traditional task analysis 
method, HTA to analyse the provision of medication in a hospital and 
concluded the need for other analysis methods that are more suitable 
to analyse complex socio-technical systems. Formative approaches to 
work analysis, notably CWA can provide an alternative method for 
analysing complex care home systems. The key features of CWA and 
WDA, the first analysis stage in CWA were described. The next 
chapter reports the application of WDA to model the care home 
medication system.
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Chapter 6: Work Domain Analysis of the Care 
Home Medication System
6.1 Introduction
The previous chapter argued the need for a different paradigm and 
method to understand complex socio-technical systems like the care 
home. In this chapter, a WDA of the care home medication system is 
presented. There is little guidance for conducting a WDA in the current 
literature. Naikar et al. (2005) have presented the most comprehensive 
guidance to date, and as such, the method used in this study was 
largely adapted from their work. Before the construction of the WDA 
framework, several fundamental decisions about the scope of the 
analysis were made. This chapter first presents these important 
considerations that shaped the construction of the WDA framework. 
The construction of the framework is then described in detail. A 
comprehensive discussion of the resultant framework, including the 
rigour and methodological challenges of constructing the framework 
follows. Finally, future research arising from this study is discussed.
6.2 Purpose of analysis
Before constructing the WDA framework, the purpose of the WDA 
needs to be established. Two important points need to be determined: 
first, the problems that need to be addressed with WDA and secondly, 
how WDA can address the problem. The problems that needed to be 
addressed with WDA were the lack of a knowledge base about the 
wider care home medication system, and the requirements of a safe 
medication system.
WDA could possibly address these problems by providing a framework 
or model of the entire care home medication system. The framework
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shows the fundamental work space of the care home medication 
system, hence provides the knowledge base of the entire care home 
medication system. Weak areas of the current system can be 
identified against this knowledge base. The medication errors 
identified in Chapter 3 could be further analysed with this framework. 
The design requirements of a safe care home medication system can 
be determined by analysing the framework of care home medication 
system and the weak areas of the system.
6.3 Constraints of the analysis
The constraints of conducting a WDA need to be established and these 
typically relate to time, budget and access to available information. 
Such constraints have a significant impact on the scope and detail of 
the analysis. In this study, the WDA was conducted within the time 
constraints and funding of a 3-year PhD research program. This 
analysis was conducted using data collected primarily from one care 
home and the information collected may not be generalisable to other 
care homes. For practical purposes relating to access to data sources, 
the care home chosen was one of the care homes that participated in 
the study reported in Chapter 3. This was a care home that provided 
both personal care (such as washing, changing and feeding) and 
nursing care to residents in a rural location in England, UK. The 
characteristics of this care home include the following:
1. Resident characteristics: Residents had different levels of 
independence and healthcare needs. The care home catered to a 
wide range of resident needs.
2. Unique group of service providers: The care home was located in a 
rural area where there was limited access to a community 
pharmacy. In these rural areas, GPs provide medical treatment and 
dispense medication. These GPs are called dispensing GPs 
(DGPs). This care home used services provided by two DGPs. 
One resident was prescribed a particular medication that required
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special authorisation to dispense. Neither dispensing GP surgery 
possessed an authorisation to dispense the medication. So, the 
care home also used a community pharmacy that had the relevant 
authorisation. The care home was also located between two district 
hospitals and care home residents could be referred to either 
hospital for treatment.
3. Ease of access: Previous contact had been established; the care 
home participated in the study reported in Chapter 3). The care 
home management was enthusiastic to participate in this study.
6.4 System boundaries
The third important consideration to make before constructing the WDA 
framework is to determine the boundaries of the work system to be 
analysed. This decision is largely pragmatic and usually takes into 
account the purposes of the WDA and the project constraints (Naikar ef 
a/. 2005).
Rasmussen et al. (1994: 35) described a work system as a
“ ....functionally coupled entity that adapts to the opportunities 
and requirements posed by its environment under the control of 
its human actors.”
Naikar et al. (2005:67) continued to argue that analysts should 
consider
“....any natural delineations that exist in the work system of 
interest so that the focus system is as well bounded as 
possible”.
The majority of residents in the care home have one or more medical 
conditions and their treatment often involves medication. The findings 
of the care home familiarisation studies reported in Chapter 2 showed 
that there was a wide range of healthcare settings and practitioners
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involved in providing healthcare in the care home system. To include 
every healthcare setting in the analysis of the care home medication 
system would result in a highly complex, resource intensive and time 
consuming analysis. In addition, the resultant analysis may not even 
be useful for the purposes of the WDA described previously. Hence, 
this study focused on the care home.
The highly-coupled nature of the care home with other healthcare 
settings meant that it was likely to identify aspects of the care home 
medication system outside the care home. Examples of these may 
include functions carried out in other locations such as the GP and 
community pharmacy and information sources related to the healthcare 
of residents. These would be included in the WDA because they 
affect how the care home medication system functions. Hence, 
functions and physical objects that were involved in providing 
healthcare to care home residents found outside of the care home 
were included in the analysis.
Caring for care home residents is complex and does not only involve 
healthcare treatments. Social care is also an important part of the 
holistic care provided to residents. However, time constraints and the 
intention to utilise the framework to potentially analyse medication 
errors resulted in the decision to not include the social care aspect in 
the WDA. Nevertheless, it is acknowledged here that health and social 
care are closely linked and difficult to separate. In fact, treatment 
decisions made are often influenced by the social context within which 
residents are placed.
6.5 Nature of the constraints in the care home 
medication system
After defining the boundaries of the care home medication system to 
be analysed, the nature of the constraints of the work system need to
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be determined. This is necessary to provide some insight into the 
sources of regularity of the work system to aid in the analysis of the 
work system. The nature of constraints can also be useful for planning 
and predicting how the work system might function. Rasmussen et al. 
(1994) described five categories of work systems, ranging from highly 
causal to highly intentional. In a highly causal work system, work 
depends largely on stable laws of nature for example, chemical 
production plants (Rasmussen et al. 1994). If a work system is highly 
intentional, work largely depends on individuals’ subjective preferences 
and values such as general public information systems (Rasmussen et 
al. 1994). The nature of constraints in a work system could lie 
anywhere along the causal-intentional continuum.
For the care home medication system, the understanding of the nature 
of constraints was largely informed by the researcher’s experience 
conducting research in the care home as reported in this thesis, and 
her professional experience as a community pharmacist providing 
medication services to care homes. The care home medication system 
is a complex system involving multiple healthcare practitioners. Their 
work is bound by rules and regulations, guidelines, policies and 
procedures. For example, the prescribing process should ideally be 
evidence-based and the administration of medication should follow 
defined procedures. At the same time, healthcare practitioners’ work 
also involves using their professional judgement and they sometimes 
have many different ways of accomplishing tasks that are equally 
acceptable. The variability of individual care home residents, 
healthcare settings and the competencies of healthcare practitioners 
required to perform their work also contribute to the irregularity of the 
work system.
Hence, the care home is partly causal and partly intentional, indicating 
elements of both predictability and uncertainty in the work. Both the 
workers and the externally-constrained work system therefore share 
control of the functioning of the system. For example, a GP may
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decide to prescribe calcium and vitamin D3 tablets for every care home 
resident due to their increased risk of falls or bone fracture but another 
GP may not do so and would only prescribe medication to those who 
have had a past history of falls. Their decisions may be based on 
guidelines or policies written by the care home, the primary care trust 
or the government or, it could be largely dependent on the experience, 
expertise and judgement of the GP if there were no available 
guidelines or policies.
6.6 Sources of information
Next, potential sources of information to conduct the WDA were 
identified. Naikar et al. (2005) recommended using readily available 
information in the work system when conducting the initial analysis. 
These may include documents in the work system, government 
documents, observations of the work setting and interviews. 
Subsequent analysis of the work system could involve additional 
interviews or observations.
For this study, several sources of information about the care home 
were readily available from previous studies, as reported in Chapters 3 
and 4. These included observation notes and interview transcripts. 
However, there was insufficient information from these sources of 
information. So, additional information was collected. The WDA 
involved three iterations and the following sections detail the three 
main sources of information used to conduct the WDA in general. 
More detailed discussion about the information sources used for each 
iteration is provided in the later parts of this chapter.
6.6.1 Documents
Different types of documents provided useful information about the 
care home medication system. Within the care home, staff manuals, 
promotional material about the care home and documents detailing the
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care home’s mission and vision were useful sources information 
sources. Governmental websites also provided useful information 
about care homes in general. The following documents were used in 
the WDA. The first three sources related specifically to the recruited 
care home and the last source related to care homes in general.
1. Care home information leaflet
2. Care home introduction document
3. Staff policies and procedures manual
4. Governmental websites such as the CSCI website
6.6.2 Observations
Observations provided a different view of the work system. It can 
reveal aspects or values of the work system that may not be readily 
gleaned from written documents. The study reported in Chapter 3 
collected care home data using observations. General observations of 
the care home environment and focused observations of medication 
administration rounds were conducted and recorded. These were used 
for the WDA.
6.6.3 Interviews
Interviews with care home staff provided another dimension to the work 
system. The written documents record what should ideally happen in 
the care home. Observations revealed how work was actually 
performed. Interviews revealed information about what needed to be 
done in the care home, why work was actually performed in a particular 
way, the values of work and the constraints faced by care home 
workers. A semi-structured interview was previously conducted with 
the care home manager of the care home recruited for this study 
(reported in Chapter 2). The interview transcript was used in the initial 
analysis of the work system. Additional semi-structured interviews 
were conducted with care home domain experts in the later stages of 
the WDA.
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6.7 Conceptual aspects of the analysis
Before conducting the WDA, several conceptual aspects of the 
analysis need to be considered. The first aspect relates to the 
modelling tool for the analysis. Two modelling tools have been used in 
WDA: abstraction-décomposition space (ADS) and abstraction 
hierarchy (AH). Naikar et al. (2005) proposed the use of the 
abstraction decomposition space (ADS) as the modelling tool for WDA 
whilst others have used the abstraction hierarchy (AH). Some analysts 
have constructed an ADS by decomposing an AH. The modelling tool 
chosen largely depends on the purposes of the WDA. For this study, 
the purpose of the WDA was to understand the care home medication 
system and to identify the requirements of a safe care home 
medication system. The focus was to understand the different 
interactions in the care home medication system instead of the 
granularity of the work system. The AH is useful to understand ‘why’ 
and ‘how’ work categories or functions are necessary in the work 
system whilst an ADS shows the organisation of the work system at 
different levels of granularity. As such, the AH suitably and sufficiently 
met the needs of this analysis.
The second decision to make is the number of levels of abstraction to 
be used in the AH. Different analysts have used different number of 
levels of abstraction in the construction of the AH. Two leading figures 
in the development of CWA, Jens Rasmussen and Kim Vicente, have 
different views on the subject. Reising (2000) reported that 
Rasmussen was now convinced that all five levels of abstraction are 
necessary and sufficient in developing the AH whilst Vicente (1999) 
was less convinced that all levels were necessary for every type of 
work system. The abstraction level that is typically excluded is the last 
level, physical object (example in Bisantz et al. 2003). Many physical 
objects were identified in the care home medication system and these 
were considered important for the functioning and understanding of the
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care home medication system. Thus, this study used all five levels of 
abstraction in the analysis of the care home medication system.
Several studies have used different labels to described the abstraction 
levels in the AH. Some studies used labels that were specific to the 
work domain analysed. Table 6.1 shows examples of labels used in 
different studies. Reising (2000) reported the new set of labels that 
Rasmussen proposed, namely: “functional purposes”, “values and 
priority measures”, “purpose-related functions”, “object-related 
processes” and “physical objects”. These were generic and could be 
used when analysing different work domains. Naikar ef al. (2005) who 
provided the most comprehensive guidance to construct a WDA to date 
preferred Rasmussen's new set of labels because they describe the 
content and relationship between each level of abstraction more 
clearly. This study agreed with Naikar et al. (2005) and adopted the 
set of labels described by Rasmussen in Reising (2000). If the labels 
already reflect the content of each abstraction level well, it was not 
necessary to use domain-specific labels.
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6.8 AH -  First Iteration
After deciding on several conceptual aspects of the WDA, the initial 
analysis of the care home medication system was conducted. The first 
iteration of the AH was constructed using readily available sources of 
information in three main steps. The sources of information used in this 
iteration included:
1. Care home information leaflet
2. Care home introduction document
3. Staff manual
4. Observation notes of the care home and medication rounds
5. Transcript of a semi-structured interview with a care home 
manager
The care home information leaflet provided a description of the care 
home and services provided to residents. The care home introduction 
document contained the care home's statement of purpose, aims and 
objectives and pledge to residents relating to their healthcare. The staff 
manual contained information about different policies and procedures 
relating to tasks in the care home. These three sources of information 
were provided by the care home manager and she gave permission to 
transfer relevant information related to medication to the researcher's 
computer. Excerpts of each of the information source are presented: 
care home information leaflet in Appendix 44, care home introduction 
document in Appendix 45, staff manual in Appendix 46, observation 
notes in Appendix 47 and interview transcript in Appendix 48. All five 
sources of information used in this iteration were analysed using QSR 
International's NVivo 7 software.
The first of the three steps involved in this first iteration of the analysis 
involved identifying work domain properties (WDPs) from all five sources 
of information. The second step involved defining each level of 
abstraction in the AH. Finally, all five sources of information were
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revisited to identify additional work domain properties. The next sections 
explain these three steps in detail.
6.8.1 Identify work domain properties (WDPs)
The first step involved identifying elements of the work system related to 
the care home medication system. These are called work domain 
properties (WDPs). From the sources of information, the analyst 
scanned and made notes on relevant details about the care home 
medication system. This process was initially performed by hand but the 
analysis increased in complexity and QSR International’s NVivo 7 was 
subsequently used for the rest of the analysis. NVivo7 was able to link 
WDPs identified in the analysis back to the sources of information. This 
was useful to check the validity of WDPs identified.
A list of prompts and keywords were provided by Naikar et al. (2005) to 
help identify WDPs at different levels of the AH. These were adapted for 
use in this study (see Appendix 49) and examples of questions asked at 
the functional purpose level of the AH are listed here.
Abstraction Level: Functional Purpose
Primarv Obiectives: Reasons that a work svstem exists
Q; What are the ultimate purposes of the care home medication system?
Q: Why does the care home medication system exist?
Alongside these questions, the how-what-why triad questions described 
in section 5.4.3 were also used to elicit additional properties at the 
abstraction level. For example, “why” does a particular work domain 
property exist? “How” can this work domain property be fulfilled? Table 
6.2 presents some examples of the initial WDPs identified from various 
data sources.
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Table 6.2 WDPs Identified In the first AH Iteration
Data Source Work Domain 
Properties (WDPs)
Excerpts from Data Source
Staff manual ■ Information
■ Record-keeping
■ Admission book
Details of discharoe should be 
documented in the home’s Admission 
book.
Care home 
introduction pack
■ Quality care
■ Monitoring standards
■ Users/Residents
■ Carers
Quality care means that there is a 
recoonised svstem of aualitv control and 
monitorlna standards of care which 
involves users and carers.
General field notes ■ Communication
■ Care staff
■ Family
Regarding management and staff 
communication.
There was a sense that staff felt like they 
were part of a family. Lots of 
conversations when staff were around.
Semi-structured
interview
■ Medicines
■ Transport medication
■ Hospital
■ Resident
■ Count medicine
■ Record-keeping
■ MAR chart
■ Medical information
■ Doctor
■ Nursing care notes
The amount of medicines sent with the 
resident to the hosoital are counted and 
recorded on MAR chart. The MAR chart is 
copied and brought to hospital together 
with the medicines. A brief history of what 
haooened. why the doctor was called, 
previous history, activities of living, 
nursina care notes are sent to the 
hospital.
CSCI inspection 
report
■ Receipt of medication
■ Record-keeping
■ Audit trail
■ Medication 
administration
The receipt of medication into the home 
must be recorded so that an audit trail can 
be completed to ensure that the correct 
medication is beina administered.
6.8.2 Define the levels of abstraction
The next stage defined the levels of abstraction in the AH. This involved 
grouping the WDPs identified, which were mostly examples or instances 
at this stage, into similar or dissimilar concepts. For example, tablets, 
capsules were grouped as “solid medication" (solid as opposed to liquid 
medication): “maximise quality of care" and “maximise quality of life” 
were grouped as “maximise quality of healthcare provision”. Tablets and 
capsules could either be dispensed in the original container or in an 
MDS. Hence there were two WDPs that differentiated these two 
dispensing systems: “solid medication in MDS” and “solid medication in 
original container”.
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These concepts were then organised into a hierarchy of means-ends 
relations by asking the “how-what-why” questions (refer to Figure 5.4 for 
an illustration of the “how-what-why” triad) and a sketch of the AH was 
developed. [To aid understanding of the description of the method used 
to develop the first iteration of the AH, the reader is directed to Figure 
6.1.] Referring to the five levels of the AH, “solid medication in MDS” 
and “solid medication in original container” were placed at the “physical 
objects” level and “maximise quality of healthcare provision” at the 
“values and priority measures” level. After placing WDPs at different 
abstraction levels, the how-what-why questions were applied to check 
whether they had been placed at the appropriate level and whether there 
were additional WDPs that had not been identified and included in the 
AH.
For example, “administer medication” was a WDP at the purpose-related 
function level. By asking how “administer medication” could be fulfilled 
in the work system, the WDPs at the level below (object-related 
processes) were considered. To illustrate, “detect clinical signs” and 
“store medication” were WDPs at the object-related processes level, and 
they could potentially contribute to “administer medication” being fulfilled 
in the work system. In addition, the “how” question encouraged broader 
analysis of the current WDPs identified at a particular level of 
abstraction. Taking the same example of “administer medication”, 
several questions could be asked. Do the current WDPs identified at the 
object-related processes level adequately answer how “administer 
medication” could be fulfilled in the work system? Are there further 
WDPs at the object-related processes level that could contribute to 
“administer medication” being fulfilled in the work system? Any missing 
WDPs and means-ends links were added to the AH.
Several attempts were made to graphically represent the AH. Different 
tools were used and these ranged from using post-it notes in the initial 
stages to using a software tool that was designed specifically for CWA. 
Appendix 50 presents an account of the tools used to represent the AH.
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The final tool used to develop the AH was called “The CWA tool” 
developed by a group of researchers at Brunei and Cranfield Universities 
(Jenkins et al. 2007).
6.8.3 Revisit data sources
The final step involved revisiting all five sources of information to identify 
further WDPs in light of the context provided by the sketch of the AH. 
The same processes described in the preceding steps were used to 
identify and organise WDPs. The re-examination of information sources 
checked for information that disconfirmed the AH and WDPs that may 
have been missed during the initial analysis. These were incorporated 
into the AH. Figure 6.1 presents the first iteration of the AH.
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6.9 AH -  Second Iteration
The second iteration of the AH involved further developing the AH. 
Another analyst, JA, who had previous experience constructing an AH 
was involved in this iteration. Discussions were conducted over three 
separate sessions on different days, totalling about eight hours. Each 
WDP was reviewed for its relevance, meaning and clarity in the AH. 
The how-what-why questions were asked to unveil additional WDPs 
and understand the rationale of placing WDPs at particular abstraction 
levels. The ‘language’ of the WDPs was refined in this iteration. The 
review process identified the need for a glossary as the meanings of 
some WDPs were unclear from the labels used. As a result, a glossary 
of items in the AH was produced (see Appendix 52 for the final 
glossary). The glossary explained what each WDP represented and 
documented the justifications for placing particular WDPs in the AH.
“Dispense medication” was an example of a WDP that was not 
explicitly represented in the first iteration of the AH. This WDP formed 
part of “supply medication” in the first iteration but was subsequently 
represented as a separate WDP at the object-related processes level. 
Other examples were “co-ordinate within care home” and “co-ordinate 
with other healthcare settings” that were previously represented at the 
“purpose-related functions” level. These were removed as their 
meanings were implicit within the definition of the “purpose-related 
function” level that relates to the functions that must be executed and 
co-ordinated to fulfil the functional purposes of the work system 
(Sanderson 2003).
Not all WDPs identified in the second iteration were included in the AH. 
A WDP identified was “making profit”. Both analysts had different 
views as to whether it should be a functional purpose of the care home 
medication system. A view considered the care home medication 
system to be like all businesses and is set up to make profit. However,
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not ail care homes are private businesses. Some care homes are run 
by charities or voluntary organisations that do not exist to make profit. 
Further analysis subsumed “making profit” in “maximise use of 
resources”, a WDP at the “values and priority measures” level. The 
second iteration of the AH is presented in Figure 6.2.
6.10 AH -  Third Iteration
The third iteration of the AH involved developing the AH using 
additional sources of information. Naikar et al. (2005) discussed 
approaching work domain experts in the construction of the AH. Care 
home domain experts were approached to participate in this final stage 
of analysis.
6.10.1 Aim and objectives
The aim of the third iteration of the AH was to review the AH for its 
accuracy and completeness. The objectives were to:
1. Review the accuracy of each WDP and means-ends links in the 
AH developed.
2. Uncover any additional WDPs and/or means-ends links in the 
AH.
3. Identify any WDPs and/or means-ends links that disproved the 
current AH.
4. Elicit opinions of the care home domain experts about the ease 
of understanding and usefulness of the AH.
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6.10.2 Participants
The study defined care home medication system domain experts as 
healthcare practitioners who have direct involvement in the provision of 
medication to care home residents. Five work domain experts were 
recruited. Table 6.3 presents brief descriptions of the participants. 
Four of the five work domain experts work in the care home whilst the 
fifth was a pharmacist. They were from different backgrounds and 
performed different functions in the care home medication system.
Table 6.3 Description of care home domain experts
Work domain expert Brief background description
Pharmacist, BJ Pharmacist with previous experience as a community 
pharmacist providing medication services to care homes, 
care home inspector, primary care trust pharmacist and 
research pharmacist.
Care home manager, MR Manager of a care home providing personal care and 
nursing services. She is a trained nurse.
Care home nurse, AH Lead clinical nurse in a care home providing personal care 
and nursing services.
Care home manager, JAU Manager of a care home providing personal care only. She 
is not a trained nurse.
Care assistant, TK Care assistant in a care home providing personal care only. 
He was a new member of staff in the care home and did not 
have nursing training.
6.10.3 Method
Semi-structured interviews were conducted with work domain experts. 
One-to-one interviews were conducted with BJ, JAU and TK whilst MR 
and AH were interviewed at the same time. The materials used in the 
interview included a copy of the AH (Figure 6.2) and the glossary of the 
AH. An interview guide was developed to aid the analysis (see 
Appendix 51). Findings from the interview, such as additional WDPs 
and means-ends links were recorded directly onto the paper copy of 
the AH used. Additional reflective notes were made after each 
interview.
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The interview involved 5 steps. Each step is described in detail here 
and the findings presented. The final AH model and accompanying 
glossary is presented and described in the results section in section 
6.10.4.
Step 1 : Introduction
A brief introduction to the wider study and the aims of the interview 
were presented at the start of the interview. Then a description of the 
interview process was explained.
Step 2: Describe the AH
The second step involved presenting and introducing the developed 
AH. The concept of levels of abstraction, WDPs and means-ends links 
were described. Then a brief description of the developed AH was 
given at this stage. Participants were given the opportunity to ask any 
questions about the AH at this time.
Step 3: Review each work domain property in the AH
The third step involved reviewing each WDP in the AH. Participants 
were asked to review WDPs represented in the AH starting from the 
first level, “functional purposes”, through to the final level, "physical 
objects”. They were asked to first consider the relevance of each WDP 
at each abstraction level. Then they were asked to think about any 
additional WDPs at that abstraction levei. In the second iteration of the 
AH, another researcher, JA and the researcher spent considerable 
time discussing the relevance of a WDP, “making profit”, at the 
“functional purposes” abstraction level. Care home domain experts 
were asked whether “making profit” should be a WDP at the “functional 
purposes” level.
All participants agreed on the relevance of all the WDPs presented in 
the AH. Additional WDPs were identified. All but one WDP identified 
were at the physical objects level. Examples of additional WDPs 
identified at the physical objects level included “temperature records”.
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“medication profile”, “handover book”, “dressings” and “dressings 
ordering book”. The only other additional WDP identified was “maintain 
resident independence”, at the “values and priority measures” level. 
“Dressings” and “dressings ordering book” were not included as 
physical objects because “dressings” was not considered to be a 
medication. Hence, “dressings ordering book” was not considered to 
be medication-related.
Regarding the discussion of the placement of the WDP, “making profit”, 
at the “functional purposes” abstraction level, every work domain 
expert did not consider “making profit” as one of the primary reasons 
for the existence of the care home medication system. All participants 
agreed however, that “making profit” was an element of “maximise use 
of resources”, which is a WDP at the “values and priority measures” 
abstraction level. A few domain experts commented that “making 
profit” could be a functional purpose for the overall care home system if 
care homes were owned by private businesses.
Step 4: Review every means-ends link
After reviewing every WDP in the AH, the means-ends links that linked 
WDPs at each level of the AH were reviewed. The concept of means- 
ends links were explained again at this stage. Participants were asked 
to review the mean-ends links starting from links linking WDPs at the 
“functional purposes” and “values and priority measures” abstraction 
levels through to the last abstraction level. They were first asked to 
consider the accuracy of the links. Then, they were asked to consider 
possible means-ends links that may have been missed out. Additional 
WDPs identified in the previous step were incorporated into the AH and 
were reviewed in this step.
Two of the domain experts did not agree that there were means-ends 
links between “district nurses” and “specialist nurses” at the “physical 
objects” level with “transport medication” at the “object-related 
processes” level because district nurses and specialist nurses do not
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routinely transport medication. However, the researcher explained that 
they could transport medication despite current practices. The domain 
experts accepted the explanation. A domain expert identified an 
additional means-ends link between “prescribe treatment” at the 
“purpose-related function” abstraction level and “dispose medication” at 
the “object-related processes” abstraction level. A treatment 
prescribed could be to stop and dispose of a medication.
Step 5: Revisit the AH
The final step involved revisiting the AH. Domain experts were asked 
to review the AH again and comment whether the WDPs and means- 
ends links were accurate and complete. Then, they were asked 
whether the AH was easy to understand in terms of its representation 
and meaning, and whether the AH would be generalisable to other 
types of care homes. Finally, domain experts were asked about the 
usefulness of the AH.
All the domain experts thought that the AH was accurate and complete. 
However, all of them commented that there was a lack of 
representation of the social care aspect of the care home medication 
system in the AH model. The researcher explained that the system 
boundary defined for this analysis was to only include medication- 
related aspects of the care home medication system. This was due to 
the intentions to utilise the AH to analyse medication errors and 
practical reasons of time constraints. Domain experts from the care 
home providing personal care only commented that not all of the WDPs 
presented at the physical objects level were relevant to their care 
home. This has implications on the generalisability of the AH model 
and is discussed in more detail in section 6.11.2.
When first presented with the AH, all five domain experts thought that 
the AH looked complicated and difficult. However, they found the 
model easy to understand after explanation. One domain expert even 
commented that she was confident of explaining the AH model to her
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care home staff. Regarding the generalisability of the AH, domain 
experts thought that the first four levels of the AH could probably apply 
to all types of care homes including those for children and those for 
people with a physical or mental disability. However, not all WDPs at 
the physical objects level would be applicable to every care home.
Finally, three domain experts identified the AH model as a potential 
training tool for new care home staff. The AH presented a view of the 
whole care home medication system and they thought that new care 
home staff would benefit from an overview of the system. It may also 
be useful for care home staff members to understand particular parts of 
the system that were relevant to them in more detail. One domain 
expert also recognised the benefit of the AH model as a knowledge 
base for understanding the care home medication system and a tool for 
building a database to study the care home setting, specifically the 
database used in the study presented in Chapter 3 (the domain expert 
was involved in the development of the CHUMS database).
6.10.4 Results
The final version of the AH is presented in Figure 6.3. This AH was 
developed using “The CWA tool" (Jenkins et al. 2007) and was further 
edited graphically before being presented here. The iteration process 
revealed ambiguities in the meanings of some WDPs such as 
“temperature chart” and “order medication”. As a result, the AH 
glossary was also revised to more clearly reflect their meanings (see 
Appendix 52). The next section describes the AH in more detail.
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The first level in the AH is “functional purposes” and shows the reason 
for the existence of the care home medication system. In the care 
home medication system, “healthcare provision” is a primary reason for 
its existence. The provision of healthcare is externally constrained by 
the “requirements of laws and regulations, guidelines, policies and 
procedures”. There are different elements in the provision of 
healthcare, ranging from the object of care, the care processes, the 
people involved in providing care to the physical objects involved. 
Dealing with each element is guided and limited by relevant laws and 
regulations, guidelines set out by the government and professional 
bodies, and policies and procedures. The provision of healthcare in 
the care home medication system also requires input from different 
healthcare settings and different requirements of laws and regulations, 
guidelines, policies and procedures apply to these settings. Hence, 
there are direct implications on the functioning of the care home 
medication system. The fulfilment of the WDP, “healthcare provision” 
quickly increases in complexity.
At the “values and priority measures” level, four criteria for measuring 
how well the work system moves towards fulfilling its functional 
purposes were identified. “Maximise resources”, “maximise the quality 
of healthcare provision”, “maximise safety” and “maximise resident 
independence” were the four work categories identified. The AH 
glossary (Appendix 52) explained that “resources” refer to personnel 
(people/expertise), physical equipment and finance. Examining these 
WDPs, conflicts between the WDPs at the “values and priorities 
measures” level may be possible. “Maximising resources” may 
compromise the quality of healthcare provision to residents and the 
safety of staff and residents. The care home may maximise its 
finances by employing minimum staff, not purchasing quality 
equipment or minimum investments in staff training and by doing so, 
the trade-off could be a compromise in the safety of staff and residents, 
and the quality of healthcare provision. Similarly, maximising the 
quality of healthcare provision and safety of staff and residents may
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require financial investments that may not meet the financial priorities 
of the system.
The AH identified four WDPs at the “purpose-related functions” level: 
“diagnose medical condition”, “prescribe treatment”, “supply 
medication” and “administer medication”. These WDPs represent 
functions that need to be co-ordinated and fulfilled in the work system. 
The meanings of each WDP can be better understood by referring to 
the glossary. Table 6.4 shows two examples of WDPs and their 
meanings.
Table 6.4 Excerpts from the AH glossary
Work Domain Property Meaning
Diagnose medical problem To identify the nature of a health problem by examining 
the signs and symptoms, interviewing patients, consulting 
other healthcare professionals, monitoring conditions and 
reviewing medical records.
Administer medication Involves ordering medication, dispensing, evaluating the 
medication and its effect on patient, giving medication to 
the patient and documenting the actions. This includes 
self-administration of medication by residents and carers 
prompting residents to take medication.
Close examination of the four WDPs reveal that these functions cannot 
be fulfilled solely within the care home and require the crossing of 
boundaries of the care home and other healthcare settings such as the 
hospital, GP surgery and pharmacy. Diagnosing a medical condition 
and prescribing treatment require expertise and equipment outside the 
care home. A medical practitioner, usually located in a different 
geographical area may require different equipment to make a 
diagnosis. Different healthcare practitioners such as a doctor, nurse or 
pharmacist may prescribe treatment to care home residents. Similarly, 
the care home usually co-ordinates with other healthcare settings to 
fulfil the WDPs “supply medication” and “administer medication”. A 
district nurse may come into a care home to administer particular types 
of medication to residents and a care home nurse may ask for advice
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about a particular medication prescribed from the pharmacist or GP. 
Finally, the supply of medication could be obtained from the community 
pharmacy or the dispensing GP.
The “object-related processes” represent the capabilities and 
limitations of the physical objects available in the work system. Eleven 
WDPs were identified at this level of the AH. These are listed below 
and are not in order of importance or task flow.
Communicate 
Record-keeping 
Medication review 
Monitor health status 
Dispose medication 
Order medication 
Dispense medication 
Transport medication 
Check stock supply of medication 
Give medication 
Store medication
Fulfilling each of the 11 WDPs require input from other healthcare 
settings. For example, medication ordering (requesting a prescription) 
can occur in the care home but the community pharmacy, the GP 
surgery or the relatives and friends of the care home resident could 
perform this function. Medication dispensing usually occurs in the 
pharmacy whilst some care homes may require district nurses or 
specialist nurses to give particular types of medication to residents. 
Doctors could also give medication to care home residents. Examining 
each WDP in more detail reveals the importance of co-ordination 
among healthcare settings.
Finally, the “physical objects” level describes the physical objects in the 
work system. A total of 49 physical objects were identified and 
included tools or equipment, personnel and infrastructure. The care
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home medication system is a part-causal and part-intentional system 
meaning that both humans and machines share control of the work 
system. Thus it is crucial to represent personnel (including care home 
residents' relatives and friends) at the “physical object” level because 
they possess crucial information about the work system that enables it 
to function. The list of physical objects in the AH was not intended to 
be exhaustive and represents the physical objects that were identified 
from the three iterations of the AH. It is possible that some physical 
objects may not be included in this AH model and indeed the purposes 
of the AH was not to identify all examples of physical objects that were 
made available to the work system. Table 6.5 lists examples of 
physical objects according to type.
Table 6.5 Examples of physical objects according to type
Type Physical Object
Tools or equipment Medication Administration Record (MAR)
Drug trolley
Medication
Care records
Drug disposal book
Nurses’ diary
Laboratory reports
Personnel Resident 
Care home nurse 
General practitioner 
Community pharmacist 
Relatives/friends 
Hospital staff 
District nurses
Infrastructure Clinical/treatment room 
Residents’ room 
Nurses’ office/locked store
Examining the objects at this level, it is clear that several physical 
objects contained similar information about the care home medication 
system. For example the repeat medication list and medication 
ordering book contain information to order medication; care records, 
nurses’ diary, handover book, GP medical records, hospital medication 
records, community pharmacy records and other healthcare
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professionals’ medical records all contain information about residents’ 
care plans, medical issues and medication; the MAR chart, medication 
profile and homely remedy book contain information about residents’ 
medication. These physical objects thus provide similar functionality. 
Some of these physical objects also reside in other healthcare settings. 
For example GP medical records are located mainly in the GP 
surgeries. Hospital medical records are located in the hospital, other 
healthcare professionals’ medical records are in various locations and 
community pharmacy records are in the community pharmacy. The 
long list of physical objects in the AH could continue to expand but this 
would lead to the AH being largely descriptive and would not contribute 
greatly to this analysis that aimed to understand the care home 
medication system and to identify the requirements of a safe system. If 
these physical objects provide similar functionality and limitations and 
are placed in different geographical locations, it may be more effective 
to have a central source of information containing all information such 
as an online version of medical records. The effect of adding to or 
removing these WDPs can be assessed using the means-ends links 
that link them to the WDPs at the level above, “object-related 
processes”. This level showed that even at the final level of the AH, 
the WDPs cross the physical boundaries of the care home.
An important feature of the AH is the means-ends links. Means-ends 
links represent the relationships between each abstraction levels by 
answering “why” a particular WDP or work category exists and “how” 
that category can be fulfilled in the work system. The means-ends 
links were applicable to every level of the AH except for “functional 
purposes” that did not have a means-ends link above because it 
explains why the work system exists in the first place, and “physical 
objects” that did not have a means-ends link at a level below because it 
was the last level of the AH model. The means-ends links suggest 
possible links between WDPs rather than only representing current 
practices or what should happen in the work system. These means- 
ends links enable care home staff to embrace a wide variety of
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possible trajectories of action and equip the system to predict and deal 
with weak areas in the system.
“Communicate” and “record-keeping” were two WDPs with the most 
means-ends links in the AH suggesting the important roles they play in 
the care home medication system. WDPs that are means-ends linked 
to “communicate” and “record-keeping” are also linked to other WDPs 
at different abstraction levels. Hence, the impact of problems with 
“communicate” and “record-keeping” could extend beyond the non- 
fulfilment of WDPs that are directly linked to them. The numerous 
means-ends links between the WDPs at the “object-related processes” 
and “physical objects” abstraction levels suggest that some of the 
physical objects may have similar functions and could possibly be 
removed from the system to reduce the complexity of the system.
6.11 Discussion
6.11.4 Value of the abstraction hierarchy 
Representation of complex systems
The AH presented a concise visual representation of the whole care 
home medication system by modelling its structural and physical 
constraints. Structural constraints refer to the fundamental work 
properties that need to be fulfilled by the system whilst physical 
constraints refer to the physical objects and their functionality to fulfil 
the fundamental work properties in the systehn. In the AH, structural 
constraints are represented by the first three levels; “functional 
purposes”, “values and priority measures” and “purpose-related 
functions”. The last two levels in the AH, “object-related processes” 
and “physical objects” show the physical constraints of the system. 
These system constraints delineated a map of the care home 
medication system and represented the whole problem space that 
workers have to deal with within the boundaries of the analysis.
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The constraints represented in the AH related to work functions and not 
tasks. Work functions represent categories of activities or tasks that 
need to be performed in the work system whilst tasks are examples of 
activities. An example of WDPs at the “purpose-related functions” and 
“object-related processes” is “diagnose medical condition” and “give 
medication” respectively. These terms could be easily understood as 
representing tasks that need to be performed in the system. However, 
the analysis was not a task analysis detailing the steps to perform a 
task but an analysis of the work domain on which tasks are performed 
represented by categories of work or tasks, or functions.
Understanding complex systems
The concise visual representation of the care home medication system 
is like a map that provides a whole view of the system. But unlike a 
conventional map, the AH is a hierarchy that has five levels. Each 
level contains WDPs relevant to a particular view or abstraction of the 
system. The uniqueness of the AH is that the WDPs at each 
abstraction level represent a view of the whole of the care home 
medication system. To illustrate, the “purpose-related functions” level 
presents all the work functions that need to be co-ordinated in order to 
fulfil the functional purposes of the work system. The work functions at 
this level represent a view of the whole system at that abstraction level: 
“diagnose medical condition”, “prescribe treatment”, “supply 
medication” and “administer medication” represent a view of the whole 
care home medication system at the “purpose-related function” 
abstraction level. Similarly, all the work functions at the “object-related 
processes” level represent a view of the whole system at that level. 
This way of presenting a complex socio-technical system greatly 
reduces the mental workload required by workers to structure and 
prioritise their work because the whole view of the system at that 
abstraction level is represented at a single level. Using the AH for 
design simplifies and structures the system information requirements 
for system designers.
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Despite the seemingly simple representation of a complex system, the 
AH can accommodate a large amount of information about the system. 
Within the work categories a variety of trajectories of action are 
possible. Hence, it is possible that unanticipated and novel situations 
to the work system are captured within these work categories. 
Equipped with the AH as a map of the care home medication system, 
workers can plan different trajectories of action to deal with novel and 
unanticipated events. For example, a worker may be faced with a 
problem related to a particular object such as an MDS and may choose 
to deal with the problem by concentrating on the MDS, or by analysing 
the means-ends links linking the MDS to the WDPs at the level above 
such as “store medication” and “dispense medication”. The problem 
WDPs and the means-ends links can be analysed right up to the first 
abstraction level, the “functional purposes” level.
The AH provides a knowledge base of the care home medication 
system for developing and prioritising solutions. There is potential of 
using the AH as an evaluation tool to assess the effectiveness of 
interventions for system improvements.
System design
The AH could also be a tool to inform system design. The AH showed 
that multiple healthcare settings contribute to the functioning of the 
care home medication system. Could it be feasible, useful or even 
safe to move all or part of the functions currently performed in other 
healthcare settings to the care home? For example, a care home could 
have a resident pharmacist who dispenses medication, gives 
medication and conducts medication reviews. Or, to have all of the 
care home residents' records in the care home instead of records being 
kept in various places such as the GP surgery, community pharmacy or 
other healthcare settings. The key question is the implications of these 
recommendations on the functioning of the care home medication 
system, and, the AH can provide the information to evaluate and
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prioritise the recommendations. The means-ends links in the AH 
indicate the areas that the recommendations could implicate. Together 
with values and priorities of the system, informed decisions can be 
made based on an understanding of the structural and physical 
constraints of the work system.
The AH is a formative model rather than a descriptive or normative 
model. In a formative model, the workers in the system complete the 
design or plan because they are not given a set of rules to follow nor 
do they rely solely on past experiences (Vicente 1999). Instead, they 
are provided with the information requirements about the work system. 
Workers can use this information to devise different actions. Further 
procedures to perform their work can then be developed.
6.11.5 Issues of rigour
Research paradigm and phiiosophical position
Surprisingly, there has been little published literature about issues of 
rigour in relation to the conduct of a WDA. Before deciding which 
criteria are suitable for measuring the quality of the WDA, an important 
question needs to be addressed first and this relates to the research 
paradigm within which WDA fits. Spencer et al. (2003) who conducted 
a comprehensive review of quality in qualitative research observed that 
the criteria chosen by qualitative researchers to assess the quality in 
qualitative research were heavily influenced by their research paradigm 
and philosophical assumptions. Hence, it is worth reflecting on the 
research paradigm and philosophical assumptions of WDA. 
Addressing this issue, however, was not easy. Spencer et al. (2003) 
discussed the confusingly different ways that paradigms are labelled 
and described in the current qualitative research literature and the 
varying philosophical assumptions on which these paradigms are 
supposedly based on. In addition to this confusion, there has been no
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attempt in the current literature to the knowledge of the researcher, to 
understand and describe WDA from this perspective.
WDA is informed by a qualitative research paradigm. Because of the 
varying philosophical assumptions associated with research 
paradigms, it is important to consider them here also. The first is the 
ontological position or view about the nature of the world. There are 
many different views and two contrasting views are realism and 
idealism. Realists believe that reality exists independently of human 
beliefs and understanding whilst idealists believe that ideas exist 
fundamentally and reality is a human construction (Spencer et al. 
2003). The researcher believes that WDA falls within neither of these 
extreme positions. Various methods are used to inform the WDA 
including the analysis of documents in the work system, observations 
of the work setting and interviewing workers in the work system. These 
are used to form a common (researcher and domain experts) 
understanding of the work system. Another ontological position relates 
to objective realism that accepts that there is a world of collectively 
shared understandings and WDA seems to fit within this position. 
Hence, the WDA represents a model that could be generally accepted 
and understood because the model was constructed based on a 
common understanding of the work system.
Another assumption that needs to be considered is the epistemological 
beliefs or view about the nature of knowledge and how it is possible to 
know about the world. Again, there are contrasting views and Spencer 
et al. (2003) discussed two differing models: the foundational and 
fallibilistic models of knowledge. The foundational model assumes that 
“it is possible to produce accurate accounts which correspond to 
reality” (Spencer et al. 2003: 46) whilst the fallibilistic model is based 
on the idea that “it is possible to produce knowledge claims which 
attempt to be as accurate as possible but they are provisional and may 
be amended in the light of new findings” (Spencer et al. 2003: 46). 
WDA claims to be suitable for analysing complex socio-technical
218
systems and in a socio-technical system, a human element is always 
involved, if the assumption here is that humans can be unpredictable 
and if the functioning of a system partly depends on the actions of 
humans, it would then be possible for reality to change with time. 
Hence, it would seem that the WDA fits within the fallibilistic model. 
This suggests that the WDA attempts to produce an accurate view of 
the system but if new information were presented, the WDA could 
change to represent the system in light of the new information.
Criteria to assess quality
Now that there is an understanding of the research paradigm and 
philosophical assumptions of WDA, the discussion considers some of 
the criteria used to evaluate quality in the general qualitative research 
literature. Spencer et al. (2003) identified a diversity of criteria used in 
the current literature to assess the quality of qualitative research and 
discussed the ‘holy trinity' of validity, reliability and objectivity. Since 
Spencer et al. (2003) reviewed a comprehensive list of literature on 
qualitative research, the researcher finds little value in reviewing this 
literature again. This discussion tackles the issue of validity, reliability, 
objectivity and generalisation or ‘external validity' in turn.
Validity
From their review of the literature, Spencer et al. (2003) identified two 
different conceptions of validity: methodological and interpretive issues. 
Methodological issues relate to whether the methods chosen are valid 
and measure what they purport to measure. Interpretive issues relate 
to the ‘truth' or ‘credibility' of the findings: whether the measurements 
used are valid and whether a particular conclusion can be made. 
Spencer et al. (2003) pointed out that since there are no standardised 
instruments or methods in qualitative research, validity cannot be a 
property of a particular method. However, Spencer et al. (2003) went 
on to discuss how these concerns about methods became concerns of 
rigour and that there is a general support for having clear and
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transparent documentation of the research process. The researcher 
also viewed it as important to provide a clear and transparent account 
of the process of conducting the WDA and both conceptions of validity; 
methodological and interpretive issues are discussed relating to WDA.
Very rarely is validity addressed in the WDA literature. An exception is 
Naikar et al. (2005) who described the need to validate the AH, the 
result of the WDA. They suggested examining whether the workers' 
reasoning patterns in different situations can be accommodated by the 
AH. If so, the AH is valid in terms of its ability to fulfil its purported 
function of providing a reasoning space for workers. In one sense, 
Naikar et al. (2005) seemed to be trying to show whether the tool itself 
(the AH) is valid and what is being examined here are the theoretical 
underpinnings of WDA. So, it is concerned with whether the theoretical 
underpinnings of the WDA can lead to workers being provided with an 
AH that provides the information requirements to deal with 
unanticipated and novel situations. In another sense, Naikar et a/.’s 
(2005) proposition seemed to also indirectly address the interpretive 
issues or ‘status of the findings' about whether particular WDPs should 
be in the AH, and whether they were placed in the right abstraction 
level and linked to the appropriate WDPs. An AH can claim to fulfil its 
purported function if these WDPs and the means-ends links are valid.
In this study, it was difficult to assess the validity of the AH in terms of 
its ability to provide a reasoning space for workers because this would 
involve specialist expertise and time that were both lacking in the 
study. The AH was however used to analyse medication errors 
identified in the care home medication system (see chapter 7). The 
analysis of errors identified vulnerable areas in the care home 
medication system and it was possible to derive trajectory of actions 
that may have averted medication errors by analysing the AH. This 
indicates the possibility that the AH could indeed provide a reasoning 
space for workers to deal with different situations. However, these are 
early assumptions that need to be further tested.
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Closely related to the issue of validity are credibility (whether the 
evidence for the claim is convincing) and plausibility (how the claim fits 
with what is already known). Credibility and plausibility could either be 
seen as alternatives to validity or ways of establishing validity. The 
WDA is performed for a specific purpose within a specific context and 
the process of constructing the WDA is highly iterative. It would be 
possible to have a different understanding of reality (of the system) with 
each iteration of the AH if each iteration was conducted by a different 
domain expert with a different background. The analysts may also be 
informed by different understandings of the system. Hence, it would 
seem that credibility and plausibility can also be viewed as alternatives 
instead of ways to establish validity in WDA.
Regarding the validity of the WDPs and means-ends links in the AH, 
Naikar et al. (2005) considered this aspect when they outlined a 
comprehensive method to conduct the WDA. Their method was 
adopted in this study. Since it was previously established that 
credibility is an alternative view of validity, these two terms are used 
interchangeably in the following discussion because of the 
inconsistencies of terms used in the literature. Triangulation is a 
common method used to establish the validity of a claim. Some 
however view triangulation as a way of ensuring comprehensiveness 
and encouraging a more reflexive analysis of the data rather than a 
way of establishing validity. Nevertheless, triangulation of data sources 
(the use of two or more data sources) was applied in each of the three 
iterations of the AH and additional WDPs and means-ends links were 
identified.
Reflexivity is a way of enhancing the credibility of the findings. This 
relates to the need for critical reflection of the researcher's biases and 
preconceptions and the effect it may have on the findings during the 
research process. There was a continuous reflective process when 
conducting the AH and the preconceptions and personal biases of the 
researcher were challenged. An example was the personal bias that
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the care home medication system should not exist to make a profit and 
this was challenged in the second iteration of the AH. The literature 
discusses attention to negative cases as a way to establish credibility 
of claims. The researcher searches and discusses elements in the 
data that contradict, or seem to contradict the emerging findings. The 
second iteration of the AH with another researcher, JA revealed WDPs 
that seemed to contradict the AH. An example was the relevance of 
“making profit” in the care home medication system. In the third 
iteration of the AH, domain experts revealed disagreements with some 
of the means-ends links between WDPs. These were discussed and 
the appropriate changes were made to the AH.
Another way of increasing the credibility of the findings is respondent 
validation or member checking where the level of agreement between 
sets of data is established and these are then incorporated into the 
findings of the study. This method is also generally accepted as part of 
a process of error reduction. The third iteration of the AH involved 
reviewing the AH with five domain experts with different backgrounds. 
The additional WDPs and means-ends links identified were further 
analysed before being incorporated Into the AH. Fair dealing ensures 
that a wide range of perspectives about a situation is represented and 
is another way to establish validity. In the WDA, the three iterations of 
the AH involved the primary researcher with a background in 
community pharmacy, an analyst with some understanding of the care 
home medication system, a care home manager of a care home 
providing nursing care, a care home manager of a care home providing 
personal care only, a care assistant, a care home nurse and a 
pharmacist with experiences as a community pharmacist, care home 
inspector, primary care trust pharmacist and research pharmacist. 
Finally, the previous discussion accepted the importance of the need 
for a clear and transparent account of the process of conducting the 
WDA and this chapter attempts to provide such an account.
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Reliability
Reliability is another criterion often used to assess the quality of 
qualitative research. In the broadest sense, reliability concerns the 
extent to which the same results could be obtained if a study was 
replicated. Spencer et al. (2003) uncovered a variety of conceptions 
about reliability and explained that the concept of reliability is 
problematic because of methodological, ontological and 
epistemological reasons. Several conceptions of reliability include 
‘reliability as replicability’, consistency and auditability, dependability or 
reflexivity (Spencer et al. 2003). The concept of reliability as the extent 
to which a study can be replicated is rejected in WDA because WDA 
relies on a variety of methods of data collection such as interviews, 
observations and document analysis. These methods of data 
collection rely heavily on the researcher who is the main instrument 
and it is difficult to standardise the interpretation of results by different 
researchers collecting data. However the data collection methods 
could be standardised. Some also believe that by studying the setting, 
the study setting changes. However, it was unlikely that the study 
setting changed during the collection of data to construct the AH.
Another conception of reliability is consistency and Spencer et al. 
(2003) discussed two distinctions of reliability as external and internal 
reliability as accounted by LeCompte and Goetz (1982). External 
reliability concerns
“whether independent researchers would discover the same 
phenomena or generate the same constructs in the same or 
similar settings” (LeCompte and Goetz 1982:32)
whilst internal reliability relates to
“the degree to which other researchers, given a set of previously 
generated constructs, would match them with data in the same 
way as did the original researcher” (LeCompte and Goetz 
1982:32).
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To ensure external reliability, clear documentation of “the status 
position adopted by the researcher, the nature of the data sources, the 
social situations in which the study was carried out, the methodology 
adopted and the theories and ideas that informed the study” (Spencer 
et al. 2003:64). Internal reliability can be addressed through “recording 
data mechanically, using low inference indicators, using a team of 
researchers, using participant researchers and peer examination” 
(Spencer et al. 2003:64). Auditability, dependability or reflexivity are 
other indicators of reliability reported by Spencer et al. (2003). There is 
no assumption that independent researchers would derive the same 
findings about phenomena or generate the same constructs. The 
emphasis is on clear documentation of the research process and how 
constructs were derived as in producing an ‘audit trail’.
With regard to WDA, the researcher is of the position that similar rather 
than identical data could be expected if another researcher conducted 
the analysis. Hence, this chapter focused on presenting a clear 
account or audit trail of the study to include the data collection process, 
analysis and the setting on which the study was conducted. 
Furthermore, it is also unclear whether there is value in replicating 
studies and it is not common to replicate an analysis like the WDA. 
The WDA is conducted for a particular purpose and the value of it is 
judged by the people who use it.
Objectivity
The general view is that complete objectivity, neutrality or the absence 
of bias in qualitative research is not achievable (Spencer et al. 2003). 
Clear documentation of the research process and reflexivity have been 
discussed as steps to ensure that a ‘reasonable’ level of objectivity is 
attained. In terms of the WDA, this chapter presented a detailed 
account of the methods used for data collection and analysis. The 
researcher also recognized and attempted to reduce the biases that 
emerged from the analysis through systematically reviewing them (e.g. 
whether “making profit" should be a WDP in the AH) with another
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researcher (e.g. JA) and with other domain experts (e.g. in the third 
iteration of the AH).
Generalisation or ‘externai validity’
There are two opposing camps regarding the desirability of 
generalisation in qualitative studies. Some argue that generalisation is 
not possible because findings from qualitative research are always 
context-specific whilst others argue that it is possible to apply findings 
in a sense of a wider applicability and that generalisation is desirable 
(Spencer et al. 2003). If generalisation was possible, it was based on 
assertional logic that relies on the strength of the arguments rather 
than probabilistic logic that relies on statistical information (Spencer et 
al. 2003). Spencer et al. (2003) discusses three broad types of 
generalisation: representational or generalisation within a case, 
empirical or inferential and analytical or theoretical. From the three 
types of generalisation, empirical or inferential generalisation is 
relevant to the discussion of WDA. Empirical generalisation is taken to 
mean whether the findings from one context or setting are applicable to 
another. In this study (as in most WDA), WDA was performed for a 
specific purpose within a specific context and generalisation in this 
sense is not necessarily meaningful.
However, the researcher did ask the five domain experts in the third 
iteration of AH, the extent to which the AH was generalisable or 
relevant to other care home settings. Every domain expert except for 
the care assistant (who did not comment) considered that the first four 
levels of the AH were applicable to other care homes including care 
homes providing personal care only, care homes for children and care 
homes for residents with physical and learning disabilities. They 
considered the “physical objects” level to be less generalisable to other 
care homes because the AH contained WDPs that did not apply to their 
own care homes. Their position on the generalisability of AH could be 
informed by the assumption that care homes operate within the same 
legal, health and social system. However, there are further elements of
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the care home medication system such as ethics and culture that may 
influence the values and priorities of the system that can in turn affect 
the fulfilment of the work system.
6.11.6 Methodological challenges
Conducting the WDA presented several methodological challenges. 
From a practical view, the analysis was highly iterative and hence time- 
consuming. A fundamental problem was the lack of a suitable tool to 
represent the AH graphically. The search for a suitable tool evolved 
from very basic tools such as post-it notes to using Microsoft 
PowerPoint, Microsoft Visio, NVivo 7 (QSR International 2006) to The 
CWA tool (Jenkins et al. 2007). A more detailed account of this 
process is reported in Appendix 50. The CWA tool (Jenkins et al. 
2007) was specifically designed to support the analysis at different 
levels of CWA. The advantages of The CWA tool included its ability to 
accommodate large amounts of data and support the construction of 
the AH (in relation to WDA). The CWA tool provided a skeleton of the 
AH and it was very easy to add, change or delete WDPs from the AH. 
Any changes made to the AH carried through subsequent phases of 
analysis in CWA. Creating physical links between WDPs was also 
easy; clicking and dragging a WDP to another location. This was in 
contrast to the other tools used previously to construct the AH. These 
advantages were important because the researcher could concentrate 
on the analysis rather than contend with software problems.
Another challenge related to the analytical process of constructing the 
AH. The identification and labelling of WDPs were sometimes difficult. 
WDPs were categories of work and activities in the work system, not 
examples of events. However, it can be difficult to label WDPs 
because labels could mean both categories of activities and examples 
of activities. For example, “dispense medication” could be taken to 
represent a work category or describe the actual dispensing of 
medication. The meanings of the labels used for WDPs were also
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sometimes unclear. Hence, a glossary of WDPs explaining their 
meanings was produced. The glossary proved to be very useful in the 
third iteration of the AH when explaining the AH to domain experts. 
There were also difficulties determining the abstraction levels of the 
WDPs identified such as whether “monitor health status” should be on 
the “purpose-related function” level or the “object-related processes” 
level. Such difficulties were resolved by reviewing the purposes and 
boundaries of the WDA and through multiple iterations of the AH with 
different participants.
The WDA required the analyst to have a good understanding of the 
work domain. It would be very difficult for another analyst without a 
background in healthcare to produce a similar model to the one 
presented here by just reviewing available documents and observing 
the work setting in a relatively short period of time. It was important to 
utilise multiple sources of information when constructing the AH. The 
researcher spent considerable time familiarising herself with the care 
home domain as discussed in Chapter 2 and conducting research in 
the care home setting as described in Chapters 3 and 4.
6.11.7 Future research
The previous study reported in Chapter 3 revealed the extent of 
medication errors in care homes. Since the AH is a useful tool for 
providing a knowledge base about the care home medication system, it 
can potentially be used to identify areas of unsafe practice in the 
system and develop system improvement strategies. The next chapter 
reports an analysis of the medication errors identified in Chapter 3, 
using the AH, and describes the recommendations generated for 
system improvement. The AH could also potentially identify the 
implications of specific recommendations through the means-ends links 
between WDPs.
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An application of the AH suggested by some of the domain experts 
interviewed in the third iteration of AH was as a training tool for care 
home staff. The AH is a map of the whole care home medication 
system and WDPs at each abstraction level could be developed into 
teaching modules as part of a larger training package Introducing the 
care home medication system. An important feature of the AH is that 
WDPs are placed in the context of the whole care home medication 
system. The implications of using the AH as a training tool is that 
WDPs that are developed into specific training modules are not taken 
out of context from the wider care home medication system. Hence, it 
is easy to see where the WDPs fit within the wider care home 
medication system.
Another area for future study is using the AH as a tool to examine the 
mental model of workers when they problem solve. Xu (2007) 
examined problems in an aircraft-automation system using various 
data including mental model test data and mapped this onto an AH of 
the work system being analysed. He found problems at different parts 
of the AH and subsequently derived recommendations for system 
improvement based on his findings. Naikar et al. (2005) also 
suggested using specially developed scenarios to examine the 
reasoning patterns of various workers in the system. The reasoning 
patterns of workers provide the information requirements to identify the 
competencies required to perform particular WDPs in the work system.
6.12 Conclusion
This study was born out of a need for a different paradigm and method 
to understand the care home. A WDA was performed to provide a 
knowledge base of the care home medication system and to determine 
the requirements of a safe medication system. An AH was produced 
and presented a visual representation of the structural and physical 
constraints of the complex care home medication system. The AH was 
likened to a map from which various trajectories of actions can be
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derived. The AH provided the knowledge base where the analysis of 
the work system could take place. The design of the system could also 
be informed by the AH. An important aspect of the AH is the means- 
ends links that provide information about the relationships between 
WDPs in the AH. This could enable the evaluation of the current 
system and show the possible effects or consequences of 
recommendations on the system. Finally, issues of rigour, the 
methodological challenges of constructing the WDA and future 
research directions were discussed.
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Chapter 7: Revisiting error analysis using the 
Abstraction Hierarchy
7.1 Introduction
The previous chapter presented a model of the care home medication 
system using the abstraction hierarchy (AH). In chapter 4, the 
shortcomings of using The London Protocol to analyse medication 
errors were discussed. These included: the lack of relationships 
between error contributory factors in the analytical framework, and an 
incomplete generalised analytical framework to analyse medication 
error that focused on addressing only identified problems. The 
previous chapter discussed the AH as a contextual framework of the 
work domain being analysed and showed the relationships between 
the WDPs in the system. This suggests that the AH could potentially 
be a useful tool to analyse medication errors. This chapter explores 
the use of AH to analyse the same medication errors previously 
analysed using The London Protocol (Taylor-Adams & Vincent 2004) 
and to generate recommendations to improve the care home 
medication system.
7.2 Aim and objectives
The aim of the analysis was to determine whether the AH is a useful 
tool to analyse medication errors compared to The London Protocol. 
Two objectives were identified. The first was to use the AH of the care 
home medication system developed in Chapter 6 to analyse the same 
medication errors previously analysed using The London Protocol 
reported in Chapter 4, for the causes of errors. The second objective 
was to compare the differences, if any, of the findings of the analyses 
of errors using the AH and The London Protocol.
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7.3 Method
The method presented here is a novel approach to analyse medication 
errors. At the time of this analysis, there had been no published study 
that used the AH to analyse the causes of medication errors In 
healthcare settings and generate recommendations for system 
Improvement. However, an example of the use of AH to analyse 
problems In another work domain was performed by Xu (2007). He 
used the AH to Identify problems In an alrcraft-automatlon system 
using data generated from pilot survey data. Incident data, simulator 
study data and mental model test data. These data sources were 
mapped onto the AH of the alrcraft-automatlon system and the location 
of the problem located on the AH. The Identification of problems led to 
the generation of recommendations to fill the gaps In the work system. 
The method used to analyse medication errors In this study differed 
from Xu’s (2007) and Is presented In the following sections.
7.3.1 Tools
The tools used to conduct this analysis Included the AH of the care 
home medication system presented In the previous chapter and the 
case summaries of the same nine medication administration errors 
analysed In Chapter 4.
7.3.2 Procedure
The novel approach of error analysis involved five steps.
Step 1: Using the AH, a list of all the WDPs at the “purpose-related 
functions” (PRFs) abstraction level was made. The decision was made 
to target WDPs at the PRF abstraction level because medication errors 
were Identified and classified according to stages of care, as reported 
In Chapter 3. Each stage of care represents a work function such as 
prescribing, monitoring of medication, dispensing and medication 
administration. The PRF abstraction level represents the functions that
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need to be performed in the work system in order to fulfil the purposes 
of the work system. So, it was logical to begin the analysis at this 
abstraction level.
Step 2: Each of the nine error case summaries were analysed to 
identify any problems with the WDPs at the PRF abstraction level that 
had led to medication errors.
Step 3: Referring to the AH, a list of WDPs that were means-end 
linked to the relevant WDPs at the PRF abstraction level was made. 
The means-ends links answer the question “why” a WDP is required in 
a system by referring to the abstraction level above. Referring to the 
abstraction level below at the “object-related processes” (ORP) level, 
the means-ends links answer the question “how” a WDP is fulfilled in 
the work system. One of the objectives of the analysis was to 
understand how medication errors occurred. So, it was logical to target 
the WDPs at the level below the PRF abstraction level, the ORP level.
Step 4: Error case summaries were revisited to identify whether any of 
the WDPs listed in Step 3 had led to medication errors.
Step 5: Finally, recommendations were generated based on the 
analysis of WDPs identified in Step 4. A systematic approach was 
adopted. For each WDP, a corresponding recommendation for system 
improvement was made. The recommendations made for each error 
were then collated. These were further abstracted to form high-level 
recommendations.
7.3.3 Example of an analysis
To provide a clearer description of the method used to analyse errors, 
an example of an analysis is provided here. The same medication 
administration error (identified by code 02-01-02-CC-ZC1) that was
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used as an example analysis in Chapter 4 is used here to provide 
familiarity with the case.
The case summary for the error was presented in section 4.4.2 and is 
not replicated here. It is useful to first read the case summary.
Step 1: The first step involved listing all the WDPs at the PRF
abstraction level in the AH. These were “diagnose medical condition”, 
“prescribe treatment”, “supply medication” and “administer medication”.
Step 2: Secondly, the error case summary was reviewed to identify 
any problems with the WDPs listed in Step 1. Problems with “supply 
medication” and “administer medication” were identified.
Step 3: Referring to the AH, a list of all the WDPs that were means- 
ends linked to “supply medication” and “administer medication” at the 
ORP abstraction level was made.
The WDPs at the ORP level linked to “supply medication” are listed 
below:
Communicate 
Record-keeping 
Monitor health status 
Dispose medication 
Medication review 
Transport medication 
Order medication 
Dispense medication 
Check stock supply of medication 
Store medication
For “administer medication”, the following list of WDPs at the ORP level 
was made:
■ Communicate
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Record-keeping
Monitor health status
Order medication
Dispense medication
Check stock supply of medication
Give medication
Store medication
Step 4: The error case summary was revisited to identify whether there 
were any problems with the WDPs listed in Step 3 that had led to the 
medication error.
For “supply medication", problems were identified with the following 
WDPs at the ORP level:
Communicate 
Record-keeping 
Medication review 
Transport medication 
Order medication 
Check stock supply of medication
There were problems with the following WDPs at the ORP level relating 
to “administer medication”:
■ Communicate
■ Monitor health status
■ Give medication
A detailed analysis describing the problems with WDPs that were 
means-ends linked to “supply medication” and “administer medication” 
is presented in Tables 7.1 and 7.2 respectively.
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Table 7.1 Detailed analysis of problems with WDPs linked to “supply
medication”
Work domain property Description of problem
Communicate Communication problems were identified between;
■ Care home staff and community pharmacy staff -  neither 
questioned why the supply of paracetamol was still in the 
pharmacy.
■ Care home staff administering medication -  information 
about the lack of paracetamol supply had initially been 
communicated between staff but care staff had not 
questioned why it was still the case after ZC had not been 
given paracetamol for at least 2 days.
■ Care home staff and resident -  resident had not questioned 
why she had not had paracetamol and care staff had not 
informed resident that there was no supply of paracetamol.
Record keeping ■ There was inadequate record-keeping in the care home and 
community pharmacy to indicate the relative urgency of 
obtaining ZC’s paracetamol supply after she had missed at 
least 2 days’ supply of paracetamol.
Monitor health status None identified
Dispose medication None identified
Medication review ■ There was a lack of regular reviewing of resident’s 
medication. A medication review may include the day-to- 
day management of medications. The supply of 
paracetamol was ordered out-of-sync with ZC’s regular 
medications. Medications for every care home resident 
were ordered at the same time. ZC’s medication had not 
been reviewed to identify problems with unsynchronised 
ordering of her medications with the rest of the residents in 
the care home.
Transport medication ■ There were no arrangements to transport medication from 
the community pharmacy to the care home.
Order medication ■ There were no problems ordering the repeat supply of 
paracetamol in this instance. This was however not an 
isolated case because there was also a problem with non­
availability of paracetamol in the previous month.
■ Care staff normally used the stock supply of paracetamol 
when the regular supply ran out. The senior supervisor who 
administered medication did not check to find out whether 
there was any stock supply of paracetamol and assumed 
that there was none. There were problems with the ordering 
of stock medication.
Dispense medication None identified
Check stock supply of ■ There was no stock supply of paracetamol tablets during
medication medication administration. There were problems with 
checking stock supply of medication.
Store medication None identified
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Table 7.2 Detailed analysis of problems with WDPs linked to “administer
medication”
Work domain property Description of problem
Communicate ■ Care home staff had not informed the resident that there 
was no supply of paracetamol tablets and as a result, she 
was not going to receive any. The resident had also not 
questioned why care staff had not offered her any 
paracetamol tablets for pain.
Record keeping None identified
Monitor health status " Paracetamol was prescribed as a regular dose and not 
“when required” as was previously prescribed. The resident 
should have been given her paracetamol tablets even if she 
had not complained of pain.
Order medication None identified
Dispense medication None Identified
Check stock supply of 
medication
None identified
Give medication ■ Paracetamol tablets were not given to the resident.
Store medication None identified
Step 5:
For each WDP described in Step 4, a corresponding recommendation 
for system improvement was made by the analyst. Tables 7.3 and 7.4 
present the recommendations that were generated corresponding to 
relevant WDPs that were means-ends related to “supply medication” 
and “administer medication”.
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7.4 Findings
This section presents a summary of the analysis of all nine medication 
administration errors. A brief description of the nine medication 
administration errors was previously presented in Table 4.4. It is useful to 
refer back to the table. Similarities were found in three pairs of errors: 02- 
01-02-CC-ZC1 and 02-01-02-CC-ZC2, 02-01-03-JJ-BG and 02-01-03-KK- 
AG and, 02-02-04-YY-MR1 and 02-02-04-YY-MR2 and were previously 
reported in section 4.5. As a result of these similarities, the analysis 
identified the same findings for each pair of errors.
7.4.1 WDPs at the PRF abstraction level
Two WDPs were identified to have contributed to the nine medication 
administration errors. These were “administer medication” and “supply 
medication”. Problems with “administer medication” were considered to 
have contributed to all the medication administration errors. Problems 
with “supply medication” contributed to two medication errors. There was 
a lack of medication supply and this contributed to the omission of a 
medication in two medication administration rounds. This highlighted the 
tightly-coupled nature between “administer medication” and “supply 
medication” in the care home medication system: a problem with one 
WDP led to a problem fulfilling the other WDP. Various healthcare 
settings are involved in fulfilling the two WDPs. Hence, co-ordination 
within and outside the care home is essential for the safe and effective 
running of the care home medication system.
7.4.2 WDPs at the ORP abstraction level
The analysis of the WDPs linked to “administer medication” and “supply 
medication” identified WDPs at the “object-related processes” level that
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contributed to the nine medication administration errors. Table 7.5 shows 
the relevant WDPs and the number of times these WDPs contributed to 
medication errors.
Table 7.5 WDPs at the ORP abstraction level that contributed to medication 
errors
Work Domain Property (WDP) Number of times implicated in errors (%)
Communicate 9(22)
Record-keeping 9(22)
Monitor health status 2(5)
Medication review 2(5)
Transport medication 2(5)
Order medication 2(5)
Dispense medication 3(7)
Check stock supply of medication 2(5)
Give medication 9 (22)
Store medication 1 (2)
Total 41 (100)
“Communicate”, “record-keeping” and “give medication” were the most 
frequent contributors to medication administration errors whilst “store 
medication” contributed to one medication error. A summary of the error 
analysis is presented in Table 7.6. Following this, the findings in order of 
the most frequent to the least frequent contributor to error are discussed.
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Table 7.6 Summary of error analysis corresponding to WDPs that
contributed to medication errors
Work Domain 
Property (WDP)
Summary of error analysis
Communicate Communication problems were identified between care home staff 
and community pharmacy staff, care home staff and care home 
residents, and care home staff in the care home.
Record-keeping Problems with record-keeping included not updating records, 
recording the wrong information, not recording information, making 
unclear records and not using recorded information.
Monitor health status It was difficult to observe and judge the health status of care home 
residents visually.
Medication review A comprehensive review of medication was not routine: the 
medication management component had not been conducted.
Transport medication The medication transportation system was not robust as it 
sometimes depended on one person to collect or deliver medication.
Order medication The medication ordering system was complex.
Dispense medication Information on the dispensing label and MAR chart was not updated. 
Medication dispensed in wrong dispensing systems.
Check stock supply of 
medication
The stock supplies of medication were not checked regularly.
Give medication Problems included giving the wrong medication, not giving 
medication and not following instructions when giving medication.
Store medication The medication storage system was complex.
Communicate
Communication problems were identified within and outside the care 
home. There were problems between the care home and community 
pharmacy and this resulted in a resident's medication being left 
uncollected in the community pharmacy. Communication across 
healthcare setting interfaces is crucial in tightly-coupled systems such as 
the care home medication system because problems in one healthcare 
setting can filter through the system to create problems in another 
healthcare setting. As the resident’s medication was left uncollected in the
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community pharmacy, the resident was subsequently not given that 
medication during the medication administration rounds. Staff members in 
the care home and community pharmacy were unable to understand the 
wider implications of their actions beyond the immediate effect that the 
resident’s medication was not collected. The lack of foresight due to poor 
understanding of the whole care home medication system can have a 
detrimental effect on the system.
Within the care home, communication problems related to the relay of 
incomplete information and the lack of communication between care home 
staff members. In one care home, it was the responsibility of the care 
home manager or duty managers that do not routinely administer 
medication, to communicate all types of information about medication to 
care home staff members that administer medication. The care home 
management team had not communicated sufficient information about the 
change of a resident’s medication therapy. The care home staff member 
who administered medication assumed wrongly about the resident’s 
medication dosage and as a result the wrong dose of medication was 
given to the resident. She had not confirmed her assumptions with the 
care home management. In two medication errors, care home staff 
members had not questioned why the supply of a medication was still 
unavailable after a few days. The lack of medication supply led 
subsequently to the resident not receiving her prescribed medication. 
Care home staff members had also not asked for help when they were 
unsure how to administer particular types of medication such as inhalers 
and antibiotics.
Communication problems between care home staff and residents were 
also identified. A resident was unable to communicate verbally to care 
home staff because of cognitive impairment. Other residents had simply 
not questioned care home staff when they had not received their
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medication. Residents trusted that staff had given them the right 
medication. Care home staff had not communicated problems such as the 
lack of supply of medication, to residents. One care home staff member 
had deliberately chosen not to follow the instructions on the dispensing 
label because she thought that the particular medication would deteriorate 
if she followed the instructions. This decision was not communicated to 
residents possibly compromising the care of residents.
Record-keeping
There were problems with records that were unclear and had not been 
updated. The care home has multiple sources of information that record 
similar types of information about medication. A large quantity of 
information sources does not mean that a large amount of information or 
detailed information had been recorded. A change in medication 
information was not reflected in every information source that routinely 
contains information about medication. Not every MDS and MAR was 
updated when there was a change in medication therapy. The recorded 
information about the medication change was not clear causing the care 
staff to make wrong assumptions about the resident's medication dosage. 
There was insufficient detail about the medication change.
In some errors, the wrong information was recorded. A care home staff 
had documented giving a medication when it had not been given. Certain 
information such as to give medication before food, had not been recorded 
in the main information source regularly used by care home staff members 
that administer medication. Medication information recorded on 
dispensing labels and patient information leaflets (PILs) was not utilised by 
care home staff when giving medication. This led to medication being 
given by the wrong administration technique.
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“Record-keeping” was identified to be tightly linked to “communicate”. 
Record-keeping is a form of written communication. It is crucial to note 
that these two WDPs are not means-ends related or hierarchical. They 
are both required to fulfil the purposes of the WDPs at the PRF abstraction 
level.
Give medication
Problems with “give medication” related to the omission of medication in 
the medication administration round. These were a consequence of the 
unavailability of medication and the medication being forgotten because it 
was placed in a separate compartment in the drug trolley. The wrong 
medication was given in one medication error. A change in medication 
therapy had been initiated but the MDS and MAR had not reflected the 
change. As a result, the wrong (old dose) of medication was given to the 
resident. Care home staff members also gave medication using the wrong 
administration technique. A resident had received her inhaler drugs using 
the wrong technique because the care home staff had not known how to 
use the inhaler. Another care home staff member had the wrong 
knowledge about the physical property of a medication and had not given 
the medication according to the administration instructions printed on the 
dispensing label. Care home staff had not given two newly prescribed 
medications before food, as they are routinely, in two medication errors.
The weakness of the care home medication system at the interface 
between the community pharmacy and care home was highlighted by 
problems such as uncollected medication from the pharmacy and the non­
updated MDSs and MARs. The problems with “give medication” were not 
due solely to the act of giving medication. There were clear links with 
problems in communication, record-keeping, medication storage and 
dispensing showing the relationships between WDPs at the ORP 
abstraction level.
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Dispense medication
Problems with “dispense medication” related to dispensing physically 
unstable medication into the MDS and not altering MDS and MARs when 
a change in the medication therapy was made. Information about the 
stability and suitability of dispensing medication into the MDS had not 
been accessed or utilised by the community pharmacy. The change in 
medication therapy was not updated on all MDS and MARs and this led to 
the resident being given the wrong dose of medication. These were 
indications of information not being communicated or recorded clearly.
Monitor health status
The health of a resident can be physically difficult to observe. In two 
medication errors, the care home staff had not gathered information about 
the resident to be able to monitor or judge the severity of the resident's 
pain and her need for paracetamol. The actions of the care home staff 
were probably influenced by the problem of the non-availability of 
paracetamol in the care home.
Transport medication
The arrangement to transport medication to the care home was not robust. 
When the particular care home staff member had not collected the supply 
of medication from the community pharmacy, nobody else performed this 
task. There were no records indicating whether the supply of medication 
had been collected and the urgency of the task.
Medication review
Medication review includes reviewing the day-to-day management of 
medication among other functions. In one error, ordering of a medication 
was not in-sync with the rest of the resident's medication and the rest of 
the care home. This resulted in problems coordinating supply. A review
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of the quantities of medication prescribed was not routine, resulting in non­
synchronised ordering of medication. This increases the complexity of the 
already complex medication ordering system.
Check stock supply of medication
There had been no supply of medication when the resident's regular 
supply of medication had run out because of a dosage change. There 
was no information to remind the care home staff to check the stock 
supplies of medication.
Store medication
The medication storage system was fragmented and complex. Different 
medications are stored in different places and this resulted in a resident's 
medication being forgotten during the medication administration round. 
There had not been any information acting as alerts or reminders that the 
resident's medication was kept at different locations.
7.4.3 Summary of findings
Figure 7.1 shows the WDPs that were implicated in the medication errors 
in italics and the means-ends links connecting these WDPs in “thick” lines. 
Two WDPs at the PRF abstraction level, “administer medication” and 
“supply medication” were identified to have contributed to medication 
errors. At the ORP abstraction level, further WDPs were identified to 
contribute to errors. “Communicate”, “record-keeping” and “give 
medication” were the three WDPs that contributed most frequently to 
medication errors. The common problem identified in the analysis of the 
nine medication administration errors related to problems with the 
information system in the care home. The system was fragmented and 
there were problems with accessing, using and recording information.
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WDPs identified to have contributed to errors were tightly-linked. This was 
reflected by the importance of each WDP in facilitating the functioning or 
non-functioning of other WDPs. Problems identified with each WDP at the 
ORP abstraction level were associated with at least a problem with 
another WDP at the same level and the level above. The analysis also re­
enforced the value of the WDPs at the ORP abstraction level in fulfilling 
the functions at the PRF abstraction level because problems with WDPs at 
the PRF abstraction level were a result of problems with multiple WDPs at 
the ORP abstraction level. Problems at the care interfaces such as 
between the care home and community pharmacy were also highlighted in 
the analysis. The tightly-coupled nature of the care home medication 
system resulted in the spread of problems across the interfaces of 
different healthcare settings.
7.4,4 Recommendations
Information about the different aspects of the care home medication 
system is represented by the AH. The fundamental problem identified in 
this analysis of the nine medication errors was the deficiency in the care 
home information system. Hence, it is logical to target this aspect of the 
system when generating recommendations for system improvements.
Access and use of information
The analysis of errors identified problems with accessing and using 
available information in the care home medication system. The availability 
of information should be made apparent to staff who require them, 
whether within or outside the care home. Staff members need to have 
relevant information so that they can make appropriate decisions and 
judgements.
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An incomplete view of the care home medication system can contribute to 
staff not knowing what information to use when performing tasks. It is also 
difficult to understand the implications of particular actions taken in the 
care home. Hence, a knowledge base of the whole system is crucial to 
ensure the safe functioning of the care home medication system. Staff 
should have sufficient information about the system that they work in so 
that they can understand the impact of their actions or non-actions on the 
wider system.
The AH of the care home medication system can be used as a tool to help 
staff visualise the system within which they work. Since the WDPs in the 
AH represent categories of information, staff can understand the 
importance of different types of information by referring to the means-ends 
links linking WDPs at different abstraction levels. Then, staff can better 
judge the usefulness of the information in light of the context of the whole 
care home medication system and use it effectively and accurately. In the 
errors analysed, information on the dispensing labels and patient 
information leaflets (PILs) was not utilised and reasons for these could be 
that staff were not aware of the availability of information and did not know 
the value of the information.
Record-keeping
In complex socio-technical systems like the care home, variations in work 
systems, practice and organisation are inevitable. No two care homes 
function in the exact same way. Instead of standardising every aspect of 
the running of the care home, a crucial point to consider is to ensure that 
information is recorded and updated promptly and clearly. However, 
without a clear view of the whole care home medication system, it is 
difficult to determine what information to record. The AH can be used to 
help determine the type of information to record. Each WDP in the AH is 
means-ends linked to other WDPs in the abstraction level above and
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below (except the first and last abstraction level). By reviewing the 
means-ends links that link WDPs at different abstraction level, the type of 
information to record can be determined. For example, “supply 
medication” at the PRF abstraction level is means-ends linked to “order 
medication” (among other WDPs) at the ORP abstraction level below. 
Hence, information about “order medication” should be considered when 
records are made about “supply medication”. The information recorded 
should also act as alerts or reminders to care staff such as alerting the 
care staff that two types of dispensing systems are being used or 
reminders to perform complete certain tasks.
Centralised records
The care home information system was fragmented. Within the care 
home, multiple sources of information that recorded similar types of 
information, and used by different staff, existed. Changes made to one 
source of information were not necessarily changed in another. Similar 
problems were identified across healthcare settings, where changes to 
medication were not communicated effectively. The care home 
medication system relies heavily on accurate, up-to-date and clear 
information. Any changes to medication should be updated promptly 
across all sources of information either within or outside the care home. 
Centralising records could help reduce the likelihood of not updating a 
particular source of information and also ensure that all staff members 
have access to the same information. The AH of the care home 
medication system shows that WDPs cannot be fulfilled within the care 
home itself. The PRF abstraction level shows the work functions that 
need to be co-ordinated in the system to fulfil the ultimate purposes of the 
care home medication system. Examining the WDPs at the PRF 
abstraction level in more detail, three of the four WDPs, “diagnose medical 
condition”, “prescribe treatment” and “supply medication” cannot be 
performed solely within the care home. Hence, there is a need for co-
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ordination with other healthcare settings to fulfil these WDPs. This further 
supports the need for a common source of information so that every 
healthcare setting has access to relevant information.
Resident Involvement
The care home medication system is co-ordinated by a variety of 
healthcare practitioners to provide healthcare to care home residents and 
to fulfil the requirements of laws and regulations, guidelines, policies and 
procedures. Care home residents are a valuable source of information 
and they should be encouraged to be more involved in their own 
healthcare, if they are able and want to. The analysis of errors identified 
that residents were often passive receivers of care during the medication 
administration rounds. Residents can provide invaluable information 
about the care home medication system. By referring to the AH, “resident” 
at the physical objects level is means-ends linked to many WDPs at the 
ORP abstraction level above, showing their crucial role in fulfilling the 
WDPs “communicate”, “medication review”, “monitor health status” and 
“give medication”. The impact of resident involvement extends to the 
WDPs at the PRF abstraction level because the WDPs at the ORP 
abstraction level are means-ends linked to WDPs at the PRF abstraction 
level. For example, “communicate” is means-ends linked to every WDP at 
the PRF abstraction level: “administer medication”, “supply medication”, 
“prescribe treatment” and “diagnose medical problem”.
Summary
The recommendations generated related to the information system in the 
care home. The care home is constantly evolving and the information 
system needs to be able to cope with this dynamic change. All staff 
members that take care of residents should have a wide view of the whole 
care home medication system. This fundamental set of information can 
help staff determine the relative importance, use and need of particular
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types of information. Residents who are able and who want to be involved 
in their medication therapy will also know what type of information is 
necessary to their care. The dynamic nature of the information system 
poses great challenges in ensuring that healthcare practitioners have 
accurate and up-to-date information. Centralising records could ensure 
that healthcare professionals have access to the most up-to-date records. 
Since the care home medication system is formed of different healthcare 
settings, any plans for change should involve every healthcare practitioner 
in the system. Each healthcare practitioner has specific roles in the wider 
care home medication system. The means-ends links linking them to 
other WDPs in the AH indicate their contribution to the care home 
medication system. Only by involving every healthcare practitioner can 
sustained system improvements be possible. The AH provides a set of 
information about the care home medication system and the means-ends 
links in the AH provides information for the system to prioritise its needs 
and speculate on the impact of implementing a particular 
recommendation.
7.5 Discussion
7.5.1 Context and robustness
One of the objectives of the error analysis was to understand how errors 
occurred. To gain a systems perspective of how errors occurred, the 
analytical tool should provide a wide systems view of the care home 
medication system. The AH developed in the previous chapter was 
specific to the care home medication system and provided a fundamental 
set of information about the whole care home medication system within 
the boundaries of the care home. The use of the contextual AH to analyse 
the nine medication administration errors avoids the problem of needing to 
either decontextualise error cases or contextualise generic analytical
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frameworks, which increases the complexity of the analysis without 
necessarily adding insight into the causes of errors. Pinpointing problem 
areas in the care home medication system was straightforward because 
the events of the errors mapped directly onto the WDPs in the analytical 
framework that was specific to the care home medication system. There 
were no problems of not being able to fit events of errors onto non-existent 
factors as occurs when using a generic analytical framework. The AH was 
also a robust framework because it guided the analyst to consider every 
WDP that was means-ends linked to the problem WDPs. Hence, it was 
unlikely that elements of the system that may have contributed to errors 
were missed, resulting in a more complete analysis of errors. Using the 
AH as the analytical framework, the identified problem areas were placed 
in the context of the wider care home medication system, providing 
information to prioritise strategies for system improvement.
7.5.2 Relationships
Each WDP represented in the AH has specific purposes. The means- 
ends links answer “why” a particular WDP is required in the system by 
referring to the abstraction level above and “how” a WDP can be fulfilled in 
the system by referring to the abstraction level below. Hence, the value of 
each WDP in the wider system and the relationships between WDPs in 
the system was represented in the AH. The relationship represented by 
the means-ends links is especially important when analysing medication 
errors. The analyst was guided to analyse WDPs at the ORP abstraction 
level that were means-ends linked to problem WDPs identified at the PRF 
abstraction level, that may not, in the first instance appear to have 
contributed to errors such as the WDPs “medication review” and “monitor 
health status” at the ORP abstraction level. The AH framework provided a 
fundamental set of information for the analyst to consider a wider scope of 
error resulting in a complete and robust analysis.
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There were also implications for the recommendations generated for 
system improvements. The analysis of errors identified a fundamental 
issue with the information system in the care home. Relationships 
represented by means-ends links between WDPs in the system 
highlighted the need for particular types of information to fulfil specific 
WDPs. By referring to the means-ends links, the analyst can identify the 
possible implications of dealing with a particular area in the system. For 
example, a recommendation was to involve residents in their own care. 
Residents are means-ends related to WDPs “communicate’, “medication 
review” and “give medication”, among others at the ORP abstraction level. 
The implications of encouraging residents to be more involved in their care 
could be more effective and accurate fulfilment of the WDPs listed. 
However, if residents themselves are unable or do not want to be involved 
in their care, workers know that the fulfilment of the WDPs may be 
compromised and contingency plans may be put in place. Hence, the 
means-ends links in the AH provide relevant information for the system to 
prioritise its plans and devise strategies to cope with the changes in the 
system.
The analysis of medication errors also showed relationships between 
WDPs at the same abstraction level. At the ORP abstraction level, the 
WDPs that were identified to have contributed to errors were tightly-linked 
to each other. For example, problems with WDPs “communicate” and 
“record-keeping” were not isolated. There were clear links with other 
WDPs at the ORP abstraction level such as between “record-keeping” and 
“give medication” because the wrong information recorded led to the 
resident being given the wrong dose of medication. The relationship 
between these WDPs is not means-ends related but it does show the 
intricate nature of a system that relies heavily on information and the 
tightly-coupled nature of WDPs.
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7.5.3 Value of recommendations
The WDPs in the AH were event-independent meaning that the WDPs 
represent categories rather than examples of tasks, events or actions. 
This unique characteristic of the AH escapes the problem of the 
impossible task of representing every possible example of an event in a 
framework. Hence, by identifying categories of work that have contributed 
to errors, as represented by WDPs, more meaningful recommendations 
were generated. This is because the recommendations made targeted 
categories of work that contributed to errors, instead of just targeting 
common error events which in themselves are invariably caused by a 
variety of work environment and individual issues. The WDPs highlighted 
categories of work that were problematic whilst the means-ends links in 
the AH showed how a weakness in a WDP can permeate through the 
entire system. It is important to have an understanding of the whole care 
home medication system when making recommendations for system 
improvements in order to know the extent to which a particular 
recommendation can affect the system. Recommendations made from a 
fragmented and incomplete view of the system will only address part of 
the problem in the care home medication system. It will be unlikely for 
these recommendations to lead to effective and sustained changes to the 
wider system.
The recommendations described in this analysis highlighted areas in the 
system that require improvement rather than detailed accounts of 
particular areas to target. The system will need to prioritise its needs and 
target specific areas for change. An extension of the AH is possible if a 
more detailed analysis on a specific area in the care home medication 
system is required. For example, “administer medication” can become the 
functional purpose of the system and further analysis can be performed to 
examine this WDP in more detail.
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7.5.4 Comparing AH and The London Protocol
The second objective of this study was to compare the findings of the error 
analysis using the AH and The London Protocol (Taylor-Adams & Vincent 
2004). Two general headings are used to make this comparison, that of 
the process and outcome of the error analyses and summarised in Table 
7.7.
Process
The London Protocol is an established method of error analysis whilst 
using the AH to analyse errors was a novel approach. Both The London 
Protocol and WDA used frameworks to analyse medication errors. The 
London Protocol used the generic Framework of Contributory Factors 
Influencing Clinical Incidents that can be applied in different work settings 
but for WDA, a contextual framework, the AH of the care home medication 
system was used.
Using The London Protocol, the analyst was guided to systematically 
examine every factor or category in the framework to identify their 
relevance to the medication errors. This allowed the analyst to consider 
whether there were elements in each error case beyond the apparent 
information collected. In contrast, the means-ends links in the contextual 
AH error analytical framework guided the analyst to consider relevant 
WDPs, those that were means-ends linked to the problem WDPs.
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Table 7.7 A comparison of The London Protocol and AH
The London Protocol Abstraction Hierarchy
Process
Analytical framework Generic ■ Contextual
Error analysis M Established method ■ Novel method
method ■ Systematic approach ■ Systematic approach
■ Considered a wide range of developed
system and individual ■ Considered a wide range
factors of factors relating to the
■ Analysis considered every work system
factor listed in the generic ■ Analysis only considered
framework relevant WDPs in the AH
according to the means-
ends links
Generating ■ Little guidance in the ■ No guidance; novel
recommendations established method method
Ease of use ■ Established method ■ Novel method
■ Guidance available ■ No guidance
■ Time consuming because ■ Less time taken and
the analysis considered easier compared to The
every generic factor within London Protocol as
the analytical framework means-ends links directed
the analyst to analyse
relevant WDPs
Outcome
Error contributory ■ May have missed factors ■ Different factors were
factors because the analytical identified.
framework was not robust
Recommendations Similar recommendations 
generated 
Difficult to relate 
recommendations to the 
wider system and 
understand their relevance. 
The generic framework did 
not show how factors were 
related to each other. 
Addressed factors 
surrounding identified 
medication errors and not 
necessarily those of the 
wider deficient system
Similar recommendations 
generated
Means-ends links in the 
AH could help to prioritise 
and assess possible 
implications of 
recommendations 
Analysis based on an 
event-independent AH; 
recommendations 
potentially relevant beyond 
specific error cases
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Analysing medication errors using a generic model led to the identification 
of contributory factors that were applicable to a range of medication errors. 
For example, skills and knowledge was found to be a common 
contributory factor to medication errors analysed. However, it was difficult 
to determine the relative importance or consequences of these 
contributory factors in the wider work system. .The means-ends links in 
the AH showed how WDPs are relevant and related to other WDPs in the 
wider care home medication system. This is important for evaluating the 
potential impact of recommendations.
For WDA, it was necessary to construct the AH of the care home 
medication system first because it was a tool for analyzing medication 
errors. However, using the same error case summaries and data sources, 
the analysis of medication errors using the AH was straightforward and 
took less time than The London Protocol. Because the AH had to be first 
developed before it could be used to analyse medication errors, 
considerably more time and resources were required. This may be 
problematic because time and expertise are expensive commodities in the 
care home setting and the care home system will have to balance their 
needs, priorities and constraints. Such decisions are difficult to make 
because of the lack of a wider view of the overall system and the 
implications of decisions on the overall running of the work system. A 
cycle of problems may result.
Training in the use of analytical methods plays an important role in 
ensuring accurate and consistent findings. The London Protocol is an 
established method for analysing adverse events or accidents and the 
developers had produced guidance for analysis. Hence, there was a point 
of reference when analysing medication errors using The London 
Protocol. Since analysing medication errors using the contextual AH of 
the care home medication system was a novel approach, there was no
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guidance on the error analysis method. There was also a need to first 
understand the theoretical concepts of WDA and the resultant AH. 
However, after the AH had been developed, the model itself guides the 
analyst in the analysis of errors. The WDPs in the AH represented work 
functions in the care home medication system and the labels clearly 
showed which WDPs were implicated in the medication errors. Because 
each WDP is means-ends linked, the AH itself directed the analyst to 
consider other WDPs that were linked to the WDPs that were implicated in 
the medication errors. Hence, analysing medication errors using the AH 
was more straightforward than using The London Protocol.
Outcome
The “Framework of Contributory Factors influencing Clinical Incidents” in 
The London Protocol lists error producing conditions under six factor 
types. By only examining these contributory factors, it was possible to 
have missed factors that may have contributed to medication errors. The 
AH on the other hand is represented by work categories arranged in a 
hierarchy of five levels. Contributors to errors were identified as work 
categories that represented work functions and not conditions. The 
distinction is that work categories cover a wide variety of conditions and 
these may not have been apparent to the analyst in the first instance. A 
more complete examination of the contributors to medication errors was 
thus possible using the AH. For example, issues related to “transport 
medication” and “medication review” were not identified from the analysis 
using The London Protocol.
Using The London Protocol, recommendations were made based on the 
contributory factors identified. For example, understanding that skills and 
knowledge was a common contributory factor to medication errors helped 
to identify the need for training. Areas requiring training were also 
recommended in the analyses. However, it was difficult to relate these
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problem areas to the wider care home medication system and understand 
their relevance because the analysis was based on a generic framework 
of conditions that could be applicable to many work settings. 
Recommendations made in the WDA were less prescriptive than those 
generated using The London Protocol. Improving the information system 
in the care home medication system was one of the recommendations 
made. The rationale for this recommendation was based on the 
identification of two work categories in the AH, namely communicate and 
record-keeping that were considered frequent contributors to medication 
errors. The AH provided a framework or a reference point where these 
work categories fit into the wider system. This is important so that the 
relevance, importance and potential problems of work categories such as 
record-keeping and communication can be reviewed in view of the wider 
system. In addition, the structural means-ends links that link all the work 
categories at each level in the AH can aid in planning and prioritising 
interventions. The links provide a way to assess the possible 
consequences of a particular intervention on other work functions.
Despite the usefulness of the AH in informing the work system of the 
potential implications of recommendations, there were fundamental 
challenges in generating recommendations based on the analysis results 
using both The London Protocol and the AH. Although the 
recommendations were generated using a systematic approach, there 
was a lack of specific guidance on utilising and transforming information 
into recommendations. There was a constant tension between generating 
prescriptive and high level recommendations. For example, when 
recommending a need for further training, there was no clear guidance 
whether to recommend training on a specific task such as ordering 
medication or to recommend training on general medication-related tasks.
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The analysis of medication errors using The London Protocol was event- 
dependent meaning that the contributory factors were identified from the 
analyses of specific individual and environmental situations where 
medication errors occurred. The implications of this are that the 
recommendations made only addressed factors surrounding identified 
medication errors and not those of the wider deficient work system. The 
AH model however is event-independent and consists of work categories 
that can include many possibilities for action. Therefore, the 
recommendations made went beyond the context of specific errors and 
had relevance to the whole system.
In summary, the analysis of errors using the AH provided potentially more 
useful information about medication errors because the context within 
which these errors occurred were represented in the AH. Problems with 
aspects of the system such as the transport of medication and the review 
of medication were not readily identified from the analysis of errors using 
The London Protocol but these were systematically identified using the 
AH. Finally, the means-ends links in the AH could provide information to 
asses the implications of the implementation of recommendations. The 
use of the AH could extend beyond an analysis tool to an evaluation and 
design tool for further implementation of strategies to improve safety. It 
may therefore be advantageous to spend time constructing the AH at the 
start of the analysis.
7.5,5 Limitations
The analysis of errors was performed by a single analyst and focused on 
the PRF and ORP abstraction levels of the AH. More insight may be 
gained about the errors if the error cases were mapped onto every 
abstraction level. For example, by understanding the problems at the 
“values and priority measures” (VPM) level, recommendations for system
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improvements may include the need for high-level management to review 
or balance any conflicting priorities. The data sources used to analyse 
errors were limited to case summaries of errors and data collected for the 
study reported in Chapter 3. The WDA could guide the data collection for 
error analysis if it was available before the analysis. Other data sources 
such as incident reporting data, surveys, mental model data as used by 
Xu (2007) in his analysis of problems in an aircraft-automation system 
could provide insight into the causes of errors from different dimensions.
The analysis of error was also limited to medication administration errors. 
Prescribing, monitoring and dispensing errors could potentially be 
analysed using the AH. It would be likely to identify areas in the care 
home medication system where errors occurred. However, it may not be 
possible to identify problems within the GP and pharmacy system if 
prescribing, monitoring and dispensing errors were analysed using the AH 
of the care home medication system. Separate AHs of the GP surgery and 
community pharmacy systems may be needed.
To analyse errors, it was necessary to first construct the AH of the care 
home medication system. The process of construction was time- 
consuming and required specific skill and expertise. The time to conduct 
the analysis of errors could thus be more time-consuming than using The 
London Protocol. But the value of the analysis based on the AH could 
outweigh the problem of having to spend more time and resources at the 
start of the analysis.
7.6 Conclusion
A novel approach was used to analyse nine medication administration 
errors. The AH of the care home medication error and error case 
summaries were used to analyse the causes of errors and generate
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recommendations for system improvements. At the PRF abstraction level, 
problems relating to “administer medication" and “supply medication” led 
to medication errors. By investigating WDPs that are means-ends related 
to these two WDPs at the ORP abstraction level, a total of 41 WDPs were 
identified to have contributed to the nine medication administration errors. 
The most frequent contributors to errors were “communicate”, “record­
keeping” and “give medication”. Even though the problem WDPs at the 
ORP abstraction level were not means-ends related, they were found to 
be tightly-linked to each other and highlighted the intricate and complex 
nature of the care home medication system. The recommendations made 
for system improvement related to the need to strengthen the information 
system in the care home by improving and increasing the access and use 
of information, and the keeping of records, centralising records and 
involving residents in their care.
A complete and informed analysis of errors was possible with the use of a 
robust and contextual AH of the care home medication system. The 
event-independent nature of the AH allowed the analyst to generate 
robust and useful recommendations that did not target specific error 
events. An important aspect of the analysis was the value of relationships 
between WDPs in the AH. The means-ends links provided relevant 
information to understand the system and prioritise recommendations 
made for system improvements. Not dealing with a particular problem in 
the system can result in a domino effect on other parts of the care home 
medication system. The means-ends links show the implications and 
areas of the system that may be affected. Recommendations made for 
system improvement were based on a whole systems view of the care 
home medication system and is arguably more robust and complete than 
those generated based on the findings of the error analysis using The 
London Protocol.
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Chapter 8: Discussion
In this chapter, an overview of the outcomes of the thesis and the 
significance of its contributions are presented. The limitations of the 
research are then presented followed by a personal reflection of the 
research journey. These provided insight into possibilities for future 
research and developments in the field of medication safety in care 
homes. The chapter discusses each of these issues:
1. Overview in terms of significance of contributions
2. Limitations
3. Reflections of the research journey
4. Future research and development
8.1 Overview of findings and significance of 
contributions
8.1.1 Prevalence and types of medication errors
This thesis presented the findings of the first large-scale epidemiological 
study of the prevalence and types of medication errors in England that 
was conducted as part of a wider study. The study presented in this 
thesis found six in ten care home residents experienced at least one 
medication error. Dispensing and medication administration errors were 
the most frequent type of medication errors identified. These were 
important findings because up until now, there had been no 
comprehensive approach and information about the problem of medication 
safety in care homes. Medication safety in care homes had been a hidden 
problem and had not received as much attention as other areas of 
healthcare such as the hospital. Care home residents also represent a 
vulnerable group of the wider population who are often unable to advocate
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for themselves. The findings of this study revealed that there is a problem 
with medication safety in care homes and highlighted the urgent need to 
address the problems and the risks facing care home residents regarding 
the use of medication.
Overall, the prevalence of the different types of medication errors in care 
homes was higher than primary and secondary care. However, caution is 
required when comparing the results of these studies because of the 
different methods and definitions used to study medication errors in 
different healthcare settings. The problems in the care home may be 
worse than the primary or secondary setting because the care provided in 
the care home needs to be co-ordinated across different healthcare 
setting boundaries unlike the hospital or primary care where it is possible 
for patients to be treated within one setting. For example, the study 
reported in Chapter 3 found a care home resident experienced a 
medication administration error because the wrong dose of medication 
was prescribed and subsequently dispensed by the community pharmacy. 
This showed that care had to be co-ordinated across different healthcare 
settings. An error in one healthcare setting could easily filter through to a 
different healthcare setting. In contrast, a patient being treated in 
secondary care may be admitted to hospital for a surgical procedure and 
return home a few days later with a course of antibiotics to complete. In 
this example, care can be provided within the boundaries of the hospital. 
A patient may also have a minor eye infection and visit the community 
pharmacist for an antibacterial eye ointment without further need for 
follow-up. However, it is also recognised that care is also very complex in 
settings such as operating theatres and intensive care units but the 
solutions to ensure safety could be addressed within that particular 
setting. This is more difficult in care homes because of the complex 
nature of the provision of healthcare involving different technologies and 
expertise across different healthcare settings. Hence, there is a need for
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research and application of novel methods that allow a complex system to 
be described or modelled, as used in this research.
8.1.2 Knowledge of the system
A systems approach to analysing the care home medication system is 
important because every part of the system that is involved in the 
provision of healthcare needs to be represented in order for a complete 
and robust analysis of the system, its problems, the generation, 
prioritisation and evaluation of system improvement recommendations. 
This is consistent with Ramo’s (1973) idea of a systems approach. The 
CWA technique adopts a broad systems approach for analysis (Vicente 
1999). It was therefore decided to use WDA, the first of five phases of 
analysis in CWA to understand the care home medication system. This 
thesis reported the first use of WDA to analyse the care home medication 
system. It was also the first time that WDA is used in healthcare for 
system analysis to the author’s knowledge. A visual representation of the 
whole care home medication system was also developed for the first time 
using the abstraction hierarchy (AH). The AH provided a powerful 
systems view showing the constraints of the system in a contextual 
framework.
The AH model served the important role of simplifying the complex care 
home medication system by abstracting information from a wealth of data. 
The means-ends links that link the WDPs represented in the AH are an 
important feature because they show possible relationships between the 
work functions modelled in the AH; it provides the means for 
understanding the work system and the implications of problem work 
functions on the wider work system. The relationships between the work 
functions in the work system provide a powerful framework that can help 
designers or decision-makers in the work system assess the potential
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effects of system designs and recommendations. For example, there may 
be potential effects on the work functions that are means-ends related to 
the particular work function that may be changed or added in the work 
system. The AH does not indicate what the potential effect may be but it 
can show the particular work function and further work functions that could 
be affected by considering the means-ends links.
The AH in itself did not provide information about the level of safety in the 
care home medication system. However, it provided an important 
fundamental contextual framework that has a definitive end at the physical 
object abstraction level that aids the analysis of the work system.
8.1.3 Analyses of medication errors
For the first time, two methods were used to analyse the same care home 
medication errors. Two methods developed using different research 
foundations were used; The London Protocol (Taylor-Adams & Vincent 
2004) and WDA. The process and outcomes of the two methods used to 
analyse medication errors were compared for their advantages and 
disadvantages. This is important to increase the current knowledge about 
error analytical methods.
The findings showed that it was important to analyse errors based on a 
robust and contextual framework of the system within which the errors 
occurred. A better understanding of how and why errors occur within the 
wider system can lead to the generation of recommendations that address 
system problems rather than problems surrounding individual errors.
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8.2 Study Limitations
All research is subject to limitations. The following sections discuss the 
exploratory nature of the work and the different constraints that limited the 
research.
8.2.1 Exploratory nature of the work
Patient safety research in care homes, specifically medication safety, has 
not been studied extensively in the UK. This thesis reported two 
perspectives to understanding the care home medication system: an 
epidemiological study and the use of WDA. Although former large-scale 
studies conducted in other countries for example the US (such as Gurwitz 
et al. 2000; 2005) helped inform the epidemiological study, there has been 
no published work to date that explored the causes of medication errors in 
care homes based on human error or organisational accident causation 
models. The analysis of care home medication errors using The London 
Protocol was also new. WDA was used for the first time to model the care 
home medication system and a novel approach to analyse medication 
errors was developed using the AH and epidemiological data of 
medication errors. Hence, the analyses presented in this thesis are 
exploratory and require further work to validate and extend the findings.
8.2.2 Constraints
The epidemiological study reported in Chapter 3 was limited by a small 
sample size and the findings of the study may not be generalisable or fully 
representative of care homes providing personal care only and, personal 
care and nursing to older residents. However, the results of the 
epidemiological study examined in context of the wider CHUMS study 
showed similar findings (see section 3.10.2). The sample of care homes 
studied in the wider CHUMS study represented a good spread of care
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home size across three geographical areas in England (AI Id red et al. 
2008). A total of 79 care homes agreed to participate and 256 residents 
were studied (Alldred et al. 2008). This figure including those reported in 
this thesis.
This study identified the point prevalence of medication errors in a sample 
of care homes. US large-scale care home studies were longitudinal 
studies conducted over 12 to 18 months (Gurwitz et al. 2000; 2005). The 
method for identifying medication errors and the definitions used in the US 
studies were different to this study so direct comparison of the prevalence 
rates of errors was not possible. Further research is required to establish 
whether studying UK care homes over a period of time may reveal 
different prevalence rates.
It was the first time that WDA was applied in the care home setting and it 
was not within the remit of the research to test the resultant AH in terms of 
its ability to help workers deal with unanticipated or novel situations. The 
thesis did not assess the implications of the recommendations generated 
for system improvements. Hence, the value of recommendations 
generated based either on the results of The London Protocol or the AH in 
this respect has yet to be substantiated. The analysis of medication errors 
using the AH was also constrained by the data that had already been 
collected (see Chapter 3). Additional sources of information may result in 
a more complete analysis of medication errors.
The epidemiological study adopted a mix of retrospective methods and 
observations to identify medication errors. Factors that may have 
contributed to these errors help inform recommendations for system 
improvement. However, factors contributing to unidentified and potential 
medication errors are not known. The work system need not, and should 
not, wait until an error or accident has occurred before taking steps to
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improve system safety. This study suggests that prospectively identifying 
potential areas where medication errors may occur in the system, 
examining how errors could occur and designing solutions would be very 
valuable. This view is also shared by other researchers (Andrews et al. 
1997; Christian et al. 2006; Habraken & Van der Schaaf 2008; Marx & 
Slonim 2003, Van Beuzekom etal. 2007; Van der Schaaf 2002).
8.3 Reflections of the research journey
At the beginning of this research study, there were particular assumptions 
that the author had about the care home medication system. The care 
home medication system was initially thought to be a largely process 
driven system where the care home system ensures that residents have 
an adequate supply of medications during a monthly medication ordering 
cycle. Hence, the assumption was that task or process-oriented analysis 
methods are suited to map the care home medication system. However, 
as the understanding of the care home system increased through the care 
home familiarisation studies reported in Chapter 2, informal conversations 
with various healthcare practitioners and care home visits that are not 
reported formally in this thesis, these assumptions were challenged. In 
addition to the tasks and processes in the care home medication system, 
there was a component of the system that played a crucial role in the 
functioning of the system: the human element. This part of the care home 
medication system, whether it was the care home residents or the 
healthcare practitioners, cannot be easily controlled or its actions 
accurately predicted. Hence, variability in the way the system functions is 
introduced and this greatly increases the complexity of the care home 
medication system. There was a paradigm shift in the way the care home 
medication system was initially viewed. In light of this insight, several 
adjustments had to be made. Notably, there was a need for methods that 
are suited to analyse complex systems and this thesis explored one
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method; WDA which is the first analysis phase in CWA. The use of WDA 
to analyse the care home system was new but the initial findings were 
useful for understanding the system and analysing medication errors. 
Future research and developments in the use of CWA to understand the 
system and in healthcare research is needed.
8.4 Future research and developments
8.4.1 Error identification and analysis
There is further scope to analyse the causes of medication errors in more 
detail. Error contributory factors were identified using The London 
Protocol (Taylor-Adams & Vincent 2004). The AH identified areas of the 
care home medication system that were implicated in the medication 
errors. The findings of both analyses need to be examined in more detail 
and the system design problems highlighted more clearly. Both analyses 
identified communication and the use of information within the care home 
and other healthcare settings to be factors that contributed to medication 
errors. This finding is consistent with studies previously conducted in 
different healthcare settings and contexts and reported in Chapter 1; 
Sackley & Pound (2002) found that the content of hospital discharge 
letters were often incomplete and inaccurate and Reed & Morgan (1999) 
found miscommunication between the different stakeholders during the 
discharge of older people from hospital to a care home. Hughes et al. 
(2003) also highlighted the lack of information specifically poor record­
keeping and the lack of standardisation of assessment and inspection. 
Further research exploring communication and the use of information in 
the care home medication system will provide more insight into the 
organisation of work in the care home system and how it impacts on 
system safety.
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Interventions to improve system safety such as training and the 
centralisation of patient medical records such as the use of IT solutions 
could be explored. There are some examples of successful 
implementation of IT solutions in care homes in Australia and the US as 
reported in Alldred et al. (2008) suggesting that there is potential for IT to 
be introduced in English care homes. The NHS Connecting for Health is 
an agency of the Department of Health, UK created to support the NHS 
“deliver better, safer care to patients, by bringing in new computer 
systems and services” (Connecting for Health 2008). However, care 
homes do not seem to be part of the overall IT strategy in the NHS and 
this is concerning because the problem of communication and co­
ordination is likely to continue in parts of the healthcare system that have 
been excluded from the wider IT strategy. These problems may 
potentially be magnified across healthcare settings where different 
information systems are used.
The analysis of medication errors using the AH reported in chapter 7 used 
data that had already been collected for another study (see Chapter 3). 
There is also further scope to develop and refine the error analysis 
method using AH. In future, the AH could be used to guide the collection 
of data about medication errors and this may result in a more complete 
analysis using the whole AH. For example, the ‘values and priority 
measures’ level in the AH was not used to analyse the medication errors 
because there was insufficient data. Further interviews could be 
conducted to explore this and other aspects of the work system.
Current methods of capturing error data such as case record reviews, 
direct observations and the reporting of near misses and errors are 
important to help define the scope of the problem of medication safety. 
There is a need for the application of these methods to capture different 
types of medication errors in future UK care home medication safety
273
studies. Different work functions, processes and tasks are involved at 
different stages of healthcare provision. It is important to identify the most 
suitable method for capturing error data, as used in the study reported in 
Chapter 3. For example, observations have been shown to be the most 
appropriate method for identifying medication administration errors and its 
use should be encouraged in future studies examining medication 
administration errors. This is important to gain a good estimate of the 
prevalence of the different types of medication errors.
There is also an increasing body of research in care homes investigating 
issues related to medication safety such as the culture of patient safety or 
organisational culture (Castle & Sonon 2006; Hughes et al. 2007) and 
staffing characteristics on the quality of care (Castle & Engberg 2007). 
Castle & Sonon (2006) conducted a survey in US care homes that 
considered attributes known to be associated with a culture of patient 
safety including among others, manager expectations and actions 
promoting safety, organisational learning, teamwork within units, 
communication openness, feedback and communication about errors and 
staffing. They found a low patient safety culture score in care homes. 
There have been no published studies that investigated patient safety 
culture in UK care homes to the best of the author’s knowledge. Hughes 
et al. (2007) discussed the possible relationships between organisational 
culture and quality and performance in the care home setting and 
encouraged more research in this area, in another study, Castle & 
Engberg (2007) found that staffing characteristics such as staffing levels, 
turnover, stability of workflow and the use of agency staff influenced the 
quality of care provided to care home residents to some degree. Other 
issues such as the impact of interruptions during medication 
administration rounds on medication safety have been identified 
(Wadsworth et al. 2008). However, these studies have not systematically 
investigated how these factors relate to medication safety. Further
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research is needed to investigate the impact of these factors on 
medication safety.
One of the constraints of the study was the use of a mix of retrospective 
methods and observations to identify medication errors. A prospective 
approach is advocated to complement the findings of retrospective and 
observational studies. The adaptation of the failure mode and effects 
analysis method, HFMEA™ (DeRosier et al. 2002) is an example of a 
prospective hazard analysis tool that has been applied extensively in 
healthcare. Examples of its application include the assessment of the 
risks of an outpatient parenteral antibiotic therapy (OPAT) service 
(Gilchrist et al. 2008), the administration of chemotherapy in a paediatric 
oncology ward (Van Tilburg et al. 2006) and the sterilisation and use of 
surgical instruments (Linkin et al. 2005). Habraken & Van der Schaaf 
(2008) discussed other prospective risk methods that have been applied in 
healthcare such as Failure Mode and Effect Analysis (FMEA), Hazard 
Analysis and Critical Control Point (HACCP), Hazard Analysis and 
operability studies (HAZOP) and Probabilisitic Risk Assessment (PRA). 
The AH, together with subsequent phases of analysis in CWA, specifically 
control task analysis could potentially be used as a prospective risk 
analysis tool to identify potential vulnerable areas in the system. There is 
a need for further studies that prospectively analyse risks in healthcare 
systems.
8.4.2 Understanding the system
The AH of the care home medication system developed in this thesis was 
the first representation of a knowledge base of the system. Further work 
is needed to test whether the AH can be generalised to other types of care 
homes such as those providing care for those with physical and mental 
disability. The AH could be tested by analysing a range of problems
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identified in different types of care homes. The medication errors 
analysed using the AH reported in Chapter 7 were identified from care 
homes other than the care home where the WDA was performed. Despite 
this, the AH provided a useful framework to identify work domain 
properties that were implicated in the errors. Further research is needed 
to test whether the AH can provide workers with the necessary information 
to deal with novel and unanticipated situations that often lead to 
medication errors. A range of scenarios could be used to analyse the 
thought patterns of how workers deal with problems with and without the 
AH.
Other analysis phases of CWA are needed to fully understand the care 
home medication system. Although the AH provided an analytical 
framework to analyse medication errors, it only provided one view of the 
care home medication system and the recommendations generated 
suffered from a lack of detail in terms of what, how and who could effect 
these changes. Subsequent levels of analysis in CWA could provide 
different dimensions to the causes of medication errors.
Table 8.1 shows possible applications of other analyses in CWA for care 
home and medication use as suggested by the author. Naikar & 
Saunders (2003) used the control task analysis (ConTA), the second 
analysis phase in CWA to analyse incidents involving a strike aircraft and 
developed technical training requirements for error management. The 
information from the analysis such as unsafe actions and strategies to 
detect and recover from errors informed the training requirements. The 
training requirements were evaluated with the strike aircraft’s aircrew and 
instructors and were very well received. ConTA is a potentially useful 
method to analyse medication errors and develop training requirements to 
reduce medication errors.
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Table 8.1 Potential applications of CWA analysis phases
Analysis phase Potential applications________________________
Control task analysis Analyse medication errors and derive training requirements to
(ConTA) manage errors.
Strategies analysis (SA) Identify the strategies for achieving medication-related tasks or
goals to help the care home system prioritise and assess the risks 
of each strategy.
Social organisation and Organise the responsibilities of various healthcare practitioners,
cooperation analysis medication-related tasks and the strategies for achieving tasks in
(SOCA) the care home system.
Worker competencies Identify the competencies of different healthcare practitioners
analysis (WCA) needed to perform their functions effectively.
The last three analysis stages in CWA have not been widely used but 
could provide the information requirements to better understand the 
system. The third analysis in CWA is strategies analysis (SA) and 
analyses how work can be performed. By considering alternative 
strategies for achieving work goals, the system can prioritise and assess 
the risks of each strategy. Strategies for achieving various work goals in 
the care home system across different healthcare settings can be 
identified allowing the care home management and/or staff members to 
decide the appropriate strategies for performing work.
Social organisation and cooperation analysis (SOCA), the fourth analysis 
stage in CWA analyses the organisation of the actors in the system and 
the allocation of responsibilities, task and strategies among the actors. A 
range of healthcare practitioners are involved in providing care to care 
home residents. They have different responsibilities and perform different 
tasks. The SOCA can help organise the work across different healthcare 
practitioners in the care home medication system. The final analysis, 
worker competencies analysis (WCA) describes the competencies of 
workers to perform their functions effectively. The competencies of 
healthcare practitioners that are involved in providing healthcare in the 
care home medication system can be analysed.
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The analysis, generation, implementation and assessment of sustained 
system improvement recommendations should ideally be informed by an 
understanding of the different dimensions of the work system.
8.4.3 Utility of CWA in heaithcare
The application of WDA in the care home medication system showed the 
usefulness of the method to analyse complex healthcare systems. Its use 
should be explored further in other complex healthcare systems where 
there are potential safety risks and where the boundaries of the system 
can be easily defined. An example is the development or evaluation of a 
new service within healthcare.
Section 6.10 reported the findings of interviews conducted with care home 
nurses, carers and a pharmacist in the final iteration of the AH. During 
these interviews, they suggested using the AH as a training tool for care 
home staff. An essential requirement for many care homes is a need for 
training and re-fresher training. The potential of WDA to design training 
systems has been explored by others such as Lintern & Naikar (2000), 
Naikar et al. (1999) and Naikar (2006).
Naikar et al. (1999) used the AH to identify training needs and functional 
specifications of an aircraft fighter system. They related the training needs 
of the system to each AH level. Naikar et al. (1999) identified the training 
objectives of the system by referring to the functional purposes of the AH 
because the functional purposes of the system must be fulfilled if the work 
system is to be considered effective. At the second level of the AH, the 
priorities and values define the criteria for measuring the performance that 
can then be used to evaluate the performance of the trainee or the training 
program. The third level of the AH shows the functions that need to be 
fulfilled in the system. Hence, workers should have the relevant skills and
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competencies to execute these functions. To perform these functions, the 
workers need to be competent in operating the physical objects in the 
system, corresponding to the fourth level of the AH. Taking the example 
of the care home medication system, workers will need to know how to 
perform a medication review (fourth level of the AH) if they were to 
prescribe medical treatment (third level). Finally, workers need to be 
aware of the functional attributes and features of the physical objects, 
corresponding to the fifth level of the AH.
Further research could examine the usefulness of the AH to develop 
training programs for care home staff. Applying the same method used by 
Naikar et al. (1999) described above, each work function at the different 
abstraction levels of the AH of the care home medication system could be 
developed into individual training modules. Taking the example of the 
third abstraction level of the AH, the “purpose-related function” level, each 
of the work functions; “diagnose medical condition”, “prescribe 
medication”, “supply medication” and “administer medication” could be 
developed into individual training modules. The syllabus of these modules 
would be tailored according to the different levels of knowledge required 
by care home staff or other healthcare practitioners involved in the 
functioning of the care home medication system. For example, care home 
staff members will not be expected to understand the intricate details of 
“diagnose medical condition” or “prescribe treatments” because they will 
not be performing these functions. However, it may be useful for them to 
understand how these work functions can be fulfilled in the care home 
medication system. A knowledge gap may lead to further problems. For 
example, “monitor health status” is a work function that is means-ends 
linked to both “diagnose medical condition” and “prescribe treatment”. By 
providing care home staff members with the relevant information about 
these two work functions, they may be better informed to report their 
observations of the care home resident that may be relevant for
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diagnosing or prescribing a treatment. Another advantage of using the AH 
as a framework to develop training packages is that the training modules 
can be placed in context of the wider work system. This is important for 
workers to understand why the particular work function in the system is 
required.
Lintern & Naikar (2000) in another paper argued that the WDA does not 
fully specify the training equipment requirements and further analysis is 
needed to bridge the gap between the identification of functional 
requirements and the specification of training equipment. The author 
agrees with this view because subsequent phases of CWA analysis that 
aim to analyse different views of the work system may provide further 
useful information when developing training packages. For example, the 
second level of analysis, ConTA analyses the cognitive tasks that are 
required when performing the work functions in the work system. The 
fourth level of analysis, SOCA analyses the distribution of tasks among 
workers. Workers performing tasks within a complex system should 
ideally be provided with information about the different dimensions of the 
particular work function including the constraints of the work domain within 
which work is performed (WDA), the information that is needed to perform 
the tasks (ConTA), the strategies to execute the task (SA), who is involved 
in performing the task (SOCA) and the competencies required to perform 
the task (WCA). This additional information together with the potential use 
of AH as a prospective risk analysis tool, could provide a robust 
framework for the development of a training package for healthcare 
practitioners involved in the provision of care in the care home medication 
system. Further work is needed to explore the application of other CWA 
analysis phases in the development of care home training packages.
2 8 0
8.5 Conclusions
The research reported in this thesis has contributed to understanding the 
care home medication system and methods for analysing medication 
errors. Six in ten care home residents studied in a sample of care homes 
in Cambridgeshire experienced at least one medication error. This finding 
is similar to the wider CHUMS study of which this study was part. They 
reported seven in ten residents experienced at least one medication error 
(Alldred et al. 2008). There is an urgent need to address the problem of 
medication errors in care homes. A systematic method of understanding 
the weak areas of the system, deriving recommendations and evaluating 
system improvements is needed. To do so, it is important to have an 
understanding of the wider context of the complex care home system. 
There is a need for medication safety research to first understand the 
complex nature of the healthcare system being researched before 
developing recommendations. There is also currently a gap between 
implementing and evaluating the effects of system recommendations. 
Hence, it is important to select methods that can capture the complexity of 
healthcare systems, guide the analysts to derive, prioritise and evaluate 
the effects of system recommendations. This thesis showed that work 
domain analysis provided a method of capturing the complexity and 
variability of the care home medication system. The resultant abstraction 
hierarchy was useful for understanding and deriving recommendations for 
system improvements. However, the potential of the AH to prioritise and 
evaluate the system recommendations has yet to be explored. Further 
research is needed to examine the usefulness of the AH to reduce 
medication errors.
2 8 1
Chapter 9: Conclusion
The aims of the research were to build a knowledge base of the care 
home medication system and identify the information requirements for a 
safe care home medication system. The objectives were to identify the 
prevalence and causes of medication errors and generate 
recommendations for system improvements.
An epidemiological study was conducted to identify the prevalence and 
types of medication errors and found six in ten care home residents 
experienced at least one medication errors. Dispensing and medication 
administration errors were the most commonly identified medication errors 
in the study. These results were the findings of the first large-scale 
epidemiological study of the prevalence and types of medication errors in 
England that was conducted as part of a wider study. The causes of 
medication errors identified in the study was analysed using The London 
Protocol (Taylor-Adams & Vincent 2004) and task and individual factors 
were identified to be the most frequent contributors to the medication 
errors. Recommendations to improve the safety of the care home 
medication system were also generated in the medication analysis 
process. Three high-level recommendations were generated: 1. Train 
care home staff, 2. Review medication-related tasks and policies and 3. 
Improve communication. These findings provided an understanding of the 
current problems in the care home medication system. However, both the 
findings of the epidemiological study and the analysis of medication errors 
provided an incomplete view of the care home medication system.
HTA was explored as an alternative method for representing complex 
healthcare systems. The limitations of HTA particularly the difficulty 
representing the complexity and variability of a system led to the
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exploration of CWA. CWA adopts a formative approach that analyses 
what could happen in the work system. There is potential to capture the 
variability and complexity of the care home medication system using a 
formative approach to work analysis. WDA, the first of five analysis 
phases in CWA was conducted because it provided a .fundamental 
framework and set of constraints on which subsequent levels of analysis 
are based on. A systems model of the care home medication system was 
represented using the AH, the modelling tool of WDA and provided a 
knowledge base of the whole care home medication system. This was the 
first time that a WDA of a care home medication system was conducted 
and the first time that a model of the care home medication system was 
developed.
The knowledge base of the care home medication system represented 
using the AH was potentially useful as a framework for analysing 
medication errors. A novel method for analysing medication errors was 
developed using the AH. The same medication errors identified in the 
epidemiological study was analysed using the AH. Different work 
categories that contributed to the medication errors were identified such 
as “transport medication” and “medication review”. Four 
recommendations were generated for system improvement: 1. Improve 
the use and access of information, 2. Improve record-keeping, 3. 
Centralised records and 4. Involve residents in their own care. A 
comparison of The London Protocol and AH to analyse medication errors 
was presented previously in section 7.5.4 suggesting that the AH provided 
a more suitable method for analysing medication errors than The London 
Protocol.
The thesis discussed two different approaches to providing a knowledge 
base of the care home medication system: an epidemiological study and 
WDA. There is a need for further studies to confirm the findings of the
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epidemiological study. There is also further scope to analyse the causes 
of medication errors in more detail. The understanding of the care home 
medications system could be further explored by analysing different views 
of the whole system and subsequent phases of analysis in CWA could be 
explored. There is potential for CWA to be used in other healthcare 
settings such as that presented in Chapters 6 and 7. Further studies are 
needed to explore the utility of CWA in healthcare.
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Appendix 1 : Care home nurses Interview schedule
Introduction
Briefly talk about the purpose of the study and the interview.
Background
■ I understand that you are a care home nurse. Can you briefly tell me in a few 
sentences what your job involves?
Probe; How many residents do you care for?
Probe; What types of patients are they?
■ Can you describe the type of MDS system that your care home uses?
Probe: Can you give me a more detailed description of the MDS system?
Probe: Weekly or monthly?
Probe: What is the function of the MAR chart?
* Can I take a copy of the MAR chart?
■ From your experience, can you tell me the healthcare professionals involved in 
the care of the resident? (care home, primary care, acute care, tertiary care
Probe: If the resident is hospitalised, who are the healthcare professionals involved 
in their care?
Event/situation-based questions
I will now bring you through the 4 situations, one at a time.
Situation 1: A resident is admitted and discharged from hospital
■ What happens before a resident is admitted to the hospital?
Probe: Could you say something more about that?
Probe: What preparation is done? Documentation?
Probe: What happens to the medicines that the resident is currently taking?
■ What does the resident bring to hospital?
Probe: What happens to the documents and the resident’s medicines?
Probe: How does the resident get to the hospital?
■ When the resident is in hospital, does the hospital communicate with the care 
home?
Probe: If yes, what is it about? Who normally takes these calls?
■ How do you know when a resident is to be discharged?
■ What happens when the resident is discharged from hospital?
Probe: What preparation is made to receive the patient?
Probe: Does the care home receive any updates about the patient’s condition? 
Discharge letter?
Probe: If yes, when does the care home receive it?
Probe: What happens with the information received?
Probe: Does the care home have a contact point with the hospital if there are any 
queries?
■ When the resident returns to the care home, what happens to the resident’s 
medicines?
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Probe; Can you give me a more detailed description of what happens?
Probe: What happens to the medicines that the resident is taking in hospital? (Who
receives information, how is it received, when does this occur, contact points if
there are questions.)
Probe: What happens to the old medicines? MDS? MAR?
Probe: What happens to the new medicines? MDS? MAR?
Probe: Who knows about the changes to the resident’s medicines? (supplying 
pharmacy, who tells them, when, how?)
■ Is there anything else that you would like to add?
Situation 2: A resident has an urgent admission to the hospital
■ What happens before a resident is urgently admitted to the hospital?
Probe: Can you give me a more detailed description of what happens?
Probe: What preparation is done? Documentation?
Probe: What happens to the medicines that the resident is currently taking?
■ What does the resident bring to hospital?
Probe: What happens to the documents and the resident’s medicines?
Probe: How does the resident get to the hospital?
■ When the resident is in hospital, does the hospital communicate with the care 
home?
Probe: If yes, what is it about? Who normally takes these calls?
■ Is there anything else that you would like to add?
Situation 3: A resident receives a routine visit by the GP
■ How often does the GP visit the residents?
■ What happens when the GP does the routine visits?
Probe: Could you say something more about that?
Probe: Does the GP visit the resident alone?
Probe: What happens when the GP decides to add or change the resident’s 
medicines? (who is informed, how, when, records, follow up?)
Probe: How much time does the GP take to review each patient on average?
■ Is it always the same GP that does the routine visits?
Probe: If not, who else does these visits?
Probe: What happens when another GP does the routine visits?
■ Is there anything else that you would like to add?
Situation 4: A resident needs urgent medical attention from the GP
■ How often is the GP called for an urgent visit?
■ What happens when the GP calls in for an urgent visit?
Probe: Does the GP visit the resident alone?
Probe: What happens when the GP decides to add or change the resident’s 
medicines? (who is informed, how, when, records, follow up?)
Probe: How long does this normally take?
■ Is it always the same GP that is called for urgent visits?
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Probe; If not, who else does these visits?
Probe: What happens if another GP was called?
■ Is there anything else that you would like to add?
Communication/relationship with other healthcare professionals
In the beginning of the interview, I asked you for a list of healthcare professionals 
who are involved in the care of the resident.
You mentioned x, y, z. (possibly: psychiatrist, district nurse, community psychiatric 
nurse, nutritionists, dietician, physiotherapist, dentist, podiatrist, optician...who 
else??). Are there any more that you have thought of?
■ From this list, who do you have a working relationship with?
Ask the following questions relating to the healthcare professionals named.
■ Can you describe this working relationship?
Probe: Can you say something more about that?
Probe: What is the content of communication? When? How? Records? Feedback?
■ Is there anything else that you would like to add?
End questions
Would you like to add other additional points or stress anything in particular about 
this interview?
Is there anything that I can do to make it better for other interviewees?
Thank you very much for your time and being willing to talk to me.
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Appendix 2: GPs interview schedule
Introduction
Briefly talk about the purpose of the study and the interview.
Background
I understand that you are a care home GP. Can you briefly tell me in a few 
sentences what your job as a care home GP involves?
Probe: How many care homes do you care for?
Probe: How many residents are there in each?
Probe: What types of patients are they?
Probe: What kind of services is provided?
From your experience, can you tell me the healthcare professionals involved in the 
care of the resident? (care home, primary care, acute care, tertiary care)
Probe: If the resident is hospitalised, who are the healthcare professionals involved 
in their care?
Event/situation-based questions
I will now bring you through 4 situations, one at a time.
Before we go through the situations, can you tell me the types of care home visit 
that you make? (Routine, non-urgent visits, opportunistic visits, part of NSF -  
medication reviews, urgent)
Situation 1 : The GP makes a routine, non-urgent visit to the care home
■ How often is the GP called for a routine, non-urgent visit?
■ Can you describe your experience of a routine visit to a care home?
(If it is easier, you could use today’s experience to answer this question)
Probe: Can you give me a more detailed description of what happens?
Probe: What usually happens during a routine visit?
Probe: Does the GP visit the resident alone?
Probe: What happens when the GP decides to add or change the resident’s 
medicines? (who is informed, how, when, records, follow up?)
Probe: How long does each visit take on average? How much time do you 
normally allocate for these visits?
■ Does the same GP make these routine visits?
Probe: If not, who else does these visits?
Probe: What happens when another GP does the routine visits?
Probe: Could you say something more about that?
■ What happens when there is a change to the resident’s medication?
Probe: Who supplies the medication? When?
■ Is there anything else that you would like to add?
Situation 2: The GP is called to make an urgent visit to the care home.
■ How often is the GP called for an urgent visit?
■ Can you describe your experience making an urgent visit to the care home? 
Probe: Can you give me a more detailed description of what happens?
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Probe: What happens when the GP calls in for an urgent visit?
Probe: Does the GP visit the resident alone?
Probe: What happens when the GP decides to add or change the resident’s 
medicines? (who is informed, how, when, records, follow up?)
Probe: How long does this normally take?
■ Is it the same GP called for urgent visits?
Probe: If not, who else does these visits?
Probe: What happens if another GP was called?
Probe: Could you say something more about that?
■ Is there anything else that you would like to add?
Situation 3: The GP decides as a treatment option that the resident needs to 
be admitted to the hospital.
■ What happens when you decide to admit a resident to the hospital?
Probe: Who is informed of this decision? Who informs them? How? When?
(hospital, resident’s family, care home Does the hospital acknowledge that the
information as been received? Any feedback from hospital about the content of the 
information conveyed?)
Probe: Can you give me a more detailed description of what happens?
■ What does the resident bring to hospital?
Probe: What happens to the documents and the resident’s medicines?
Probe: How does the resident get to the hospital?
■ Do you know what happens to the resident in hospital once admitted?
Probe: If yes, what is known? How do you know about it? When do you know 
about it?
■ How do you know when a resident is to be discharged?
■ What happens when the resident is discharged from hospital?
Probe: Does the GP receive any updates about the patient’s condition? Discharge 
letter?
Probe: If yes, when does the GP receive it?
Probe: What happens with the information received?
Probe: Does the GP have a contact point with the hospital if there are any queries? 
Probe: Who else knows about any changes to the resident’s medicines? (supplying 
pharmacy, who tells them, when, how?)
■ Is there anything else that you would like to add?
Situation 4: The GP decides that the resident needs to be admitted to the 
hospital urgently.
■ What happens before a resident is urgently admitted to the hospital?
Probe: Who is informed of this decision? Who informs them? How? When?
(hospital, resident’s family, care home Does the hospital acknowledge that the
information as been received? Any feedback from hospital about the content of the 
information conveyed?)
■ What does the resident bring to hospital?
Probe: What happens to the documents and the resident’s medicines?
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Probe: How does the resident get to the hospital?
■ When the resident is in hospital, does the hospital communicate with the GP? 
Probe: If yes, what is it about? Who normally takes these calls?
■ Is there anything else that you would like to add?
Situation 5: Nursing home residents require repeat medication
■ What happens when the care home residents require their repeat medicines? 
Probe: Who requests for the residents’ repeat Rxs? How is this done?
Probe: When are Rxs requested?
Probe: How and when does the servicing pharmacy receive the Rxs? Do you get 
old the MAR charts?
Probe: What happens when the pharmacy receives the Rxs?
Probe: What happens if the pharmacy does not receive the Rxs in time?
Probe: Who normally dispenses the medicines?
Probe: When does the care home receive the medicines?
Probe: Who delivers/collects the medicines?
Probe: Can you tell me more about the MAR charts?
■ What happens if there is a supply problem with a particular medicine?
" Is there anything else that you would like to add?
Situation 6: Community pharmacy receives an acute prescription for a 
resident
■ How does the supplying pharmacy receive the acute prescription?
■ What happens when an acute prescription is received?
Probe: When is the acute prescription dispensed?
Probe: Who dispenses the acute prescription?
Probe: What happens to the MAR chart?
What happens if an acute prescription is received on a weekend?
Probe: Who normally-dispenses the medicines?
Probe: If the MDS pharmacy is not open, what happens? Records? MAR chart? 
Probe: When is the acute prescription dispensed?
If the Rx is not handed in person to the pharmacy, how does the resident receive 
the acute medicine?
What happens if there is a problem with supplying the medicine?
Is there anything else that you would like to add?
Communication/relationship with other healthcare professionals
In the beginning of the interview, I asked you for a list of healthcare professionals
who are involved in the care of the resident.
You mentioned x, y, z. (possibly: psychiatrist, district nurse, community psychiatric 
nurse, nutritionists, dietician, physiotherapist, dentist, podiatrist, optician...who 
else??). Are there any more that you have thought of?
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From this list, who do you have a working relationship with?
Ask the following questions relating to the healthcare professionals named.
Can you describe this working relationship?
Probe; Can you say something more about that?
Probe: What is the content of communication? When? How? Records? Feedback? 
Is there anything else that you would like to add?
End questions
Would you like to add other additional points or stress anything in particular about 
this interview?
Is there anything that I can do to make it better for other interviewees?
Thank you very much for your time and being willing to talk to me.
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Appendix 3: Community pharmacists interview scheduie
Introduction
Briefly talk about the purpose of the study and the interview.
Background
I understand that you are a community pharmacist servicing care homes. Can you 
briefly tell me in a few sentences what does this involve?
Probe: How many care homes do you care for?
Probe: How many residents are there in each?
Probe: What types of patients are they?
Probe: What kind of services is provided?
Probe: What type of MDS system do you use? Is this the same for every care 
home that you service? Can you tell me more about this system?
From your experience, can you tell me the healthcare professionals involved in the 
care of the resident? This could be in the care home, primary care, acute care or 
tertiary care.
Event/situation-based questions
I will now bring you through 6 situations, one at a time.
Situation 1: Community pharmacy supplies care home residents with regular 
repeat medication
■ What happens when the care home residents require their repeat medicines? 
Probe: Who requests for the residents’ repeat Rxs? How is this done?
Probe: When are Rxs requested?
Probe: How and when does the servicing pharmacy receive the Rxs? Do you get 
old the MAR charts?
Probe: What happens when the pharmacy receives the Rxs?
Probe: What happens if the pharmacy does not receive the Rxs in time?
Probe: Who normally dispenses the medicines?
Probe: When does the care home receive the medicines?
Probe: Who delivers/collects the medicines?
Probe: Can you tell me more about the MAR charts?
■ What happens if there is a supply problem with a particular medicine?
■ Is there anything else that you would like to add?
Situation 2: Community pharmacy receives an acute prescription for a 
resident
■ How does the supplying pharmacy receive the acute prescription?
■ What happens when an acute prescription is received?
Probe: When is the acute prescription dispensed?
Probe: Who dispenses the acute prescription?
Probe: What happens to the MAR chart?
■ What happens if an acute prescription is received on a weekend?
Probe: Who normally dispenses the medicines?
Probe: If the MDS pharmacy is not open, what happens? Records? MAR chart?
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Probe: When is the acute prescription dispensed?
■ if the Rx is not handed in person to the pharmacy, how does the resident 
receive the acute medicine?
■ What happens if there is a problem with supplying the medicine?
■ Is there anything else that you would like to add?
Situation 3: The resident’s repeat medicine is changed
■ How does the supplying pharmacy know that there is a change to the resident’s 
regular medicine?
■ When does the pharmacy know about this change?
■ What happens when there is a change to the resident’s regular medicine?
Probe: What happens to the MAR chart?
■ Is there anything else that you would like to add?
Situation 4: The resident requires an emergency supply of a medicine
■ What happens when the resident requires an emergency supply of a medicine? 
Probe: What records are made?
Probe: What happens to the MAR chart?
■ Is there anything else that you would like to add?
Situation 5: The resident is discharged from hospital
■ How does the pharmacy know that the resident has been discharged from 
hospital?
■ What happens when the resident is discharged from hospital?
Probe: Does the community pharmacy receive any updates about the patient’s 
condition? Discharge letter?
Probe: If yes, when does the pharmacy receive it?
Probe: What happens with the information received?
Probe: Do you have a contact point with the hospital if there are any queries?
■ How does the pharmacy know that there are changes to the resident’s 
medicine?
■ What happens to the resident’s medicines when discharged from the hospital? 
Probe: What happens to the old medicines?
Probe: What happens to the new medicines?
Probe: What happens to the MAR chart?
■ Is there anything else that you would like to add?
Situation 6: An acute Rx is brought to another pharmacy to be dispensed.
■ How does the supplying pharmacy know that the resident is prescribed an 
acute medicine?
■ When does the supplying pharmacy know of this change?
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■ What information is conveyed?
■ What happens when this information is obtained?
Probe: Are there any records made?
■ Is there anything else that you would like to add?
Communication/relationship with other healthcare professionals
In the beginning of the interview, I asked you for a list of healthcare professionals 
who are involved in the care of the resident.
You mentioned x, y, z. (possibly: psychiatrist, district nurse, community psychiatric 
nurse, nutritionists, dietician, physiotherapist, dentist, podiatrist, optician...who 
else??). Are there any more that you have thought of?
" From this list, who do you have a working relationship with?
Ask the following questions relating to the healthcare professionals named.
■ Can you describe this working relationship?
Probe: What is the content of communication? When? How? Records? Feedback? 
Probe: Care home staff -  What kind of advice does the care home asks for? (the 
way to use medicine?)
■ Are there medicines that are not routinely prescribed by the GP?
Probe: Does the pharmacy have a record of these medicines?
Probe: Does the pharmacy have an up-to-date medication history for the residents 
that they supply medicines?
= Is there anything else that you would like to add?
End questions
Would you like to add other additional points or stress anything in particular about 
this interview?
Is there anything that I can do to make it better for other interviewees?
Thank you very much for your time and being willing to talk to me.
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Appendix 4: Hospital pharmacists interview schedule
Introduction
Briefly talk about the purpose of the study and the interview.
Background
I understand that you are a hospital pharmacist. Can you briefly tell me in a few 
sentences what your job as a hospital pharmacist involves?
Probe: Can you describe in more detail your involvement in the care of a care 
home resident?
From your experience, can you tell me the healthcare professionals involved in the 
care of the resident? This may include the care home, primary care, acute care, 
tertiary care.
Event/situation-based questions
I will now bring you through 6 situations, one at a time.
Scenario 1: A care home resident has a planned admission to the hospital.
■ What happens when a care home resident comes into hospital?
Probe: Who takes the patient’s medical history? When? What are the sources of 
information? Where is it recorded? Are the records accessible for everyone who 
needs it? Are there separate records e.g. doctors, nurses and pharmacists? How 
are they different from each other? Where are they kept? Who can access them? 
Why are there different records?
Probe: Does the patient normally bring in their current medicines?
Probe: What happens to the medicines that they bring in? If it is an MDS, what 
happens to the supply of medicines?
Probe: If the patient did not bring their current medicines to the hospital, what 
happens?
■ Is there anything else that you would like to add?
Scenario 2: Patient’s medication changed during hospital stay.
■ What happens when the doctor decides to change the patient’s medication? 
Probe: Is this documented? What is documented? Where? Who does it?
■ How do the nurses/pharmacists know of this change?
■ When do they know of this change?
■ Is there anything else that you would like to add?
Scenario 3: A patient changes wards within the same hospital
■ What happens when a patient changes wards?
Probe: What preparation is made prior to the change? Who does it?
Probe: What does the patient brings to the new ward?
Probe: Is there a handover process? Who does it? How is it done?
Probe: Are the healthcare professionals involved in the care of the patient aware of 
this change? How do they know? When?
Probe: How often do patients change wards?
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■ Does every ward in your hospital function in the same way?
Probe: How is it different in terms of documentation, communication?
■ Is there anything else that you would like to add?
Scenario 4: A patient is transferred to a different hospital
■ What happens before a patient is transferred to a different hospital?
Probe: What preparation is made prior to the change? Who does it?
Probe: What does the patient brings to the new hospital?
Probe: Is there a handover process? Who does it? How is it done?
Probe: Are the healthcare professionals involved in the care of the patient aware of 
this change? How do they know? When?
Probe: How often do patients change hospitals?
■ Is there any communication with the hospital that the patient ha s , been 
transferred?
Probe: Feedback that patient has arrived, documents received, etc.
■ Are you always aware of how the other hospital documents information?
■ Is there anything else that you would like to add?
Scenario 5: Pharmacy services for patients during the weekend
■ Describe the hospital pharmacy weekend service.
Probe: Ward rounds?
Probe: What is the on-call pharmacist’s role?
Probe: Are patients normally discharged on the weekends?
■ How do you know if a patient’s medicines have been changed during the 
weekend?
■ What happens if there is a change?
Probe: Who supplies the medicine?
■ Is there anything else that you would like to add?
Scenario 6: A patient is discharged to care home
■ How do you know when a patient is to be discharged?
Either on ward round/TTO will arrive in pharmacy/TTO written up
■ What happens when the resident is discharged from hospital?
Probe: Who writes and/or authorises discharge medication?
Probe: What is the format of the discharge letter?
Probe: Who is it sent to? By whom and when? Feedback that discharge letter has 
been received?
Probe: Is every discharge ‘clinicalled’ by a pharmacist?
■ When the patient returns to the care home, what happens to the medicines that 
the resident was discharged with?
Probe: What happens to the old medicines? MDS?
Probe: What happens to the new medicines? MDS?
Probe: Who knows about the changes to the resident’s medicines? (supplying 
pharmacy, who tells them, when, how? Contact points?)
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Communication/relationship with other healthcare professionals
In the beginning of the interview, I asked you for a list of healthcare professionals 
who are involved in the care of the resident.
You mentioned x, y, z. (possibly: psychiatrist, district nurse, community psychiatric 
nurse, nutritionists, dietician, physiotherapist, dentist, podiatrist, optician...who 
else??). Are there any more that you have thought of?
■ From this list, who do you have a working relationship with?
Ask the following questions relating to the healthcare professionals named.
■ Can you describe this working relationship?
Probe: Can you say something more about that?
Probe: What is the content of communication? When? How? Records? Feedback?
■ Is there anything else that you would like to add?
End questions
Would you like to add other additional points or stress anything in particular about 
this interview?
Is there anything that I can do to make it better for other interviewees?
Thank you very much for your time and being willing to talk to me.
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Appendix 5: Findings of care home nurse interviews
Communication between the care home and hospital
Four scenarios were presented to nurses during the interview. Scenario 1 related 
to a resident being admitted and discharged from the hospital. Resident being 
admitted to hospital urgently was the second scenario presented. Both nurses 
found communication or the transfer of information with the hospital to be poor. 
Depending on the hospital to which the resident was admitted, the hospital may 
request the resident’s medication be brought to the hospital. If it was an urgent 
admission to the hospital, it was unlikely that the resident’s medication would be 
sent to the hospital because the care home may be in a rush. The medication 
administration record (MAR) may be photocopied by some care homes and 
brought to the hospital together with the medicines. One care home nurse 
described providing the hospital with a brief history of the resident’s problem, why 
the GP was called in before hospital admission, previous medical history, activities 
of daily living and nursing care notes. The care home nurse in-charge of the care 
home on that day will usually complete the hospital admission procedure.
During a resident’s hospitalisation, the hospital seldom made contact with the care 
home. The care home would usually call the hospital on a daily basis to find out 
about the resident’s progress but it was not unusual for the care home to rely on 
the resident’s relatives for information about the progress of the resident. One 
nurse described her care home sending a care home staff member to visit the 
resident in the hospital. There were sometimes many people involved in the care 
of the resident and the care home often spoke to different people in the hospital 
regarding the care home resident. One nurse commented that the hospital would 
rather speak to the resident’s GP instead of the care home about the care of the 
resident because the hospital wanted to speak to a doctor.
Care homes were sometimes not informed of residents’ hospital discharge dates. 
They have had to call the hospital to identify the exact dates on some occasions. 
One nurse described her experience of a care home resident arriving at the 
doorstep of the care home without the care home having been first informed by the 
hospital. She added that that was not an isolated incident. The care home nurse 
described this lack of information to be problematic because the care home needs 
to prepare the resident’s room and inform and prepare care home staff for the high 
dependency level of care that residents may require when they are discharged 
from the hospital.
Hospital discharge information was poor. Depending on the hospital, the care 
home may receive the last carbon copy of the discharge letter and the information 
could be unreadable. Hospital discharge letters did not always indicate which 
medication had been stopped in hospital. In such cases, the care home nurse 
follows the information on the hospital discharge letter. There have also been 
occasions when resident’s medications were not sent with the resident during 
discharge. Medicines were sent to the care home by taxi a few days later. 
Residents’ discharge medications will be counted, signed-in on the medication 
administration record (MAR) and may be counter-signed by another nurse in the 
care home.
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Communication between the care home and GP surgery
The third and fourth scenarios presented to nurses related to when a care home 
resident was seen by the GP during routine care home visits and when a care 
home resident required urgent medical attention from the GP respectively.
Both nurses described that GPs only visited the care home when requested by the 
care home. During a GP’s consultation visit, a nurse will be present. If the GP 
wanted to alter the resident’s medication therapy, the GP would either hand-write a 
prescription and leave it in the care home or issue a prescription when he/she 
returns to the GP surgery. The care home either calls or faxes the prescription to 
the community pharmacy or dispensing GP and collects the medication either the 
same day or when the medication is ready. The care home updates changes to 
the resident’s care plan and MAR chart appropriately after the GP’s visit. One 
nurse described GPs as being very thorough in their visits. Residents also 
received more attention from the GP if the GP visited the care home. However, 
residents may not always be seen by the same GP from the same GP surgery.
If a resident required an emergency visit from the GP out of normal surgery times, 
the out-of-hours service is called. Sometimes the out-of-hours service would send 
paramedics and this usually meant that residents would be admitted to hospital. 
This is problematic if residents choose not to be admitted to hospital. Out-of-hours 
GPs normally carry a certain amount of medication and they may sometimes fax 
relevant consultation notes to the resident’s GP.
Both care home nurses reported that communication with GPs varied. One nurse 
worked in a care home that was serviced by two dispensing GP surgeries. 
Dispensing GPs prescribe and dispense medication to patients. She described 
regular communication with the dispensing GP surgery. The experience of the 
other care home nurse with GPs differed greatly. She reported working in care 
homes that used between 1 and 15 GPs.
Communication between the care home and other healthcare providers
Care home nurses described a range of healthcare professionals involved in 
providing care to residents. These included care home nurses, GPs, social 
workers, community psychiatric nurses, physiotherapists, occupational therapist, 
chiropodist, district nurses, palliative care team, pharmacists and dispensers. The 
nurse who worked in the care home serviced by dispensing GPs had little contact 
with community pharmacies but had a good relationship with the dispenser in the 
dispensing GP surgery. The other care home nurse described varying levels of 
communication with community pharmacists. Some care homes had good working 
relationships with their community pharmacy(ies), and contacted each other 
regularly either through the telephone or face-to-face while others did not. 
Occupational therapists and physiotherapists were two healthcare providers 
identified by one nurse that may need information about resident’s medication.
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Appendix 6: Findings of GP interviews
Communication between the GP surgery and care home
Four scenarios were presented to GP participants. The first two related to the GP 
making routine and urgent visits to the care home respectively. The level of 
communication between the GP surgery and care homes varied. For one GP, 
requests for urgent visits occurred every two or three weeks. During GP visits, the 
nurse or the resident would explain the problem. The GP would then decide on the 
most appropriate treatment which may sometimes involve reassurance rather than 
prescribing medication. Other visits were opportunistic and were usually more 
than twice a year to coincide with residents’ 6 monthly medication review. 
Residents’ illness and treatment in context of their other illnesses are reviewed 
during this time. The GP would assess whether residents were well in themselves 
and optimise their treatment because illnesses, therapeutics and the resident can 
change with time.
The group of four GPs described that they have had to sometimes wait until the 
resident is brought back to their own room before seeing the resident and this 
wasted GP’s time. Their experiences differed depending on the care home, 
whether they were ‘good’ or ‘bad’. ‘Bad’ care homes were the ones who ‘did not 
take responsibility for their work’. GPs did not like the nature of the request visits 
that included GPs being called for non-urgent matters, relatives pressuring care 
homes to request a GP visit so that they can talk to the GP, care home staff asking 
for services that are not within the GP surgery’s responsibility and unusual 
requests such as asking the surgery to send out a nurse to show care home staff 
how to take blood. A ‘good’ care home, on the other hand, knows how to deal with 
GPs and takes responsibility for their work. This was often facilitated by a good 
care home manager.
If a medication is prescribed, the prescription will usually be handwritten and this 
change is entered onto the GP’s computer on return to the surgery. Depending on 
the resident’s condition, each consultation takes around 15 minutes. If residents 
were seen by an out-of-hours team, the out-of-hours GPs often emailed the 
consultation notes to the GP, or they sometimes faxed or post the information. 
The information would be updated onto the GP’s computer records. GPs also 
mentioned having to sign multiple prescriptions for 7 or 14 days supply of 
medication because care homes used 7 or 14-day monitored dosage systems 
(MDS) dispensed by the community pharmacist. They have had to deal with odd 
requests such as prescribing for one tablet because the care home had dropped 
the tablet.
Variations in the way information is communicated between the GP surgery and 
care homes existed. Some GPs described good communication with care homes 
whilst others thought that care homes required more commitment in terms of time 
and service, above what they were willing and able to provide. The care home 
nurse or the GP knowing the resident adds a new dimension to the care of the 
resident despite the quality of medication information. The nature of the 
consultation is enhanced but this is difficult to ensure.
Communication between the GP surgery and hospital
The last two scenarios related to the GP making a decision to admit the resident to 
the hospital on a planned admission and the GP deciding that the resident requires
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an urgent hospital admission. If a GP decides that a resident needs to be admitted 
to the hospital they either call the hospital directly or a central number that will co­
ordinate a bed space for the resident. This central service would then call the care 
home and inform them of the details of the hospital admission. If a GP assesses 
the need for the resident to be urgently admitted to the hospital, an ambulance is 
called. Unless the GP referred the care home resident to the hospital, they may 
not know that a resident was in hospital until a hospital discharge letter was 
received or they were informed by care home staff.
Very rarely would the GP be informed that a resident was to be discharged from 
the hospital. They are usually only made aware when they receive hospital 
discharge letters or are informed by care home staff. GPs complained about the 
lack of information on hospital discharge letters. Discharge letters detail the 
diagnosis but do not always indicate which medications had been initiated or 
stopped in the hospital, and the reasons for the change. Discharge letters may be 
faxed or carbon copies of the discharge letters posted to GPs.
Communication between the GP surgery and other healthcare providers
GPs described a range of healthcare providers who are involved in providing care 
to care home residents. Besides GPs themselves, these included other GPs in the 
practice, GP registrars, nurse practitioners, out-of-hours service, care home 
nurses, carers, community pharmacists, dentists, podiatrists, district nurses (for 
residential homes), community physiotherapist, hospital specialist, psychiatrist, 
psychiatric nurses, physician in elderly, community matron and phlebotomist.
All GPs interviewed did not have direct contact with the community pharmacy but 
described good relationships with them. One GP had a good relationship with a 
psychiatrist and district nurse. Psychiatrists will inform GPs of their treatment plan 
in the form of a letter. They seldom write prescriptions and usually leave this to the 
GP. The same GP described difficulties communicating with psychiatric nurses 
because they were ‘very individual' and tried to avoid the GPs.
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Appendix 7: Findings of community pharmacist
interviews
Communication between the community pharmacy and care home
The first was the provision of residents' regular prescribed medication by the 
community pharmacy. Both pharmacists requested residents' prescriptions to be 
made available to the pharmacy about two weeks before the start of the care 
home's monthly medication cycle. Sometimes, old MAR charts are sent to the 
pharmacy. The pharmacy then checks the prescription against the patient 
medication record (PMR) on their computer system to identify any medication 
changes. In one pharmacy, medication was sometimes dispensed according to 
the PMR and then checked against the new prescriptions when they arrived in the 
pharmacy. A common problem described by both pharmacists was not receiving 
prescriptions from the care home in good time or at all.
The second scenario presented to pharmacists was when they receive an acute 
prescription for a care home resident. If this event occurred, GPs or care homes 
usually faxed the prescription to the pharmacy. Sometimes the nurse from the 
care home brings the prescription to the pharmacy. Care homes may also 
telephone the community pharmacist first and then bring the prescription when 
collecting the supply of medication. Medication could be dispensed and delivered 
by the pharmacy the same day, dispensed and collected by the care home the 
same day or delivered by the pharmacy the next day. Both pharmacies used a 
type of MDS. One pharmacy dispensed acute medication in its original container 
without providing the care home with a new MAR chart. Care home staff 
handwrites the details of the new medication onto the MAR chart. The other 
pharmacy would dispense the medication in an MDS, synchronise the newly 
prescribed medication with the current medication cycle in the care home and 
provide a new MAR chart. If there was a problem with the supply of the prescribed 
medication, the pharmacists would either ‘borrow' from another pharmacy or 
request the GP to change the prescription. However, this was not common in both 
pharmacies. One pharmacist mentioned the problem of unwanted medications 
being requested on the repeat prescriptions such as antibiotics.
The third scenario surrounds the resident requiring an emergency supply of a 
medication from a community pharmacy. One pharmacist had never had to 
provide an emergency supply to care home residents. The other pharmacist felt 
caught between not providing medication to residents because she knows she 
‘shouldn't do it' and residents being at risk if they did not have their medications. 
When she does provide an emergency supply to residents, it was because a 
particular repeat medication had been left off the monthly prescriptions and the 
formal documentation associated with providing an emergency supply was usually 
not followed because it would require a lot of work.
Communication between the community pharmacy and GP surgery
Scenario four related to a change being made by the GP to the care home 
residents' medication. Community pharmacists would not know that medications 
had been changed unless they were informed by the care home nurse or more 
often when they received prescriptions for new medications. This could sometimes 
be very time consuming for the community pharmacy because they would usually 
query these changes either with the care home or GP. It is usually unclear why or 
in what setting changes to medication were made. One pharmacist raised her
316
concerns because residents could end up with the wrong dose, either under-dose 
or overdose because of a lack of communication between the community 
pharmacy and the GP surgery.
Communication between the community pharmacy and hospital
The fifth scenario related to the resident being discharged from hospital. Both 
pharmacists would not know normally know that the resident had been admitted to 
or discharged from the hospital. The care home may inform the community 
pharmacy when they need a new supply of medication. Community pharmacist 
participants described no contact with the hospital and they would not have any 
information about changes made to the resident’s medication therapy in the 
hospital. Any changes to medication were usually inferred from the prescriptions 
presented to the community pharmacy or when care homes return resident's old 
medication to the pharmacy for disposal. Residents discharged from hospital may 
be supplied with medication dispensed in original packs or a different MDS system. 
Care homes may not use these supplies because they were not dispensed in their 
usual MDS. Hence, there is a safety issue because residents have two sets of 
medication increasing the risk of them being given the same medication twice. 
One community pharmacist was concerned about the lack of communication and 
the problems of receiving available information from a third party.
Communication between the community pharmacy and other healthcare 
providers
The last scenario related to a resident's acute prescription being dispensed by 
another community pharmacy. Community pharmacists would not normally know 
that the resident's medication had been dispensed by another pharmacy unless 
informed by the care home. They may know about the change from the old MAR 
chart where information about the new drug had been recorded or when the 
pharmacy receives a new prescription for the new medication in the next month. 
This suggests that the patient medical records (PMR) on the community 
pharmacy's computer may not be a complete and accurate medication history. 
The lack of information may result in the care home using two types of dispensing 
system that may lead to confusion.
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Appendix 8; Findings of hospital pharmacist interviews
The first two scenarios involved patients being admitted and discharged from the 
hospital respectively. Care homes may or may not bring residents’ medication 
when they are admitted to the hospital. Hospitals do not usually use medication 
dispensed in MDS and if care home residents’ medications are dispensed in an 
MDS, these are usually stored in the patient’s own drug locker. On discharge, 
these are returned to the patient. Sometimes, hospital pharmacists may not know 
that the patient is to be discharged to their care homes. They may find out during 
ward rounds or when the patient’s discharge prescription is written and arrives at 
the hospital pharmacy to be dispensed. The hospital pharmacy may dispense 
discharge medication in an MDS but they do not issue MAR charts so the care 
home would normally handwrite the details of the new medication onto the MAR 
chart or send the supply of medication to the community pharmacy for them to 
issue new MAR charts.
Communication between the hospital pharmacy and the hospital team
The next three scenarios presented to hospital pharmacists related to 
communication within the hospital team when there was a change in a patient’s 
medication during their hospital stay, when a patient changes wards within the 
same hospital and the provision of pharmacy services during the weekend.
When a hospital doctor changes a patient’s medication therapy, the information is 
documented on the hospital in-patient drug chart and medical notes. The level of 
information written in the medical notes differed for different doctors; the rationale 
for starting or stopping a medication may not be recorded. If the pharmacist was 
on the ward round or on the ward when a change in medication was made, she 
may know about the change. If not, the ward nurse may bleep the hospital 
pharmacist to inform her of the need for a supply of new medication. Depending 
on the level of pharmacy services provided in the hospital during the medication 
change, the nurse may bring the drug chart to the pharmacy to be dispensed. 
Hospital pharmacists thought that this system could sometimes be confusing but it 
usually worked. Nurses were seen to be conscientious and developing a 
relationship with them was important to enable the provision of medication in the 
hospital.
One hospital pharmacist described the process of a patient changing wards within 
the same hospital as a ‘disaster’. Pharmacists may not know that the patient was 
to be transferred to another ward. Sometimes, pharmacists may be informed just 
before the patient is transferred or when the patient has already been transferred. 
The timing and level of information received usually depended on the level of the 
pharmacist’s involvement on the ward. During transfer, patient’s medical notes 
would normally follow the patient but their medication could often be forgotten. 
Hospital wards functioned in a largely similar way but depending on the type of 
care and specialty, the drug charts may be different. It was however not the norm 
for elderly patients to be transferred between different wards in the same hospital.
Hospital pharmacies provided skeleton services during the weekend. Pharmacists 
run an on-call service and they may sometimes have to go back to the hospital to 
dispense medication. Patients were very rarely discharged on weekends requiring 
pharmacy services. If a patient’s medication had been changed during the 
weekend, hospital pharmacists would not know about this until after the weekend.
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Communication between the hospital pharmacy and other healthcare 
providers
The last scenario surrounds the patient being transferred to a different hospital. 
Hospital pharmacists may not know that patients are scheduled to be transferred. 
They may only know when nurses request them to dispense discharge medication. 
It was difficult to keep everyone involved in the transfer and the process could 
sometimes be very disjointed.
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The Chief Investigator or sponsor should Inform the local Principal Invesb’gator at each site of the 
favourable opinion by sending a  copy of this letter and the attached form. The research should not 
commence at any NHS site until research governance approval from the relevant NHS care 
organisation has been confirmed.
Statement of compliance
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Ethics Committees ir
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Appendix 10: Ethical approval from the University of
Surrey research ethics committee
UniS
Ethics Committee
22 September 2006
Ms Rosemary Hwee Mei Lim 
Robens Centre for Health Ergonomics 
E I H M S
Dear Ms Lim
Care Home Use of Medication Study (CHUMSI fEC/2006/93/ROBENS) -  FAST TRACK
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the submitted protocol and supporting 
documentation.
Date of confirmation of ethical opinion: 22 September 2006
The list of documents reviewed and approved by the Committee under its Fast Track 
procedure is as follows:-
Document Date
Application 11/09/2006
Copy of the NHS Application Form 04/04/2006
Research Proposal 11/09/2006
Letter to GPs with Consent Form and Information Sheet 11/09/2006
Letter to Care Home Managers with Consent Form and Information Sheet 11/09/2006
Letter to Residents with Consent Form and Information Sheet 11/09/2006
Letter to Carers with Consent Form and Information Sheet 11/09/2006
Letter to Pharmacist with Consent Form and Information Sheet 11/09/2006
Pharmacy Staff Interview Schedule 01/03/2005
Care Staff Interview Schedule 01/03/2005
GP Interview Schedule 01/03/2006
The Error Producing Conditions Questionnaire 01/03/2005
Insurance Proforma 11/09/2006
This opinion is given on the understanding that you will comply with the University's Ethical
Guidelines for Teaching and Research, and with the conditions set out below.
1. The Consent Forms should include a space for signature of a witness, as shown on the 
enclosed sample.
2. On the Information Sheets, please could you include a section on complaints. 
Suggested wording: “Any complaint or concerns about any aspects of the way you 
have been dealt with during the course of the study will be addressed; please contact 
[insert name of Principal investigator]. Principal Investigator on [insert contact number].
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The Committee should be notified of any amendments to the protocol, any adverse 
reactions suffered by research participants, and If the study is terminated earlier than 
expected, with reasons.
I would be grateful if you would confirm, in writing, your acceptance of the conditions 
above.
You are asked to note that a further submission to the Ethics Committee will be required in 
the event that the study is not completed within five years of the above date.
Please inform me when the research has been completed.
Yours sincerely
Catherine Ashbee (Mrs)
Secretary, University Ethics Committee 
Registry
cc: Professor T Desombre, Chairman, Ethics Committee 
Professor P Buckle, Supervisor, Robens Centre 
Dr J Anderson, Supervisor, Robens Centre
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Appendix 11: Letter to the University of Surrey research
ethics committee
UniS
28 September 2006
Mrs Catherine Ashbee 
Secretarj^
University Ethics Committee 
Registry
University of Surrey
Dear Mrs Ashbee,
Care Home Use of Medication Study (CHUMS) ŒC/2006/93/ROBENS) 
TRACK
University 
of Surrey
Guildford
Surrey GU2 7XH. UK
Telephone
444 (0)1483 300800
Facsmile
444 (0)1483 300803 
\WAV.surrey.ac.uk
European 
Institute of 
Health and 
Médical 
Sciences
The Robens Centre for 
Health Ergonomics
Duke of Kent Building 
University Campus 
Stag H21. Guildford 
Surrey GU2 T IE . UK
T&’epfrana
+44 (0)1483 689213
w,w.eihms.sunrey.ac.uk/
robens/erg
FAST
I  am uTiting to confirm my acceptance of the conditions set out by the Ethics 
Committee in the letter dated 22 September 2006 to do the following:
1. Consent Forms w ill include a space for signature of a witness.
2. A section on complaints will be included on all Information Sheets and the 
following wordings w ill be used;
“Any complaints or concerns about any aspects of the way you have been dealt 
with during the course of the study w ill be addressed; please contact Denise 
Buttress on 0113 3431340.
Yours sincerely,
Rosemarj' Lim
Robens Centre for Health Ergonomics 
EIHMS
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Appendix 12: Initial letter to care home managers
Hinchlngbrooke Health Care
NHS Trust
mm
University 
of Surrey
«Title» «First_Name» «Surname» Our ref: CHUMS
«Address_1 » Date: / 706
«City» «Post_Code»
Dear «Title» «Surname»
Care Homes Use of Medicines Study (CHUMS)
Following our recent conversation, I am writing to seek your home’s participation in this 
important study that is being conducted in nursing and residential homes in eight PCTs 
across England. The national coordinating centre for the study is at the University of 
Leeds.
As a care home manager, you know that managing residents’ medication is not a simple 
job. Nearly half a million older people in England live in care homes, and most are on at 
least five long-term medicines. The issues you face are different from hospitals, but -  
unlike hospitals -  there is very little research on how the medicines process actually 
operates in UK care homes, or where the strengths and weaknesses are.
We have been awarded a research grant to study the prescribing, ordering, monitoring 
and administering medicines in 100 care homes like yours. This will include the 
dispensing of medicines and how they are packaged and delivered to the home. The aim 
is to describe where different types of muddles and misunderstandings can happen, which 
ones matter most, and to suggest how the system could be designed to work better. No 
blame will be apportioned.
As part of this, a clinical pharmacist would carry out a detailed medication review for up to 
five of your residents. We would also seek the cooperation of each resident’s GP. The 
study has formal NHS Research Ethics approval. Consent for inclusion in the study would 
be sought individually from the residents and we may need your help with this process. 
For residents whose mental or physical state does not allow them to provide informed 
consent, permission would be sought from a relative. Suggestions for improvements in 
the medicines would be discussed with the resident, the nurse or care manager in charge 
and the GP.
The study would also involve a researcher watching and learning about your medicine 
rounds, and your system for ordering medicines from the pharmacy or doctor’s dispensary. 
The whole process will be designed to keep to a minimum any disruption to the home. 
Please do not hesitate to contact us if you require any further information or have any 
queries. Many thanks for your help in this matter.
Yours sincerely,
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principai investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.iim@surrev.ac.uk Email: ianet.watkinson@hinchinqbrooke.nhs.uk
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Appendix 13: Information leaflets for care home staff
Hinchlngbrooke Health CareU /f jR
NHS Trust
University 
of Surrey
Care Home Use of Medicines Study (CHUMS) 
Information leaflet for Care Home Staff
As a care home worker, you know that managing residents’ medication is not 
a simple job. But - unlike hospitals - there is very little UK research about 
how the whole medicines process actually works in homes. We have been 
asked by the Department of Health to study the way that medicines are used
in care homes like yours.
Can you help us? Please read the information below, and discuss it with 
your colleagues, before you decide.
If anything is not clear, or if you would like more information, then please ask
us. Our contact details are overleaf.
What is the purpose of the study?
This research project will study the prescribing, ordering, monitoring and 
administration of medicines in care homes like yours. This will include the 
dispensing of medicines and how they are packaged and delivered to the home. 
The aim is to describe how different types of muddles and misunderstandings to do 
with medication can happen, which ones matter most, and to suggest possible 
changes.
We will be working with care homes in three areas: Yorkshire, Cambridgeshire and 
London. The study would involve a researcher watching and learning about 
medicine rounds, and your system for ordering medicines from the pharmacy or 
GP practice. Up to five residents in each home will have their medication 
reviewed.
Why have I been chosen?
Because you are involved in the care of a resident who has agreed to take part in 
our study. He or she will have their medication reviewed by one of our research 
pharmacists. If the pharmacist thinks the treatment could be improved he or she 
will discuss this with the resident, care staff and the GP before making any 
changes.
What will happen if I take part?
First we will make sure that you are clear about the study, and ask you for written 
consent. You will be given a copy of the consent form to keep. Then our research
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pharmacist will arrange a suitable time to talk to you and observe one of your 
medicine rounds.
Do I have to take part?
That’s entirely up to you. No one will mind if you say no, or if you say yes, and then 
change your mind.
Are there any benefits?
For the residents, a medication review could lead to changes which improve health 
or behaviour. Home staff would benefit from this too.
With your help, the research team may identify specific ways to simplify or 
reorganise the current systems for prescribing, ordering and giving medicines in 
care homes like yours. These changes could make your job just a bit easier.
What about possible disadvantages and risks?
You may worry about talking about problems with medicines for fear of being 
blamed or punished. If you do tell us about specific incidents -  or perhaps make a 
mistake of some kind yourself during a medicines round -  we will not pass your 
name on to anyone outside our research team.
Will my taking part in this study be kept confidential?
Absolutely. The notes our researchers make will be given a code, and only this 
code will be used in our research. Names will not be used.
What will happen to the results?
The findings will be presented as a report, which should eventually become 
available via the Department of Health website. The care home will not be named, 
and it will not be possible to identify individuals.
Who is organising and funding the research?
The study is being done by researchers from:
• The Pharmacy Practice and Medicine Management Group at Leeds University,
• The School of Pharmacy at London University and
• The Robens Centre for Health Ergonomics at Surrey University.
The work is funded by the Patient Safety Research Programme at the Department 
of Health.
Who has reviewed the study?
This study has been reviewed by Peterborough & Huntingdon Local Research 
Ethics Committees.
Any complaints?
Any complaints or concerns about any aspects of the way you have been dealt 
with during the course of the study will be addressed; please contact Mrs Denise 
Buttress on 0113 343 1340.
Contact for Further Information
Our project is being done in three locations: Yorkshire, Cambridgeshire and 
London. Our project secretary, Mrs Denise Buttress will put you in touch with a 
member of the research team in your own area. You can contact her on 0113 343 
1340 or email: A.D.Buttress@leeds.ac.uk
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Appendix 14: Care home consent form
Hinchingbrooke Health Care[2S S I
University 
of Surrey
NHS Trust
REC Project Reference Number: 05/01202/57
Centre: Cambridgeshire 
Home Identification Code:
CARE HOME CONSENT RECORD
Title of Project: Care home use of medicines study (CHUMS)
Name of Researcher: Professor Nicholas Barber,
School of Pharmacy, London University
Please Initial box
1. I confirm that I have read and understand the letter dated / / 2006 
about the above study and have had the opportunity to ask questions.
2. I understand that residents will only be approached to participate if 
their GP agrees.
3. I agree for this home to participate in the above study, and that 
___________________________ may approach residents
Name Date Signature
Job title
Name of Witness Date Signature
Local researcher Date Signature
1 copy for home; 1 copy for researcher
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Appendix 15: Introduction letter to GP practice managers
Hinchingbrooke Health Care
NHS Trust
m s
University 
of Surrey
Please reply to:
Rosemary Lim
Robens Centre for Health Ergonomics
EIHMS, Duke of Kent Building
University of Surrey
Guildford
Surrey
GU2 7TE
Our Ref: CHUMS 
Date: / /06
Dear
Care Homes Use of Medicines Study (CHUMS)
I am writing to request the co-operation of the partners of your practice in this 
major research project. We hope to improve the quality of medicines care of 
elderly care home residents by examining in detail the way in which medicines are 
prescribed, dispensed, administered and taken.
I enclose individual copies for each partner in your practice of a request for their 
help.
Can I ask you to circulate them to the partners, and if you are able to do so, 
co-ordinate their response on the individual pink forms enclosed with each 
letter? Please return these to me using the self-addressed envelope 
provided.
It would be very helpful if you could seek a response from the practice within 2 
weeks.
If you or any of your doctors would like any further details of the project, please feel 
free to contact any one of us or the national project manager David AI Id red 
(d.p.alldred@leeds.ac.uk).
Yours sincerely.
Rosemary Lim 
PhD student & Pharmacist 
Phone: 0777 177 6260 
Email: r.lim@surrev.ac.uk
Dr Janet Watkinson
Principal Investigator for Cambridgeshire 
Phone: 01480 416 143
Email: ianet.watkinson@hinchinqbrooke.nhs.uk
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Appendix 16: Introduction letter to GPs
Hinchingbrooke Health C are ffliS
University 
of Surrey
Please reply to: Our Ref: CHUMS
Rosemary Lim Date: / 706
Robens Centre for Health Ergonomics 
EIHMS, Duke of Kent Building 
University of Surrey •
Guildford 
Surrey 
GU2 7TE
Dear Dr
Care Homes Use of Medicines Study (CHUMS)
Many GPs are concerned about the problems of ensuring accurate and appropriate use of 
medicines in care homes for older people.
Our research team has been funded as a national project to examine the issues involved 
from the prescription through dispensing and administration of the medicine to the actual 
effect on the patient. The study has formal NHS Research Ethics approval.
We are seeking you and your partners’ cooperation. We should like you to allow our 
clinical pharmacist (with the patient’s consent or near relative’s assent) access to the 
clinical and medication records of a small number of randomly selected care home 
residents. Each patient will then have a consultation with the clinical pharmacist to review 
their medicines. He/she will then write to you to confirm that the review has taken place 
(so you can code this in the patient’s records for Quality and Outcome purposes) and 
where appropriate to make recommendations for the patient’s care. You are free to accept 
or reject these. In the event of any medicine-related problem he/she may wish to discuss 
this with you. The aim of the study is not to apportion blame.
We enclose a blue fact sheet with further details of the project, and a pink consent form. 
We do hope you will be willing to help us with this important project. We have asked your 
Practice Manager to collate the partners’ consent forms and return them to us.
If you or any of your doctors would like to have any further details of the project, please 
feel free to contact us, or the national project manager David Alldred 
(d.p.alldred@leeds.ac.uk).
Yours sincerely.
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principal investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.lim@surrev.ac.uk Email: ianet.watkinson@hinchinqbrooke.nhs.uk
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Appendix 17: Information leaflet for GPs
Hinchingbrooke Health Care[2S 3
NHS Trust
University 
of Surrey
Care Homes Use of Medicines Study (CHUMS)
This is a major multi-centre research project conducted by a team of doctors, 
clinical pharmacists, nurses and other health-related professionals from the 
Universities of Leeds, London, Surrey and Cambridge.
What is the aim of the project?
The aim of the project is to establish the prevalence, types and underlying causes 
of medication errors in care home residents and the ensuing harm. We intend to 
use this information to develop solutions to improve patient safety, and by 
conducting clinical medication reviews to optimise patients' therapy.
Why have i been chosen?
You have been chosen because you have patients who live in a care home. We 
wish to recruit some of your patients into the study.
Do i have to take part?
You do not have to participate. If you agree to do so, you are free to withdraw at 
any time without giving a reason.
What win happen if i agree to take part?
A pharmacist will contact your practice manager to arrange a convenient time to 
view the medical notes of consented patients. He/she will then conduct a 
consultation with the patient (if feasible) and carer at the home. A letter will be 
sent to you detailing any medicine-related issues identified with recommendations. 
You are free to accept or reject the recommendations and to implement them as 
you see fit. Previous work we have undertaken in this area has not resulted in an 
increase in GP consultations and the time commitment has been minimal. If a 
medicine-related issue arises, we may wish to discuss the case with you at your 
convenience.
What are the benefits of taking part?
The new GP contract recommends that patients over 75 have a medication review 
annually (six-monthly for those on >4 medicines - the majority of care home 
residents). Our clinical pharmacist will conduct a review of consented patients, 
fulfilling this requirement.
Win information be kept confidential?
All information that is collected about your practice and your patients will be kept 
strictly confidential. All data collected will be anonymised. No blame w ill be 
apportioned.
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What will happen to the results of the study?
A report to the National Patient Safety Research Programme will be written and we 
intend to publish the results in medical and pharmaceutical journals.
Who is funding the research?
The research is being funded by the National Patient Safety Research Programme 
which is responsible to the Department of Health.
Who has reviewed the study?
The study has been peer-reviewed on behalf of the National Patient Safety 
Research Programme and ethical approval has been granted by the NHS 
Research Ethics Committee.
I
If you would like any further information, please contact Mr. David Alldred (details 
below).
Any complaints?
Any complaints or concerns about any aspects of the way you have been dealt 
with during the course of the study will be addressed; please contact Denise 
Buttress on 0113 343 1340.
If you agree to take part in the study, please complete and return the 
attached consent form in the stamped addressed envelope provided. You 
should also sign the duplicate consent form and keep this information leaflet 
for your records.
Many thanks for taking the time to read this.
The CHUMS Research Team
Professor N. Barber, London School of Pharmacy 
Professor D.K. Raynor, University of Leeds 
Professor P. Buckle, University of Surrey 
Dr J. Ward, University of Cambridge 
Dr A. Zermansky, University of Leeds 
Dr I. Savage, London School of Pharmacy 
Dr B. Dean-Franklin, London School of Pharmacy 
Dr M. Woloshynowych, Imperial College London 
Dr J. Watkinson, Hinchingbrooke hospital 
Denise Buttress, University of Leeds
Mr David Alldred MSc MRPharmS
Project Manager and Research Clinical Pharmacist
School of Healthcare Studies
Baines Wing
University of Leeds
0113 343 1339
07952 084 245
d.p.alldred@leeds.ac.uk
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Appendix 18: GP consent form
Hinchingbrooke Health Care[2 3 8
University
of Surrey
NHS Trust
REC Project Reference Number: 05/Q1202/57
Centre number: 02 
Participant Identification Code:
Title of Project: 
(CHUMS)
GP CONSENT FORM
Care Home Use of Medicines Study
Name of Researcher: Professor Nicholas Barber,
School of Pharmacy London University
Please initial box
1. I confirm that I have read and understand the information sheet
da ted ............................. (version.............) for the above study and
have had the opportunity to ask questions.
2. I give permission for responsible individuals from University of 
Leeds Pharmacy Practice and Medicines Management Group, the 
School of Pharmacy London University and Robens Centre for 
Health Ergonomics Surrey University to contact me at work where it is 
relevant to this research.
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my legal 
rights being affected.
4. I agree to take part in the above study.
Name of Participant Date Signature
Name of Witness Date Signature
Researcher Date Signature
1 copy for participant; 1 copy for researcher
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Appendix 19: Random sampiing list
TABLE A6 R A N D O M  S A M P L IN G  NU M BERS  
I
03 47 43 73 86 36 96 47 36 61 46 9S 63 7! 62 33 26 16 80 4 5 60 11 14 10 95
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Appendix 20: introduction letter to care home residents
Hinchingbrooke Health Care
NHS Trust
N m
University 
of Surrey
Please reply to: Our Ref: CHUMS
Rosemary Lim Date: / /06
Robens Centre for Health Ergonomics
EIHMS, University of Surrey
Guildford GU2 7TE
United Kingdom
«Address_1 »
«Address_2»
«Post Code»
Dear Resident
Care Homes Use of Medicines Study (CHUMS)
We have been asked by the Department of Health to look at the way medicines are 
used in care homes for the elderly.
We are writing to you because you get at least one regular medicine on 
prescription. Because of this, we would like to invite you to join our study. It does 
not involve any new treatments or drugs. We have the agreement of the manager 
of the home to conduct this study in «Address_1» and will tell your doctor about it.
If you take part, a specially trained pharmacist (chemist) will talk to you about your 
health and medicines. She will then suggest to your doctor any changes in your 
treatment that might improve your care. If the pharmacist thinks your treatment 
can be improved, she will discuss it with you and then with your doctor before 
changing your medicines. Your treatment will only be changed if you and your 
doctor say yes.
One of our research pharmacist will be visiting «Address_1 » soon to talk to you 
and ask if you want to take part in our study. Please read the enclosed leaflet 
before you decide. No-one will mind if you say “No”.
• If you want some time to think about it or discuss it with a relative or 
friend that will be fine.
• If you say yes then change your mind later that will be fine.
• Whatever you decide to do, it will not affect the healthcare you receive.
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principal Investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.lim@surrev.ac.uk Email: ianet.watkinson@hinchinqbrooke.nhs.uk
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Appendix 21 : Information leaflet for residents
Hinchingbrooke Health Care[2 ZË
NHS Trust
University 
of Surrey
STUDY TITLE: CARE HOME USE OF MEDICINES STUDY 
(CHUMS)
We have been asked by the Department of Health to look at the way 
medicines are used in care homes iike yours.
Can you help us? Please read the information below before you
decide.
What is the purpose of the study?
Many care home residents have several regular medicines but we know 
very little about how these medicines are ordered, given and monitored. 
This is different from hospitals, where we know quite a lot about how 
things work.
The aim of our study is to describe how different types of muddles and 
misunderstandings to do with medicines can happen, which ones matter 
most, and to suggest how things could be designed to work better. We 
will be working with care homes in three different areas of England.
Why have I been chosen?
Because you have regular medicines on prescription.
Do I have to take part?
That’s entirely up to you. No-one will mind if you say no, or if you say 
yes, then change your mind.
What will happen to me if I take part?
• First our research pharmacist would check that you are clear about the 
study, and ask you to sign a consent form. You would be given a copy 
of this to keep with this leaflet.
• Then a specially trained pharmacist would make a detailed review of 
all the medicines you take or use.
• This normally takes about 20 minutes and would be done at a time to 
suit you.
• We would also like to come and see how the home staff actually give 
you your medicines.
Are there any benefits?
Yes, there could be. The pharmacist who reviews your medicines could 
suggest changes that could help you in some way. The type of change,
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and the benefit from making it, would depend on what your medicines 
are, and why you take them. If the pharmacist thinks your treatment can 
be improved, he or she will discuss it with you and then with your doctor 
before changing your medicines. Your treatment will only be changed if 
you and your doctor approve.
There could also be benefits for other people in care homes. What you 
tell our pharmacist might help to identify general things to do with 
medicines that could be improved in some way.
What about possible disadvantages and risks?
You may be concerned about describing things to do with your medicines 
which you are not happy about. The pharmacist will not pass on what 
you say to your GP, or to home staff without your permission.
Will my taking part in this study be kept confidential?
Yes. Your name will not be recorded on the form the pharmacist uses. 
Your record will be given a code, and only this code will be used in our 
research. The homes will not be named, and it will not be possible to 
identify you or the staff.
What will happen to the results?
The findings will be presented as a report, which will eventually become 
available on the internet at the Department of Health website.
Who is organising and funding the research?
The study is being done by researchers from:
e The University of Leeds, Pharmacy Practice and Medicine 
Management Group;
® The School of Pharmacy London University and 
• The Robens Centre for Health Ergonomics at Surrey University.
The work is paid for by the Patient Safety Research Programme at the 
Department of Health.
Who has reviewed the study?
This study has been reviewed by the Huntingdon Local Research Ethics 
Committee.
Any complaints?
Any complaints or concerns about any aspects of the way you have been 
dealt with during the course of the study will be addressed; please 
contact Mrs Denise Buttress on 0113 343 1340.
Who can I contact for more information?
Our project is being done in three locations: Yorkshire, Cambridgeshire 
and London. Our project secretary, Mrs Denise Buttress will put you in 
touch with a member of the research team in your own area. You can 
contact her on 0113-3431340.
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Appendix 22: Resident consent form
Hinchingbrooke Health CareM n R
University
of Surrey
NHS Trust
REC Project Reference Number: 05/Q1202/57
Centre number: 02 
Participant identification Code:
RESIDENT CONSENT FORM
Title of Project: Care Home Use of Medicines Study (CHUMS) 
Name of Researcher: Professor N. Barber, 
School of Pharmacy London University
Please initial box
1. 1 confirm that I have read (or had explained to me) the
information sheet dated...................... (version............... ) for the
above study and have had the opportunity to ask questions.
2. 1 understand that my participation is voluntary and that I am free
to withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected.
3. I understand that my medical notes may be looked at by 
Responsible individuals from University of Leeds Pharmacy 
Practice and Medicines Management Group, the School of Pharma 
London University and Robens Centre for Health Ergonomics, Surrey 
University where it is relevant to this research. I give permission for 
these people to have access to my records.
agree to take part in the above study
Name of Participant Date Signature
Name of person taking Consent 
(if different from Researcher)
Date Signature
Name of Witness Date Signature
Researcher Date Signature
1 copy for participant; 1 copy for researcher; 1 copy to be kept with GP notes
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Appendix 23: introduction ietter to relatives
Hinchingbrooke Health Care
NHS Trust
N m
University 
of Surrey
Please reply to: Our Ref: CHUMS
Rosemary Lim Date: / /06
Robens Centre for Health Ergonomics
EIHMS, University of Surrey
Guildford GU2 7TE
United Kingdom
Recipient address 
Dear
Care Homes Use of Medicines Study (CHUMS)
We are writing to you because we understand that you are the nearest relative of 
 __________________ who is a resident o f____________________ .
We have been asked by the Department of Health to look at the way medicines are used 
in care homes for the elderly. Our study does not involve any new treatments or drugs.
Because your relative is receiving regular medication, we would like to invite him/her to 
join our study. We have the agreement of the manager of the home to conduct this study 
in _________________ and would inform_______ ’s doctor about it.
Residents taking part in the study would have their medicines looked at by a specially 
trained pharmacist (chemist). If the pharmacist thinks your relative’s treatment can be 
improved, he or she will discuss it with the carers (and yourself if you wish) and then with 
the GP. The treatment will only be changed with the approval of your relative’s GP.
We are told by the manager of the home that (because of memory, confusion, or 
communication difficulties) your relative may not be able to give consent to participate in 
our study. We think it is very important to include such residents in the study, and that is 
why we are seeking your agreement to include your relative.
One of our researchers will be visiting ___________________  soon, and will
contact you to ask if you w a n t to take part in our study.
Please read the enclosed leaflet before you decide whether to agree or not.
Your decision will not affect the healthcare your relative receives.
Yours sincerely
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principal Investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.lim@surrev.ac.uk Email: ianet.watkinson@hinchingbrooke.nhs.uk
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Appendix 24: Information leaflet for relatives
Hinchingbrooke Health C areg g Q
NHS Trust
University 
of Surrey
Study title: Care Home Use of Medicines Study (CHUMS)
1/1/e have been asked by the Department of Health to look at the way 
medicines are used in care homes.
Can you help us? Please read the information below before you
decide.
What is the purpose of the study?
Many care home residents have several regular medicines on prescription 
but we know very little about how these medicines are ordered, given and 
monitored. This is different from hospitals, where we know quite a lot about 
how things work.
The aim of our study is to describe how different types of muddles and 
misunderstandings to do with medicines can happen, which ones matter 
most, and to suggest how things could be designed to work better.
Why has my relative been chosen?
Because he or she is receiving regular medicines.
What’s my role in this?
Some care home residents may not be able to give consent to take part in 
our study. We think it is very important to include such residents in the 
study, and that is why we are asking you to agree to include your relative. If 
you agree, our research pharmacists will ask you to sign an assent form, on 
behalf of your relative. You would be given a copy to keep with this leaflet. 
If you decide later that you do not want your relative to take part after all, 
that will be fine. Your decision will not affect the care your relative receives.
What will happen to my relative if she/he takes part?
A specially trained pharmacist would make a detailed review of all the 
medicines he or she takes or uses. We would also like to come and see 
how the home staff actually give your relative his or her medicines.
Are there any benefits?
Yes, there could be. The pharmacist who reviews your relative’s medicines 
could suggest changes which could help in some way. The type of change, 
and the benefit from making it, would depend on what the medicines are, 
and why they are being taken. If the pharmacist thinks your relative’s
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treatment can be improved, he or she will discuss changes with the carers, 
and yourself if you wish. He or she will only change your treatment with the 
approval of yourself and your relative's doctor.
There could also be benefits for other people in care homes. What residents 
tell our pharmacist might help to identify general things to do with medicines 
that could be improved in some way.
What about possible disadvantages and risks?
It is extremely unlikely that anything will go wrong as a result of taking part in 
this study. Taking part in this study will not affect your relative’s usual rights 
by law to claim compensation for injury where fault can be proved.
Will taking part in this study be kept confidential?
Yes. Your relative’s name will not be recorded on the form the pharmacist 
uses. The record will be given a code, and only this code will be used in our 
research. The homes will not be named, and it will not be possible to 
identify individual residents or staff.
What will happen to the results?
The findings will be presented as a report, which will eventually become 
available on the internet at the Department of Health website.
Who is organising and funding the research?
The study is being done by researchers from:
• The University of Leeds Pharmacy Practice and Medicine Management 
Group;
• The School of Pharmacy London University and
• The Robens Centre for Health Ergonomics at Surrey University.
The work is funded by:
• The Patient Safety Research Programme at the Department of Health. 
Who has reviewed the study?
This study has been reviewed by the Huntingdon Local Ethics Committee. 
Any complaints?
Any complaints or concerns about any aspects of the way you have been 
dealt with during the course of the study will be addressed; please contact 
Mrs Denise Buttress on 0113 343 1340.
Who can I contact if I want more information?
Our project is being done in three locations: Yorkshire, Cambridgeshire and 
London. Our project secretary, Mrs Denise Buttress will put you in touch with 
a member of the research team in your own area. You can contact her on 
0113 3431340 or email A.D.Buttress@leeds.ac.uk
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Appendix 25: Relative assent form
Hinchingbrooke Health C are^S Q
REC Project Reference Number: 05/Q1202/57
Centre number: 02 
Participant Identification Code:
RELATIVE ASSENT FORM
Title of Project: Care Home Use of Medicines Study (CHUMS)
Name of Researcher: Professor N. Barber,
School of Pharmacy London University
I am the nearest relative of______________________________________
who is a resident at _______________
Pease initial box
1. I confirm that I have read and understand the information sheet dated
............................  (version ) for the above study and have had
the opportunity to ask questions.
2. I understand that taking part is voluntary. I am free to withdraw my
assent at any time, without giving any reason, and without my 
relative's care being affected.
3. I understand that sections of my relative’s medical notes may be
looked at by responsible individuals from University of Leeds 
Pharmacy Practice and Medicines Management Group, the School 
of Pharmacy London University and Robens Centre for Health 
Ergonomics, Surrey University. I give permission for these people 
to have access to my relative's records.
4. I assent to my relative taking part in the above study.
Name of relative 
Address
Relationship to patient
Date Signature
Name of Person taking assent Date Signature
(if different from researcher)
Name of Witness Date Signature
Researcher Date Signature
1 copy for participant; 1 copy for researcher; 1 copy to be kept with GP notes
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Appendix 26: introduction ietter to carers
Hinchingbrooke Health Care
NHS Trust
ms
University 
of Surrey
Please reply to: Our Ref: CHUMS
Rosemary Lim Date: / /06
Robens Centre for Health Ergonomics
EIHMS, University of Surrey
Guildford GU2 7TE
United Kingdom
«Title» «First_Name» «Surname»
«Position»
«Address_1 »
«City» «Post_Code»
Dear Carer
Care Homes Use of Medicines Study (CHUMS)
We are writing to you because we understand that you are the Carer of «Title» 
«First_Name» «Surname» who is a resident of «Address_1 ».
We have been asked by the Department of Health to look at the way medicines are used 
in care homes for the elderly. Our study does not involve any new treatments or drugs.
Because your resident is receiving regular medication, we would like to invite <him/her> to 
join our study. We have the agreement of the home to conduct this study in «Address_1 » 
and would inform «First_Name»’s doctor about it.
Residents taking part in the study would have their medicines looked at by a specially 
trained pharmacist (chemist). If the pharmacist thinks your resident’s treatment can be 
improved, he or she will discuss it with you and then with the GP. The treatment will only 
be changed with the approval of your resident’s GP.
We are told by the home that (because of memory, confusion, or communication 
difficulties) your resident may not be able to give consent to participate in our study. We 
think it is very important to include such residents in the study, and that is why we are 
seeking your agreement to include your resident.
One of our researchers will be visiting «Address_1» soon, and will contact you to 
ask if you want «First_Name» to take part in our study. Please read the enclosed 
leaflet before you decide whether to agree or not. Your decision will not affect 
the healthcare your resident receives.
Yours sincerely
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principal Investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.lim@surrev.ac.uk Email: ianet.watkinson@hinchinqbrooke.nhs.uk
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Appendix 27: Information leaflet for carers
Hinchingbrooke Health CarefJ /jjR
NHS Trust
University 
of Surrey
Study title: Care Home Use of Medicines Study (CHUMS)
We have been asked by the Department of Health to look at the way 
medicines are used in care homes.
Can you help us? Please read the information below before you
decide.
What is the purpose of the study?
Many care home residents have several regular medicines on prescription 
but we know very little about how these medicines are ordered, given and 
monitored. This is different from hospitals, where we know quite a lot about 
how things work.
The aim of our study is to describe how different types of muddles and 
misunderstandings to do with medicines can happen, which ones matter 
most, and to suggest how things could be designed to work better.
Why has this resident been chosen?
Because he or she is receiving regular medicines.
What’s my role in this?
Some care home residents may not be able to give consent to take part in 
our study. We think it is very important to include such residents in the 
study, and that is why we are asking you to agree to include your resident. If 
you agree, our research pharmacist will ask you to sign an assent form, on 
behalf of your resident. You would be given a copy to keep with this leaflet. 
If you decide later that you do not want your resident to take part after all, 
that will be fine. Your decision will not affect the care your resident receives.
What will happen to the resident if she/he takes part?
A specially trained pharmacist would make a detailed review of all the 
medicines he or she takes or uses. We would also like to come and see 
how the home staff actually give the resident his or her medicines.
Are there any benefits?
Yes, there could be. The pharmacist who reviews your resident's medicines 
could suggest changes which could help in some way. The type of change, 
and the benefit from making it, would depend on what the medicines are,
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and why they are being taken. If the pharmacist thinks your resident’s 
treatment can be improved, he or she will discuss the changes with yourself 
if you wish. He or she will only change the treatment with the approval of 
yourself and the resident’s doctor.
There could also be benefits for other people in care homes. What residents 
tell our pharmacist might help to identify general things to do with medicines 
that could be improved in some way.
What about possible disadvantages and risks?
It is extremely unlikely that anything will go wrong as a result of taking part in 
this study. Taking part in this study will not affect your resident’s usual rights 
by law to claim compensation for injury where fault can be proved.
Will taking part in this study be kept confidential?
Yes. Your resident’s name will not be recorded on the form the pharmacist 
uses. The record will be given a code, and only this code will be used in our 
research. The homes will not be named, and it will not be possible to 
identify individual residents or staff.
What will happen to the results?
The findings will be presented as a report, which will eventually become 
available on the internet at the Department of Health website.
Who is organising and funding the research?
The study is being done by researchers from:
• The University of Leeds Pharmacy Practice and Medicine Management 
Group;
• The School of Pharmacy London University and
• The Robens Centre for Health Ergonomics at Surrey University.
The work is funded by:
• The Patient Safety Research Programme at the Department of Health. 
Who has reviewed the study?
This study has been reviewed by Huntingdon Local Ethics Committee.
Any complaints?
Any complaints or concerns about any aspects of the way you have been 
dealt with during the course of the study will be addressed; please contact 
Mrs Denise Buttress on 0113 343 1340.
Who can I contact if i want more information?
Our project is being done in three locations: Yorkshire, Cambridgeshire and 
London. Our project secretary, Mrs Denise Buttress will put you in touch with 
a member of the research team in your own area. You can contact her on 
0113 3431340 or email A.D.Buttress@leeds.ac.uk
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Appendix 28: Carer assent form
Hinchingbrooke Health C a re [E |3
NHS Trust
REG Project Reference Number: 05/Q1202/57 
Uni3^ rsity Centre number: 02
of Surrey Participant Identification Code;
CARER ASSENT FORM
Title of Project: Care Home Use of Medicines Study (CHUMS)
Name of Researcher: Professor N. Barber,
School of Pharmacy London University
I am the carer o f_______________________________
who is a resident at ___
Please initial box
1. I confirm that I have read and understand the information sheet dated
.................. .......... (version ) for the above study and have had the
opportunity to ask questions.
2. I understand that taking part is voluntary. I am free to withdraw my assent 
time, without giving any reason, and without my resident's care 
being affected.
3. I understand that sections of my resident's medical notes may be looked 
at by responsible individuals from University of Leeds Pharmacy 
Practice and Medicines Management Group, the School of Pharmacy 
London University and Robens Centre for Health Ergonomics Surrey University. 
I give permission for these people to have access to my 
resident's records.
4. I assent to my resident taking part in the above study.
Name of Carer Date Signature
Address
Relationship to patient
Name of Person taking assent Date Signature
(if different from researcher)
Name of Witness Date Signature
Researcher Date Signature
1 copy for participant; 1 copy for researcher; 1 copy to be kept with GP notes
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Appendix 29: Introduction letter to community pharmacy
Hinchingbrooke Health Care
NHS Trust
mm
University 
of Surrey
Please reply to: Our Ref: CHUMS
Rosemary Lim Date: / 706
Robens Centre for Health Ergonomics
EIHMS, Duke of Kent Building
University of Surrey
Guildford
Surrey
GU2 7TE
Dear
Care homes use of medicines study (CHUMS)
This important study is being conducted in nursing and residential homes in eight PCTs 
across England. You may have already heard about it through your LPC. We am writing to 
give you more information, and to seek your consent for future contact, should the need 
arise.
As someone who dispenses for a care home, you know that managing residents’ 
medication is not a simple job. But -  unlike hospitals - there is very little research in the UK 
about how the medicines process actually operates or where the weak areas are. We 
have been awarded a Department of Health research grant to study the prescribing, 
ordering, monitoring and administering of medicines in care homes such as the ones you 
supply. The aim is to describe where different types of muddles and misunderstandings 
can happen, which ones matter most, and to suggest possible changes. No blame will be 
apportioned.
We will be working with care homes in three geographical areas, one of which has a fair 
number of dispensing doctors. Five residents in each home will have their medication 
reviewed by a research pharmacist, who will also observe medication being given. A visual 
check of each patient’s medication will be made before the medicines round. All confirmed 
errors identified will be followed up in interviews with the relevant health workers 
concerned. The incidence of dispensing errors identified before a medicine round is 
likely to be very low but we would wish to contact you should one be found. We also 
hope to visit a small number of pharmacies to gain an understanding of the care home 
medication supply process from the pharmacy perspective.
If you agree in principle to be contacted by one of our research team, we would be grateful 
if you would return the attached consent form using the self-addressed envelope provided. 
Please read the enclosed information leaflet before you decide.
If you need any further information or have any queries, please do not hesitate to contact 
any one of us. Many thanks for your help in this matter.
Yours sincerely,
Rosemary Lim Dr Janet Watkinson
PhD student & Pharmacist Principal Investigator for Cambridgeshire
Phone: 0777 177 6260 Phone: 01480 416 143
Email: r.lim@surrev.ac.uk Email: ianet.watkinson@hinchinobrooke.nhs.uk
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Appendix 30: Information leaflet for community
pharmacists
Hinchingbrooke Health Care
NHS Trust
University 
of Surrey
Study title: Care home use of medicines study (CHUMS)
As a pharmacist, you know that managing care home residents’ medication is not 
a simple job. We have been asked by the Department o f Health to study the way
medicines are used in care homes.
Can you help us?
Please read the information below, and discuss it with 
your colleagues, before you decide.
If anything is not clear or i f  you would like more information, then 
please ask us. Our contact details are overleaf.
What is the purpose of the study?
This research project will stucîy the prescribing, ordering, monitoring and 
administration of medicines in care homes like the ones you supply. This will 
include the dispensing of medicines and how they are packaged and (delivered to 
the home. The aim is to describe how different types of medication errors can 
happen, which ones matter most, and to suggest possible changes 
We will be working with care homes in three areas: Yorkshire, Cambridgeshire and 
London. All confirmed medication errors will be followed up in interviews with the 
relevant health workers concerned. The main study focus is on prescribing and 
administration in the home but we will also be looking at medicine packaging 
systems and ordering procedures.
Why are you writing to me?
Because your pharmacy supplies medicines to a resident who has agreed to take 
part in our stucdy. Five residents in each home will have their medication reviewed 
and a researcher will observe their medication being given. A visual check of each 
patient’s medication will be made before the medicines round. The incidence of 
dispensing errors identified before a medicine round is likely to be very low but we 
would obviously wish to contact you should one be found.
What would I have to do if I take part?
Taking part in this study would not involve any additional work on your part. But we 
do need your consent to contact you. If a dispensing error is identified, one of the 
research team will arrange a suitable time to talk to you about it. The same 
interview format will be used for GPs and home staff.
We may also ask for permission to observe the care home medication supply 
process in your pharmacy, to gain a better understanding from the pharmacy 
perspective.
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So what do you want me to do now?lf you agree in principle to being contacted 
by our research team, then please complete and return the enclosed initial consent 
form. Then we can enter you and your pharmacy into our project database.
Do I have to take part?
That’s entirely up to you. No-one will mind if you say no, or if you say yes, then 
change your mind.
Are there any benefits?
With your help, the research team may identify specific ways to simplify or 
reorganise the current systems for ordering and supplying medication to care 
homes like yours. These changes could make your job just a bit easier.
What about possible disadvantages and risks?
You may worry about talking about problems to do with care home medicines for 
fear of being blamed or punished. If you do tell us about specific incidents -  or 
perhaps make a mistake of some kind yourself during dispensing -  we will not 
pass your name on to anyone outside our research team.
Will my taking part in this study be kept confidential?
Absolutely. The notes our researcher makes will be given a code, and only this 
code will be used in our research. Names will not be used.
What will happen to the results?
The findings will be presented as a report, which should eventually become 
available via the Department of Health website. The care home will not be named, 
and it will not be possible to identify individuals.
Who is organising and funding the research?
The study is being done by researchers from
■ The Pharmacy Practice and Medicine Management group at University of 
Leeds,
■ The School of Pharmacy, University of London and
■ The Robens Centre for Health Ergonomics at University of Surrey.
The work is funded by the Patient Safety Research Programme at the Department 
of Health.
Who has reviewed the study?
This study has been reviewed by the Huntingdon Local Research Ethics 
Committee.
Any complaints?
Any complaints or concerns about any aspects of the way you have been dealt 
with during the course of the study will be addressed; please contact Mrs Denise 
Buttress on 0113 343 1340.
Contact for Further Information
Our project is being done in three locations: Yorkshire, Cambridgeshire and 
London. Our project secretary, Mrs Denise Buttress will put you in touch with a 
member of the research team in your own area. You can contact her on 0113 343 
1340 or email: A.D.Buttress@leeds.ac.uk. You can also contact Dr Imogen 
Savage at the School of Pharmacy, University of London. Her telephone number is 
020 7753 5854; email: imoqen.savaqe@pharmacv.ac.uk.
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Appendix 31 : Community pharmacy consent to contact
Hinchingbrooke Health Care[2ZS
University REC Project Reference Number: 05/Q1202/57
of Surrey Centre number: 02
«Title» «First__Name» «Surname» 
«Position»
«Address_1 »
«Address_2»
«City» «Post_Code»
Pharmacy staff CONSENT TO CONTACT
Title of Project: Gare home use of medicines study (CHUMS)
Name of Researcher: Professor Nicholas Barber,
School of Pharmacy London University
Please initial box
1. I confirm that I have read and understood the information sheet 
da ted ........................... (version ) for the above study.
2. I understand that responsible individuals from the University of Leeds 
Pharmacy Practice and Medicines Management Group, the School of 
Pharmacy University of London and the Robens Centre for Health 
Ergonomics University of Surrey may wish to contact me to discuss matters 
relevant to this research.
3. I give permission for these individuals to contact me.
4. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my legal rights 
being affected.
Name Date Signature
Name of Witness Date Signature
Please return this form in the SAE provided. Thank you.
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Appendix 32: Care home familiarisation profile
GûiREHGrÆ PROFILE toe: LædE/Lcncfcin iOuifôrtc^e P C i:  HOM E ref fjd:
Care Home Use of Medicines Study
CARE HOME PROFILE
Home ref number.
Date of profile,*.
13 B rie f d e& s fis to fi o f hom e location:
W ould f  a u  cfsLSsify th is  sls svbarbsn? o r rursi?  
A p p ro x  m itüs fro m  y a u r facslrosssxch hssa?
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LEEDS 
LOU Don 
CA M Brldge
EEE
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Ealing /  Lambadi / Lewladam f SoathwarK
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□Psrt Dffa G faïi ........   ._{nsma>
□Local auiTfaiiiy
□r-Joi-fcr-pei^L... ....... ...............................ÇfHTOj
5? SüB dT oaret^ oroaiViBEllon 
□ N/E-Blngensfre 
D  2-5ïiDmsE
O  LargErorgBrtEëîon (ptease spetg '^ apfm% nunÆer AornsE In üiefTsup)L.....
Ha tsrgë üigàn^nu'a’i- ha*' often rso you rtm'e corôact vffîi yrax l%aü arnseterea managsE ?
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CARE HOME PRGfFlIE Itr. LgedE / Lcnsfan /CsmSitdge PC i : HOME ref no:
g] sMmia
Appfojt&isatBly h p * many bI hêT would W  on duty on a fyplcaf day?
Em ^m iît Lace sum Ngnls
Team leaders
C iie  assistanfis
RGWs
Adapôatldfî (e/EfESâs) 
narsas
Ottrarslpfeass stars)
71-Stairtnalnlmr
V\mat ijpe of Irantig Ig Ifere M rm s  cfaffon rnedfcliies prcKiEiirEE? 
W ii^dses ^ aSiŸigeivc^i's snd imo pmvlües £
Wîiat abixiim -gAig tralnlag ^refliGham or updates} for stair ■
WhatdiXJS éiù Savdvi? h  Êaâhix c^m ù feg i^èsîij7
Does yoiir PCT peodcie any training sjppait for yourîiooie? 
ya;. sorf crappoff, and vâio pjm**5s £
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GAREHOf/EPROrEEtcc: üKdG f Lcmcün rcamtdc^e PCi: HOME ref no:
8] G Pvlato
H m  many GP pradlces does tre Home dast vÆîi? tpSaK #cfe)
1 2  3 4 5 msrelfanS
Urn ma%5 D fA e praratees Siicf ssJf ftflfc-fl tfocrarfsf i/sirairy sfifVfcB dm fiKim  77ie ftiV sfc^iK  fncfjsftg  
fatadsd dscte's a itf fsgi’Snar^ J can fie cfija’frndJEtef
On isft'aragir Ikiw  ortaft do GPs vlall: resltfei^ ?
PmcCcel
Name
Approx Î1 vJsis. par
WEEK Regular vfeiifi ViÊîiscnrEqpsEt
MJreas Y/N Y1M
Practice 2 
Nsma Approx 11 visis par meK Regulsn^ts ^'lEîiscrireîfjaai:
Addraas Y/N Y/M
Practices
Nama
Approx Î1 vlSs par 
Msek Regularvlslis vnaiactirKfjEBt
Addraas
Y/N Y/N
Pcadjcei
Name Approx 11 visfis per week Regular vlslla \nEË5onregjaEi:
Addraas Y/N YfN
Practices
Name Apprax Ï1 visis per WEEk RegularvMII^
\nG!c5cnraq'dSEt
Addraas Y/N Ym
Practices
Name
Approx Î1 vfsis par 
week SiegularvëllE \nEBscnrEqjeEi:
Addraas Y.fN Y/N
/f  fimre iftafi G pTEOCtees, pj&ësd caiTiifnuB oioanfeaff 
How would you daaorllm yotff woaîîing rslalloneinip wltti flm GP praollceB?
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CAREHOf/E PROHIE TcE Ussls/London CaniMdgE PCT: HOME is f no:
9i Clinical a id  communfcatl&nregDiKlsTQrreslifente
a} WJsat fypa a f racordB are Kepi: In die Mme?
(m : PSssss jeOTJdffis acfta' feiTis tfm Mme uses- Cl's may vaiyfnamp,ia% to pficejl
□  AdrrJBSionB inllKiratlan 
D  PailsrdAïlartipranSs
□  Cars racHds /raising ndtes
O  iSiarsd cam reoonfe (eg anfficoagnlart boolc; LrtWum:dasaplne}
Does the rarrsuEus/ly ges ixiplES of latj lest resulis? KoO Y aiD
D i^  anyone else (eg piisinasy?) NoO Yw □  plesjM sffsdfy^  ..................
Dms ine hoira uEua/iy gd ooplEs of Kosplai diEchaiga Infoimabon? NoO YasO
Does anyora eles (eg pnanracy?) N d D  YcsD  p/cais ................................ .....
b) WhBre are cllant records Kepi?
15 ihls ifie same for all soor&'unltE In tfe Home? itoD  Yas O
(If no, gel detaîs If poslKe}
WHDlia&accESfi?
HkKlceJ, w1io tidife Ë15 Key?
c)W ,Ncft1^}^ of ccmiTiantlcallon records doesiim HcmrnKsep?
ODocicr’SbooK
OfAiM Edpinai)' recdd sftaet Sir all îieaCBh care prafKsJonals 
O SapanjLta d S W lM S ^ P N  records
DdB ine d W d  nurse Ha va a 'dkiKal rDom" ki tie  Home? N’oD  YasO
d) Are if i i  GP"a cflnlcaf records for resldsnfe:
□  All kepi at tie  praÆce 
O  AHkeplliilieîiccne
O  Partly kept In ttie hooie
Does itiB GP îiave a Yiflnfcal rocnf In tîie rame? Mod Yaz O
Is itiera a compder itik n  itie fiome to GP reccfds kepi at tds practice? NoD YasO
is Itiee  a computer ibk b  tna pnarmscy? Koo YasO
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GARE HOME PROrliE tor: LESdE / Lcndan/-Cantoridge PCi: HOME ref no:
IflS Résidante niefflclnfls
aj HawïïisiyreSdsnteEër-frïedlsaie?.....................
OD Risy kE^ tie k  am  megctnes? NoO YasO
bjt Am iiEfs lri£t'/fJifal copboardE tormedfetnes h  reWdsnto' reams?
OKd □YesL.TcrecmereskJsrJs OYestoralresldEds 
iryes, %%re is toe &IAR ttosi kepi?
c) Vfneie are topical melldnes (aeams eit) UEuaJly kept?.______________________________
NsO YasG
IF YES. Istols:
□ s  casseite systsm Oa Hfeier sfisEt system
vvnat to tra rame of toe FÆïS syslEm (to >du use?
Oltomad OVensank, DBoolE □  M ^ras OUoyds OAnotoerEymem.............
Ha,Y long dees It nnrmaiy lake tor a rew resldeolto be put oeiId MDS?
Amtoersi
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GARE HQfÆ PROFILE I k : Lfâds /  Lcnctcn iOômïrfic^e P C i: H O M E re fn o :
Ifljl EontfnüBCf Reaidante madlclnes
c} Madlcme aW m leW on racorda
Daes ywir bDms use ifie piTnW Msacbs Admlnlalrabon Record (M4R) cbsis IsIcO YasO
Euppred by ihe makara fie  MDS system?
Ef KO, îiDV/ito you rsGM maacaüon aambMmBm?
(gef as mwcf? dSteYss poss/fiS!)
Hav kmg dïss one S,1AR cîiôrt last? 
wnsTi are o ïl cfiaris stoŒd?
wnat o itie  racords do yen keep of iredldnes admbiîstersd: ta reSdanteî 
(eg se&ramdrsldrailai^  disifld rKjrse reccnte)
dji GPpPHfGdptiDn records
Are me repeat pfBKïÿmmster a ï resldenis produced by fie  GP pradlce onrrputer? 
OYfes O K d pracfim ^ dcoï use a corryiura'?'..  .......................
WliEfti lE tfie repeal medfcfnes lEt (toe RHS of toe FPIfltüm i) 
□  In toe berne 
O  intoepMim aq'
O  Somewtoereelss (gfm deSBs)..............
360
CARE HOME PROFILE toc / LsrscÈîn tOsimbrtdge PCs: HOME mf no:
111 FojItigsiflHilvarrflPflatmBdlcattofi: 
a} How are prescrTptlDns for repasrt niadfclrsa fm  raaRfamta wauawy OTdered?
□  HHTie DTÉ^ tsractfram GP pacltoe lElng repeal Sip (RHS of pceEoîpiîan tocrn}
O  Home aTtore drsctfram GP predice using ilie ¥J ^  sbesia
□  Pbarmacy corereHraîi llie GP practice aüenfslttog'conaultlng wtlti ffie tiome 
O  Pbarmsg Dnreisfraji GP pcidlce sïtüicut airiiadtng toe fiome
O  Anctoer metocd galease dascitoe)
[frepem mecllclnes are adened by tlie Home, wta uscsdydoeatolE?------------------------------------
fiappans tobe orsbe ft ot feavs?j
Does toe hcrre keep ptioiccc^iæ of r e a d s ' rej^ Jtor repeat prescslpHcns? Nc O  YasO
D&es toe fierce keep ptiotoccpes of Interim ar acute preacdptlcm? NcD YasO
Dd yea tiarre any fKldeois on bstcfi {repeaists’e ) preso^bcne? NsO YasO
b) How m  dispensed imdlclnas m i^ lly  readi fire M m e?
□ RiarmsdBt deEvere peam aly
O  Someone from the pharmacy iMlvera
□  Heme EÎalïccIlec! irom ptism sg
O  Ancbrer airangement (pease tteserte)
0} W lretllm aordayece dlBpanaWreKllclirea uetiaOy dalh-arad?
How are disperiSBd mBdlctoBs ctiBcksd m  dstlvary?!
#fiB  usiaJty dees tots, and ^ .luers?
Are reconm nxCkiely ioept of dEcrepandes? {eg a  ptismecy "enor beck"?) NcO YasO
121 Fgrirew orctianrred nrediclnBa 
W ild fiappsRS tf toare Is ait uigsnf «YisnsE or sddBcc to a  reBHenf s medcsbai? Plea^ M  a î toat apply 
□Home toxES ecrfpé Id ukibI pfaimacy 
DGP cmtactE isual phaoraey %lto sapt 
QReqireS tdepdcired: to uEuaC pOarmaey 
OF^eBcilpeDa taken Id nsareet pêiarmacy 
DAnoltiK' cCTangement (pfease dsEcbtre)
m a t Eiappans IT toare Is an urgent change oraddffon to a reBidenrs madcabon ooîsïë mmuarpMmnacyope.#g 
heure?
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GAREHOfÆPROFILEfs" üs-dG/LcncünfCsntorti^E P C i: H O M E re fn o :
151 Suppb/lng ptiamiasy 
How many pitarmadea doaa toia homre ms m a  reg/f/arêasft: to obWm madlcatlm Tor roardefite?
(Lftf nan»£ and cdnpete di'ï£rd£ia\ïl3f&')
Pharmæyname Address- POElosde Approx mifes imrn frame
How «ten do yen Mære letephone or kaos-ic-iace cmisct wflh toe pharmacy sPeut rKltSents' medioailon? 
V\,TiD ds usuaîy speak to?
HoArvffluld yra deecrDe y o f wsrttng relabensrfp with toat parson?
Htwr «ten doas tre phaimadsl ilslt toe trame?
O  Most days
O  Qraeair/aEk
O  Cnceamento
O  Le^ often than toai
O  NavETT^te
Wfii^ doES he ex'Efie do vUien tlra^' \tslt?
(itoEck E tœ ^  Etc? cr m ie w  maàcaiJan?)
te toem anvltilmi maa toat you WMild Iffice to tefl m ?
TTianics and ctoae 
Have you asked for a room list for sampling?
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Appendix 33: Field notes template
General Field notes CHUMS STUDY
To be completed for each care home.
Care Home Identifier...............................................
Date(s) of visit
Building
General atmosphere 
Lighting levels 
Temperature 
Noise levels
Residents
Residents mood (all residents in general)
Staff
Are they welcoming to you
Do they socialize with residents
Training on drug administration
Sufficient staff to cover all tasks at busy times
Sense of team working
Time pressures
Management and staff communication
General Documentation comments
Care home records are:-
Clear and easy to read for each resident 
Kept up to date 
Have blank spaces
Is there sufficient continuity and follow up of issues
General MAR chart comments
Many discontinued lines
Clear or cluttered with many hand written changes
Who makes handwritten changes
Blank admin boxes (for meds meant to be given)
Non-Administration codes used
Is dosage/purpose for ‘when required’ medicines given
Observation of drug round comments
Which round observed 
How is round organized 
Are there interruptions 
When is MAR chart referred to
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When is MAR chart signed 
Is it Chaotic and busy, or calm 
Is the trolley cluttered or tidy 
Sufficient space for drugs/MAR etc
Which round observed 
How is round organized 
Are there interruptions 
When is MAR chart referred to 
When is MAR chart signed 
Is it Chaotic and busy, or calm 
Is the trolley cluttered or tidy 
Sufficient space for drugs/MAR etc
Communication with additional prescribers
How do specialists communicate changes 
Do they handwrite changes on MAR 
Are the changes clear
How do they communicate with the G P/Staff
Computer hardware/software
Internet access 
Office IT facilities 
Links with Pharmacy 
Links with GP
Other comments (e.g. Using other residents drugs, drugs in wrong place in MDS 
tray explore why who put them there?, allergy discrepancies in documentation. Any 
other observations o f interest!)
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Appendix 36: Medication administration data coiiection 
form
Medication administration 
Data collection form for CHÜMs study
Dale: Observer: Care home identifier
Time of day; Day of week: Page _  o f__
Time Case
fdenfifier
Drug details MDS
Y/N
OE? MAE
9
Signed?
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Appendix 37: Medication review report for GPs
Care Home Use of Medicines Study, University of Surrey
Name of patient DOB Date of GP Home
review
have reviewed the above patient’s medication and the following issues were raised: 
Drug-related problems:
Suggested changes/monitoring:
Yours sincerely,
Rosemary Lim
Research Medication Review Pharmacist
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Appendix 38: Care home staff consent form
Hinchingbrooke Health CareftV«jt>i
NHS Trust
University REC Project Reference Number: 05/Q 1202/57
of Surrey Centre number: 02
Participant Identification Code:
CARE HOME STAFF CONSENT FORM
Title of Project: Care Home Use of Medicines Study (CHUMS)
Name of Researcher: Professor Nicholas Barber,
School of Pharmacy London University
Please initial box
1. I confirm that I have read and understand the information sheet dated..............
(version............... ) for the above study and have had the opportunity to ask
questions.
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected.
3. I understand that I may be observed during a medication round. I give 
permission for responsible individuals from University of Leeds Pharmacy 
Practice and Medicines Management Group, the School of Pharmacy London 
University and Robens Centre for Health Ergonomics Surrey University to observe 
me at work where it is relevant to this research.
4. I agree to take part in the above study
Name of Participant Date Signature
Name of Witness Date Signature
Researcher Date Signature
1 copy for participant, 1 copy for researcher
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Appendix 39: Database check
1) Go into the back of the database by entering the password and hold down the shift 
key before you press enter.
2) Print out a patient id/CHUMS ID reference table.
Go into “T-PtReview” by double clicking on it.
This table gives you the review fields but most importantly it gives the “Ptid” which is 
the Patietnt ID number (within the database) and it’s corresponding CHUMS ID 
number. The Patient ID (PtId) is used in all the tables in the database so it is important 
you can cross reference it to your CHUMS ID number for when you need to add 
missing information to the database from your CHUMS files.
You only need to print the first six columns of this table (see below), so you need to 
HIDE the rest, do this by moving mouse to top of each column you want to hide in turn 
and left clicking (this highlights the column). Then RIGHT click and choose HIDE 
COLUMN.
Print out the FIRST SIX COLUMNS ONLY.
Ptid Area code PCT code Home
Code
Pt Code Pt Initials
1 01 02 34 AA KP
3) ONCE you have this table then you need to look at all the following tables to check 
for blank entries. You will need to constantly be referring to this printed list in order to 
locate the patient in your database and make the changes. You can make changes 
directly into the tables at the back of the database and this is obviously much quicker.
NB when you come to close the window it will ask you if you want to “save changes to 
the design of the table?” Just click NO and no data will be lost.
4) GO INTO THE FOLLOWING TABLES
It is much easier to look at the patients in “Ptid” number order so if you highlight this 
column and then rightclick and select “Sort ascending” it will sort in Ptid number so 
this is easier to work with.
• T-PtReview
Check for blank spaces and go back to your data collection folders to fill in the blanks. 
I quite often missed out a Date of data collection or weight/height entry.
• T-PtAllergies
Check that all columns are completed; delete any blank rows which may have been 
entered by accident. Check that you fill in the “where documented” columns.
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If the Allergy was printed by the chemist on the MAR chart then I have assumed it /s 
on the PMR but if it was handwritten on the MAR then I have assumed it is NOT in the 
PMR.
• T-PtMedicationMain
Check for blank entries especially in the “agrees with the Previous MAR”, “agrees with 
GP computer records” and “agrees with Other GP clinical records” columns. I quite 
often found blanks here and had to go back and check the repeat lists in my data 
collection folders.
• T-PtDataSources
Again go through and delete any blank lines and check you have completed all the 
columns. I have put “not available” in the Pharmacy column as I did not look in any 
chemists records.
Quite often I found I had missed out completing the “Not-available” column.
• T-PtErrors table
I spent a lot of time in this table
Error ID is the error number in this error table and does not bear any other 
significance.
The easiest way to check these are to do prescribing, monitoring, dispensing, 
administration separately. You can do this as follows
In the “type of error” column.
Move cursor to the type of error you wish to focus on e.g. Prescribing and then Right 
click then select “filter by selection”. This will pull out all the prescribing errors.
I then found it a good idea to order the Ptid column ascending in numerical order.
You can then check for blank lines or rogue entries. Quite often I had filled in details 
for a prescribing error but had accidentally classed it as a administration error so these 
anomalies are easily corrected here.
You can see full blank lines where you may have accidentally started to enter an error 
and then changed your mind these whole lines can be deleted.
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Appendix 40: GP interview template
Topic guide for CHUMS GPs: Four main questions 
INTRODUCE SELF and REMIND THEM ABOUT PROJECT
The Care Home Use of Medicines Study - CHUMS -  is a DoH-commissioned project
running in approx 70 homes in 3 areas -London, Leeds and Cambridge......................
our research pharmacist, completed medication reviews for 5 residents at 
......................... . several months ago.
I have been asked to carry out follow-up interviews with GPs, to try and fill some basic 
gaps in our understanding of how things work.
This is research data so can I tape our conversation so I can get what you say exactly 
right?
It will not be possible to identify individuals in our final report.
The identity of all homes and people will remain strictly confidential.
1) Clear homes are a lot of extra work.
Our first basic question concerns how the extra workload of care home 
residents in the PCT is distributed between practices
Your practice covers............................................... .........
-do you look after all residents in those two homes?
Were they on your list already, or did the PCT allocate them to you?
What if a new resident is admitted who was not on your list before?
How much choice do you have- can you say “no”?
2) How does your practice share/manage the work?
Background preparation:
How often does this doctor visit the home?
How many other doctors are there in the practice?
What do you know about other staff?
Explore use of following:
-use a rota?
-use a salaried GP?
-use nurses?
-get support from PCT?
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What about the routine repeat prescriptions- so many every month 
Who deals with them?
3) Which aspects of care home work give you the most work or problems?
Background preparation:
What type of home is it?
Staff levels and training
Explore areas relevant to errors identified in review.
ADD to this list as necessary!
-Instructions to home staff (prn meds laxatives, GTN, analgesics)
-Hospital visits or discharges 
Discharge info 
Meds changes 
Generic prescribing
-Monitoring for disease registers- QoF 
BP
Diabetes Hb1Ac
-Monitoring for specific drugs
Lithium, amiodarone. Diuretics -Us and Es
Insulin- who gives it?
-Repeat medicines svstem
Infrequently prescribed medicines (B12)
Acutes: getting interims or prn meds into computer 
Changes
4) In an ideal world, what would you MOST like to change?
-explore repeat med system 
-links with pharmacy 
-relationship with home
THANKS
Reassure on confidentiality 
CLOSE
END TIME:
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Appendix 41: Community pharmacist interview tempiate
INTRODUCE SELF and REMIND THEM ABOUT PROJECT
The Care Home Use of Medicines Study - CHUMS -  is a DoH-commissioned project
running in approx 70 homes in 3 areas -London, Leeds and Cambridge...................... ,
our research pharmacist conducted research in a care home that received dispensing 
services from your pharmacy.
I have been asked to carry out follow-up interviews with pharmacists, to try and fill 
some basic gaps in our understanding of how things work.
This is research data so can 1 tape our conversation so I can get what you say exactly 
right?
It will not be possible to identify individuals in our final report.
The identity of all homes and people will remain strictly confidential.
Background
■ Can you tell me a bit about your background? How long have you worked in this 
pharmacy?
■ How many care homes do you supply? How many patients in total do you have for 
the care homes?
■ The level of service provided? Collect or delivery the medicines?
Dispensing procedure
■ Do care homes use an MDS system? Do you provide the same type of MDS?
■ Who orders the prescriptions for the care homes?
■ Do you dispense all types of medications for the care homes who also receive 
dispensing services from dispensing GPs?
■ How far in advance do you dispense medications for care homes?
■ Designated staff responsible for contacting same care home? All the time?
■ Do you have routine visits to care homes to sort out medication issues?
Explore relationship with the GP
Communicate with GPs? Informed about change in medication?
End questions
In an ideal world, what would you MOST like to change?
-explore repeat med system 
-links with pharmacy 
-relationship with home
Would you like to add any additional points or stress anything in particular?
THANKS. Reassure on confidentiality 
CLOSE
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Appendix 42: Care home staff interview template
INTRODUCE SELF and REMIND THEM ABOUT PROJECT
The Care Home Use of Medicines Study - CHUMS -  is a DoH-commissioned project 
running in approx 70 homes in 3 areas -London, Leeds and Cambridge. The aim of 
the research is to understand the medication system, identify the weak areas in the 
system and develop strategies to improve medication safety.
The aim of this interview is to try and fill some basic gaps in our understanding of how 
things work.
This is research data so can I tape our conversation so I can get what you say exactly 
right?
It will not be possible to identify individuals in our final report.
The identity of all homes and people will remain strictly confidential.
Background
Can you tell me a bit about your background? What sort of training in medicines have 
you had?
How long have you worked in this care home?
What does your current job involve?
What is your general feeling about medicines in this setting?
Medication round and the case
Explore the environment during the medication round 
Usual drug round? Interruptions? Other duties?
Any difficulties during the drug round?
Explore the case -  familiar with drug? why was it administered a particular way? Or 
not administered? Knowledge about correct technique, warning instructions?
End questions
In an ideal world, what would you MOST like to change?
-explore repeat med system 
-links with pharmacy 
-relationship with home
Would you like to add any additional points or stress anything in particular?
THANKS. Reassure on confidentiality 
CLOSE
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Appendix 43: Hospital pharmacists Interview schedule
Introduction to the study and aim of the interview.
Indicate that the interview may take up to 45 minutes, notes will be written during the 
interview.
A. Admission
■ Where are patients admitted from? (home/GP surgery/treatment centre/A&E/MAU)
■ Can you describe what happens when a patient is admitted to the hospital?
Probe: Who takes the patient’s medical history when first admitted to the hospital? 
When? What are the sources of information? Where is it recorded?
Are the records accessible for everyone who needs it?
Are there separate records e.g. doctors, nurses and pharmacists?
How are they different from each other?
Where are they kept?
Who can access them?
Why are there different records?
Probe: Do patients normally bring in their current medicines?
Probe: What happens to the medicines that patients bring in?
If it is an MDS, what happens to the supply of medicines?
Probe: What happens if the patient did not bring their current medicines to the 
hospital?
B. Stay in hospital
■ Can you describe what happens to the management of the patient’s medicines 
when a patient is in a hospital ward?
Probe: What happens when a healthcare professional intends to initiate a change to 
the patient’s medicines management?
Is it recorded? If so, who, where and what is documented Are the intended changes 
followed through and evaluated?
How is this done? How do the nurses/pharmacists know of this change?
When do they know of this change?
Changing wards within the same hospital
■ What happens when a patient changes wards?
Probe: What preparation is made prior to the change? Who does it?
Probe: What does the patient brings to the new ward?
Probe: Is there a handover process? Who does it? How is it done?
Probe: Are the healthcare professionals involved in the care of the patient aware of 
this change? How do they know? When?
Probe: How often do patients change wards?
■ Does every ward in your hospital function in the same way?
Probe: How is it different in terms of documentation, communication?
Transferring to another hospital
■ What happens before a patient is transferred to a different hospital?
Probe: What preparation is made prior to the change? Who does it?
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Probe: What does the patient brings to the new hospital?
Probe: Is there a handover process? Who does it? How is it done?
Probe: Are the healthcare professionals involved in the care of the patient aware of 
this change? How do they know? When?
Probe: How often do patients change hospitals?
■ Is there any communication with the hospital that the patient has been transferred? 
Probe: Feedback that patient has arrived, documents received, etc.
■ Are you always aware of how the other hospital documents information?
C. Discharge
■ Can you describe what happens when a patient is to be discharged?
Probe: Who decides whether a patient is ready to be discharged? (consultants, 
nurses, multidisciplinary team?)
Probe: When do you know about the discharge date/time?
Probe: What happens when a discharge date is arranged?
Probe: What arrangements are made before a patient is discharged? (If a patient is to 
be discharged to their own homes, care homes (including new admissions). Discharge 
summaries, liaison with family/relatives/GP/care homes, etc.
Discharge letters/summaries
■ Who writes the discharge letters? (Which doctors? Why?)
■ Who else is involved in the writing of discharge letters?
■ What is the format of the discharge letters?
■ Who is it sent to? By whom and when? Feedback that discharge letter has been 
received?
■ Is every discharge letter clinically checked by a pharmacist?
D. Post-discharge
■ Can you describe what happens when a patient is discharged from hospital?
Probe: What happens in the hospital -  notes, drug charts, letters etc.?
Probe: What happens in the care home?
Probe: Does the care home receive a discharge letter?
Probe: Are there special information for care home staff?
Probe: What happens to the medicines that the resident was discharged with?
Probe: What happens to the old medicines? MDS?
Probe: What happens to the new medicines? MDS?
Probe: Who knows about the changes to the resident’s medicines? (supplying 
pharmacy, who tells them, when, how? Contact points?)
End questions
Would you like to add other additional points or stress anything in particular about 
issues talked about in this interview?
Thank you very much for your time and being willing to talk to me.
378
Appendix 44: Excerpt from care home information leaflet
This document is intended for prospective residents and their relatives.
* Names were omitted to maintain confidentiality*
Friendship and a ‘home from home' atmosphere...with respect and dignity, privacy 
and independence within a caring environment.
A home with traditional family atmosphere set in six acres of tranquil 
surroundings 
Bedrooms decorated to please
Meals may also be taken in the privacy of clients’ own accommodation.
Clients encouraged to make use of courtyard which is secluded, well-stocked with 
plants and flowers, a rockery and a pond with a fountain and goldfish.
Food freshly cooked each day. A daily well balanced and nutritious menu ensures 
clients maintain a sense of enjoyment while dining.
Statement of Principle
“....the locality of ^geographical areas* and the surrounding districts, is in need of 
quality care for the elderly -  the community demands it and we aim to provide. We 
believe that *name of care home* is well suited to provide this quality of care with its 
history, charm and character together with its vast expanse of land around the 
Home...
...the emphasis in every case is always on people -  comfort and care of the clients in 
harmony with professional and trained staff twenty four house of the day and 
throughout the year....”
Safety -  Nurse Call System is provided in all the personal accommodation areas; this 
is further supplemented with Fire and Smoke Detectors and our own power generator 
in case of electricity failures. The *name of care home* personal transport is always at 
hand in case of emergencies.
Families and visitors are made welcome at all times and specific requests always 
favourably considered.
Special needs are discussed with clients and their families -  be it personal, social, 
hygiene, dietary or health. Every effort is made to provide for these.
Health -  the local *name of hospital* is virtually next door and the Doctors’ surgery is 
but a few minutes away. Doctors, District Nurses, Chiropodists, hairdressers and 
other health and beauty professionals provide for all of the clients’ health and beauty 
needs.
Activities numerous in-house and out-door activities including social outings are 
planned throughout the year.
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Appendix 45: Excerpt from care home introduction
document
This document was intended for prospective residents and their relatives.
* Names were omitted to maintain confidentiality*
Our pledge
We at *name of care home* are committed to ensuring that those who live in the 
Home will do so with dignity, that they will have the respect of those who care and 
support them, that they will live with no reduction of their rights as citizens and that 
they will be entitled to as full and active life as their physical and mental condition will 
allow.
Irrespective of mental and or physical disability, residents will have a fundamental right 
to self determination and individuality. Equally they will have a right to live in a 
manner and in circumstances which corresponds, as near as possible, with how they 
had lived prior to admission to the Home. This will allow for an individual to maintain 
their culture, traditions and lifestyle.
Statement of aims and objectives
Our aim is to provide a residential nursing environment, which offers people the 
opportunity to enhance their quality of life, by providing a safe, manageable and 
comfortable environment, plus support and stimulation to help them to maximize their 
potential physical, intellectual, emotional and social capacity.
We aim to provide a holistic approach to care, taking into consideration the physical, 
social, spiritual and emotional needs of our residents thus providing a multidisciplinary 
team approach to our care.
We aim to provide privacy and ensure dignity and freedom from pain for those whose 
lives are coming to an end and offer support and help to their loved ones.
The assumption underlying care decisions is that Residents are capable of making 
choices about their own lifestyle until there is clear evidence that this assumption is 
not valid.
The care we give is based on evidence-based practice.
Aims and Objectives
It is the objective of *name of care home* to provide care to all Service Users to a 
standard of excellence which embraces fundamental principles of good care practice, 
and that this may be witnessed and evaluated through the practice, conduct and 
control of quality care in the Home. It is the fundamental ethos that those Service 
Users who live in the Home should be able to do so in accordance with the Home’s 
Statement of Values.
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It is the object of the Home that all Service Users shall live in a clean and safe 
environment and be treated with respect and sensitivity to their individual needs and 
abilities. Staff will be responsive to the individual needs of Service Users and will 
provide the appropriate degree of care to assure the highest possible quality of life 
within the Home.
To meet the clients’ needs the care services within the Home is designed to achieve 
the following objectives:
• To deliver a service of the highest quality that will improve and sustain the Service 
User’s overall quality of life. In this respect the care service is designed to meet 
the requirements of a recognized accredited quality standard e.g. Blue Cross Mark 
of Excellence, but in a people oriented fashion.
• To ensure that the care service is delivered flexibly, attentively, and in a non- 
discriminatory fashion while respecting each Service User’s right to independence, 
privacy, dignity, fulfilment and the rights to make informed choices and to take 
risks.
• To ensure that each Service User’s needs and values are respected in matters of 
religion, culture, race or ethnic origin, sexuality and sexual orientation, political 
affiliation, marital status, parenthood and disabilities or impairments.
« To ensure that the care service in whole is delivered in accordance with agreed 
contracts of care.
• To manage and implement a formal programme of staff planning, selection, 
recruitment, training and personal development to enable Service User care needs 
to be met.
• To manage the care service efficiently and effectively to^  make the best use of 
resources and to maximize value for money for the Service User.
• To ensure all Service Users receive written information on the Home’s procedure 
for handling complaints, comments and compliments and how to use it.
June 2006
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Appendix 46: Excerpt from staff policy and procedure 
manual
* Names were omitted to maintain confidentiality*
Policy on the Control and Administration of Medications
Medications at *name of care home* are administered to residents by qualified staff, 
unless the resident chooses, and is assessed as safe to do so, to administer their own 
medications.
All qualified nurses commencing employment, observe and are observed 
administering the medicines by Manager until they are assessed as competent to 
‘Administer Medications within the Home”. They are reminded of their professional 
accountability, and expected to read and follow the NMC guidelines on administration 
of medicines
New residents
On admission resident's medications are counted and recorded on their MAR charts. 
Unless they are going to self medicate, the medicines are locked away in the drug 
cupboard or drug trolley, situated in the nurse’s office. If the resident needs to change 
General Practitioners, they are registered immediately, to enable repeat medicines to 
be ordered.
Self medicating
If a resident wishes to self medicate, and is assessed as safe to do so, all their 
medicines are counted and recorded on their MAR chart, and the resident is provided 
with a lockable drawer in which to keep their medicines. To enable staff to monitor 
self-medication, all surplus medications are kept locked in the medicine cupboard until 
required, all surplus medications are kept locked in the medicine cupboard until 
required, and recorded on the MAR chart when handed to the resident.
Supply of medicines
Residents medicines are obtained from their appropriate doctors surgeries. 
Occasionally it may be necessary to collect a prescription from the surgery and get it 
dispensed at a chemist.
1. All medicines received from the surgery/chemist are recorded on the residents 
MAR charts with the date, quantity and signature of the nurse checking them in.
2. All controlled drugs are counted and recorded in the controlled drug register, 
witnessed by a second member of staff, and kept in the controlled drug cupboard.
3. Any drugs prescribed or required after hours are obtained through the General 
Practitioners at *name and telephone number of surgeries* or from the visiting on 
call doctors
4. Repeat medicines are ordered monthly when required from the residents General 
Practitioners Surgery. They are ordered by a qualified nurse, and checked, on 
receipt and signed for on the MAR chart by a different nurse.
5. Transcription from one MAR chart to another or any new prescription is checked 
and counter-signed by two qualified nurses.
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storage
All medicines are stored in the locked medicine cabinet or in the drug trolley, which is 
secured to the wall when not in use.
Separate lockable cupboards are provided for:
■ medicines for internal use
■ medicines for external use
■ controlled drugs
■ medicines requiring cool storage
■ a separate cupboard is used to store dressings
On no account is anything other than medicines to be stored in medicines cupboards 
No medicines should be transferred from one container to another 
To ensure that medicines are stored at a temperature which does not exceed 25C, the 
temperature of the nurses office will be monitored and recorded daily. A wall 
thermometer is situated by the medicine cabinet.
The keys for all cupboards used for storage of medicines must be in the personal 
possession of and be the personal responsibility of the nurse in charge of the shift.
A spare set of keys is kept by the Manager.
Cool storage
The medical refrigerator is kept in the nurse's office and is for medicines only. The 
temperature of the refrigerator should be recorded daily and maintained at between 
three and four degrees centigrade. It should be kept locked. The refrigerator is 
serviced twice a year by the maintenance person.
Storage of medical gases
Oxygen is stored at *name of care home* only when it is prescribed for a resident. 
The spare cylinder is attached by chain to the wall in either the nurses office or in the 
locked shed situated outside the main entrance. Equipment for the oxygen cylinder, 
keys, spare masks etc are stored in the cupboard in the nurses office.
Administration of medicines
The majority of medicines are administered at drug rounds at approx 0800, 1300, 
1800 and 2200, although some medicines are prescribed to be given at other times, 
and this is recorded on the residents MAR chart
Medicines are administered by the nurse in charge, either first or second level, who 
has been assessed as competent to do so. Untrained staff should never give 
medicines.
All medicines are recorded on the MAR chart which includes: 
name and age of resident 
name of medicine 
dosage
route of administration 
the frequency and time of administration 
date of prescribing
any known drug hypersensitivity (in red) 
any special requirements
a photograph of the resident for identification purposes.
Medicines are only to be administered to the resident for whom they are prescribed. 
Under no circumstances must they be used for other residents. When no longer 
required they are to be disposed of.
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When administering medication the procedure should be:
■ read the MAR chart
■ check the dose has not already been given
■ select the medicine required, checking the label against the MAR chart
■ prepare the dose required
■ check the identification of the resident
■ ensure the resident has taken the medication
■ sign the MAR chart as appropriate, together with refusals and omissions 
Controlled drugs are administered by a registered nurse, and witnessed by another 
nurse, or if this is not possibly by a competent carer. This is recorded in the controlled 
drug book, the record to include date, time, amount given, given by (signature), and 
witnessed by (signature), and the stock balance.
Medicines for residents going out for the day or for a longer period are dispensed into 
Medi-Dose dispenses and handed to the resident or their relatives. The number of 
each medicines taken from the premises is recorded on the MAR chart and counter 
signed. Any medicines returned by the resident are disposed of in the appropriate 
way. Medi-Dose containers are kept in the nurse’s office.
Disposal
Medicines dispensed for individual residents are their personal property and should be 
sent with the resident on discharge. If this is inappropriate, then they should be 
destroyed. They must not be used for other residents.
Medicines are to be destroyed:
■ when the expiry date is reached
■ when they are in poor condition
■ when a course of treatment is completed or discontinued
■ when the resident for whom they were prescribed dies. In such cases they
should be held for seven days, in case they are required by the Coroner, but
recorded in the drug disposal book immediately.
Medicines no longer required are returned to the surgery which dispensed them. The 
surgery should sign the drug disposal book. This includes unused ampoules and 
aerosols.
When controlled drugs are returned to the surgery, it is recorded in the controlled drug 
register, including date, drug and quantity returned, and signed and witnessed by two 
qualified nurses. Small quantities of liquid medication can be flushed down the toilet 
by a qualified nurse, witnessed by another nurse, the destruction being recorded and 
the records signed by both nurses concerned.
Revised and updated February 2006.
Policy on care planning and record keeping
All residents will have a pre-admission assessment carried out, incorporating 
information given by themselves, relatives and professionals, eg doctors, nurses, 
social workers, etc.
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On admission, a Manual handling and tissue viability (Modified Waterlow) assessment 
will be carried out and care planned.
Within 7 days of admission, given information and observations made, care plans will 
be implemented.
Each care plan will be evaluated once a month, and when necessary, ensuring that 
any entry made can be identified by the signature of the person performing the task.
Good record keeping promotes
1. High standards and continuity of care
2. Better communication between members of the care team
3. An accurate account of treatment, delivery and care planning
4. The ability to detect problems, such as, changes in residents condition, at an early 
stage
Content
Resident’s records should
1. Be factual, consistent and accurate
2. Not include abbreviations, jargon, meaningless phases, irrelevant speculation, and 
offensive subjective statements
3. Be written clearly, providing evidence of care planned, decisions made and care 
delivered, any problems that have occurred and action taken to rectify them
4. All entries must be accurately dated, timed and signed.
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Appendix 47: Excerpt from care home observations
Staff
Are they welcoming to you: Very welcoming. The care home manager is very friendly
and interested in helping in the research. Another nurse is 
present - she is also very helpful. I met her the last time 
when I came to consent residents. I was fed lunch by the 
care home!!
Do they socialize with residents:
Training on drug administration:
Yes. One carer noted that the ankles of one of the 
residents are swollen. She mentioned it to another 
carer/nurse. Obvious that she was noticing changes 
in resident's health and alerted this to another 
person. Not sure whether there is further follow up 
on this.
Newer nurse was supervised before she started 
administering medicines on her own. She trained 
overseas and had to undergo conversion course 
before registering with the RON. Now qualified 
about a year plus. As I was going to give feedback 
to the care home manager about my observed drug 
round, she mentioned that she supervised the then 
adaptation nurse 6 times (standard) before she 
administered medication independently.
Sufficient staff to cover all tasks at busy times: Seemed to be fine on the day that I
visited. Carers were available to help 
feed residents during lunch time.
Sense of team working: Yes. Referred to others when unsure e.g. noticing that one
of the resident's ankles were swollen.
Time pressures: Seemed fine.
Management and staff communication: Good. There was a sense that staff felt like
they were part of a family. Always lots of 
conversations when staff are around.
Observation of drug round comments
Which round observed: Tea-time. Started 4.45pm till 6.20pm
How is round organized: Started with residents in the dining areas (tea-time), rooms 
downstairs then rooms upstairs. Nurse waited for each 
resident to take their medication before leaving them to 
sign the MAR chart. Some residents needed a lot more 
time than others - she did not complain, rather apologised 
to me(?l?) because I had to observe a long drug round. 
Nurse was meticulous and seemed to enjoy what she was 
doing. She was previously an adaptation nurse and 
qualified slightly more than 1 year ago. Some areas of the 
house had poor lighting - 1 found it difficult to see the MAR 
chart clearly. She often chatted with residents when giving
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out medication. Seemed to refer to the MAR chart more 
than the dispensing labels - trusted accuracy of MAR chart 
more than dispensing label - any changes were marked on 
the MAR chart first before prescription (and thus 
dispensing labels) is altered. She carefully checks 
medication labels for resident's name and expiry date and 
the name of the drug. However, the instructions were not 
normally noted on the dispensing label - referred to MAR 
chart for this. She also checked the expiry date on the 
blister and drug name on blister to check that it was the 
right drug. She forgot to sign chart for 1 resident (not 
recruited resident) - this resident went to the toilet just as 
nurse was giving meds. When the resident came out, the 
nurse gave the meds but forgot to sign the MAR chart. On 
one occasion, nurse took the wrong resident's medication 
but realised soon after - she was very careful in checking 
names.
Are there interruptions: Few.
When is MAR chart referred to: Most of the time before taking medicines out, or
before administering medicines. She was very 
careful and went through each item on the MAR 
chart before administering medicine to residents.
When is MAR chart signed: After residents had taken medicines.
Is it Chaotic and busy, or calm: Calm
Is the trolley cluttered or tidy: Tidy. Each resident had their own compartment for
solid medication. Liquid medicines and inhalers or 
bulky items are placed on the doors of the trolley. 
But there isn't enough space for liquids if resident 
each had their own bottles of lactulose. So 
residents share supply of medicine (lactulose). She 
had to prepare medicines to be adminstered via 
PEG in the clinical room - then took it to resident.
Sufficient space for drugs/MAR etc: Little space on top of the drug trolley to
prepare medicines and place the MAR charts.
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Appendix 48: Excerpt from interview with care home
manager
This is an excerpt of the notes taken in an interview with a care home manager.
Situation 1: A resident is admitted and discharged from hospital
GP visits, if decides to admit a patient because of a fall -  will go straight into A&E. If 
the resident has a medical problem, can by-pass A&E and go straight to MALI.
In *name of hospital*, hospital require all medicines to be brought in as the hospital 
has a POD system. In *name of another hospital*, this is not a requirement. The 
amount of medicines sent with the resident to the hospital are counted and recorded 
on MAR chart. The MAR chart is copied and brought to hospital together with the 
medicines. A brief history of what happened, why Dr was called, previous history, 
activities of living, nursing care notes are sent to the hospital.
When resident is in hospital, does the hospital communicate with the care home?
Care home calls hospital. If the resident is admitted for some time, one of the care 
home staff will visit. Rely on relatives of resident for information. Care home gives 
them more information than hospital gives them.
How do you know when a resident is to be discharged?
The last few times, care home called hospital, then was informed. Care home is not 
always informed. Residents in this care home have high dependency level.
There were a few times when the resident's medicines were not sent together when 
discharged. Medicines were sent by taxi to the home at a later stage.
Whilst I was there (Wednesday), a resident just appeared at the door from the 
hospital. The resident was due to be back on a Monday, however the hospital decided 
to observe the patient for a few more days and did not inform the care home of when 
they've finally decided to discharge the resident from hospital.
Discharge letter -  care home receives the last carbon copy of the discharge letter. Un­
readable. The GP receives a copy and GP's copy contains more information.
Discharge letter comes with resident. Includes PC, what happened in hospital 
Information received on the discharge letter -  if there are changes in treatment, to add 
to the MAR chart/change in care management.
When the resident returns to the care home, what happens to the resident’s 
medicines?
Signed and counted and written on MAR chart -  counter-signed.
Discharge letter doesn't always say what's stopped. Go by what's in the discharge 
letter.
(MAR charts are handwritten by the care home manager, who is also a nurse, not by 
the dispensing GP surgery)
Is there anything else that you would like to add?
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It works, never going to be perfect. Medicines don’t come with patients after discharge 
-  slip in the hospital ward, or not ready in pharmacy.
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Appendix 49: Prompts and keywords to conduct a WDA
Work system: care home medication system 
Functional purposes
Primary Objectives: Reasons that a work system exists
1. If you were to sum up the overall purpose of your role in one sentence, what 
would that be?
2. For what reasons does the care home medication system exist?
3. What has the care home medication system been designed to achieve?
4. What are the highest level objectives or ultimate purposes of the care home 
medication system?
5. What services does the care home medication system provide to the 
society/environment?
6. What needs of the society/environment does the care home medication system 
satisfy?
7. What role does the work system play in the environment?
Secondary Objectives: Values of people within the work system
8. What are the values of the people in the work system?
Keywords: Reasons, goals, objectives, aims, intentions, mission, ambitions, plans, 
services, products, roles, targets, aspirations, desires, motives, values, beliefs, views, 
rationale philosophy, policies, norms, conventions, attitudes, customs, ethics, morals, 
principles
External constraints: Values of the environment of society
1. What kinds of constraints does the environment impose on the work system?
2. What values does the environment impose on the work system?
3. What laws and regulations does the environment impose on the work system?
4. What societal conventions and norms does the environment impose on the work 
system?
Keywords: Laws, regulations, guidance, standards, directives, requirements, rules, 
limits, public opinion, policies, values, beliefs, views, rationale, philosophy, policies, 
norms, conventions, attitudes, customs, ethics, morals, principles.
Values and prioritv measures
1. What aspects of your environment are you trying to maximize and minimize?
2. What are your priorities in order to achieve the ultimate goals?
Purpose related function
1. What functions need to be performed to achieve the ultimate goals?
2. What is the goal of doing that?
Object-related processes
1. What does that piece of equipment or physical object do?
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2. What function does it carry out?
Physical objects
1. What equipments do you use in order to perform the tasks mentioned previously?
2. What physical objects are you using at this stage?
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Appendix 50: Evolution of tools used to represent the AH
Representing the AH graphically was a continual challenge when conducting the 
WDA. Several tools were used. The earliest tool used was very useful for organising 
work domain properties and organising them into categories albeit a primitive one. 
This involved using post-it notes. Complex analyses rendered this tool inefficient and 
NVivo7 was used for the purposes of analysing data sources and for representing the 
AH. However, NVivo7 was also unable to represent the increasingly complex AH 
model. Two other software tools were then utilised. Microsoft PowerPoint and 
Microsoft Visio were used to represent the AH. Both software were useful when 
representing the AH at the higher levels. Conducting the WDA was highly iterative 
and both Microsoft PowerPoint and Visio were unable to adapt to the frequent 
changes to the AH. The increasingly complex AH was also not readily accommodated 
by both software tools. Representing the AH using Microsoft Visio was easier 
because of readily available shapes to use. Finally, the CWA tool was used. This tool 
was developed by a team of researchers from Brunei University and Cranfield 
University. Although the CWA tool is still in its development stages, it was found to be 
useful for representing the AH. The dynamic nature of the tool passes any changes in 
the analysis through to the rest of the analysis. The complex AH was also easily 
accommodated by the tool. There are however some outstanding issues for example 
the need to edit the AH exported from the CWA tool such as the need to do so for this 
thesis. The following provide examples of AH developed using the tools described 
above.
1. Post-it notes
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2. NVivo7
There was great difficulty representing the AH using NVivo7 so an example of an AH 
was unavailable.
3. Microsoft Powerpoint
WDA: Care Home Medication System (4)
Functional
Purposes
Values
and
Priority
Measures
Purpose-
related
functions
related
Physical
Objects
Healthcare
Provision
Requirements of Laws, Guidelines, 
Policies and Procedures, 
and Social Values
Maximise Use of 
Resources
Maximise quality 
of healthcare provision
Ensure
safety
Clinical Observation Medical Consultation Co-ordination Medication Supply | Medication
Administration
Medication Disposal
1 Communication | Medication Storage Checking 1 Healthcare Service Providers | I Documentation | Medication Delivery 
Systems
Care
Assistants
Admissions Book
Other 
H/Care Prof
Nurses
Care Records
Dispensing Label
Nurses’ Diary
Discharge/
Transfer
Letter
Prescription
MAR Chart
Homely
Remedy
Book
Controlled
Drug
Register
Drug Disposal 
Book
Repeat
Medication
List
Controlled
Drugs
Cupboard
Locked
Drug
Cupboard
Drug
Trolley
Medical
Refrigerator
Nurses’ Office/ 
Locked Shed
Medicine Container
4. Microsoft Visio
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Work Domain Analysis of the Care Home Medication System
Functional
Purposes
Healthcare
Provision
Requirements of Laws, 
Guidelines, Policies and 
Procedures, and Social Values
-
Values and 
Priority 
Measures
Maximise Use of 
Resources
Maximise quality of I Ensure Safety 
healthcare provision 1 -^-----
Purpose-
reated
Functions
Medication Supply MedicationAdministration
Medication
Disposal
Clinical
Observation
Medical
Consultation
Object-related
Medication
Storage
Documentation Communication Checking | Healthcare
Service
Providers
Medication
Delivery
Systems
Physical
Objects
Medical
Refrigerator Cupboard
Controlled
Drug
Cupboard
Dispensing Nurses'
Records
Nurses' Office/ 
Locked Shed
Medicine
Container
I Controlled 
I Drug Admissions
Homely
Remedy Medication
Discharge/
Transfer
Assistants
Healthcare
Professionals
5. CWA tool
Please refer to Chapter 6 of the thesis for the AH produced.
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Appendix 51: Interview guide -  third iteration of AH with 
care home domain experts
It is anticipated that the approach taken to conduct this part of the research will differ 
slightly (the language and style) with the different participants.
Introduction
I conducted a study to model the care home medication system. I have now produced 
a model called the Abstraction Hierarchy (AH) and would like your input as to whether 
this model adequately and accurately represents the care home medication system. 
First, I'll briefly explain what an AH is, then I’ll run through what we will be doing 
together to validate this AH.
Do you mind if I audiotape the session so I don’t have to write everything down? This 
is confidential and will only be used to check that I’ve noted all the points that we 
discussed.
Explain the AH
The AH is a representation of the work area of the care home medication system. It 
shows the ‘where’ of the system independent of any task, event, worker, goal or 
interface.
Let me show you the AH of the care home medication system that I have developed. 
There are 5 levels in this AH.
The first level is called functional purposes and represents the reasons why a system 
exists.
The second level is called values and priority measures and represents the criteria 
that measures how well the whole system is moving towards fulfilling the functional 
purposes of the work system.
The third level is called purpose-related functions. This level represents the tasks that 
need to be done in the work system in order to meet the functional purposes of the 
system.
The fourth level is called object-related functions and represents the capabilities and 
limitations of the physical objects that are available in the work system.
The fifth and final level is called physical objects and represents the physical objects 
available in the work system and can include tools and equipment, personnel 
categories, work infrastructure.
We can see that these levels are connected with lines which are called means-ends 
links. Means-ends links show how one level is linked to another.
Taking an example, looking at a category at the purpose-related function level, the link 
above explains why a category exists. Looking at the level below explains how a 
category can be performed.
Explain using different examples if needed.
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What I’d like your input today is firstly to check that the AH produced had included 
all the categories in the care home medication system. We will do this by going 
through each level in turn. I will ask several questions at each level.
Then we will check the means-ends links between the different levels of the AH.
Let’s start with the first level of the AH -  functional purposes.
The functional purposes of the work system are the reason why the work system 
exists.
In this AH, the functional purpose of the care home medication system identified is 
healthcare provision.
-what about “making profit”?
Do you think this is the reason the care home medication system exists? Are there 
any other purposes that you can think of?
The work system is also constrained (controlled, guarded?) by external values for 
example laws and regulations or values.
The care home medication system is externally constrained by the requirements of
laws and regulations, guidelines, policies and procedures.
Are there any other constraints that you can think of?
(I anticipate that it will be very unlikely to ask all the questions listed below. It is
provided here as a guide.)
The next section is taken from Appendix F: Prompts and Keywords to conduct a WDA.
Now, we’ve gone through all the categories at each level. Are there any other 
categories that you think we should include?
Now we will check the means ends links between the levels.
I’ve marked the lines with colours to make it clearer.
We will look at each level in turn once again and I will ask the questions ‘why’ and 
‘how’ to the levels above and below.
In order to fulfil the functional purposes of the care home medication system, the 
system needs to maximise the use of resources available in the care home, maximise 
the quality of healthcare provision and maximise safety.
Carry on with the other levels asking the questions why and how.
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We’ve gone through all the links between these categories. Are there any links that we 
have missed out?
Let’s have a view of the whole care home medication system.
Do you think this is a complete and accurate model of the care home medication 
system?
Thank you so much for your time.
Additional questions asked during the reviewing process:
■ Was the AH difficult to understand?
■ Do you think that the AH is generalisable to other care home settings?
■ Can you think of any further applications of the AH?
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Appendix 52: Final glossary of WDPs in the AH of the care 
home medication system 
Glossary
Administer medication -  involves ordering medication, dispensing, evaluating the 
medication and its effect on patient, give medication to patient and documenting the 
actions. This includes self-administration of medication by residents and carers 
prompting residents to take medication.
Admissions information -  document containing all types of information about a care 
home resident when first admitted including medication, allergies, medical condition, 
social care needs, family history, social history, etc.
Care home nurse -  nurse that works in a care home.
Care records -  records different aspects of care for the care home resident and may 
include daily log of care (daily care notes), sleep, bowel activity, care plans, weight, 
pressure sores, food and fluid intake, blood glucose levels, nursing care notes, GP 
communication book, other healthcare professional communication book. These 
records may also be called nursing notes, client profile depending on the care home.
Carer -  a trained person who helps residents with their personal care. Some carers 
who have had medicines training can administer medication.
Check stock supply of medication -  to ask and be informed verbally about the 
quantities of medication, to deduce from written information available and/or to 
physically examine the amount of medication available.
Clinical/treatment room -  preparation room for medication administration and storage 
area for medication, medical appliances, equipments for medication administration, 
medication files and documents are stored
Clinical waste bin -  yellow-marked bin used to discard clinical waste like used gloves.
Communicate -  to convey, impart, give or exchange information by writing or speaking
Community pharmacist -  healthcare professional that clinically assesses the 
appropriateness of prescribed medication, dispenses medication, conducts medication 
reviews and sometimes initiate and/or order medication.
Community pharmacy staff -  refers to dispensers or pharmacy assistants who deals 
with care home medication issues, dispenses medication and the pharmacy driver 
who delivers medication.
Community pharmacy records -  record of medication dispensed from the pharmacy. 
These records may include information about the patients’ preferences in using 
medication and any medication management issues.
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Controlled Drugs -  specific classes of medication requiring additional control in 
requisition and storage according to the Misuse of Drug Act 1971 and The Misuse of 
Drug Regulations 2001
Controlled Drug Cupboard -  a locked cupboard that stores Controlled Drugs
Controlled Drug Register -  a register that is required by law to record the receipt and 
supply of Controlled Drugs
Denaturing kit -  a kit used to dispose medication, usually controlled drugs
Diagnose medical condition -  identify the nature of a health problem by examining the 
signs and symptoms, interviewing patients, consulting other healthcare professionals, 
monitoring conditions and reviewing medical records
Discharge letter -  a formal letter describing the presenting complaint, investigations 
done, treatment given and any further actions to be taken when patient is discharged
Dispense medication -  prepare and distribute medication by community pharmacist or 
dispensing GPs. Also includes secondary dispensing where carers or care home 
nurses re-dispense medication into a different container for residents to take with them 
when they’re not in the care home during medication administration rounds such as 
when residents spend time in day centres during the day.
Dispensing label -  label that is usually printed containing administration instructions 
given by the prescriber and warning information about how to give the medication
Dispose medication -  discard medications that are
1. Not required e.g. medication had been stopped, resident death
2. Expired/deteriorated
3. Not suitable for use e.g. damaged when handling
District nurse -  nurse that is based outside the care home but travels to the care home 
to provide specific types of services for example administer insulin, change dressings
Drug disposal book -  book that records the quantity and name of drugs disposed
Drug trolley -  a moveable and lockable trolley that is usually quite large and heavy. 
The drug trolley stores medication in the main body compartment and the in the trolley 
doors.
Friend -  refers to the friends of the care home resident
General Practitioner (GP) -  usually diagnoses, prescribes treatment and monitors the 
health status of the care home resident. The GP is responsible for the healthcare of 
the care home resident.
Give medication -  act of transferring medication to another person
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GP medical records -  medical records that are stored at the GP surgery. These 
records include consultation notes, treatment prescribed, laboratory results and 
relevant social and family history.
GP surgery staff -  usually refer to prescription staff who deals with the prescription 
requests
Handover book -  a book that records issues that need to be passed on to care staff in 
the next working shift
Homely remedy -  a list of simple remedies for example paracetamol, simple linctus, 
senna that are used for very short periods of time for treatment of very minor ailments. 
The list of medications are approved and signed by the GP.
Homely remedy book -  book that records the name, quantity and reason for giving a 
‘homely remedy' to care home residents
Hospital medical records -  medical records that are stored in the hospital. Hospital 
records include consultation notes, treatment prescribed and given, laboratory results, 
and any relevant social and family history
Hospital s ta ff-these  include doctors at all levels and specialties, nurses, pharmacists, 
physiotherapists, occupational therapists, social workers
Laboratory reports -  results from blood tests. X-rays, microbiology
Locked drug cupboard -  locked cupboard that stores prescribed medication
Medical references -  this includes the British National Formulary (BNF), medical 
dictionaries, any medical references books or materials
Medical refrigerator -  a designated refrigerator for storing medication
Medication -  this includes solid, liquid medication for external and internal use, 
oxygen, medication packed in monitored dosage systems (MDS), medication to be fed 
through PEG, suppositories, pessaries, eye drops, injections, devices like spacers, 
appliances like dressings.
Medication Administration Record (MAR) -  a record of all medication administered by 
care home staff, including reasons for non-administration
Medication ordering book -  a list of medication ordered and received
Medication profile -  a list of all the medication that residents are prescribed, including 
those not administered by care home staff. There may be some medication that are 
administered by district nurses, specialist nurses or other healthcare professionals.
Medication review -  refers to the systematic approach to reviewing patients' 
medicines at specified intervals, to ensure clinical and cost effectiveness usually 
covering clinical, compliance, access to medication and day-to-day medication
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management issues. Each medication is reviewed in terms of continued 
appropriateness, safety, clinical effectiveness and cost effectiveness in line with the 
patient's current medical and pharmaceutical needs.
Medicine container -  a pill pot used to store medication when it is being prepared 
before it is given to the care home resident
Monitor health status -  involves a person monitoring different aspects of the resident's 
health. A holistic view of health that may include the physical (direct observation of 
the resident), biochemical properties (from blood tests), emotional, mental and 
possibly spiritual aspects.
Monitored Dosage System (MDS) -  a dispensing system that organises medication 
into specific times of day. There are many types of MDS varying on the number of 
days medication is supplied for, multi-dose (more than one medication packed in the 
same compartment e.g. all morning medication) or single dose (only one medication 
packed in one compartment) dispensing.
Nurses’ Diary -  a diary that is used by nurses to communicate information about care 
home residents and tasks that need to be completed
Nurses’ office/locked shed -  a storage area for oxygen
Order medication -  request for prescription to obtain supply of medication. This does 
not refer to the procurement of medication by the community pharmacy or dispensing 
GP.
Other care home staff/visitors -  this includes staff that do not provide direct care to 
residents such as the cooks, gardener, maintenance staff, cleaners, laundry staff. 
Visitors to the care home may include entertainers, chaplains
Other healthcare professionals -  this category includes speech and language 
therapists, dieticians, nutritionists, physiotherapists, consultant psychiatrists, 
occupational therapist, dentists, podiatrists, clinical psychologists.
Other healthcare professional medical records -  medical records documented by 
various healthcare professionals that may include consultation notes, treatment 
prescribed and administered
PEG (percutaneous endoscopic gastrostomy) -  a method of feeding for those who are 
unable to consume sufficient calories orally
Prescribe'treatment -  advise and authorise the use of (a medicine or treatment), 
especially in writing. Treatment refers not only to the use of conventional medicine 
and may include the use of other forms of therapy.
Prescription -  a written order for medications by authorised prescribers such as 
general practitioners, trained nurses and trained pharmacists
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Quality of healthcare provision -  includes quality assurances, staff training, relating to 
service provision considering residents’ healthcare needs and quality of life.
Record-keeping -  documenting flow of drugs, actions, decisions, flow of people, 
instructions, information
Relative -  this refers to the relative of the care home resident
Repeat medication list -  this is a list of all regular medications prescribed by the GP.
Resources -  refer to personnel (people/expertise), physical equipment and finance.
Sharpsbin -  yellow-marked bin used to discard sharps like needles
Specialist Nurse -  a nurse that specialises in a particular area of clinical care
Store medication -  long term and temporary storage of medication
Supply medication -  to provide medication for use
Temperature record -  records maximum and minimum temperature of the clinical 
room and medical refrigerator
Transfer letter -  a formal letter providing information about the patient on transfer to 
another healthcare facility
Transport medication -  to move or deliver medication from one location to another 
Waste disposal bin -  a yellow-marked bin used to store unwanted medication
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A major challenge in improving safety in complex socio-technical systems for 
example care homes is in the analysis and design. This study is part o f a larger 
project examining medication safety in care home patients who have been admitted 
to hospital. For this study, the aim was to investigate the role of ward pharmacists 
in ensuring the safe delivery o f medicines to patients in hospital with an emphasis 
on care home residents. Semi-structured interviews were conducted with 9 ward 
pharmacists in a district general hospital. Four main themes about the pharmacists’ 
work emerged and Hierarchical Task Analysis (HTA) was used to model the ward 
pharmacists’ tasks and processes. HTA was successfully applied in the first few 
levels of the process model, but the usefulness of the method was limited by the 
wide variation in task processes. There is a need for the application of other 
methods, such as Cognitive Work Analysis (CWA), that model the whole system 
and are able to capture the complexity of processes in a dynamic system like 
healthcare.
Introduction
Care homes in the United Kingdom (UK) provide accommodation, together with nursing or 
personal care, for persons who have been ill, who have a mental disorder, who are disabled or 
infirm and those who have been dependent on alcohol or drugs (Department of Health 2000). 
The care home system is a complex socio-technical system composed of workers with different 
backgrounds and disciplines in different geographical locations who must work together to 
achieve health care goals. Previous exploratory studies identified four parts o f the healthcare 
system involved in the provision o f medication to care home residents: the care home, general 
practitioners (GP), community pharmacy and hospital (Lim, 2006). Medication provision is 
therefore a complex co-ordination task involving communication between different care 
providers in different locations. Coordinating communication across system boundaries is often 
problematic (Hallock, Alper & Karsh, 2006) and it is likely that there are gaps in 
communication between these different parts of the health care system.
A recent report found that almost half of admissions to care homes are from hospital 
and the main reasons for admission are physical and mental health problems (Office of Fair 
Trading 2005). Care home residents are therefore likely to be vulnerable and may not have the
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ability to monitor their own medication. A major challenge in improving safety in complex 
systems such as care homes is in the analysis and design of work and information systems. 
This is particularly difficult in the healthcare system because there are many different pathways 
to successful patient management and many variations in clinical practice. It is a system that is 
dynamic and has leamt to adapt to the demands o f the environment. This makes it difficult to 
identify which practices may be risky and where there is potential for improving practice. It is 
therefore important to choose a modeling method that will assist with understanding the system 
and identifying opportunities for change.
Aim
This study is part o f a larger project examining medication safety in care homes. The aim of 
this study was to investigate the role of hospital ward pharmacists in ensuring the safe delivery 
of medicines to care home patients in hospital wards. The study objectives were to model the 
process of medication provision by ward pharmacists on admission to hospital, during hospital 
stay, on hospital discharge and post-discharge and to understand the role o f ward pharmacists 
in the care of the care home patient. In particular, the communication processes involved in 
caring for care home residents in hospital and the boundaries of the pharmacists’ role were 
investigated.
Method
Semi-structured one-to-one interviews were conducted with nine ward pharmacists working in 
the same district general hospital. These pharmacists had different levels of pharmacy 
experience, ranging from pre-registration to senior levels of management in the pharmacy 
department. They worked in eight different hospital wards including Medicines Admission 
Unit (MAU), elderly care wards and surgical wards, which are the wards to which care home 
residents are usually admitted.
The interview questions were based on scenarios surrounding patients’ routine hospital 
journey. Four major points in the patients’ stay were explored: admission to hospital, stay in 
hospital, hospital discharge and post hospital discharge. Probes were regularly used to elicit 
more information from the pharmacists. The interviews were conducted in a private area and 
lasted between 35 minutes to 65 minutes. Handwritten notes were taken during the interviews 
and analysed for common themes.
Results
The main themes about the pharmacists’ work that emerged were:
(a) There were variations between the wards in pharmacists’ perceptions o f their own roles, the 
documentation that was used, the availability o f information sources and the reliability o f  
information sources.
(b) Multiple healthcare professionals with different training backgrounds can share roles. For 
example, pharmacy technicians and pharmacists often share roles.
(c) Shift work is routine. There may be more than one pharmacist designated to a ward 
because o f varying working days and hours.
(d) The work regularly involves people and/or information crossing system boundaries (such as 
between the hospital and care home, GP surgery and hospital). Figure 1 illustrates the 
complexity of the patient pathway to and from the hospital and shows the multiple system 
boundaries that a hospital system has to cope with.
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Figure 1. Patient pathway to and from hospital
The tasks performed by hospital pharmacists were variable and using Hierarchical Task 
Analysis (HTA), a process model showing the tasks and processes required to supply a patient 
in the hospital ward with drugs was constructed (See Figure 2). The HTA only showed the 
first few levels o f hospital pharmacists’ tasks. This is because of the greater variability in 
performing tasks at the lower levels.
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Figure 2. Hierarchical Task Analysis of Drug Supply to Patient in a Hospital Ward 
Discussion
The main themes identified about ward pharmacists’ work do not only impact the hospital 
system. There is a direct and/or indirect effect on the patient when they are discharged from 
the hospital. The variability in documentation in the hospital wards, the lack o f awareness 
about the need for care homes to receive discharge information and the reliability o f  
information sources that are available compromises safety. This problem is magnified at 
system boundaries for example moving from the hospital to the care home resulting in the 
discontinuity of care.
HTA was successfully applied in the first few levels o f the process model, but the usefulness o f  
the method was limited by the wide variation found in task processes. Hospital wards even 
within the same hospital function very differently and tasks are situation-dependent, reflecting
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the dynamic and complex process of providing patient care. HTA was also unable to present 
the social organisational factors and the competencies o f the healthcare professionals that 
influence medication-related processes.
HTA describes current practices and as such is a useful tool for understanding the system as it 
works now. However, it proved difficult to use because of the complexity of the processes. The 
diversity in work systems and practices found within one health care organization show that 
descriptive approaches need to be supplemented with approaches that are able to identify the 
information requirements for safe medication practices. We are currently exploring the 
potential of Cognitive Work Analysis (CWA) in helping us to understand and design a safer 
care home medication system. CWA is a suite of methods that use a formative approach to 
identifying the requirements to successfully deal with unanticipated events (Vicente 1999).
CWA uses a broad systems approach to analyse five different aspects o f work. This model 
could provide a framework for identifying the information needs and the support that the 
healthcare workers will require to successfully handle the unanticipated events and variations 
encountered in the care home system. CWA is a method that has been applied successfully in 
other industries for example in aviation and the nuclear industry to analyse and design systems. 
The healthcare industry can leam from the experiences o f these high-risk industries.
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This paper presents a novel method for analysing medication errors in care homes using a 
systems approach. Work Domain Analysis (WDA), which is the first analysis in a suite of 
methods called Cognitive Work Analysis (CWA) (Rasmussen, Petjersen & Goodstein 
1994; Vicente 1999) was used. An abstraction hierarchy (AH) of the care home 
medication system was used to analyse 9 medication administration errors. The work 
functions or work domain properties (WDPs), that contributed to the medication errors 
were identified. At the ‘purpose-related functions’ abstraction level, ‘administer 
medication’ and ‘supply medication’ were the functions that contributed to errors. Further 
analysis of these two "^DPs identified WDPs at the ‘object-related processes’ abstraction 
level that were implicated in the errors. The three WDPs that contributed most frequently 
to the medication errors were ‘communicate’, ‘record-keeping’ and ‘give medication’. It 
was less likely to miss elements of the system that may have contributed to errors with the 
use of a contextual analytical and robust framework such as the AH of the care home 
medication system. Means-ends links between WDPs were especially important when 
analysing medication errors because the analyst was guided to analyse WDPs at other 
abstraction levels, that may not, in the first instance appeared to have contributed to the 
errors. The analysis of medication errors showed the intricate nature of a system that relies 
heavily on information and the tightly-coupled nature of WDPs.
Introduction
This paper presents a novel approach to the analysis of medication errors in care homes using a broad 
systems approach. Work Domain Analysis (WDA), which is the first analysis phase of Cognitive Work 
Analysis (CWA) (Rasmussen, Petjersen & Goodstein 1994; Vicente 1999) was used. CWA aims to help 
workers deal effectively with unanticipated and novel situations that pose the greatest threat to system 
safety by analysing different dimensions of the work system (Vicente 1999). WDA analyses the work 
domain by modelling the constraints of the work domain using an abstraction hierarchy (AH).
In the AH, constraints are represented as work functions or work domain properties (WDPs) that 
capture a wide variety of events that can occur in the work system. This is an important characteristic of 
the WDA because it would be very complex, if not impossible to represent all possible events in dynamic 
complex systems. By representing work functions in the AH, the AH is able to accommodate routine, 
unanticipated and novel events. Hence, the AH is event-independent. The work domain is represented as 
five distinct abstraction levels in the AH: functional purposes, values and priority measures, purpose- 
related functions, object-related processes and physical objects. These levels present the work system at
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different levels of abstraction. Mean-ends links between each abstraction level answer ‘why’ a WDP 
exists (referring to the level above) and ‘how’ a WDP can be fulfilled in the work system (linked to level 
below). These links are structural means-ends links and do not represent actions to fulfil goals but 
indicate the work functions. Finally, the WDA uses a formative approach to work system analysis 
meaning that it analyses what could happen in the work system instead of what is happening (descriptive) 
or what should happen (normative) (Vicente 1999).
The aim of the study was to analyse medication errors using an AH of the care home medication 
system developed by Lim (2008). The objectives of the analysis were to identify the factors 
contributing to medication errors by mapping error data onto the AH.
Method
Tools
An abstraction hierarchy (AH) of the care home medication system and nine case summaries of 
medication administration errors were used. The nine medication administration errors were identified in 
a separate study by observing 14 drug rounds in 7 care homes involving 31 patients (Lim 2008). Figure 1 
presents the third and fourth levels of the five abstraction levels in the AH of the care home medication 
system developed in a previous study reported in Lim (2008).
Procedures
Analysing the errors involved four steps. Each of the nine medication errors was analysed following 
the four steps outlined.
Step 1: Using the AH, a list of all the work domain properties (WDPs) or items on the AH at the 
purpose-related functions (PRF) abstraction level was made. The decision was made to target WDPs at 
the PRF abstraction level because medication errors were identified and classified according to stages of 
care that represented a work function such as prescribing, monitoring of medication, dispensing and 
medication administration. The PRF abstraction level represents the functions that need to be performed 
in the work system in order to fulfil the purposes of the work system. So, it was logical to begin the 
analysis at this abstraction level.
Step 2: Each of the 9 error case summaries was analysed to identify whether there were any problems 
related to the WDPs represented at the PRF abstraction level. A list was made of the WDP(s) at the PRF 
abstraction level identified to have been implicated in each error.
Step 3; Referring to the AH, a list of WDPs at the object-related processes (ORP) abstraction level 
(the level below the PRF abstraction level in the AH) that were means-ends linked to the relevant WDPs 
at the PRF abstraction level was made. The means-ends links answer the question ‘why’ a WDP is 
required in a system by referring to the abstraction level above. Referring to the abstraction level below, 
the means-ends links answer the question ‘how’ a WDP is fulfilled in the work system. One of the 
objectives of the analysis was to understand how medication errors occurred. So, it was logical to target 
the WDPs at the level below the PRF abstraction level -  the object-related processes (ORP) level.
Step 4: Error case summaries were revisited to identify whether any of the WDPs at the ORP 
abstraction level listed in Step 3 had led to medication errors.
Purpose-related 
function level
Diagnose medical 
problem Supply medication
Object-related 
processes level
supply of
Transport Dispense
keeping
Figure 1. Part of an abstraction hierarchy of the care home medication system
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Results
The results of the analysis are divided into two parts. The first presents the WDPs at the PRF (third) 
abstraction level of the AH that contributed to the 9 medication administration errors analysed. Then, the 
WDPs at the ORP abstraction level that contributed to medication errors are presented.
WDPs at the purpose-related Junctions abstraction level
Two WDPs were identified to have contributed to all 9 medication administration errors: ‘administer 
medication’ and ‘supply medication’. Problems with ‘supply medication’ contributed to two medication 
errors. Lack of medication supply contributed to the omission of a medication in two medication 
administration rounds. This highlighted the tightly-coupled nature between ‘administer medication’ and 
‘supply medication’ in the care home medication system: a problem with one WDP led to a problem 
fulfilling the other WDP. Various healthcare settings are involved in fulfilling these two WDPs. For 
example, the GP surgery provides medical services such as prescribing medication, the community 
pharmacy dispenses medication and the care home staff routinely administers the prescribed and 
dispensed medication. Hence, co-ordination within and outside the care home is essential for the safe and 
effective running of the care home medication system.
WDPs at the object-related processes abstraction level
Further analysis of the WDPs at the ORP abstraction level linked to ‘administer medication’ and 
‘supply medication’ identified WDPs that contributed to the 9 medication administration errors. Table 
1 presents the number of errors (N) that had specific WDPs as a cause. ‘Communicate’, ‘record- 
keeping’ and ‘give medication’ contributed to every medication administration error whilst ‘store 
medication’ contributed to only one medication error.
A summaiy of the error analysis corresponding to the three most frequent WDPs is presented in Table
2. The common problem identified in the analysis of the 9 medication administration errors related to 
deficiencies in the care home information system. The information system was fragmented and there 
were problems with accessing, using and recording information. The results emphasized the importance 
of each WDP in the functioning of the care home medication system. Problems identified with each WDP 
at the ORP abstraction level were associated with deficiencies of at least another WDP at the ORP 
abstraction level that led to medication errors. The analysis also reinforced the value of the WDPs at the 
ORP abstraction level in fulfilling the functions at the PRF abstraction level because problems with WDPs 
at the PRF abstraction level were a result of problems with multiple WDPs at the ORP abstraction level. 
Problems at the care interfaces such as between the care home and community pharmacy were also 
highlighted in the analysis. Medication errors in the care home were influenced by events outside the care 
home in settings such as the community pharmacy.
Table 1. WDPs at the object-related processes level that contributed to medication errors
Work Domain Property (WDP) N
Communicate 9
Record-keeping 9
Monitor health status 2
Medication review 2
Transport medication 2
Order medication 2
Dispense medication 3
Check stock supply of medication 2
Give medication 9
Store medication 1
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Table 2. Analysis of the three most frequent WDPs that contributed to medication errors
Work Domain 
Property (WDP)
Summary of error analysis
Communicate Communication problems were identified between care home 
staff and community pharmacy staff, care home staff and care 
home residents, and care home staff in the care home
Record-keeping Problems with record-keeping included not updating records, 
recording the wrong information, not recording information, 
making unclear records and not using recorded information
Give medication Problems included giving the wrong medication, not giving 
medication and not following instructions when giving 
medication.
Discussion
Context and robustness
To gain a systems perspective of how errors occurred, the analytical tool should provide a wide systems 
view of the care home medication system. The AH is a model of the care home medication system and 
provided a fundamental set of information about the whole care home medication system. A contextual 
framework such as this avoids the problem of having to either decontextualise error cases or 
contextualize generic analytical frameworks, which increases the complexity of the analysis without 
necessarily adding insight to the cause of errors. Pinpointing problem areas in the care home 
medication system was straightforward because the events of the errors mapped directly onto the WDPs 
in the analytical framework that was specific to the care home medication system. The AH was a 
robust framework because it guided the analyst to consider every WDP that was means-ends linked to 
the problem WDPs. Hence, it was less likely that elements of the system that contributed to errors 
would be missed resulting in a more complete analysis of errors. Using the AH as the analytical 
framework, the identified problem areas were placed in the context of the wider care home medication 
system, providing information for the system to prioritise its strategies for system improvement.
Relationships
Means-ends links linking each WDP to another in the AH answer ‘why’ and ‘how’ it is needed or 
fulfilled in the work system. Hence, the value of each WDP in the wider system and the relationships 
between WDPs in the system was represented in the AH. The relationship represented by the means- 
ends links is especially important when analyzing medication errors because the analyst was guided to 
analyse WDPs at the ORP abstraction level that were means-ends linked to problem WDPs identified at 
the PRF abstraction level, that may not, in the first instance appear to have contributed to errors.
The analysis of medication errors also showed relationships between WDPs at the same abstraction 
level. At the ORP abstraction level, the WDPs that had contributed to errors were tightly-linked to each 
other. For example, problems with WDPs ‘communicate’ and ‘record-keeping’ were not isolated. 
There were clear links with other WDPs at the ORP abstraction level such as between ‘record-keeping’ 
and ‘give medication’ because the wrong information recorded led to the resident being given the 
wrong dose of medication. This shows the intricate nature of a system that relies heavily on 
information and the tightly-coupled nature of WDPs.
Conclusion
This paper presented a novel approach to analysing medication errors using WDA. An informed 
analysis of errors was possible with the use of the robust and contextual AH of the care home 
medication system. An important aspect of the analysis was the value of relationships between WDPs 
in the AH. The means-ends links provided relevant information to understand the system and to 
prioritise recommendations for system improvements.
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Analysing Care Home Medication Errors: A Comparison of The 
London Protocol and Work Domain Analysis.
Rosemaiy Lim, Janet Anderson &  Peter Buckle 
Robens Centre for Public Health 
University o f Surrey, Guildford, UK
Although methods for investigating safety in complex systems have been widely applied, few studies 
have made explicit comparisons o f two or more methods used to study one system problem. This paper 
presents a comparison o f two methods that were used to analyse medication errors identified in UK  care 
homes namely, The London Protocol and Work Domain Analysis (W DA). The London Protocol is based 
on an organisational accident causation model and W DA is the first phase o f analysis in Cognitive Work 
Analysis (CW A) that models work domain constraints. Nine medication administration errors identified in 
seven care homes involving thirty-one residents were analysed. The analyses resulted in the identification 
of contributory factors to medication errors and changes that would improve system safety. The London 
Protocol was comparatively easier to use and required less time than the W DA. In The London Protocol, 
contributory factors were identified jfrom a context-fi-ee list o f error contributory conditions. From the 
identified error contributory factors, recommendations to improve system safety were made. However, it 
was difficult to relate these recommendations to the wider context o f the system being studied. The W DA  
used a contextual model o f the care home medication system in the form of an abstraction hierarchy (AH ) 
to analyse errors. Factors contributing to medication errors were specific to the work domain and the 
resultant recommendations had broad applications, extending beyond the context o f the specific errors 
analysed and were relevant to the whole system. The London Protocol would be a suitable analysis tool if  
the aim o f the analysis was to generate short-term solutions in a short time and with limited financial 
resources. To make a long-term impact on system safety, the W DA is a useful tool. The A H  can be used 
to analyse the current system, evaluate recommendations for system improvement, design interventions, 
implement strategies and used throughout the system’s life cycle.
INTRODUCTION
Although methods for investigating safety in complex 
ems have been widely applied, few studies have made 
licit comparisons of two or more methods used to study 
system problem. This paper presents a comparison o f two 
tiods used to analyse medication errors identified in UK  
! homes. Systems Analysis o f Clinical Incidents: The 
don Protocol (Taylor-Adams &  Vincent, 2004) and Work 
tiain Analysis (W DA), the first stage of analysis in 
pitive Work Analysis (CW A) (Rasmussen, Petjersen &  
>dstein, 1994; Vicente, 1999) were the two methods used. 
The London Protocol is a method that was first developed 
le healthcare setting and has since been used to investigate 
ithcare incidents. So it was considered to be a suitable 
hod for analysing medication errors. In contrast, W DA has 
been applied to study medication errors in healthcare 
ings to our knowledge. However, W DA has been used 
/iously to analyse errors in an aircraft-automation system 
, 2007). The theoretical foundations of W DA propose the 
hod to be a suitable tool for analysing, evaluating and 
igning complex socio-technical systems. Thus, it would be 
fill to investigate its applicability and contributions to the 
lysis o f medication errors in care homes.
The London Protocol is the revised version of the original 
)tocol for the Investigation and Analysis o f Clinical 
[dents’ and outlines a process of incident investigation and 
lysis. The research foundations o f The London Protocol
are based on Reason’s organizational accident causation 
model (1990), focusing on factors other than the individuals 
directly involved in an incident. Errors or accidents (active 
failures) are seen as a result o f fallible decisions made at 
higher levels o f the organization (latent conditions). 
Management decisions can weaken the defences and barriers 
o f the work system increasing the system’s vulnerability to 
errors. This vulnerability creates error producing conditions. 
In the London Protocol, error producing conditions and 
organizational factors are classified to produce a Framework 
of Contributory Factors influencing Clinical Practice. The 
fi-amework is used to analyse incidents (Taylor-Adams &  
Vincent, 2004).
W DA, the first o f five phases o f analysis in CW A, is a 
representation o f the work setting being studied. The W DA  
models the purposive and physical constraints o f the work 
system using an abstraction hierarchy (A H ). In the AH, 
constraints are represented as functions instead o f examples of 
events. This is an important characteristic o f the W DA  
because it would be very complex, if  not impossible to 
represent all possible events in dynamic complex systems. 
Work functions can encompass a wide range o f events. In this 
study, work functions are generically called work categories. 
Classification o f examples o f events into work categories 
highlights another key characteristic o f the AH: it is event- 
independent (Vicente, 1999). Work categories are constant 
and the purposes and the physical resources modelled by the 
A H  do not change from one event to another. In the AH,
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work categories are represented as five distinct abstraction 
Is: functional purposes, values and priority measures, 
•ose-related functions, object-related processes and physical 
cts. The levels present the work system at different levels 
DStraction. Means-ends links between each abstraction level 
ver ‘why’ a work category exists (referring to the level 
/e) and ‘how’ a work category can be fulfilled in the work 
sm (linked to level below). Structural means-ends links do 
represent actions but work functions to fulfil the purposes of 
system. Finally, the W DA uses a formative approach to 
k systems analysis meaning that it analyses what could 
len in the work system instead of what is happening 
criptive) or what should happen (normative) (Vicente, 
)).
PRACTICE INNOVATION
This paper compared the relative strengths and weaknesses 
A^o methods used to analyse medication errors: The London 
ocol and WDA. These were used to analyse a sample of 
iication errors identified in UK care homes. The 
jibutions of each method were examined and comparisons 
e made.
thod
A previous study conducted in 7 care homes involving a 
pie o f 31 care home residents identified a total o f 9 
lication administration errors (Lim, 2008). Semi-structured 
rviews were conducted with the care home staff involved in 
linistering medication to understand the causes of errors, 
rview transcripts and data sources collected during the study 
e then analysed to produce individual case summaries for 
1 medication administration error. Data sources used 
uded field notes from general and focused observations of 
care home and medication administration rounds 
lectively, residents’ medical records, care home profiles and 
ical medication reviews. The types of medication 
linistration errors included omissions (n=3), extra dose 
1), wrong dose (n = l) and other administration errors that 
uded not following specific instructions for administering 
lication (n=4). These errors were analysed using two 
hods: The London Protocol and WDA to identify the factors
contributed to errors and formulate recommendations to 
rove system safety.
The first analysis used The London Protocol. A chronology 
dedication administration errors was determined from the 
ir case summaries. Care delivery problems (GDPs) were 
itified from the chronology of events. Further analysis of 
Ps was guided by the Framework of Contributory Factors 
uencing Clinical Practice that consisted of six factors: 
anizational and management, work environment, team, 
ividual, task and patient factors. Within each factor type, 
tributory influencing factors were identified such as 
ision-making aids under task factors and knowledge and 
Is under individual factors. This fi-amework was used to
identify possible contributory factors for each medication error. 
Further from this, recommendations were made.
W DA was the second method used to analyse the same nine 
medication administration errors. An abstraction hierarchy 
(AH) of the care home medication system was developed (Lim, 
2008). Figure 1 shows part o f the AH: the work categories at 
the purpose-related function (PRF) and object-related processes 
(ORP) levels and the means-ends links linking relevant work 
categories. The same 9 error case summaries developed and 
used in The London Protocol, and the AH of the care home 
medication system were tools used to analyse the causes of these 
errors. From the AH, a list o f all the work categories at the PRF 
or third level was made. Each o f the nine medication 
administration error cases were analysed to identify the work 
categories at the PRF level that were relevant to the errors. 
Work categories at the PRF level were chosen to be the starting 
point of the analysis because medication errors are usually 
associated with the failure of at least one work function and 
these are represented at the PRF level. So, it was logical to 
approach the analyses from this level. Next, a list of all the 
work categories at the ORP level linked to work categories at 
the PRF level was made. Each work category at the ORP level 
was further analysed using the error case summaries to identify 
possible contributions to the non-fulfilment o f the relevant work 
categories at the PRF level. Finally, recommendations were 
made following the identification of relevant work categories.
Kagnosemedd
Check stodf supply
processes te d
Figure 1: Purpose-related functions and object-related 
processes in the AH of the care home medication system
FINDINGS
Contributory Factors
The London Protocol. 17 CDPs were identified from 
the analysis o f nine medication administration errors. Table 1 
shows factors contributing to medication errors and the number 
of times these factors were implicated in the errors. Task and 
individual factors were considered to be the most frequent 
contributors to medication administration errors. Inadequate 
decision-making aids and non-availability and use of protocols 
within the task factor category were the most frequent 
contributors to medication administration errors. Non-utilisation 
of patient information leaflets, incomplete or inaccurate 
information on the medication administration records (M AR), 
and lack of a double-checking system to identify whether 
medication had been given to residents were some issues 
identified under inadequate decision-making aids. Examples of 
problems with the availability and use of protocols included the 
lack of protocols for administering
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dication requiring additional administration instructions 
1 lack o f a protocol for implementing changes in the 
itents o f the medication dosage systems and corresponding 
\R  to reflect changes in medication therapy. Under 
lividual factors, lack o f skills and knowledge was the most 
quent contributor to medication administration errors, 
ese mostly related to care home staff not knowing how to 
ninister particular types o f medication such as inhalers and 
libiotics. Not understanding the physical properties of 
dication such as the effect o f dispersing medication in 
ter was an issue identified. Other issues identified under 
11s and knowledge included care home manager and duty 
inagers not knowing the procedures for updating 
dication storage systems such as the monitored dosage 
item and corresponding M AR  when care home residents’ 
dication therapy was altered.
ible 1: Factors contributing to medication 
ministration errors
Contributory Factors N
Organisational and management factors
Policy, standards and goals 9
^ork environment
Education and training 10
Workload 3
Equipment/supplies 6
eam
Supervision, seeking help and 6
teamwork
Verbal communication 3
Written communication 1
ndividual (Staff)
Skills and knowledge 13
Physical and mental stressors 4
ask
Availability and use o f protocols 13
Decision-making aids 14
Task design 3
atient
History -  medically 3
History -  other 2
Staff-patient relationship 6
Treatment 1
Condition 5
WDA. A t the PRF level, two work categories 
ntributing to the nine medication administration errors 
:re identified. “Administer medication” was identified as a 
ntributor to all the medication administration errors 
alysed and “supply medication” was a contributor to two 
edication errors. A t the ORP level, ten work categories 
3re considered to be contributors to the 9 medication 
[ministration errors. These were communicate, record- 
seping, monitor health status, medication review, store 
edication, transport medication, order medication, dispense
medication, check stock supply o f medication and give 
medication. Communicate, record-keeping and give 
medication were the three m6st frequent contributors to 
medication errors. Figure 2 shows the observations made 
from the analyses o f 9 medication administration errors that 
corresponded to these three work categories.
Work Categories
Communicate
Record­
keeping
Give
medication
Observations from Error Analyses
etween care home staff and community pharmacy stafi 
Between care home staff 
Care home staff and care home resident
Records not updated 
Wrong information recorded 
Records not clear 
Records not used 
_______ No record made______
Wrong medication 
Medication not given 
Wrong administration instructions
Figure 2: E rro r observations related to three work 
categories at the object-related processes level
Recommendations
The London Protocol. Initial recommendations for 
system improvement were made separately for each 
medication error from the list o f identified factors that 
contributed to errors. Recommendations made for all nine 
errors were then amalgamated. These recommendations were 
further analysed to produce three high level 
recommendations.
1. Care home staff training. This recommendation 
included training care home staff and management in the 
following areas: medication administration techniques, 
record-keeping (mcluding the use of medication 
administration record (M AR) charts), basic physical 
properties and pharmacology o f medication, the 
importance o f adhering to prescribing instructions unless 
there had been prior consultation with the prescriber, the 
implications of non-adherence and the relevant changes 
that need to be made to medication dispensing systems 
and documents used to document information about 
medication.
2. Review current medication-related tasks and policies.
Medication-related tasks implicated in the errors 
analysed were medication administration, ordering, 
supply and storage, record-keeping and the workload of 
care staff administering medication. These tasks and 
their corresponding policies should be reviewed. 
Contingency plans should be put in place to address 
problems with obtaining and achninistering medications. 
Clinical issues such as the length o f time that patients can 
be without their regular medication should also be 
considered. Regular checking o f the medication supply 
is recommended to ensure adequate supply o f medication 
in the care home at all times. The allocation o f tasks 
such as collecting medication from the community 
pharmacy should be reviewed. Further exploration of
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Improve communication. Efficient, accurate and clear 
communication among staff -within the care home and 
across care home boundaries such as the community 
pharmacy is needed to ensure a safe medication system. 
The use of readily available written information such as 
the patient information leaflet in medication boxes is 
encouraged. Care home staff who routinely administer 
medication to care home patients should have authorised 
access to relevant written information about the patient, in 
addition to the verbal passing o f information.
WDA. Like The London Protocol, initial 
tnmendations were also made for each medication error 
[ the list o f work categories identified as contributors to 
s. A t this stage, recommendations made were specific to 
context o f medication errors. The recommendations made 
ill nine errors were then amalgamated to produce high 
[ recommendations. Three high level recommendations 
; made.
Availability and use of information. Communicate and 
record-keeping were two work categories considered to 
be major contributors to medication errors and are 
fundamentally related to the availability and use of 
information. One o f the problems identified from the 
analysis o f errors related to staff not being given 
sufficient information to perform tasks. There is a need 
to keep clear records and to document relevant 
information in appropriate data sources . The difficulty 
here is to know what types o f information need to be 
recorded and to what detail. To do this, the AH can be 
utilised. The means-ends links between work categories 
at the different A H  levels aids in determining whether 
particular information would be required to fulfil certain 
functions. To illustrate, the type of information required 
to administer medication can be considered by analysing 
the means-ends links. Administer medication is linked to 
many work categories at the ORP level, see Figure 1. 
Information relating to each o f these work categories 
needs to be considered when determining the types of 
information required.
Review medication processes. These processes are 
work categories represented at the PRF and ORP levels 
identified to be contributors to medication errors. Again, 
the A H  can be used here. The means-ends links linking 
work categories at the PRF and ORP levels identify 
which work categories need reviewing and provide 
relevant information so decision makers can decide 
whether or not to make interventions that affect the work 
categories identified. The consequences o f not dealing 
with particular work categories can be readily gleaned 
from the AH through the means-ends links and has wider 
implications on the whole system.
Care home resident involvement in their healthcare. 
Care home residents are crucial stakeholders and are also 
represented as a work category at the physical objects 
level in the AH. An increase in resident involvement may 
help to improve system safety. By referring to the means- 
ends links linking care home residents at the last level of
the A H  to work categories at the ORP level (4 * level), 
possible contributions that could be made by care home 
residents towards fulfilling the functions o f the care home 
medication system can be explored.
DISCUSSION
The London Protocol and W DA used to analyse 
medication errors are discussed under two general headings, 
namely method and theory.
Method
Frameworks. Both The London Protocol and W DA used 
pre-determined frameworks to analyse medication errors. The 
London Protocol used the generic Framework o f Contributory 
Factors Influencing Clinical Incidents but for W DA, an A H  of 
the care home medication system was used. This was the first 
time that medication errors were analysed using an AH to our 
knowledge. In both methods, the analyst was guided to 
examine every factor or category in these frameworks and 
identify their relevance to the medication errors identified. 
This allowed the analyst to consider whether there were 
elements in each error case beyond the apparent information 
collected.
Contributory factors. The Framework o f Contributory 
Factors influencing Clinical Incidents lists error producing 
conditions under six factor types. By only examining these 
contributory factors, it was possible to have missed factors 
that may have contributed to medication errors. The A H  on 
the other hand is represented by work categories arranged in a 
hierarchy o f five levels. Contributors to errors were identified 
as work categories which represented work functions and not 
conditions. The distinction is that work categories cover a 
wide variety o f conditions that may not have been apparent to 
the analyst in the first instance. A  more complete examination 
of the contributors to medication errors was thus possible 
using the AH.
Recommendations. Using The London Protocol, 
recommendations were made based on the contributory factors 
identified. For example, understanding that skills and 
knowledge was a common contributory factor to medication 
errors helped to identify the need for training. Areas requiring 
training were also recommended in the analyses. However, it 
was difficult to relate these problem areas to the wider care 
home medication system and understand their relevance 
because the analysis was based on a generic framework of 
conditions that could be applicable to many work settings. 
Recommendations made in the W DA were less prescriptive. 
Improving the information system in the care home 
medication system was one o f the recommendations made.
The rationale for this recommendation was based on the 
identification o f two work categories in the A H , namely 
communicate and record-keeping that were considered 
frequent contributors to medication errors. The A H  provided 
a framework or a reference point where these work categories 
fit into the wider system. In  addition, the structural means- 
ends links that link all the work categories at each level in the
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IH  can aid in planning and prioritising interventions, 
inks provide a way to assess the possible consequences 
«articular intervention on other work functions. 
ïase o f use. Less time was taken to analyse errors using 
.ondon Protocol compared to W DA. Both analyses used 
ame error case summaries and data sources. For W DA, 
;onstruction of the AH of the care home medication 
tn was necessary as it was a tool for analysing medication
3. The process o f construction was time-consuming. 
3ver, the value of the AH extends beyond an analysis tool 
le evaluation and design o f an improved medication 
m.
iry
Context. Although both methods used pre-defined 
sworks to analyse medication errors, one crucial 
rence is that the Framework for Contributory Factors 
encing Clinical Incidents was context-free and can be 
ed in different work settings whilst the AH was specific 
e care home medication system. Therefore, the analysis 
edication errors using the A H  was based on a relevant 
; domain model containing specific purposive and 
ical constraints. Analysing medication errors using a 
ric model on the other hand led to the identification of 
ibutory factors that were applicable to a range of 
[cation errors. For example, skills and knowledge was 
d to be a common contributory factor to medication errors 
>^ sed but analysis o f the relative importance o f the factors 
tified was difficult.
Events. The analysis o f medication errors using The 
ion Protocol was event-dependent meaning that the 
ributoiy factors were identified from the analyses of 
ific individual and environmental situations where 
[cation errors occurred. The implications o f this are that 
recommendations made only addressed factors 
)unding identified medication errors and not those o f the 
îr deficient work system. The A H  model however is 
Lt-independent and consists o f work categories that can 
ide many possibilities for action. Therefore, the 
mmendations made went extended beyond the context o f 
specific errors analysed and were relevant to the whole 
3m. The way the W DA was used in the analysis was 
ever constrained by the data that had already been 
icted in a separate study. The AH could be used to guide 
collection o f data about medication errors and this may 
It in a more complete analysis using the whole AH. For 
nple, the values and priority measures level in the AH was 
analysed because there was insufficient data. There is 
ler scope to develop the error analysis method using AH.
difficult to relate these recommendations to the wider context 
of the system being studied. The W DA used a contextual 
model o f the care home medication system in the form of an 
AH. Contributors to medication errors were specific to the 
work domain and the resultant recommendations had broad 
applications that went beyond the context o f specific errors 
and had relevance to the whole system. The use o f the AH  
tool constructed for the purposes o f the initial analysis 
extended beyond an analysis tool to an evaluation and design 
tool for further implementation o f strategies to improve safety. 
It may therefore be advantageous to spend time constructing 
the A H  at the start o f the analysis.
The London Protocol would be a suitable analysis tool if 
the aim o f the analysis was to generate short-term solutions 
with little time and financial resources. To make a long-term 
impact on system safety, the W DA is a useful tool. The AH  
developed can be used to analyse the current system, evaluate 
recommendations for system improvement and design 
interventions and implementation strategies. The AH is a 
usefiil tool that can be used throughout the system’s life cycle. 
Subsequent phases of analysis in CW A, namely control task 
analysis (CTA) and strategies analysis (SA) should be 
explored following W DA to further inform and strengthen the 
understanding o f the system and recommendations for system 
changes. CTA analyses the cognitive tasks that need to be 
fulfilled and SA analyses different strategies that can be used 
for carrying out tasks.
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CONCLUSION
The London Protocol was comparatively easier to use and 
lired less time than the W DA. In The London Protocol, 
Tibutory factors were identified from a context-free list o f 
iitions. Recommendations were made from the list o f 
[ributory factors. This presented problems because it was
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Using Work Domain Analysis 
to understand the Care Home 
Medication System
Conclusion
• The AH provided a concise visual representation of the care home medication work system.
• This AH provided a knowledge base of the system on which the analyses of current system 
issues can draw upon.
• Further stages of the CWA will provide different views of the work system for example the 
tasks that needs to be performed on the work domain, the strategies used to perform these 
tasks, the social organisation and co-operation of workers to perform these tasks and the 
competencies of competencies of workers themselves.
Current work using CWA
The authors are currently using WDA and Control Task Analysis (the second level of 
CWA analysis) to analyse the causes of medication errors. This work will be reported at 
a later stage.
Introduction
Currently, little is known about how the care home medication system works and the medi­
cation problems. Medication errors studies in healthcare have largely adopted a bottom-up 
approach in understanding and analysing medication errors, and are limited by analysing 
known errors. Thus some system problems remain unknown. Work Domain Analysis 
(WDA), the first layer of analysis in the suite of methods in Cognitive Work Analysis (CWA) 
analyses the work system first before investigating any problems, a top-bottom approach.
Aim
The aim of this study was to use Work Domain Analysis (WDA) to develop a model 
(Abstraction Hierarchy) of a care home medication system and identify the requirements 
of a safe care home medication system.
Method
The process of conducting a WDA largely iterative and followed the methodology outlined 
by Naikar et al. (2005). The modelling tool was the Abstraction Hierarchy (AH).
The authors thank the Ergonomics Design group at Brunei University for the use of the CWA Software Tool in producing 
the AH and, Dr Janet Watkinson and Hinchingbrooke Healthcare NHS Trust for sponsoring the first author in conducting 
this piece of work.
• Naikar, N., Hopcroft, R., & Moylan, A. 2005, Work Domain Analysis: Theoretical Concepts and Methodology. DSTO-TR-1665 
System Sciences Laboratory: Edinburgh, Australia.
• Rasmussen, J., Petjersen, A.M., & Goodstein, L.P. 1994, Cognitive Systems Engineering. New York: Wiley.
• Vicente, K. 1999, Cognitive Work Analysis: Toward safe, proactive, and healthy computer-based work. Mahwah, NJ: Lawrence 
Erlbaum Associates
• http://www.brunel.ac.uk/4286/ergdocuments/CWAforbrunelwebsite.swf
All correspondence to be directed to
• Focused on the care home; central work domain for information and medication exchange, 
place where care home residents are located.
• Care home medication system is tightly-coupled to other healthcare settings, so the analysis 
included healthcare interfaces like the GP surgery, community pharmacy and hospital.
1. Documents: mission statement, staff manuals, standard 
operating procedures, policies relating to medication
2. General and focused (medication round) observations 
of the care home medication system
3. Interview with care home m anager^
>teo 3: First iteration of an A r
1. Work domain properties were identified from the sources
of information using NVivo7.
2. These properties were categorised.
3. Categories were then organised into a hierarchy of 
m eans-ends relations.
Means-ends relations
(the how-what-why triad)
• The representation of the work domain 
at one level provides the means for 
achieving the Immediate ends of 
another level.
• Moving one level above answers the 
question ‘why’, moving one level below 
answers the question ‘how’ functions 
are fulfilled.
Results
An AH of the care home medication system was constructed (Figure 1).
Functional purpose
Purvoies o f the work system 
and external consiromis
Abstract function /
Generalised function / 
Purpose-related functions
/uncf/ons that are required to be 
performed rn order tc achieve the 
funcOonal purposes
Physical function / 
Object-related processes
funtffo/Ril tapubi/itieb and 
/imitocfons o f :he physical obieas
Physical form  / 
Physical objects
physical objects afforded 
by the work system
Healthcare
Provision
Requirements
Guidelines.
Policies and
Procedures
Values & p rio rity  measures
Cnteno thot «.«ess the work
Maximise 
Use of 
Resources
Maximise 
Quality of 
Healthcare 
Provision
Safety
system's progress towards lutfiliiog
Co-ordinate 
Care Home
Co-ordinate 
with other 
h/c settings
Diagnose
medical
problem
medical
problem
M onitor 
health status
Supply
Medication
Administer
Medication
Dispose
Medication
Communicate
information
medication
Process and
medication 
suitable 
dosage form
Display
medication
Information
medication
information
healthcare
information
Communicate
healthcare Clinical Signsavailable
information
Medication
Dispensing
Label Prescription Medication
List
Controlled
Drug
Register
Drug
Disposal
Book
Homely
Remedy
Book
Medication
Administration
(MAR)
Admissions
Book Diary Records
Discharge
Letter
Transfer Resident Care Home Carers Practitoner 
surgery staff
Community
pharmacy
staff
Hospital
staff
- medication 
and pharmacy
District 1 
Specialist 
Nurses
Solid 
medication 
in MDS
Solid 
medication 
in original 
containers
medication
PEG and 
PEG 
equipment
Oxygen 
and oxygen 
equipment
Nurses' 
Office / 
Locked 
Shed
Controlled
Drug
Register
Medical
Refridgerator Drug
Cupboard
Drug Trolley
Monitored
Dosage
(MDS)
Medicine
Container
Clinical 
waste bin
Discussion
• The AH is like a ‘m ap’ of the care home 
medication system that showed:
- the reasoning space for workers to conduct 
routine and unanticipated tasks
- the constraints and structure of the work system
• Important functions identified were co-ordination 
within the care home and co-ordination with other 
healthcare settings. These functions showed 
crucial relationships across work system 
boundaries and the significance are shown by 
the means-ends links.
Example: The purpose-related function of 
co-ordination with other healthcare settings 
influences the values and priorities of the 
medication system which are maximising the 
quality of healthcare provision, ensuring safety 
and maximising the use of resources.
To co-ordinate with other healthcare settings, 
communication about medication information, 
healthcare needs are some ways to meet 
this function.
The means-ends links between each level in 
the AH provide a framework for understanding 
the causes of problems, their consequences 
and assessment/evaluation of the current 
system processes.
W eak areas or gaps in the current system can 
be identified and further evaluated to inform 
the design and operation of an improved care 
home medication system.
